{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from datetime import datetime\n",
    "import pandas as pd\n",
    "import random\n",
    "from requests_html import HTML\n",
    "from selenium import webdriver\n",
    "from selenium.webdriver.firefox.options import Options\n",
    "from selenium.webdriver.common.by import By\n",
    "from selenium.webdriver.support.ui import Select\n",
    "from selenium.webdriver.support.ui import WebDriverWait\n",
    "from selenium.webdriver.support import expected_conditions as EC\n",
    "from selenium.webdriver.firefox.service import Service\n",
    "from selenium.common.exceptions import *\n",
    "from time import sleep"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# service = Service('geckodriver.exe')\n",
    "# options = webdriver.FirefoxOptions()\n",
    "# options.add_argument('-headless')\n",
    "# base_url = 'https://www.fiercebiotech.com/'\n",
    "# driver = webdriver.Firefox(service=service, options=options)\n",
    "# wait = WebDriverWait(driver, 10)\n",
    "\n",
    "# # pages = range(0, 5)\n",
    "# # urls = []\n",
    "# # for page in pages:\n",
    "# #     url = f'https://www.fiercebiotech.com/?page={page}'\n",
    "# #     urls.append(url)\n",
    "\n",
    "# urls = ['https://www.fiercebiotech.com']\n",
    "# article_list = []\n",
    "# for url in urls:\n",
    "#     driver.get(url)\n",
    "#     # body = driver.page_source\n",
    "#     # html = HTML(html=body)\n",
    "\n",
    "#     sleep(5)\n",
    "#     target = driver.find_element(By.LINK_TEXT, 'See more articles')\n",
    "#     driver.execute_script('arguments[0].scrollIntoView(true);', target)\n",
    "#     sleep(5)\n",
    "\n",
    "#     # driver.execute_script('window.scrollTo(0, document.body.scrollHeight)')\n",
    "\n",
    "#     body = driver.page_source\n",
    "#     html = HTML(html=body)\n",
    "\n",
    "#     articles = html.find('article.node-listing.prosumer.row')\n",
    "#     print(len(articles))\n",
    "\n",
    "#     for article in articles:\n",
    "#         channel = article.find('.label.label-small > span > a', first=True).text\n",
    "#         # print(channel)\n",
    "\n",
    "#         title = article.find('.element-title.small', first=True).text\n",
    "#         print(title)\n",
    "\n",
    "#     # driver.execute_script('window.scrollTo(0, document.body.scrollHeight)')\n",
    "\n",
    "#     # driver.find_element(By.LINK_TEXT, 'See more articles').click()\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "30\n",
      "InfraScan’s handheld brain bleed detector cleared for kids\n",
      "How an OTC cough med could help design arrhythmia drugs\n",
      "Ribon taps former Novartis VP Raman as CEO\n",
      "Ligand to spin off J&J-partnered antibody unit with $70M funding\n",
      "FDA gives Class I rating to Vyaire Medical's ventilator recall\n",
      "Califf returns as FDA chief with Senate nod—Chutes & Ladders\n",
      "Curebase adds real-world data, digital health experts to board\n",
      "FDA grounds BioMarin gene therapy for months over tumor risk\n",
      "GSK slams brakes on maternal RSV vaccine over safety signal\n",
      "Biotech lags in ESG disclosures but execs plan to step it up\n",
      "MindMaze chases down $105M financing, AHA partnership\n",
      "Second Sight slashes support for 'bionic eyes': report\n",
      "Collins returns as science adviser weeks into retirement\n",
      "Yumanity to cut 60% of workforce by April, looking for buyers\n",
      "Applying mRNA to healing broken bones\n",
      "Outset Medical doubled revenue in 2021 amid widening net loss\n",
      "Phase 3 hits tee Innovent up to rival Amgen and Sanofi in PCSK9\n",
      "Billionaire backs biotech to carve out niche in busy BCMA space\n",
      "Remix Therapeutics signs licensure deal with Janssen topping $1B\n",
      "NIAID vaccine chief who collaborated with Moderna to retire\n",
      "FDA clears Tandem's smartphone app for programming insulin doses\n",
      "Companion Spine nets $55M to develop ex-Medtronic implants in US\n",
      "Merck KGaA pharma CEO reflects on I-O bispecific flop\n",
      "Sage scores on depression trial, but durability unanswered\n",
      "Casio scores FDA clearance for dermatology camera system\n",
      "Mirati slips further behind Amgen with December KRAS decision\n",
      "Gilead, Hookipa amend HIV treatment pact for $237M in biobucks\n",
      "Third Harmonic Bio raises $105 million series B\n",
      "Equillium adds 3 drugs to pipeline via $329M Bioniz buy\n",
      "Reach for the Star: Electra nabs $84M for rare disease drugs\n",
      "InfraScan’s handheld brain bleed detector cleared for kids\n",
      "How an OTC cough med could help design arrhythmia drugs\n",
      "Ribon taps former Novartis VP Raman as CEO\n",
      "Ligand to spin off J&J-partnered antibody unit with $70M funding\n",
      "FDA gives Class I rating to Vyaire Medical's ventilator recall\n",
      "Califf returns as FDA chief with Senate nod—Chutes & Ladders\n",
      "Curebase adds real-world data, digital health experts to board\n",
      "FDA grounds BioMarin gene therapy for months over tumor risk\n",
      "GSK slams brakes on maternal RSV vaccine over safety signal\n",
      "Biotech lags in ESG disclosures but execs plan to step it up\n",
      "MindMaze chases down $105M financing, AHA partnership\n",
      "Second Sight slashes support for 'bionic eyes': report\n",
      "Collins returns as science adviser weeks into retirement\n",
      "Yumanity to cut 60% of workforce by April, looking for buyers\n",
      "Applying mRNA to healing broken bones\n",
      "Outset Medical doubled revenue in 2021 amid widening net loss\n",
      "Phase 3 hits tee Innovent up to rival Amgen and Sanofi in PCSK9\n",
      "Billionaire backs biotech to carve out niche in busy BCMA space\n",
      "Remix Therapeutics signs licensure deal with Janssen topping $1B\n",
      "NIAID vaccine chief who collaborated with Moderna to retire\n",
      "FDA clears Tandem's smartphone app for programming insulin doses\n",
      "Companion Spine nets $55M to develop ex-Medtronic implants in US\n",
      "Merck KGaA pharma CEO reflects on I-O bispecific flop\n",
      "Sage scores on depression trial, but durability unanswered\n",
      "Casio scores FDA clearance for dermatology camera system\n",
      "Mirati slips further behind Amgen with December KRAS decision\n",
      "Gilead, Hookipa amend HIV treatment pact for $237M in biobucks\n",
      "Third Harmonic Bio raises $105 million series B\n",
      "Equillium adds 3 drugs to pipeline via $329M Bioniz buy\n",
      "Reach for the Star: Electra nabs $84M for rare disease drugs\n"
     ]
    }
   ],
   "source": [
    "# service = Service('geckodriver.exe')\n",
    "# options = webdriver.FirefoxOptions()\n",
    "# # options.add_argument('-headless')\n",
    "# base_url = 'https://www.fiercebiotech.com/'\n",
    "# driver = webdriver.Firefox(service=service, options=options)\n",
    "# wait = WebDriverWait(driver, 10)\n",
    "\n",
    "# driver.get(base_url)\n",
    "# sleep(5)\n",
    "\n",
    "# # sleep(5)\n",
    "# # # Scroll to the \"see more articles\" pagination link at the bottom\n",
    "# # see_more_link = driver.find_element(By.LINK_TEXT, 'See more articles')\n",
    "# # driver.execute_script('arguments[0].scrollIntoView(true);', see_more_link)\n",
    "# # sleep(5)\n",
    "\n",
    "# for i in range(2):\n",
    "#     try:\n",
    "#     see_more_link = driver.find_element(By.LINK_TEXT, 'See more articles')\n",
    "#     driver.execute_script('arguments[0].scrollIntoView(true);', see_more_link)\n",
    "#     see_more_link.click()\n",
    "#     sleep(10)\n",
    "#     # articles = html.find('article.node-listing.prosumer.row')\n",
    "#     # print(len(articles))\n",
    "\n",
    "# body = driver.page_source\n",
    "# html = HTML(html=body)\n",
    "\n",
    "# articles = html.find('article.node-listing.prosumer.row')\n",
    "# print(len(articles))\n",
    "\n",
    "# for i in range(2):    \n",
    "\n",
    "#     for article in articles:\n",
    "#         channel = article.find('.label.label-small > span > a', first=True).text\n",
    "#         # print(channel)\n",
    "\n",
    "#         title = article.find('.element-title.small', first=True).text\n",
    "#         print(title)\n",
    "\n",
    "#     try:\n",
    "#         close_button = driver.find_element(By.CSS_SELECTOR, '.close-persistent-bar').click()\n",
    "#     except:\n",
    "#         driver.find_element(By.LINK_TEXT, 'See more articles').click()            \n",
    "\n",
    "#     sleep(5)\n",
    "#     # Scroll to the \"see more articles\" pagination link at the bottom\n",
    "#     see_more_link_link = driver.find_element(By.LINK_TEXT, 'See more articles')\n",
    "#     driver.execute_script('arguments[0].scrollIntoView(true);', see_more_link)\n",
    "#     sleep(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'2022-02-18'"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dte = 'Feb 18, 2022 12:01pm'\n",
    "\n",
    "datetime.strptime(dte[:-2], '%b %d, %Y %H:%M').strftime('%Y-%m-%d')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "InfraScan’s handheld brain bleed detector cleared for kids\n",
      "https://www.fiercebiotech.com/medtech/infrascan-wins-fda-ok-bring-its-hand-held-device-brain-bleed-detection-children\n",
      "2022-02-18\n",
      "MedTech\n",
      "How an OTC cough med could help design arrhythmia drugs\n",
      "https://www.fiercebiotech.com/research/how-otc-cough-med-could-serve-steppingstone-creating-heart-rhythm-drugs\n",
      "2022-02-18\n",
      "Research\n",
      "Ribon taps former Novartis VP Raman as CEO\n",
      "https://www.fiercebiotech.com/biotech/ribon-therapeutics-taps-former-novartis-vp-raman-be-ceo\n",
      "2022-02-18\n",
      "Biotech\n",
      "Ligand to spin off J&J-partnered antibody unit with $70M funding\n",
      "https://www.fiercebiotech.com/biotech/ligand-plans-spin-antibody-unit-partnered-likes-jj-and-fund-it-70m\n",
      "2022-02-18\n",
      "Biotech\n",
      "FDA gives Class I rating to Vyaire Medical's ventilator recall\n",
      "https://www.fiercebiotech.com/medtech/fda-hands-down-class-i-rating-vyaire-medicals-ventilator-recall\n",
      "2022-02-18\n",
      "MedTech\n",
      "Califf returns as FDA chief with Senate nod—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-califf-confirmed-senate-fda-commissioner\n",
      "2022-02-18\n",
      "Biotech\n",
      "Curebase adds real-world data, digital health experts to board\n",
      "https://www.fiercebiotech.com/cro/curebase-adds-rwe-and-digital-health-experts-board-dct-growth-effort\n",
      "2022-02-18\n",
      "CRO\n",
      "FDA grounds BioMarin gene therapy for months over tumor risk\n",
      "https://www.fiercebiotech.com/biotech/fda-grounds-biomarin-gene-therapy-trial-many-months-demand-tumor-risk-data\n",
      "2022-02-18\n",
      "Biotech\n",
      "GSK slams brakes on maternal RSV vaccine over safety signal\n",
      "https://www.fiercebiotech.com/biotech/gsk-close-race-pfizer-slams-brakes-phase-3-maternal-rsv-vaccine-program-over-safety-signal\n",
      "2022-02-18\n",
      "Biotech\n",
      "Biotech lags in ESG disclosures but execs plan to step it up\n",
      "https://www.fiercebiotech.com/biotech/early-stage-majority-biotechs-dont-disclose-esg-practices-most-plan-near-term\n",
      "2022-02-18\n",
      "Biotech\n",
      "MindMaze chases down $105M financing, AHA partnership\n",
      "https://www.fiercebiotech.com/medtech/mindmaze-chases-down-another-100m-funding-plus-aha-partnership\n",
      "2022-02-17\n",
      "MedTech\n",
      "Second Sight slashes support for 'bionic eyes': report\n",
      "https://www.fiercebiotech.com/medtech/second-sights-bionic-eyes-have-gone-obsolete-while-still-implanted-report-finds\n",
      "2022-02-17\n",
      "MedTech\n",
      "Collins returns as science adviser weeks into retirement\n",
      "https://www.fiercebiotech.com/biotech/biden-taps-ex-nih-director-francis-collins-next-science-advisor-fill-shoes-lander-who\n",
      "2022-02-17\n",
      "Biotech\n",
      "Yumanity to cut 60% of workforce by April, looking for buyers\n",
      "https://www.fiercebiotech.com/biotech/yumanity-cut-60-its-workforce-april-looking-buyers\n",
      "2022-02-17\n",
      "Biotech\n",
      "Applying mRNA to healing broken bones\n",
      "https://www.fiercebiotech.com/research/applying-mrna-healing-broken-bones-mayo-clinic\n",
      "2022-02-17\n",
      "Research\n",
      "Outset Medical doubled revenue in 2021 amid widening net loss\n",
      "https://www.fiercebiotech.com/medtech/outset-medical-doubled-2021-revenue-102m-amid-widening-net-loss\n",
      "2022-02-17\n",
      "MedTech\n",
      "Phase 3 hits tee Innovent up to rival Amgen and Sanofi in PCSK9\n",
      "https://www.fiercebiotech.com/biotech/pivotal-hits-tee-innovent-challenge-amgen-and-sanofi-chinese-pcsk9-market\n",
      "2022-02-17\n",
      "Biotech\n",
      "Billionaire backs biotech to carve out niche in busy BCMA space\n",
      "https://www.fiercebiotech.com/biotech/billionaires-fund-backs-heidelberg-carve-out-niche-busy-bcma-space\n",
      "2022-02-17\n",
      "Biotech\n",
      "Remix Therapeutics signs licensure deal with Janssen topping $1B\n",
      "https://www.fiercebiotech.com/biotech/remix-therapeutics-signs-licensure-deal-janssen-could-exceed-1-billion\n",
      "2022-02-17\n",
      "Biotech\n",
      "NIAID vaccine chief who collaborated with Moderna to retire\n",
      "https://www.fiercebiotech.com/biotech/john-mascola-director-niaids-vaccine-research-center-resign-end-march\n",
      "2022-02-16\n",
      "Biotech\n",
      "FDA clears Tandem's smartphone app for programming insulin doses\n",
      "https://www.fiercebiotech.com/medtech/tandems-smartphone-app-first-cleared-fda-program-insulin-delivery\n",
      "2022-02-16\n",
      "MedTech\n",
      "Companion Spine nets $55M to develop ex-Medtronic implants in US\n",
      "https://www.fiercebiotech.com/medtech/companion-spine-nets-55m-carry-ex-medtronic-implants-us-market\n",
      "2022-02-16\n",
      "MedTech\n",
      "Merck KGaA pharma CEO reflects on I-O bispecific flop\n",
      "https://www.fiercebiotech.com/biotech/merck-kgaa-healthcare-ceo-peter-guenter-reflects-i-o-bispecific-flop-spots-new-multiple\n",
      "2022-02-16\n",
      "Biotech\n",
      "Sage scores on depression trial, but durability unanswered\n",
      "https://www.fiercebiotech.com/biotech/sage-biogen-score-phase-3-depression-trial-we-still-dont-know-about-durability\n",
      "2022-02-16\n",
      "Biotech\n",
      "Casio scores FDA clearance for dermatology camera system\n",
      "https://www.fiercebiotech.com/medtech/electronics-giant-casio-scores-first-fda-clearance-decades-dermatology-camera-system\n",
      "2022-02-16\n",
      "MedTech\n",
      "Mirati slips further behind Amgen with December KRAS decision\n",
      "https://www.fiercebiotech.com/biotech/miratis-very-big-kras-drug-gets-december-decision-date-further-extends-lumakras-first-mover\n",
      "2022-02-16\n",
      "Biotech\n",
      "Gilead, Hookipa amend HIV treatment pact for $237M in biobucks\n",
      "https://www.fiercebiotech.com/biotech/gilead-amends-hiv-immunotherapy-pact-hookipa-15m-upfront-237m-biobucks\n",
      "2022-02-16\n",
      "Biotech\n",
      "Third Harmonic Bio raises $105 million series B\n",
      "https://www.fiercebiotech.com/biotech/third-harmonic-bio-raises-105-million-series-b-push-hives-treatment-through-phase-1b\n",
      "2022-02-16\n",
      "Biotech\n",
      "Equillium adds 3 drugs to pipeline via $329M Bioniz buy\n",
      "https://www.fiercebiotech.com/biotech/single-asset-equillium-buys-bioniz-329m-expand-pipeline-three-drugs\n",
      "2022-02-16\n",
      "Biotech\n",
      "Reach for the Star: Electra nabs $84M for rare disease drugs\n",
      "https://www.fiercebiotech.com/biotech/electra-one-two-star-biotechs-snags-84m-apply-brakes-immune-system-haywire\n",
      "2022-02-16\n",
      "Biotech\n",
      "Merck inks oncology, neurology discovery deal with U.K. biotech\n",
      "https://www.fiercebiotech.com/biotech/merck-gets-ahead-curve-inking-oncology-and-neurology-drug-discovery-deal-emerging-british\n",
      "2022-02-16\n",
      "Biotech\n",
      "UCB, Novartis back SpliceBio with $57M for gene therapy R&D\n",
      "https://www.fiercebiotech.com/biotech/ucb-novartis-and-more-pile-splicebio-series-ponying-57m-tackle-big-barrier-gene-therapy\n",
      "2022-02-16\n",
      "Biotech\n",
      "Cytokinetics' heart drug fails a phase 3 as it awaits FDA nod\n",
      "https://www.fiercebiotech.com/biotech/cytokinetics-heart-failure-drug-slated-nov-30-fda-decision-fails-improve-exercise-capacity\n",
      "2022-02-15\n",
      "Biotech\n",
      "Despite SPAC market woes, a blank check enters the fray at $75M\n",
      "https://www.fiercebiotech.com/biotech/12-month-old-spac-decides-enter-murky-waters-downsized-75m-ipo\n",
      "2022-02-15\n",
      "Biotech\n",
      "Biotech pipeline is outpaced by antibacterial resistance: study\n",
      "https://www.fiercebiotech.com/biotech/new-report-finds-lackluster-investments-antibiotics-industry-resistance-threats-loom\n",
      "2022-02-15\n",
      "Biotech\n",
      "Study validates Veracyte’s test for prostate cancer aggression\n",
      "https://www.fiercebiotech.com/medtech/veracytes-prostate-cancer-genomic-test-can-speed-time-best-treatment-study-finds\n",
      "2022-02-15\n",
      "MedTech\n",
      "Tyto Care nabs European approval for its lung sound-spotting AI\n",
      "https://www.fiercebiotech.com/medtech/digital-stethoscope-maker-tyto-care-nabs-european-approval-its-lung-sound-identifying-ai\n",
      "2022-02-15\n",
      "MedTech\n",
      "Founder Rothberg named interim CEO of Quantum-Si\n",
      "https://www.fiercebiotech.com/medtech/quantum-si-taps-founder-rothberg-prolific-medtech-entrepreneur-interim-ceo\n",
      "2022-02-15\n",
      "MedTech\n",
      "Larimar in limbo as FDA maintains clinical hold\n",
      "https://www.fiercebiotech.com/biotech/larimar-kept-limbo-fda-maintains-clinical-hold-leading-candidate\n",
      "2022-02-15\n",
      "Biotech\n",
      "Intellia-ONK sign $920M pact on CRISPR-edited cell therapies\n",
      "https://www.fiercebiotech.com/biotech/intellia-onk-ink-920m-pact-five-crispr-edited-cell-therapies-cancer\n",
      "2022-02-15\n",
      "Biotech\n",
      "Legend's early-stage CAR-T on FDA hold after single patient dose\n",
      "https://www.fiercebiotech.com/biotech/legends-early-stage-car-t-fda-hold-after-single-patient-dosed\n",
      "2022-02-15\n",
      "Biotech\n",
      "AC Immune, Janssen Alzheimer's vaccine spurs tau antibodies\n",
      "https://www.fiercebiotech.com/biotech/ac-immunes-janssen-partnered-alzheimers-vaccine-spurs-tau-attacking-antibodies-early-stage\n",
      "2022-02-15\n",
      "Biotech\n",
      "Deleting a gene in mice helps delay age-related inflammation\n",
      "https://www.fiercebiotech.com/research/deleting-gene-mice-helps-delay-age-related-inflammation\n",
      "2022-02-15\n",
      "Research\n",
      "Lilly reunites with ImmunoGen to expand into ADCs\n",
      "https://www.fiercebiotech.com/biotech/lilly-reunites-immunogen-expand-adcs-paying-13m-upfront-and-17b-backend\n",
      "2022-02-15\n",
      "Biotech\n",
      "The top 10 M&A targets in biotech for 2022\n",
      "https://www.fiercebiotech.com/special-report/top-10-m-a-targets-biotech-for-2022\n",
      "2022-02-15\n",
      "Expect a 'buoyant year' in biopharma M&A with $1.7T to deploy\n",
      "https://www.fiercebiotech.com/biotech/biopharma-ma-2022-different-animal-drugmakers-coffers-lined-17t\n",
      "2022-02-15\n",
      "Biotech\n",
      "Kallyope delays IPO to snag $236M series D for 22 programs\n",
      "https://www.fiercebiotech.com/biotech/kallyope-ex-merck-exec-helm-rakes-236m-type-2-diabetes-and-gi-diseases\n",
      "2022-02-15\n",
      "Biotech\n",
      "NMD pulls in $40M from Jeito-led, Roche-backed syndicate\n",
      "https://www.fiercebiotech.com/deals/nmd-pulls-40m-jeito-led-roche-backed-syndicate-gaining-financial-muscle-crack-myasthenia\n",
      "2022-02-15\n",
      "Deals\n",
      "Editor's Corner: Fierce Biotech gets a fierce makeover\n",
      "https://www.fiercebiotech.com/biotech/editors-corner-fierce-biotech-gets-fierce-makeover\n",
      "2022-02-14\n",
      "Biotech\n",
      "Enzymes meant to fend off viruses play role in cancer 'cyclones'\n",
      "https://www.fiercebiotech.com/research/how-a-family-enzymes-meant-to-stave-off-virus-can-lead-to-cyclones-drive-cancer\n",
      "2022-02-14\n",
      "Research\n",
      "J&J's Cerenovus sets €50M for stroke device R&D at Irish site\n",
      "https://www.fiercebiotech.com/medtech/j-j-s-cerenovus-allots-eu50m-to-stroke-device-development-at-ireland-research-site\n",
      "2022-02-14\n",
      "MedTech\n",
      "To incentivize organ donations, DaVita offers staff extra PTO\n",
      "https://www.fiercebiotech.com/medtech/to-incentivize-organ-donations-davita-offers-employees-extra-pto\n",
      "2022-02-14\n",
      "MedTech\n",
      "Musk's Neuralink disputes accusations of animal abuse\n",
      "https://www.fiercebiotech.com/medtech/elon-musk-s-neuralink-disputes-accusations-animal-abuse-brain-implant-experiments\n",
      "2022-02-14\n",
      "MedTech\n",
      "Merck KGaA taps into Quris' stem cell-powered drug screening AI\n",
      "https://www.fiercebiotech.com/medtech/merck-kgaa-taps-into-quris-stem-cell-powered-drug-screening-ai\n",
      "2022-02-14\n",
      "MedTech\n",
      "Improving RNA editing by recruiting the body's natural protein\n",
      "https://www.fiercebiotech.com/research/improving-rna-editing-for-genetic-diseases-by-recruiting-body-s-natural-protein\n",
      "2022-02-14\n",
      "Research\n",
      "Roivant decants another Vant armed with Eisai blood cancer drug\n",
      "https://www.fiercebiotech.com/biotech/roivant-decants-another-vant-armed-eisai-blood-cancer-drug-and-plans-to-start-phase-1-2\n",
      "2022-02-14\n",
      "Biotech\n",
      "FDA fingers tox assessment as cause of Denali clinical hold\n",
      "https://www.fiercebiotech.com/biotech/fda-fingers-tox-assessment-as-cause-denali-clinical-hold-leaving-biotech-a-to-do-list-to\n",
      "2022-02-14\n",
      "Biotech\n",
      "J&J's DePuy acquires foot implant system maker CrossRoads\n",
      "https://www.fiercebiotech.com/medtech/at-crossroads-j-j-s-depuy-synthes-acquires-foot-and-ankle-implant-system-maker\n",
      "2022-02-14\n",
      "MedTech\n",
      "Roche, Lilly push back against CMS' Aduhelm decision\n",
      "https://www.fiercebiotech.com/biotech/big-pharmas-roche-lilly-push-back-against-cms-s-aduhelm-decision\n",
      "2022-02-11\n",
      "Biotech\n",
      "Metacrine lays off 50% of staff, axes more R&D to focus on IBD\n",
      "https://www.fiercebiotech.com/biotech/metacrine-fired-half-its-staff-mainly-researchers-and-ditches-more-work-to-focus-ibd-after\n",
      "2022-02-11\n",
      "Biotech\n",
      "Dexcom bests its 'best year ever' with 27% revenue surge in 2021\n",
      "https://www.fiercebiotech.com/medtech/dexcom-bests-its-best-year-ever-27-surge-to-2-5b-revenue-2021\n",
      "2022-02-11\n",
      "MedTech\n",
      "ProQR treatment for congenital eye disease flops in trials\n",
      "https://www.fiercebiotech.com/biotech/proqr-treatment-for-congenital-eye-disease-kids-flops-phase-2-3-trial-shares-plummet-to-new\n",
      "2022-02-11\n",
      "Biotech\n",
      "Ex-FDA interim head Giroir returns to biotech to make antivirals\n",
      "https://www.fiercebiotech.com/biotech/ex-fda-interim-chief-giroir-rejoins-biotech-world-eyes-50m-fundraising-new-infectious\n",
      "2022-02-11\n",
      "Biotech\n",
      "Senseonics lands long-awaited FDA OK for 6-month CGM implant\n",
      "https://www.fiercebiotech.com/medtech/senseonics-lands-long-awaited-fda-approval-for-6-month-implanted-cgm-system\n",
      "2022-02-11\n",
      "MedTech\n",
      "Cassava scores a win as FDA declines to halt Alzheimer's trials\n",
      "https://www.fiercebiotech.com/biotech/cassava-scores-a-win-as-fda-denies-citizen-petition-over-data-manipulation-allegations-for\n",
      "2022-02-11\n",
      "Biotech\n",
      "Editas fires medical chief, no interim in place—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-editas-fires-chief-medical-officer-without-explanation\n",
      "2022-02-11\n",
      "Biotech\n",
      "What are taxpayers spending for those 'free' COVID tests?\n",
      "https://www.fiercebiotech.com/medtech/what-are-taxpayers-spending-for-those-free-covid-tests-government-won-t-say\n",
      "2022-02-11\n",
      "MedTech\n",
      "Illumina CEO: Why Grail must become 'fully part of the loop'\n",
      "https://www.fiercebiotech.com/medtech/illumina-posts-record-revenues-as-ceo-desouza-pitches-path-forward-for-grail\n",
      "2022-02-11\n",
      "MedTech\n",
      "Fujifilm sets up biotech fund to hunt early-stage opportunities\n",
      "https://www.fiercebiotech.com/biotech/hunting-for-cutting-edge-biotech-fujifilm-sets-up-early-stage-vc-fund\n",
      "2022-02-11\n",
      "Biotech\n",
      "With approval in sight, ObsEva offloads women's health drug\n",
      "https://www.fiercebiotech.com/biotech/approval-sight-obseva-sells-regional-rights-to-women-s-health-drug-for-tiny-upfront\n",
      "2022-02-11\n",
      "Biotech\n",
      "Vivocore combines InterVivo, Transpharmation to form CRO\n",
      "https://www.fiercebiotech.com/cro/vivocore-combines-intervivo-and-transpharmation-to-form-neuroscience-cro\n",
      "2022-02-10\n",
      "CRO\n",
      "BD joins Day Zero's $21M funding for genomics-based diagnostics\n",
      "https://www.fiercebiotech.com/medtech/bd-joins-day-zero-s-21m-funding-for-sequencing-based-infectious-disease-diagnostics\n",
      "2022-02-10\n",
      "MedTech\n",
      "Curevo will go head-to-head against GSK's Shingrix with $60M\n",
      "https://www.fiercebiotech.com/biotech/curevo-cashes-60m-series-a-round-preps-for-head-to-head-shingrix\n",
      "2022-02-10\n",
      "Biotech\n",
      "Philips rolls out blood flow software to its Lumify ultrasound\n",
      "https://www.fiercebiotech.com/medtech/philips-rolls-out-blood-flow-measuring-software-to-its-lumify-handheld-ultrasound\n",
      "2022-02-10\n",
      "MedTech\n",
      "Ada Health tops up series B with $120M for symptom checker app\n",
      "https://www.fiercebiotech.com/medtech/ada-health-hits-120m-series-b-top-up-for-symptom-assessment-ai-app\n",
      "2022-02-10\n",
      "MedTech\n",
      "FDA denies Ardelyx's appeal against kidney drug rejection\n",
      "https://www.fiercebiotech.com/biotech/fda-denies-ardelyx-s-appeal-against-kidney-drug-rejection-hammering-another-nail-tenapanor\n",
      "2022-02-10\n",
      "Biotech\n",
      "AstraZeneca dumps late-phase, next-gen COVID-19 vaccine\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-dumps-late-phase-next-gen-covid-19-vaccine-calling-time-a-beta-player-omicron\n",
      "2022-02-10\n",
      "Biotech\n",
      "Pfizer re-ups collab with AI disease model maker CytoReason\n",
      "https://www.fiercebiotech.com/medtech/pfizer-re-ups-cytoreason-collab-applying-ai-disease-models-to-drug-development\n",
      "2022-02-10\n",
      "MedTech\n",
      "Indapta snags $50M and signs on former Juno exec as CEO\n",
      "https://www.fiercebiotech.com/biotech/indapta-tops-50m-series-a-taps-former-juno-exec-as-ceo-as-focus-turns-toward-clinical\n",
      "2022-02-10\n",
      "Biotech\n",
      "Lilly, Pfizer-backed Arkuda bags $64M to test drug in dementia\n",
      "https://www.fiercebiotech.com/biotech/lilly-pfizer-backed-arkuda-bags-64m-to-test-drug-frontotemporal-dementia-2023\n",
      "2022-02-10\n",
      "Biotech\n",
      "TCR-T cells fend off evasive leukemia, solid tumors in mice\n",
      "https://www.fiercebiotech.com/research/engineered-tcr-t-cells-by-fred-hutch-san-raffaele-intellia-fend-off-evasive-leukemia-solid\n",
      "2022-02-09\n",
      "Research\n",
      "Silence says its drug lowers levels of heart disease risk factor\n",
      "https://www.fiercebiotech.com/biotech/silence-touts-data-drug-reduces-levels-a-lipoprotein-leads-to-cardiovascular-disease\n",
      "2022-02-09\n",
      "Biotech\n",
      "Federal probe uses mob laws to target spine surgery fraud\n",
      "https://www.fiercebiotech.com/medtech/federal-investigation-into-spine-surgeries-uses-mob-laws-to-target-healthcare-fraud\n",
      "2022-02-09\n",
      "MedTech\n",
      "Orthox nabs $12M to take artificial cartilage to clinical trials\n",
      "https://www.fiercebiotech.com/medtech/orthox-spins-up-12m-to-kick-off-trials-spider-inspired-artificial-cartilage-implant\n",
      "2022-02-09\n",
      "MedTech\n",
      "Avrobio gene therapy shows signs of durability in rare disorder\n",
      "https://www.fiercebiotech.com/biotech/avrobio-hopes-to-chart-rebound-after-fabry-setback-lysosomal-storage-disorder-gene-therapy\n",
      "2022-02-09\n",
      "Biotech\n",
      "Checkmate plucks BMS exec to be new CEO\n",
      "https://www.fiercebiotech.com/biotech/checkmate-plucks-bms-exec-bash-to-be-new-ceo\n",
      "2022-02-09\n",
      "Biotech\n",
      "Sequencing tech maker Element Biosciences acquires Loop Genomics\n",
      "https://www.fiercebiotech.com/medtech/element-biosciences-acquires-loop-genomics-to-add-long-read-tech-to-dna-sequencing-platform\n",
      "2022-02-09\n",
      "MedTech\n",
      "Bausch Health files for Solta IPO as its 3-way split nears goal\n",
      "https://www.fiercebiotech.com/medtech/bausch-health-files-for-solta-ipo-as-its-three-way-split-nears-completion\n",
      "2022-02-09\n",
      "MedTech\n",
      "Rivus throws down liver fat data on quest to climb NASH mountain\n",
      "https://www.fiercebiotech.com/biotech/rivus-throws-down-mid-stage-liver-fat-data-quest-to-climb-nash-mountain\n",
      "2022-02-09\n",
      "Biotech\n",
      "Chasing Novartis and Roche, Ventus banks $140M for clinical work\n",
      "https://www.fiercebiotech.com/biotech/chasing-novartis-and-roche-ventus-banks-140m-to-take-inflammatory-disease-drug-into-clinic\n",
      "2022-02-09\n",
      "Biotech\n",
      "Seismic, padded by ex-Pandion C-suite, unveils with $101M\n",
      "https://www.fiercebiotech.com/biotech/seismic-emerges-101m-harvard-billionaire-founder-and-ex-pandion-leadership-a-year-after-1-9\n",
      "2022-02-09\n",
      "Biotech\n",
      "GSK kills one of Barron's early darlings, axing Epizyme pact\n",
      "https://www.fiercebiotech.com/biotech/gsk-kills-one-barron-s-early-darlings-axing-two-synthetic-lethal-programs-and-epizyme-pact\n",
      "2022-02-09\n",
      "Biotech\n",
      "Jabra sends self-fitting hearing aids to market for $799\n",
      "https://www.fiercebiotech.com/medtech/gn-s-jabra-sends-self-fitting-hearing-aids-to-market-for-799-ahead-fda-over-counter-ruling\n",
      "2022-02-08\n",
      "MedTech\n",
      "Pfizer axes 3 drugs but eyes extra $25B in 2030 via outside work\n",
      "https://www.fiercebiotech.com/biotech/pfizer-culls-three-assets-but-eyes-external-science-to-add-25b-to-2030-revenue\n",
      "2022-02-08\n",
      "Biotech\n",
      "Axsome's migraine drug slated for FDA inspection after all\n",
      "https://www.fiercebiotech.com/biotech/axsome-s-migraine-drug-slated-for-fda-inspection-but-questions-remain-halted-depression\n",
      "2022-02-08\n",
      "Biotech\n",
      "CooperSurgical to buy Cook's IVF, OB-GYN portfolio for $875M\n",
      "https://www.fiercebiotech.com/medtech/coopersurgical-to-acquire-cook-medical-s-ivf-ob-gyn-businesses-for-875m\n",
      "2022-02-08\n",
      "MedTech\n",
      "Second Sight eyes buyout of Nano Precision Medical\n",
      "https://www.fiercebiotech.com/medtech/second-sight-eyes-buyout-nano-precision-medical-and-its-diabetes-drug-implant\n",
      "2022-02-08\n",
      "MedTech\n",
      "$12B biotech Biosplice lays off 41, axes hair loss asset\n",
      "https://www.fiercebiotech.com/biotech/biosplice-lays-off-41-drops-baldness-program-as-12b-valuation-confuses-everyone\n",
      "2022-02-08\n",
      "Biotech\n",
      "Ovid pens deal to offload twice-failed former lead program\n",
      "https://www.fiercebiotech.com/biotech/ovid-pens-deal-to-offload-twice-failed-former-lead-program-positioning-healx-to-write-new\n",
      "2022-02-08\n",
      "Biotech\n",
      "Bristol Myers Squibb announces $8M in health equity grants\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-squibb-announces-nearly-8-million-new-grants-to-address-health-equity\n",
      "2022-02-08\n",
      "Biotech\n",
      "New CRISPR tool maps out routes to better immune cell therapies\n",
      "https://www.fiercebiotech.com/research/new-crispr-tool-maps-out-routes-to-better-immune-cell-therapies-for-cancer-autoimmune\n",
      "2022-02-08\n",
      "Research\n",
      "Pfizer, in a rare COVID-19 setback, dumps Paxlovid's IV sibling\n",
      "https://www.fiercebiotech.com/biotech/pfizer-a-rare-covid-19-setback-dumps-paxlovid-s-intravenous-sibling-to-leave-activ-3-future\n",
      "2022-02-08\n",
      "Biotech\n",
      "DNA-based HIV vaccine produces critical antibodies in mice\n",
      "https://www.fiercebiotech.com/research/dna-based-hiv-vaccine-produces-critical-tier-2-neutralizing-antibodies-mouse-model\n",
      "2022-02-08\n",
      "Research\n",
      "Editas gets rid of chief medical officer without explanation\n",
      "https://www.fiercebiotech.com/biotech/editas-terminates-chief-medical-officer-lisa-michaels-employment-no-reason-given\n",
      "2022-02-07\n",
      "Biotech\n",
      "Discovery of genetic variants could aid new acne treatments\n",
      "https://www.fiercebiotech.com/research/researchers-find-29-genetic-variants-people-acne-could-lead-to-new-treatments\n",
      "2022-02-07\n",
      "Research\n",
      "Abbott launches 1st study of its dual-chamber leadless pacemaker\n",
      "https://www.fiercebiotech.com/medtech/abbott-delivers-first-implant-its-dual-chamber-leadless-pacemaker-a-clinical-study\n",
      "2022-02-07\n",
      "MedTech\n",
      "Zimmer Biomet sets date for spine, dental spinoff ZimVie\n",
      "https://www.fiercebiotech.com/medtech/zimmer-biomet-plots-1b-revenue-for-spine-dental-business-zimvie-sets-spinoff-date\n",
      "2022-02-07\n",
      "MedTech\n",
      "CVS, Medable team up on late-stage clinical trials\n",
      "https://www.fiercebiotech.com/cro/cvs-to-bring-late-stage-clinical-trials-to-certain-locations-push-to-serve-underrepresented\n",
      "2022-02-07\n",
      "CRO\n",
      "SPAC fervor dwindles as biotechs get 'realistic and pragmatic'\n",
      "https://www.fiercebiotech.com/biotech/not-afraid-not-transacting-spac-appetite-declines\n",
      "2022-02-07\n",
      "Biotech\n",
      "HeartFlow exits SPAC deal due to 'unfavorable market conditions'\n",
      "https://www.fiercebiotech.com/medtech/heartflow-halts-spac-deal-citing-current-unfavorable-market-conditions\n",
      "2022-02-07\n",
      "MedTech\n",
      "Correcting heart rhythm with bacteria-derived gene therapy\n",
      "https://www.fiercebiotech.com/research/gene-therapy-inspired-by-bacteria-shows-promise-for-heart-rhythm-diseases\n",
      "2022-02-07\n",
      "Research\n",
      "Boundless Bio lures Berkley from Ionis to support clinical push\n",
      "https://www.fiercebiotech.com/biotech/boundless-bio-lures-berkley-from-ionis-to-support-clinical-push\n",
      "2022-02-07\n",
      "Biotech\n",
      "CANbridge posts early-phase data on rival to AstraZeneca drug\n",
      "https://www.fiercebiotech.com/biotech/canbridge-targeting-gaps-astrazeneca-s-rare-disease-coverage-posts-early-phase-data-c5\n",
      "2022-02-07\n",
      "Biotech\n",
      "Takeda joins Novartis, Merck in $45M funding for Koneksa\n",
      "https://www.fiercebiotech.com/biotech/novartis-and-takeda-join-45m-series-c-funding-for-koneksa-health\n",
      "2022-02-07\n",
      "Biotech\n",
      "Endeavor nabs $101M for IPF, cancer trials—and asset shopping\n",
      "https://www.fiercebiotech.com/biotech/endeavor-snags-101m-to-go-after-boehringer-roche-idiopathic-pulmonary-fibrosis-and-consider\n",
      "2022-02-07\n",
      "Biotech\n",
      "Sanofi culls 2 cancer assets weeks after axing Sangamo deal\n",
      "https://www.fiercebiotech.com/biotech/sanofi-ends-two-phase-1-cancer-assets-weeks-after-axing-sangamo-deal-prioritizing-covid-19\n",
      "2022-02-04\n",
      "Biotech\n",
      "Bayer nixes midstage cough med weeks after Merck's was rejected\n",
      "https://www.fiercebiotech.com/biotech/bayer-ends-midstage-work-evotec-partnered-med-being-studied-cough-three-other-conditions\n",
      "2022-02-04\n",
      "Biotech\n",
      "FDA clears Ambu’s single-use gastroscope, touchscreen display\n",
      "https://www.fiercebiotech.com/medtech/ambu-lances-fda-clearance-for-single-use-gastroscope-and-touchscreen-display\n",
      "2022-02-04\n",
      "MedTech\n",
      "Arcellx raises $124M in IPO to fund CAR-T multiple myeloma trial\n",
      "https://www.fiercebiotech.com/biotech/arcellx-raises-124m-wall-street-debut-to-bankroll-pivotal-study-multiple-myeloma-car-t\n",
      "2022-02-04\n",
      "Biotech\n",
      "Tasso, Vault Health team up to provide home-based blood testing\n",
      "https://www.fiercebiotech.com/medtech/tasso-vault-health-team-up-to-provide-at-home-blood-testing-for-siteless-clinical-trials\n",
      "2022-02-04\n",
      "MedTech\n",
      "Labcorp launches online platform for ordering diagnostic tests\n",
      "https://www.fiercebiotech.com/medtech/labcorp-launches-online-platform-for-ordering-at-home-tests-scheduling-person-appointments\n",
      "2022-02-04\n",
      "MedTech\n",
      "Exicure exodus: CEO resigns, CTO exits, 3 board members depart\n",
      "https://www.fiercebiotech.com/biotech/resignation-galore-exicure-ceo-resigns-cto-departs-three-board-members-exit-after-december\n",
      "2022-02-04\n",
      "Biotech\n",
      "Pfizer snags Roche early R&D head Pao—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-pfizer-poaches-roche-s-early-r-d-leader-william-pao-to-replace-development\n",
      "2022-02-04\n",
      "Biotech\n",
      "United BioSource, Seqster to boost decentralized study offering\n",
      "https://www.fiercebiotech.com/cro/remote-possibilities-ubc-teams-seqster-to-boost-decentralized-study-offering\n",
      "2022-02-04\n",
      "CRO\n",
      "UCB races to regulators after $2B rare disease bet delivers data\n",
      "https://www.fiercebiotech.com/biotech/ucb-races-to-regulators-after-2-5b-rare-disease-bet-delivers-data-for-attack-astrazeneca\n",
      "2022-02-04\n",
      "Biotech\n",
      "Pfizer's $130M Lyme disease vaccine advances to phase 3\n",
      "https://www.fiercebiotech.com/biotech/pfizer-s-130m-lyme-disease-vaccine-advances-to-phase-3-after-booster-shown-to-increase\n",
      "2022-02-04\n",
      "Biotech\n",
      "No unity here: Unity slashes half of staff to focus on eye drug\n",
      "https://www.fiercebiotech.com/biotech/unity-once-again-lays-off-large-number-staff-to-focus-ophthalmology-assets\n",
      "2022-02-03\n",
      "Biotech\n",
      "'One-stop shop': Synaffix inks $586M MacroGenics pact for ADCs\n",
      "https://www.fiercebiotech.com/biotech/synaffix-lines-up-586m-pact-macrogenics-en-route-to-one-stop-shop-for-adc-tech\n",
      "2022-02-03\n",
      "Biotech\n",
      "Arrowhead 'changing horses' for ENaC pulmonary program\n",
      "https://www.fiercebiotech.com/biotech/arrowhead-changing-horses-for-enac-pulmonary-program-as-phase-1-2-asset-shelved\n",
      "2022-02-03\n",
      "Biotech\n",
      "Quest CEO to step down after a decade\n",
      "https://www.fiercebiotech.com/medtech/quest-ceo-rusckowski-to-step-down-after-a-decade-office-following-record-setting-2021\n",
      "2022-02-03\n",
      "MedTech\n",
      "Roche's 2021 test sales once again reap COVID demand\n",
      "https://www.fiercebiotech.com/medtech/roche-s-2021-test-sales-collect-covid-demand-base-business-rebounds\n",
      "2022-02-03\n",
      "MedTech\n",
      "Completion of Lilly's Alzheimer's submission slips out of Q1\n",
      "https://www.fiercebiotech.com/biotech/completion-lilly-s-alzheimer-s-submission-slips-out-q1-after-cms-s-aduhelm-decision\n",
      "2022-02-03\n",
      "Biotech\n",
      "Intellia Rewrites in $200M acquisition of UC Berkeley startup\n",
      "https://www.fiercebiotech.com/biotech/intellia-rewrites-pipeline-expansion-200m-acquisition-uc-berkeley-dna-writing-startup\n",
      "2022-02-03\n",
      "Biotech\n",
      "BD doubles COVID sales forecast for 2022, despite test drop-offs\n",
      "https://www.fiercebiotech.com/medtech/bd-doubles-covid-sales-forecast-for-2022-even-as-steep-testing-dropoff-leads-to-revenue\n",
      "2022-02-03\n",
      "MedTech\n",
      "Amgen inks $500M Plexium biobucks deal for protein degradation\n",
      "https://www.fiercebiotech.com/biotech/amgen-lines-up-500m-biobucks-deal-plexium-for-protein-degradation-therapies\n",
      "2022-02-03\n",
      "Biotech\n",
      "Pfizer accuses former employees of stealing trade secrets\n",
      "https://www.fiercebiotech.com/biotech/pfizer-accuses-former-employees-treachery-stealing-trade-secrets-to-form-regor-therapeutics\n",
      "2022-02-03\n",
      "Biotech\n",
      "At nursing homes, long waits render COVID tests 'useless'\n",
      "https://www.fiercebiotech.com/medtech/at-nursing-homes-long-waits-for-results-render-covid-tests-useless\n",
      "2022-02-03\n",
      "MedTech\n",
      "Roche lets go of etro, dumping phase 3 Crohn's prospect\n",
      "https://www.fiercebiotech.com/biotech/roche-lets-go-etro-dumping-phase-3-crohn-s-prospect-18-months-after-posting-weak-colitis\n",
      "2022-02-03\n",
      "Biotech\n",
      "AstraZeneca punts midphase cardiovascular prospect to startup\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-punts-midphase-cardiovascular-prospect-to-startup\n",
      "2022-02-03\n",
      "Biotech\n",
      "J&J's Janssen joins Mersana ADC collabs in $1B biobucks pact\n",
      "https://www.fiercebiotech.com/biotech/j-j-s-janssen-inks-1b-biobucks-pact-for-mersana-s-adc-tech-for-three-targets\n",
      "2022-02-03\n",
      "Biotech\n",
      "Dewpoint snags $150M for programs with Pfizer, Merck and Bayer\n",
      "https://www.fiercebiotech.com/biotech/dewpoint-secures-150m-to-advance-20-programs-partnered-pfizer-merck-bayer-volastra\n",
      "2022-02-03\n",
      "Biotech\n",
      "J&J ends work on eczema drug, a $610M dent to ex-XBiotech asset\n",
      "https://www.fiercebiotech.com/biotech/j-j-discontinues-work-eczema-drug-leading-to-610m-impairment-charges-for-ex-xbiotech-asset\n",
      "2022-02-02\n",
      "Biotech\n",
      "Thermo Fisher logs 22% revenue growth for 2021\n",
      "https://www.fiercebiotech.com/medtech/thermo-fisher-logs-22-revenue-growth-for-2021-buoyed-by-product-launches-and-year-s-biggest\n",
      "2022-02-02\n",
      "MedTech\n",
      "Paragonix's lung donor system completes cross-country transplant\n",
      "https://www.fiercebiotech.com/medtech/paragonix-s-lung-transport-system-completes-4-700-mile-cross-country-transplant\n",
      "2022-02-02\n",
      "MedTech\n",
      "Biden aims to halve cancer death rate, forms cancer cabinet\n",
      "https://www.fiercebiotech.com/biotech/moonshot-2-0-biden-wants-50-drop-cancer-death-rate-by-2047-establishes-cancer-cabinet\n",
      "2022-02-02\n",
      "Biotech\n",
      "Gilead's CD47 hold expands as CEO expresses 'sense of urgency'\n",
      "https://www.fiercebiotech.com/biotech/gilead-s-cd47-clinical-hold-expands-as-ceo-expresses-sense-urgency-getting-trials-back\n",
      "2022-02-02\n",
      "Biotech\n",
      "Medtronic's Hugo surgical robot makes European debut\n",
      "https://www.fiercebiotech.com/medtech/medtronic-s-hugo-robotic-assisted-surgery-system-used-first-european-procedure\n",
      "2022-02-02\n",
      "MedTech\n",
      "Fractyl's T2D device shows HbA1c benefits through 2 years\n",
      "https://www.fiercebiotech.com/medtech/fractyl-s-device-based-treatment-for-type-2-diabetes-shows-hba1c-gains-after-2-years\n",
      "2022-02-02\n",
      "MedTech\n",
      "FDA puts LogicBio genome editing therapy trial on hold\n",
      "https://www.fiercebiotech.com/biotech/fda-puts-logicbio-genome-editing-therapy-trial-hold-after-second-infant-suffers-adverse\n",
      "2022-02-02\n",
      "Biotech\n",
      "Novartis JAKs in rival to Incyte after seeing clinical data\n",
      "https://www.fiercebiotech.com/biotech/novartis-jaks-rival-to-incyte-s-topical-eczema-drug-after-seeing-clinical-data\n",
      "2022-02-02\n",
      "Biotech\n",
      "FDA clears AliveCor's credit-card-sized ECG\n",
      "https://www.fiercebiotech.com/medtech/alivecor-s-credit-card-sized-ecg-snags-fda-clearance-for-30-second-arrhythmia-detection\n",
      "2022-02-01\n",
      "MedTech\n",
      "Pfizer snags Roche pharma R&D head Pao to fill development post\n",
      "https://www.fiercebiotech.com/biotech/pfizer-poaches-roche-s-pharma-r-d-leader-william-pao-to-fill-mackenzie-s-development-shoes\n",
      "2022-02-01\n",
      "Biotech\n",
      "Otsuka, Jolly Good link up for $43M mental health VR deal\n",
      "https://www.fiercebiotech.com/medtech/otsuka-signs-jolly-good-for-mental-health-vr-program-deal-worth-up-to-43m\n",
      "2022-02-01\n",
      "MedTech\n",
      "After changing study goals, Anavex touts Rett syndrome win\n",
      "https://www.fiercebiotech.com/biotech/anavex-touts-very-large-phase-3-win-for-rett-syndrome-drug-2-weeks-after-moving-study-s\n",
      "2022-02-01\n",
      "Biotech\n",
      "Biogen pays Roche $30M as lymphoma bispecific heads to FDA, EU\n",
      "https://www.fiercebiotech.com/biotech/biogen-opts-at-30m-for-roche-s-lymphoma-bispecific-at-eu-s-doors-headed-to-fda\n",
      "2022-02-01\n",
      "Biotech\n",
      "Scipher Medicine’s blood test decodes RA treatment: study\n",
      "https://www.fiercebiotech.com/medtech/scipher-medicine-decodes-rheumatoid-arthritis-treatment-drug-response-blood-test-study\n",
      "2022-02-01\n",
      "MedTech\n",
      "Coalition urges NIH to disclose cost of federally-funded trials\n",
      "https://www.fiercebiotech.com/cro/doctor-groups-urge-hhs-biden-admin-to-disclose-costs-federally-funded-clinical-trials\n",
      "2022-02-01\n",
      "CRO\n",
      "BD picks up Spanish developer of MRD cancer blood tests\n",
      "https://www.fiercebiotech.com/medtech/bd-picks-up-spanish-developer-mrd-cancer-blood-tests\n",
      "2022-02-01\n",
      "MedTech\n",
      "Takeda shunts jewel of Shire takeover to new spinoff Oak Hill\n",
      "https://www.fiercebiotech.com/biotech/takeda-shunts-jewel-shire-takeover-to-new-spinoff-oak-hill\n",
      "2022-02-01\n",
      "Biotech\n",
      "Sarepta, GenEdit ink $57M collab for neuromuscular gene editing\n",
      "https://www.fiercebiotech.com/biotech/sarepta-to-pay-genedit-up-to-57m-near-term-for-non-viral-delivery-for-neuromuscular-gene\n",
      "2022-02-01\n",
      "Biotech\n",
      "As CEO goes, cash woes drive Sio to throw Parkinson's program\n",
      "https://www.fiercebiotech.com/biotech/as-ceo-goes-cash-woes-drive-sio-to-give-parkison-s-program-heave-ho\n",
      "2022-02-01\n",
      "Biotech\n",
      "Twist is doing better than most on ESG, but opportunities remain\n",
      "https://www.fiercebiotech.com/biotech/twist-bioscience-doing-better-and-worse-than-most-biotechs-when-it-comes-to-diversity\n",
      "2022-01-31\n",
      "Biotech\n",
      "Relieving depression with LSD-like drugs without hallucinations\n",
      "https://www.fiercebiotech.com/research/relieving-depression-lsd-like-drugs-without-hallucinations\n",
      "2022-01-31\n",
      "Research\n",
      "A new 'atlas' of the brain spurs hope for new stroke treatments\n",
      "https://www.fiercebiotech.com/research/newly-discovered-immune-cells-communicate-brain-could-pave-way-for-new-stroke-treatments\n",
      "2022-01-31\n",
      "Research\n",
      "Leo Pharma's new CEO comes from failed meme stock Orphazyme\n",
      "https://www.fiercebiotech.com/biotech/leo-pharma-picks-christophe-bourdon-as-ceo-after-one-year-stint-at-failed-danish-meme-stock\n",
      "2022-01-31\n",
      "Biotech\n",
      "Taysha ready to engage with regulators on gene therapy\n",
      "https://www.fiercebiotech.com/biotech/taysha-to-ask-fda-eu-to-approve-its-gene-therapy-potential-first-for-a-rare\n",
      "2022-01-31\n",
      "Biotech\n",
      "Empowered Diagnostics recalls 286K unauthorized COVID tests\n",
      "https://www.fiercebiotech.com/medtech/empowered-diagnostics-lands-fda-class-i-tag-for-recall-286k-unauthorized-covid-tests\n",
      "2022-01-31\n",
      "MedTech\n",
      "Pfizer to promote Alex Therapeutics' smoking cessation app\n",
      "https://www.fiercebiotech.com/medtech/pfizer-signs-up-to-promote-alex-therapeutics-smoking-cessation-app-germany\n",
      "2022-01-31\n",
      "MedTech\n",
      "U.K. biotechs raised record $3.4B in 2021 as Europe VC declined\n",
      "https://www.fiercebiotech.com/biotech/u-k-startups-secure-half-europe-s-biotech-vc-funding-3-4b-record-setting-2021\n",
      "2022-01-31\n",
      "Biotech\n",
      "Glooko acquires AI medical coach developer Xbird\n",
      "https://www.fiercebiotech.com/medtech/glooko-adds-ai-powered-coaching-to-digital-diabetes-management-tools-xbird-acquisition\n",
      "2022-01-31\n",
      "MedTech\n",
      "States were sharing COVID test kits. Then omicron hit\n",
      "https://www.fiercebiotech.com/medtech/states-were-sharing-covid-test-kits-then-omicron-hit\n",
      "2022-01-31\n",
      "MedTech\n",
      "Gamida drops mixed bag of news on FDA submission, staffing cuts\n",
      "https://www.fiercebiotech.com/biotech/gamida-cell-readies-stem-cell-transplant-therapy-for-fda-submission-but-seeks-strategic\n",
      "2022-01-31\n",
      "Biotech\n",
      "Madrigal's NASH prospect clears first phase 3 test\n",
      "https://www.fiercebiotech.com/biotech/madrigal-s-nash-prospect-clears-first-phase-3-test-raising-hopes-it-can-magic-up-positive\n",
      "2022-01-31\n",
      "Biotech\n",
      "Pfizer ends $3B drug dream despite phase 2b success\n",
      "https://www.fiercebiotech.com/biotech/pfizer-ends-3b-drug-dream-despite-phase-2b-success-leaving-regeneron-a-clear-run-at\n",
      "2022-01-31\n",
      "Biotech\n",
      "Leaps by Bayer leads $40M Gandeeva funding\n",
      "https://www.fiercebiotech.com/biotech/bayer-s-venture-arm-finds-another-startup-worth-leaping-for-40m-gandeeva-financing\n",
      "2022-01-31\n",
      "Biotech\n",
      "Kaleido cuts staff, halts COPD work and COVID program disappears\n",
      "https://www.fiercebiotech.com/biotech/kaleido-a-flagship-microbiome-startup-lays-off-staff-cash-runway-shrinking-report\n",
      "2022-01-28\n",
      "Biotech\n",
      "RNA sequencing enhances pediatric cancer diagnoses: study\n",
      "https://www.fiercebiotech.com/medtech/rna-sequencing-spots-40-more-cancer-mutations-children-than-standard-genetic-tests-study\n",
      "2022-01-28\n",
      "MedTech\n",
      "Charles River Labs deals with SAMDI to boost discovery tech\n",
      "https://www.fiercebiotech.com/cro/charles-river-labs-deals-samdi-tech-to-boost-discovery-business\n",
      "2022-01-28\n",
      "CRO\n",
      "ConvaTec breaks into wound biologics with $450M Triad buy\n",
      "https://www.fiercebiotech.com/medtech/convatec-breaks-into-wound-biologics-market-450m-bid-for-triad-life-sciences\n",
      "2022-01-28\n",
      "MedTech\n",
      "FDA clears Insulet's Omnipod 5 closed-loop tubeless insulin pump\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-insulet-s-omnipod-5-closed-loop-tubeless-insulin-pump-type-1-diabetes-adults\n",
      "2022-01-28\n",
      "MedTech\n",
      "ResMed posts strong Q2 amid vacuum created by Philips recall\n",
      "https://www.fiercebiotech.com/medtech/resmed-reaps-rewards-from-seemingly-infinite-demand-philips-ventilator-recall\n",
      "2022-01-28\n",
      "MedTech\n",
      "Ex-J&J science lead to run struggling Galapagos—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-ex-j-j-science-chief-returns-to-troubled-galapagos-as-ceo\n",
      "2022-01-28\n",
      "Biotech\n",
      "Another delay at Amryt as EMA calls in experts to inform review\n",
      "https://www.fiercebiotech.com/biotech/yet-another-delay-at-amryt-as-ema-calls-experts-to-inform-review-rare-disease-drug\n",
      "2022-01-28\n",
      "Biotech\n",
      "FDA expands oversight over TG's stalled U2 cancer combo therapy\n",
      "https://www.fiercebiotech.com/biotech/fda-places-hold-some-studies-tg-s-u2-combo-cancer-therapy-s-already-under-agency-question\n",
      "2022-01-28\n",
      "Biotech\n",
      "Homology scratches cash itch with $130M deal to fund trials\n",
      "https://www.fiercebiotech.com/biotech/homology-scratches-cash-itch-manufacturing-deal-bagging-130m-to-fund-gene-therapy-trials\n",
      "2022-01-28\n",
      "Biotech\n",
      "Provention med for delaying diabetes clear for FDA resubmission\n",
      "https://www.fiercebiotech.com/biotech/provention-s-med-for-delaying-diabetes-granted-go-ahead-for-fda-resubmission\n",
      "2022-01-27\n",
      "Biotech\n",
      "New Galapagos CEO Stoffels jumps into deals, key hiring decision\n",
      "https://www.fiercebiotech.com/biotech/up-to-paul-now-ex-j-j-science-leader-stoffels-talks-new-ceo-post-at-galapagos-outgoing\n",
      "2022-01-27\n",
      "Biotech\n",
      "InnovHeart lands $55M to take TMVR system to clinical trials\n",
      "https://www.fiercebiotech.com/medtech/innovheart-opens-funding-valve-55m-to-usher-tmvr-system-through-clinical-trials\n",
      "2022-01-27\n",
      "MedTech\n",
      "BioVentrix buys MateraCor for hydrogel heart failure implants\n",
      "https://www.fiercebiotech.com/medtech/bioventrix-cinches-up-materacor-for-a-hydrogel-based-approach-to-heart-failure\n",
      "2022-01-27\n",
      "MedTech\n",
      "Moderna, Excision each enter HIV battle with mRNA, CRISPR tech\n",
      "https://www.fiercebiotech.com/biotech/moderna-starts-testing-mrna-hiv-vaccine-and-excision-launches-crispr-trial-for-virus-months\n",
      "2022-01-27\n",
      "Biotech\n",
      "Philips adds even more ventilators to Class I recall\n",
      "https://www.fiercebiotech.com/medtech/philips-adds-even-more-ventilators-to-class-i-recall-caused-by-faulty-sound-muffling-foam\n",
      "2022-01-27\n",
      "MedTech\n",
      "With GSK, Alector to capitalize on big moment in Alzheimer's\n",
      "https://www.fiercebiotech.com/biotech/gsk-alector-has-big-pharma-backing-to-capitalize-a-big-moment-alzheimer-s-drug-development\n",
      "2022-01-27\n",
      "Biotech\n",
      "Taysha mulls tweaks to gene therapy trial after subject dies\n",
      "https://www.fiercebiotech.com/biotech/taysha-mulls-tweaks-to-gene-therapy-trial-after-subject-dies\n",
      "2022-01-27\n",
      "Biotech\n",
      "Neck and neck with Pfizer, Moderna starts omicron booster trial\n",
      "https://www.fiercebiotech.com/biotech/neck-and-neck-pfizer-moderna-gives-first-dose-omicron-specific-booster-phase-2-trial\n",
      "2022-01-27\n",
      "Biotech\n",
      "Septerna launches with $100M and GPCR pioneer co-founder\n",
      "https://www.fiercebiotech.com/biotech/septerna-emerges-100m-to-spark-second-golden-age-most-prolific-drug-target-gpcr-pioneer-bob\n",
      "2022-01-27\n",
      "Biotech\n",
      "Ex-J&J science chief Stoffels lands at Galapagos to lead rebound\n",
      "https://www.fiercebiotech.com/biotech/nine-year-j-j-science-chief-stoffels-to-steer-galapagos-rebound-as-ceo-amid-m-a-hunt\n",
      "2022-01-26\n",
      "Biotech\n",
      "Blockbuster cancer med Keytruda may help flush out dormant HIV\n",
      "https://www.fiercebiotech.com/research/approved-cancer-drug-keytruda-shows-signs-releasing-hidden-hiv-as-existing-treatments-don\n",
      "2022-01-26\n",
      "Research\n",
      "A tumor growth dilemma offers clue to treating pancreatic cancer\n",
      "https://www.fiercebiotech.com/research/to-be-or-not-to-be-a-tumor-growth-dilemma-offers-clue-to-pancreatic-cancer-drug\n",
      "2022-01-26\n",
      "Research\n",
      "Abbott weathers COVID testing fluctuations with $7.7B in sales\n",
      "https://www.fiercebiotech.com/medtech/abbott-weathers-2021-s-covid-testing-roller-coaster-ride-7-7b-annual-sales\n",
      "2022-01-26\n",
      "MedTech\n",
      "Ziopharm rebrands to Alaunos to put rough year behind it\n",
      "https://www.fiercebiotech.com/biotech/after-halving-workforce-last-fall-ziopharm-rebrands-and-closes-boston-office\n",
      "2022-01-26\n",
      "Biotech\n",
      "Distalmotion nets $90M to take its surgery robot to FDA\n",
      "https://www.fiercebiotech.com/medtech/robotic-surgery-developer-distalmotion-nets-90m-to-expand-worldwide\n",
      "2022-01-26\n",
      "MedTech\n",
      "Cortexyme to focus on 2nd Alzheimer's bet after clinical hold\n",
      "https://www.fiercebiotech.com/biotech/fda-slaps-hold-cortexyme-s-failed-alzheimer-s-drug-forcing-biotech-to-seek-alternatives-for\n",
      "2022-01-26\n",
      "Biotech\n",
      "CytoDyn ousts CEO Pourhassan after a wild year\n",
      "https://www.fiercebiotech.com/biotech/cytodyn-ousts-ceo-after-a-wild-year-leaving-board-albatross-a-c-suite-job-to-fill\n",
      "2022-01-26\n",
      "Biotech\n",
      "Akili to take prescription video game tech public in $1B SPAC\n",
      "https://www.fiercebiotech.com/medtech/akili-inks-1b-spac-deal-to-take-prescription-video-game-tech-public\n",
      "2022-01-26\n",
      "MedTech\n",
      "Incyte pulls approval filing, following Gilead out of the exitIn\n",
      "https://www.fiercebiotech.com/biotech/incyte-pulls-fda-filing-for-cancer-drug-approval-over-confirmatory-study-following-gilead\n",
      "2022-01-26\n",
      "Biotech\n",
      "Gilead's $4.9B oncology bet hit with partial clinical hold\n",
      "https://www.fiercebiotech.com/biotech/gilead-s-4-9b-oncology-bet-hit-partial-clinical-hold-forcing-pause-pivotal-trials-and\n",
      "2022-01-26\n",
      "Biotech\n",
      "Kyverna locks in Gilead, Intellia for $85M financing\n",
      "https://www.fiercebiotech.com/biotech/gilead-tags-along-again-to-support-cell-therapy-biotech-kyverna-85m-fundraising\n",
      "2022-01-26\n",
      "Biotech\n",
      "Iterative Scopes brings AI to Janssen's IBD clinical trials\n",
      "https://www.fiercebiotech.com/medtech/iterative-scopes-brings-gastrointestinal-disease-ai-to-janssen-s-ibd-clinical-trials\n",
      "2022-01-25\n",
      "MedTech\n",
      "Atomwise bulks up C-suite with Boehringer, Moderna alums\n",
      "https://www.fiercebiotech.com/medtech/atomwise-bulks-up-executive-team-boehringer-moderna-bridgebio-alums\n",
      "2022-01-25\n",
      "MedTech\n",
      "AI program predicts annual heart attack risk from retinal scans\n",
      "https://www.fiercebiotech.com/medtech/using-eyes-as-a-window-ai-predicts-annual-heart-attack-risk-from-retinal-scans\n",
      "2022-01-25\n",
      "MedTech\n",
      "FDA approves Medtronic spinal cord stimulators for diabetic pain\n",
      "https://www.fiercebiotech.com/medtech/medtronic-lines-up-fda-approval-for-spinal-cord-stimulators-to-treat-painful-diabetic\n",
      "2022-01-25\n",
      "MedTech\n",
      "Pfizer, BioNTech launch trial for omicron-busting vaccine\n",
      "https://www.fiercebiotech.com/biotech/pfizer-biontech-launch-omicron-busting-vaccine-trial\n",
      "2022-01-25\n",
      "Biotech\n",
      "Sierra’s bet on Gilead castoff pays off, teeing up FDA filing\n",
      "https://www.fiercebiotech.com/biotech/sierra-s-bet-gilead-castoff-pays-off-teeing-up-fda-filing-for-rival-to-incyte-novartis\n",
      "2022-01-25\n",
      "Biotech\n",
      "Moderna partner Metagenomi nabs $175M for CRISPR, new startups\n",
      "https://www.fiercebiotech.com/biotech/moderna-partnered-gene-editor-metagenomi-snags-175m-from-bayer-bms-novo-and-vc-shops\n",
      "2022-01-25\n",
      "Biotech\n",
      "AstraZeneca success torpedoes PCI's pivotal plan, crushing stock\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-success-torpedoes-pci-s-pivotal-plan-crushing-stock\n",
      "2022-01-25\n",
      "Biotech\n",
      "Cell therapy boosts survival in pancreatic cancer animal model\n",
      "https://www.fiercebiotech.com/research/car-natural-killer-cell-therapy-extends-survival-pancreatic-cancer-mouse-model-cytoimmune\n",
      "2022-01-25\n",
      "Research\n",
      "Leyden nabs $140M to stop viruses 'at the gate' with nasal spray\n",
      "https://www.fiercebiotech.com/biotech/leyden-labs-license-from-j-j-secures-140m-to-stop-viruses-at-gate-nasal-spray\n",
      "2022-01-25\n",
      "Biotech\n",
      "Capricor, Nippon ink $705M biobucks deal for phase 3 DMD therapy\n",
      "https://www.fiercebiotech.com/biotech/capricor-lines-up-705m-biobucks-deal-for-phase-3-dmd-therapy-nippon-a-dmd-drugmaker\n",
      "2022-01-25\n",
      "Biotech\n",
      "New understanding of tau could inform Alzheimer's treatments\n",
      "https://www.fiercebiotech.com/research/new-research-shows-how-tau-popular-alzheimer-s-treatment-target-spreads-and-binds-to\n",
      "2022-01-24\n",
      "Research\n",
      "89bio's NASH candidate spurs disease improvement\n",
      "https://www.fiercebiotech.com/biotech/89bio-trying-to-rise-from-ashes-nash-failures-sees-improvement-disease-severity\n",
      "2022-01-24\n",
      "Biotech\n",
      "Mammoth gets green light for CRISPR-powered COVID test\n",
      "https://www.fiercebiotech.com/medtech/fda-authorizes-mammoth-bio-s-high-throughput-crispr-test-for-covid-19\n",
      "2022-01-24\n",
      "MedTech\n",
      "Medtronic snags Class I recall for HawkOne atherectomy system\n",
      "https://www.fiercebiotech.com/medtech/medtronic-snags-another-class-i-recall-time-for-its-artery-clearing-hawkone-system\n",
      "2022-01-24\n",
      "MedTech\n",
      "Fluidigm scores $250M infusion and a new CEO\n",
      "https://www.fiercebiotech.com/medtech/fluidigm-scores-250m-investment-microfluidics-tech-and-a-corporate-makeover-to-boot\n",
      "2022-01-24\n",
      "MedTech\n",
      "Clinical trial organization launches to cut costs\n",
      "https://www.fiercebiotech.com/cro/new-clinical-trial-organization-will-apply-covid-19-learnings-to-reinvent-randomized-studies\n",
      "2022-01-24\n",
      "CRO\n",
      "Next-gen COVID shots need differentiation, pan-variant potential\n",
      "https://www.fiercebiotech.com/biotech/does-world-need-more-covid-19-vaccines-these-companies-think-there-s-still-room-for\n",
      "2022-01-24\n",
      "Biotech\n",
      "Merck's chronic cough med gets a nay from FDA\n",
      "https://www.fiercebiotech.com/biotech/merck-s-chronic-cough-med-rejected-by-fda-accepted-japan-potentially-paving-way-for-bellus\n",
      "2022-01-24\n",
      "Biotech\n",
      "Philips took €719M hit to bottom line after ventilator recall\n",
      "https://www.fiercebiotech.com/medtech/philips-prepares-for-rocky-start-to-2022-after-ventilator-recall-aimed-eu719m-hit-at-2021\n",
      "2022-01-24\n",
      "MedTech\n",
      "Casana lands $30M to take its smart toilet seat to the FDA\n",
      "https://www.fiercebiotech.com/medtech/casana-lands-30m-to-take-its-heart-scanning-smart-toilet-seat-to-fda\n",
      "2022-01-24\n",
      "MedTech\n",
      "FDA hits Viking clinical hold over mix-up in phase of trial\n",
      "https://www.fiercebiotech.com/biotech/1b-or-not-1b-fda-hits-viking-clinical-hold-over-mixup-phase-rare-disease-trial\n",
      "2022-01-24\n",
      "Biotech\n",
      "MaaT wraps up microbiome trial early to power into phase 2/3\n",
      "https://www.fiercebiotech.com/biotech/maat-wraps-up-cancer-microbiome-trial-early-to-power-into-phase-2-3-year\n",
      "2022-01-24\n",
      "Biotech\n",
      "Exact Sciences offers early look at its next-gen Cologuard test\n",
      "https://www.fiercebiotech.com/medtech/exact-sciences-posts-early-positive-data-from-its-next-generation-cologuard-home-screening\n",
      "2022-01-21\n",
      "MedTech\n",
      "Alnylam touts data replication for next-generation Onpattro\n",
      "https://www.fiercebiotech.com/biotech/alnylam-touts-data-replication-for-next-generation-onpattro-attr-trial-as-fda-ponders\n",
      "2022-01-21\n",
      "Biotech\n",
      "Rockley Photonics' blood pressure sensors clear pilot study\n",
      "https://www.fiercebiotech.com/medtech/apple-partner-rockley-photonics-wearable-blood-pressure-sensors-clear-pilot-study\n",
      "2022-01-21\n",
      "MedTech\n",
      "Mirati's KRAS drug has 41% response in GI amid Amgen competition\n",
      "https://www.fiercebiotech.com/biotech/mirati-s-very-big-drug-adagrasib-at-fda-s-doors-for-lung-cancer-leads-to-41-response-gi\n",
      "2022-01-21\n",
      "Biotech\n",
      "BD debuts cell sorter that links fluorescence with visual images\n",
      "https://www.fiercebiotech.com/medtech/bd-unveils-high-throughput-cell-sorter-merges-fluorescence-visual-imaging\n",
      "2022-01-21\n",
      "MedTech\n",
      "Bayer's VC arm making 'Leaps' via 'fewer, but maybe bigger bets'\n",
      "https://www.fiercebiotech.com/biotech/biopharma-vc-world-what-does-it-mean-to-take-a-leap-interview-head-leaps-by-bayer\n",
      "2022-01-21\n",
      "Biotech\n",
      "GSK to Bezos-backed biotech: Barron hops jobs—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-glaxosmithkline-s-chief-science-officer-barron-departs-for-bezos-backed\n",
      "2022-01-21\n",
      "Biotech\n",
      "MD Anderson inks deal to put Chinese cancer drugs through trials\n",
      "https://www.fiercebiotech.com/biotech/md-anderson-inks-deal-to-put-chinese-cancer-drugs-through-trials-starting-a-pi3k-inhibitor\n",
      "2022-01-21\n",
      "Biotech\n",
      "Kura exits FDA clinical hold after agreeing to mitigation plans\n",
      "https://www.fiercebiotech.com/biotech/kura-exits-fda-clinical-hold-after-agreeing-mitigation-measures-enabling-resumption-blood\n",
      "2022-01-21\n",
      "Biotech\n",
      "How decoy vesicles could be a new COVID-19 drug against variants\n",
      "https://www.fiercebiotech.com/research/decoy-vesicles-protect-against-covid-19-from-coronavirus-variants-mice\n",
      "2022-01-20\n",
      "Research\n",
      "FDA urges limited blood draws as collection tube supply dwindles\n",
      "https://www.fiercebiotech.com/medtech/fda-urges-doctors-to-prioritize-blood-draws-as-collection-tube-supplies-dwindle\n",
      "2022-01-20\n",
      "MedTech\n",
      "Acutus Medical plans layoffs to cut costs amid rising revenues\n",
      "https://www.fiercebiotech.com/medtech/acutus-medical-plans-cost-cutting-layoffs-despite-doubling-revenue-2021\n",
      "2022-01-20\n",
      "MedTech\n",
      "Senators call for FTC probe into COVID test price gouging\n",
      "https://www.fiercebiotech.com/medtech/senators-request-ftc-investigation-unfair-deceptive-and-harmful-covid-test-price-gouging\n",
      "2022-01-20\n",
      "MedTech\n",
      "Super-resolution microscope maker Oni nabs $75M for US expansion\n",
      "https://www.fiercebiotech.com/medtech/super-resolution-microscope-maker-oni-nabs-75m-for-us-expansion\n",
      "2022-01-20\n",
      "MedTech\n",
      "CROs embracing tech to decentralize trials, speed enrollment\n",
      "https://www.fiercebiotech.com/cro/cros-embracing-tech-to-decentralize-trials-and-speed-enrolment-study\n",
      "2022-01-20\n",
      "CRO\n",
      "Eli Lilly CEO Ricks is ready to take on Biogen in Alzheimer's\n",
      "https://www.fiercebiotech.com/biotech/fierce-jpm-week-confidence-high-for-eli-lilly-ceo-ricks-showdown-biogen-s-aduhelm\n",
      "2022-01-20\n",
      "Biotech\n",
      "Metis poaches Kala CSO to support move into the clinic\n",
      "https://www.fiercebiotech.com/biotech/fresh-from-86m-series-a-metis-poaches-kala-cso-to-support-move-into-clinic\n",
      "2022-01-20\n",
      "Biotech\n",
      "Bloodletting at Zymeworks as new CEO axes half of senior leaders\n",
      "https://www.fiercebiotech.com/biotech/bloodletting-at-zymeworks-as-new-ceo-axes-half-senior-leaders-plans-25-reduction-headcount\n",
      "2022-01-20\n",
      "Biotech\n",
      "Eleusis signs $288M SPAC deal to test psychedelic depression med\n",
      "https://www.fiercebiotech.com/biotech/eleusis-joins-cooled-off-spac-market-288m-to-bankroll-psychedelic-based-drug-for-depression\n",
      "2022-01-20\n",
      "Biotech\n",
      "Novartis-backed ImmPACT Bio gets $111M, ex-Pfizer exec for CEO\n",
      "https://www.fiercebiotech.com/biotech/novartis-backed-immpact-bio-snags-111m-new-ceo-and-provides-phase-1-data-cancer-car-t\n",
      "2022-01-20\n",
      "Biotech\n",
      "Artificial pancreas app shows strong control of T1D in toddlers\n",
      "https://www.fiercebiotech.com/medtech/artificial-pancreas-app-delivers-stronger-control-type-1-diabetes-toddlers-and-young\n",
      "2022-01-19\n",
      "MedTech\n",
      "Sage wants to 'raise the bar' on depression meds\n",
      "https://www.fiercebiotech.com/biotech/fierce-jpm-week-depression-through-roof-amid-covid-19-sage-wants-to-raise-bar-meds\n",
      "2022-01-19\n",
      "Biotech\n",
      "Novartis tries to avoid 'me-too' meds in M&A hunt\n",
      "https://www.fiercebiotech.com/biotech/fierce-jpm-week-as-novartis-hunts-for-m-a-gems-among-me-too-companies-r-d-chief-urges\n",
      "2022-01-19\n",
      "Biotech\n",
      "Johnson & Johnson's JLABS: Taming the beast\n",
      "https://www.fiercebiotech.com/biotech/johnson-johnson-s-jlabs-taming-beast-while-letting-it-roam-world\n",
      "2022-01-19\n",
      "Biotech\n",
      "Stop sugarcoating cancer cells to empower CAR-T in solid tumors\n",
      "https://www.fiercebiotech.com/research/stop-sugarcoating-cancer-cells-to-empower-car-t-therapy-solid-tumors\n",
      "2022-01-19\n",
      "Research\n",
      "Exscientia appoints first chief scientist of biologics AI\n",
      "https://www.fiercebiotech.com/medtech/exscientia-appoints-oxford-bioinformatics-expert-as-first-chief-scientist-biologics-ai\n",
      "2022-01-19\n",
      "MedTech\n",
      "ProtaGene to target analytics demand; plans US testing facility\n",
      "https://www.fiercebiotech.com/cro/new-cro-protagene-to-target-analytics-demand-plans-us-testing-facility\n",
      "2022-01-19\n",
      "CRO\n",
      "Iterative Scopes bags $150M with colonoscopy AI under FDA review\n",
      "https://www.fiercebiotech.com/medtech/iterative-scopes-bags-150m-as-its-colonoscopy-ai-undergoes-fda-review\n",
      "2022-01-19\n",
      "MedTech\n",
      "Eisai takes baton from Biogen for next Alzheimer's prospect\n",
      "https://www.fiercebiotech.com/biotech/eisai-takes-baton-from-biogen-as-next-alzheimer-s-prospect-follows-aduhelm-s-footprints\n",
      "2022-01-19\n",
      "Biotech\n",
      "Sensorion sinks as lead hearing loss med fails phase 2\n",
      "https://www.fiercebiotech.com/biotech/sensorion-fails-midstage-sudden-hearing-loss-study-but-awaits-more-data-march-before\n",
      "2022-01-19\n",
      "Biotech\n",
      "Smith & Nephew kicks in $135M for cementless knee implant tech\n",
      "https://www.fiercebiotech.com/medtech/smith-nephew-kicks-135m-for-cementless-knee-implant-maker-engage-surgical\n",
      "2022-01-19\n",
      "MedTech\n",
      "After mRNA fame, biotech looks to tinker with winning formula\n",
      "https://www.fiercebiotech.com/biotech/fierce-jpm-week-after-objectively-astonishing-progress-mrna-biotech-looks-to-tinker-winning\n",
      "2022-01-19\n",
      "Biotech\n",
      "Altos exits stealth with $3B, dream team C-suite and big vision\n",
      "https://www.fiercebiotech.com/biotech/altos-bursts-out-stealth-3b-a-dream-team-c-suite-and-a-wildly-ambitious-plan-to-reverse\n",
      "2022-01-19\n",
      "Biotech\n",
      "Barron quits GSK to take CEO post at $3B biotech startup\n",
      "https://www.fiercebiotech.com/biotech/barron-quits-gsk-to-take-ceo-post-at-3b-biotech-startup-leaving-wood-to-finish-what-he\n",
      "2022-01-19\n",
      "Biotech\n",
      "BMS, VCs back Ceptur with $75M for RNA meds to silence pre-mRNA\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-vcs-launch-new-rna-therapeutics-biotech-ceptur-75m-to-silence-pre-mrna\n",
      "2022-01-19\n",
      "Biotech\n",
      "Schrödinger picks up protein crystallographer XTAL BioStructures\n",
      "https://www.fiercebiotech.com/medtech/schrodinger-picks-up-protein-crystallographer-xtal-biostructures\n",
      "2022-01-18\n",
      "MedTech\n",
      "Bayer's new R&D chief wants to push past Aspirin legacy\n",
      "https://www.fiercebiotech.com/biotech/jpm-2022-bayer-s-research-head-looks-to-reinvent-r-d-as-pharma-innovates-biotech\n",
      "2022-01-18\n",
      "Biotech\n",
      "Philips adds AI, 3D mapping to mobile X-ray platform\n",
      "https://www.fiercebiotech.com/medtech/philips-taps-cydar-to-add-ai-3d-mapping-to-mobile-x-ray-platform\n",
      "2022-01-18\n",
      "MedTech\n",
      "Pharma reflects on the 'aha! moments' of the pandemic\n",
      "https://www.fiercebiotech.com/biotech/fierce-jpm-week-pharma-reflects-aha-moments-pandemic-which-spurred-new-drive-for-clinical\n",
      "2022-01-18\n",
      "Biotech\n",
      "Lilly extends JPM collab theme in $1B Evotec pact, Abbisko deal\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-lines-up-1b-258m-pacts-across-metabolic-diseases-evotec-abbisko\n",
      "2022-01-18\n",
      "Biotech\n",
      "UCB's bispecific notches phase 3 win for spinal arthritis\n",
      "https://www.fiercebiotech.com/biotech/as-it-awaits-psoriasis-nod-ucb-s-bimekizumab-also-meets-phase-3-goal-spine-arthritis\n",
      "2022-01-18\n",
      "Biotech\n",
      "Officials struggle to regulate pop-up COVID testing sites\n",
      "https://www.fiercebiotech.com/medtech/officials-struggle-to-regulate-pop-up-covid-testing-sites-and-warn-patients-to-beware\n",
      "2022-01-18\n",
      "MedTech\n",
      "Sema4 signals $623M bid for genetic testing provider GeneDx\n",
      "https://www.fiercebiotech.com/medtech/sema4-signals-623m-acquisition-genetic-testing-provider-genedx\n",
      "2022-01-18\n",
      "MedTech\n",
      "Heart arrhythmia drug reduces tumor spread in cancer mouse model\n",
      "https://www.fiercebiotech.com/research/repurposing-approved-heart-arrhythmia-drug-to-treat-spread-tumor-cells-breast-cancer\n",
      "2022-01-18\n",
      "Research\n",
      "DNA vaccine spurs antibodies against Parkinson's target in mice\n",
      "https://www.fiercebiotech.com/research/dna-vaccine-induces-antibodies-against-common-parkinson-s-target-mice\n",
      "2022-01-18\n",
      "Research\n",
      "ProKidney’s $825M SPAC merger tees up cell therapy phase 3\n",
      "https://www.fiercebiotech.com/biotech/825m-spac-merger-prokidney-sets-stage-for-phase-3-trial-kidney-disease-cell-therapy\n",
      "2022-01-18\n",
      "Biotech\n",
      "Roche returns to phase 2 after seeing signal in pivotal flop\n",
      "https://www.fiercebiotech.com/biotech/rewind-roche-returns-to-phase-2-after-seeing-post-hoc-signal-failed-pivotal-huntington-s\n",
      "2022-01-18\n",
      "Biotech\n",
      "The top 10 medtech M&A deals of 2021\n",
      "https://www.fiercebiotech.com/special-report/top-10-medtech-m-a-deals-2021\n",
      "2022-01-18\n",
      "Special Reports\n",
      "After Wegovy win, Novo extends obesity research in EraCal collab\n",
      "https://www.fiercebiotech.com/biotech/novo-nordisk-teams-up-eracal-therapeutics-obesity-research-collaboration\n",
      "2022-01-17\n",
      "Biotech\n",
      "Medtronic shows relief, longer battery life with low-power SCS\n",
      "https://www.fiercebiotech.com/medtech/medtronic-projects-pain-relief-longer-battery-life-low-power-spinal-cord-stimulation\n",
      "2022-01-14\n",
      "MedTech\n",
      "Bausch + Lomb files IPO for its eye care spinout\n",
      "https://www.fiercebiotech.com/medtech/jpm-2022-bausch-lomb-files-ipo-for-its-eye-care-spinout\n",
      "2022-01-14\n",
      "MedTech\n",
      "Verana Health lands J&J, Novo backing in $150M round\n",
      "https://www.fiercebiotech.com/medtech/verana-lands-j-j-novo-led-150m-funding-to-hone-real-world-database-for-drug-device\n",
      "2022-01-14\n",
      "MedTech\n",
      "New era: Flagship CEO, Moderna chair's first annual letter\n",
      "https://www.fiercebiotech.com/biotech/shots-goal-to-deterministic-drug-development-flagship-ceo-moderna-chair-noubar-afeyan-pens\n",
      "2022-01-14\n",
      "Biotech\n",
      "Decentralized trials, broader services key trends for CROs\n",
      "https://www.fiercebiotech.com/biotech/jpm22-decentralized-trials-broader-service-offering-and-novel-drugs-key-trends-cro-space\n",
      "2022-01-14\n",
      "CRO\n",
      "Galapagos aims to announce new CEO within weeks—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-galapagos-says-new-ceo-expected-within-weeks-not-months\n",
      "2022-01-14\n",
      "Biotech\n",
      "JPM 2022: Licensing and research tie-ups trump M&A\n",
      "https://www.fiercebiotech.com/biotech/jpm-2022-reflection-last-year-licensing-tie-ups-trump-m-a-at-conference\n",
      "2022-01-14\n",
      "Biotech\n",
      "FDA approval, partnership on agenda at Mithra as phase 3 hits\n",
      "https://www.fiercebiotech.com/biotech/fda-approval-global-partnership-agenda-at-mithra-as-phase-3-menopause-trials-hit-goals-one\n",
      "2022-01-14\n",
      "Biotech\n",
      "EMA sets out plan to accelerate clinical trials\n",
      "https://www.fiercebiotech.com/biotech/ema-sets-out-plan-to-accelerate-clinical-trials-reduce-administrative-burdenema-sets-out\n",
      "2022-01-14\n",
      "Biotech\n",
      "PacBio taps Google to boost long-read DNA sequencing accuracy\n",
      "https://www.fiercebiotech.com/medtech/jpm-2022-pacbio-taps-google-to-boost-long-read-dna-sequencing-accuracy\n",
      "2022-01-13\n",
      "MedTech\n",
      "Biden pledges to make 1B COVID tests available for free online\n",
      "https://www.fiercebiotech.com/medtech/biden-to-make-1b-covid-tests-available-for-free-online-doubling-previous-500m-pledge\n",
      "2022-01-13\n",
      "MedTech\n",
      "Blocking immune cells' smelling ability to treat heart disease\n",
      "https://www.fiercebiotech.com/research/fending-off-heart-disease-by-blocking-how-immune-cells-smell-their-surroundings\n",
      "2022-01-13\n",
      "Research\n",
      "Galapagos' 2022 rebuild means M&A and a new CEO\n",
      "https://www.fiercebiotech.com/biotech/jpm-2022-galapagos-m-a-hunt-5-6b-cash-as-new-ceo-expected-within-weeks-to-rebuild-after\n",
      "2022-01-13\n",
      "Biotech\n",
      "Renalytix aims for 2022 FDA clearance for kidney disease AI\n",
      "https://www.fiercebiotech.com/medtech/jpm-2022-renalytix-plots-de-novo-fda-nod-for-kidney-disease-ai-expands-into-drug-response\n",
      "2022-01-13\n",
      "MedTech\n",
      "Fosun Pharma invests in Insilico for its AI drug discovery work\n",
      "https://www.fiercebiotech.com/medtech/jpm-2022-fosun-pharma-invests-insilico-medicine-for-its-ai-drug-discovery-programs\n",
      "2022-01-13\n",
      "MedTech\n",
      "Stanford sets Guinness World Record for fastest DNA sequencing\n",
      "https://www.fiercebiotech.com/medtech/stanford-s-new-five-hour-dna-sequencing-technique-lands-guinness-world-record\n",
      "2022-01-13\n",
      "MedTech\n",
      "AstraZeneca doubles down on BenevolentAI drug hunting project\n",
      "https://www.fiercebiotech.com/medtech/astrazeneca-doubles-down-benevolentai-drug-hunting-partnership-adding-heart-failure-lupus\n",
      "2022-01-13\n",
      "MedTech\n",
      "Denali denied: FDA says no trial to Takeda-aided Alzheimer's med\n",
      "https://www.fiercebiotech.com/biotech/fda-stops-denali-s-takeda-partnered-alzheimer-s-drug-from-entering-clinic\n",
      "2022-01-13\n",
      "Biotech\n",
      "JPM22, Day 4: Gritstone wants new biomarker; Galapagos' rebound\n",
      "https://www.fiercebiotech.com/biotech/jpm22-day-4-vertex-aims-to-be-cystic-fibrosis-leader-into-2030s\n",
      "2022-01-13\n",
      "Biotech\n",
      "Sarepta, with pivotal data in sight, dumps Lysogene gene therapy\n",
      "https://www.fiercebiotech.com/biotech/sarepta-pivotal-data-sight-dumps-lysogene-gene-therapy\n",
      "2022-01-13\n",
      "Biotech\n",
      "AstraZeneca inks $75M undruggable target pact with Scorpion\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-pays-hoos-helmed-scorpion-75m-to-take-sting-out-undruggable-cancer-targets\n",
      "2022-01-13\n",
      "Biotech\n",
      "Amid expanded ventilator recall, Philips misses Q4 earnings mark\n",
      "https://www.fiercebiotech.com/medtech/philips-still-hobbled-by-expanded-ventilator-recall-braces-for-q4-earnings-miss\n",
      "2022-01-12\n",
      "MedTech\n",
      "Editas plans to layer on gene editing proof of concept in 2022\n",
      "https://www.fiercebiotech.com/biotech/jpm22-editas-which-caught-flack-2021-for-limited-gene-editing-data-plans-to-layer-proof\n",
      "2022-01-12\n",
      "Biotech\n",
      "Intellia stacks ATTR trial with new patient group\n",
      "https://www.fiercebiotech.com/biotech/jpm22-intellia-eye-to-bridgebio-s-phase-3-set-back-stacks-attr-trial-new-patient-group\n",
      "2022-01-12\n",
      "Biotech\n",
      "Fighting leukemia by targeting a little-known protein\n",
      "https://www.fiercebiotech.com/research/fighting-leukemia-by-targeting-a-little-known-protein\n",
      "2022-01-12\n",
      "Research\n",
      "AI discovery tech firm Quris snags $28M seed round\n",
      "https://www.fiercebiotech.com/cro/ai-discovery-tech-firm-quris-completes-28-million-seed-funding-round\n",
      "2022-01-12\n",
      "CRO\n",
      "Suneva Medical books makeover with $511M SPAC deal\n",
      "https://www.fiercebiotech.com/medtech/aesthetics-devicemaker-suneva-medical-lines-up-511m-spac-makeover\n",
      "2022-01-12\n",
      "MedTech\n",
      "BeyondSpring axes 35% of US staff after November drug rejection\n",
      "https://www.fiercebiotech.com/biotech/beyondspring-axes-35-u-s-staff-after-november-drug-rejection-upcoming-fda-filing\n",
      "2022-01-12\n",
      "Biotech\n",
      "FDA cracks down on use of unauthorized LuSys COVID tests\n",
      "https://www.fiercebiotech.com/medtech/fda-cracks-down-use-lusys-laboratories-unauthorized-covid-tests\n",
      "2022-01-12\n",
      "MedTech\n",
      "Roche taps Glytec app for its hospital bedside glucose monitor\n",
      "https://www.fiercebiotech.com/medtech/jpm-2022-roche-launches-smart-handheld-glucose-meter-for-hospital-bedside\n",
      "2022-01-12\n",
      "MedTech\n",
      "Abbott nabs FDA clearance for its EnSite heart mapping platform\n",
      "https://www.fiercebiotech.com/medtech/abbott-scores-fda-clearance-for-its-latest-ensite-heart-mapping-platform\n",
      "2022-01-12\n",
      "MedTech\n",
      "Sanofi makes $75M preclinical bet to join busy Parkinson's field\n",
      "https://www.fiercebiotech.com/biotech/sanofi-makes-75m-preclinical-bet-to-join-roche-novartis-and-more-congested-parkinson-s\n",
      "2022-01-12\n",
      "Biotech\n",
      "Decentralized trials pay off financially, study finds\n",
      "https://www.fiercebiotech.com/cro/decentralized-studies-offer-financial-benefits-says-new-study\n",
      "2022-01-12\n",
      "CRO\n",
      "JPM22, Day 3: BeiGene promises 10 new molecules per year by 2024\n",
      "https://www.fiercebiotech.com/biotech/jpm22-day-3-beigene-promises-10-new-molecules-per-year-for-2-years\n",
      "2022-01-12\n",
      "Biotech\n",
      "Daiichi axes Plexxikon R&D facility to free up cash for ADC work\n",
      "https://www.fiercebiotech.com/biotech/daiichi-axes-60-person-plexxikon-r-d-facility-california-to-free-up-cash-for-adc\n",
      "2022-01-12\n",
      "Biotech\n",
      "Enanta's COVID med hits clinic next month expecting more demand\n",
      "https://www.fiercebiotech.com/biotech/pfizer-merck-can-t-fill-all-covid-19-treatment-demand-so-enanta-will-enter-clinic-next\n",
      "2022-01-11\n",
      "Biotech\n",
      "Sana inks $204M biobucks pact with IASO, Innovent for CAR access\n",
      "https://www.fiercebiotech.com/biotech/sana-links-arms-iaso-innovent-204m-biobucks-pact-for-access-to-car-for-up-to-six-products\n",
      "2022-01-11\n",
      "Biotech\n",
      "Dexcom shows off new G7 sensor data after submitting to FDA\n",
      "https://www.fiercebiotech.com/medtech/jpm-2022-dexcom-shows-off-new-g7-sensor-data-after-submitting-for-fda-review\n",
      "2022-01-11\n",
      "MedTech\n",
      "Cardiovascular Systems recalls faulty embolic protection devices\n",
      "https://www.fiercebiotech.com/medtech/cardiovascular-systems-recalls-embolic-protection-devices-may-break-off-during-atherectomy\n",
      "2022-01-11\n",
      "MedTech\n",
      "BMS, 2seventy axe multiple myeloma CAR-T after Abecma greenlight\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-2seventy-cull-multiple-myeloma-car-t-as-abecma-sales-pick-up\n",
      "2022-01-11\n",
      "Biotech\n",
      "Withings picks up skin-sensor maker Impeto for its home devices\n",
      "https://www.fiercebiotech.com/medtech/jpm-2022-withings-picks-up-skin-sensor-maker-impeto-for-its-smart-scales-and-other-consumer\n",
      "2022-01-11\n",
      "MedTech\n",
      "First pig heart successfully transplanted in human patient\n",
      "https://www.fiercebiotech.com/medtech/revivicor-s-genetically-modified-pig-heart-first-successfully-transplanted-human-patient\n",
      "2022-01-11\n",
      "MedTech\n",
      "JPM22, Day 2: Freenome passes $1B in funds; Amgen taps Arrakis\n",
      "https://www.fiercebiotech.com/biotech/jpm22-day-2\n",
      "2022-01-11\n",
      "Biotech\n",
      "Amgen teams up with Arrakis in $75M RNA-destroying research deal\n",
      "https://www.fiercebiotech.com/biotech/amgen-teams-up-arrakis-to-destroy-disease-causing-rna-75m-research-deal\n",
      "2022-01-11\n",
      "Biotech\n",
      "Regeneron, 2seventy name target of first solid tumor CAR-T\n",
      "https://www.fiercebiotech.com/biotech/regeneron-2seventy-name-target-their-first-solid-tumor-car-t-target-2023-ind\n",
      "2022-01-11\n",
      "Biotech\n",
      "Freenome passes $1B funding mark with $290M from Roche\n",
      "https://www.fiercebiotech.com/medtech/freenome-passes-1b-funding-mark-290m-from-roche-for-cancer-blood-tests\n",
      "2022-01-11\n",
      "MedTech\n",
      "Amgen dons BigHat to bring AI insights to next-gen antibodies\n",
      "https://www.fiercebiotech.com/biotech/amgen-dons-bighat-to-bring-ai-insights-to-next-gen-antibodies\n",
      "2022-01-11\n",
      "Biotech\n",
      "Easing blood clotting through a new pathway\n",
      "https://www.fiercebiotech.com/research/new-pathway-shows-signs-new-treatment-target-for-blood-clotting-study\n",
      "2022-01-11\n",
      "Research\n",
      "Illumina outlines future long-read chemistry, posts sales record\n",
      "https://www.fiercebiotech.com/medtech/jpm-2022-illumina-posts-new-sales-records-outlines-future-long-read-chemistry-plans\n",
      "2022-01-10\n",
      "MedTech\n",
      "Hormone in fat tissue could lead to new diabetes meds: study\n",
      "https://www.fiercebiotech.com/research/researchers-find-hormone-fat-tissue-could-help-insulin-resistant-patients-diabetes\n",
      "2022-01-10\n",
      "Research\n",
      "Amicus axes gene therapy program for type of Batten disease\n",
      "https://www.fiercebiotech.com/biotech/jpm-2022-amicus-axes-gene-therapy-program-for-type-batten-disease-advances-another\n",
      "2022-01-10\n",
      "Biotech\n",
      "23andMe snags 3rd FDA nod for genetic cancer risk test\n",
      "https://www.fiercebiotech.com/medtech/23andme-snags-3rd-fda-nod-for-cancer-risk-test-time-to-spot-signs-prostate-cancer\n",
      "2022-01-10\n",
      "MedTech\n",
      "Seer launches next-generation proteomics research platform\n",
      "https://www.fiercebiotech.com/medtech/seer-launches-next-generation-proteomics-research-platform\n",
      "2022-01-10\n",
      "MedTech\n",
      "Sarepta gene therapy improves motor skills, FDA filing next year\n",
      "https://www.fiercebiotech.com/biotech/sarepta-likely-to-ask-fda-to-approve-duchenne-muscular-gene-therapy-next-year-following-new\n",
      "2022-01-10\n",
      "Biotech\n",
      "Acadia to Stoke up pipeline with $60M CNS research pact\n",
      "https://www.fiercebiotech.com/biotech/jpm-2022-acadia-to-stoke-up-pipeline-60m-central-nervous-system-research-pact\n",
      "2022-01-10\n",
      "Biotech\n",
      "J&J taps Microsoft to connect its digital surgery efforts\n",
      "https://www.fiercebiotech.com/medtech/jpm22-johnson-johnson-links-up-microsoft-to-cloud-connect-its-digital-surgery-programs\n",
      "2022-01-10\n",
      "MedTech\n",
      "Bristol Myers inks $3B in Century, ArsenalBio cell therapy deals\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-signs-3b-biobucks-deal-century-for-cell-therapies-for-hematologic-solid\n",
      "2022-01-10\n",
      "Biotech\n",
      "Moderna strikes $45M deal with macrophage biotech Carisma\n",
      "https://www.fiercebiotech.com/biotech/moderna-finds-carisma-s-macrophage-tech-compelling-enough-for-45m-cancer-research-deal\n",
      "2022-01-10\n",
      "Biotech\n",
      "FDA allows Allogene to resume CAR-T trials after safety scare\n",
      "https://www.fiercebiotech.com/biotech/fda-allows-allogene-to-resume-all-five-its-car-t-trials-after-safety-scare-october\n",
      "2022-01-10\n",
      "Biotech\n",
      "Exact Sciences nabs cancer tester PreventionGenetics\n",
      "https://www.fiercebiotech.com/medtech/jpm22-exact-sciences-nabs-cancer-tester-preventiongenetics-for-190m\n",
      "2022-01-10\n",
      "MedTech\n",
      "Medtronic offers $925M for Affera’s cardiac mapping tech\n",
      "https://www.fiercebiotech.com/medtech/jpm22-medtronic-makes-925m-offer-for-affera-aiming-to-break-into-advanced-cardiac-mapping\n",
      "2022-01-10\n",
      "MedTech\n",
      "BioNTech builds to a Crescendo with $750M cancer research pact\n",
      "https://www.fiercebiotech.com/biotech/biontech-its-way-to-deal-crescendo-a-750m-biobucks-pact-for-immunotherapies\n",
      "2022-01-10\n",
      "Biotech\n",
      "BioMarin's hemophilia A gene therapy hits goal in phase 3\n",
      "https://www.fiercebiotech.com/biotech/biomarin-s-hemophilia-b-gene-therapy-hits-goal-phase-3-teeing-up-fda-filing-despite\n",
      "2022-01-10\n",
      "Biotech\n",
      "Maze snares $190M as its top asset aims for clinic\n",
      "https://www.fiercebiotech.com/biotech/maze-therapeutics-navigates-190m-financing-round-as-it-plots-course-to-clinic\n",
      "2022-01-10\n",
      "Biotech\n",
      "Pfizer locks in 2 partners to solidify status as mRNA powerhouse\n",
      "https://www.fiercebiotech.com/biotech/jpm-2022-pfizer-locks-2-partners-to-solidify-status-as-mrna-powerhouse\n",
      "2022-01-10\n",
      "Biotech\n",
      "Pfizer digs into gene editing with $300M Beam pact\n",
      "https://www.fiercebiotech.com/biotech/jpm-2022-pfizer-sees-bright-light-300m-beam-research-pact-for-base-editing-candidates\n",
      "2022-01-10\n",
      "Biotech\n",
      "Novartis splashes cash on COVID-19 antiviral, plans FDA filing\n",
      "https://www.fiercebiotech.com/biotech/novartis-splashes-cash-covid-19-antiviral-plans-fda-filing-as-molecular-partners-links-drug\n",
      "2022-01-10\n",
      "Biotech\n",
      "JPM22, Day 1: Bayer strikes a Mammoth deal and more\n",
      "https://www.fiercebiotech.com/biotech/jpm-day-1-bayer-strikes-a-mammoth-deal-no-sunday-buyouts-pfizer-delves-deeper-gene-editing\n",
      "2022-01-10\n",
      "Biotech\n",
      "Bayer bolsters gene therapy ambition with Mammoth CRISPR deal\n",
      "https://www.fiercebiotech.com/biotech/bayer-gene-therapy-ambition-mammoth-crispr-deal-gene-editing-science-jennifer-doudna-lab\n",
      "2022-01-10\n",
      "Biotech\n",
      "MeMed nets $93M for tests spotting viral, bacterial infections\n",
      "https://www.fiercebiotech.com/medtech/memed-secures-93m-for-tests-to-identify-viral-bacterial-infections\n",
      "2022-01-10\n",
      "MedTech\n",
      "DOJ charges doctor in $46M Medicare fraud scheme\n",
      "https://www.fiercebiotech.com/medtech/doj-charges-doctor-reusing-single-use-devices-46m-medicare-fraud-scheme\n",
      "2022-01-07\n",
      "MedTech\n",
      "Merck leans into AI with $610M in biobucks for Absci\n",
      "https://www.fiercebiotech.com/biotech/merck-leans-into-ai-610m-biobucks-for-absci-drug-discovery-pact\n",
      "2022-01-07\n",
      "Biotech\n",
      "Medtronic recalls StealthStation neurosurgery software, again\n",
      "https://www.fiercebiotech.com/medtech/medtronic-s-stealthstation-neurosurgery-navigation-software-hit-class-i-recall\n",
      "2022-01-07\n",
      "MedTech\n",
      "Cue to develop omicron-specific COVID test with BARDA backing\n",
      "https://www.fiercebiotech.com/medtech/cue-health-to-develop-omicron-specific-portable-covid-test-barda-backing\n",
      "2022-01-07\n",
      "MedTech\n",
      "Cytokinetics, Royalty partner on heart failure drug for $450M\n",
      "https://www.fiercebiotech.com/biotech/cytokinetics-finds-a-worldwide-partner-royalty-pharma-for-heart-failure-drug-and-up-to-450m\n",
      "2022-01-07\n",
      "Biotech\n",
      "Atea sticks it out with COVID antiviral and taps Merck HCV drug\n",
      "https://www.fiercebiotech.com/biotech/atea-ever-hopeful-for-failed-covid-19-antiviral-lays-out-path-includes-licensing-merck-s\n",
      "2022-01-07\n",
      "Biotech\n",
      "Maraganore as biotech matchmaker and mentor—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-maraganore-s-post-alnylam-ambitions-take-flight\n",
      "2022-01-07\n",
      "Biotech\n",
      "AstraZeneca picks up new weapon in fight with Alnylam and Pfizer\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-picks-up-new-weapon-rare-disease-fight-alnylam-and-pfizer-paying-30m-for-rights\n",
      "2022-01-07\n",
      "Biotech\n",
      "Sanofi makes AI play, putting up $100M and billions in biobucks\n",
      "https://www.fiercebiotech.com/biotech/sanofi-makes-ai-play-putting-up-100m-and-billions-biobucks-to-form-broad-deal-exscientia\n",
      "2022-01-07\n",
      "Biotech\n",
      "Verily links up with Sosei Heptares for GPCR drug discovery\n",
      "https://www.fiercebiotech.com/medtech/verily-links-up-sosei-heptares-for-gpcr-drug-discovery\n",
      "2022-01-06\n",
      "MedTech\n",
      "Aligos says stop right now to lead med after fruitless data\n",
      "https://www.fiercebiotech.com/biotech/aligos-lead-hep-b-med-crumbles-early-phase-1-trial-data-a-little-over-a-year-after-150m-ipo\n",
      "2022-01-06\n",
      "Biotech\n",
      "Abbott unveils Lingo line of sports biosensors\n",
      "https://www.fiercebiotech.com/medtech/abbott-ceo-ford-unveils-lingo-line-sports-biosensors-based-diabetes-monitoring-tech\n",
      "2022-01-06\n",
      "MedTech\n",
      "Penn's mRNA-turned-CAR-T therapy repairs heart damage in mice\n",
      "https://www.fiercebiotech.com/research/mrna-shot-car-t-therapy-body-repair-heart-disease-damage-university-pennsylvania\n",
      "2022-01-06\n",
      "Research\n",
      "Altasciences buys Sinclair to boost preclinical reach, capacity\n",
      "https://www.fiercebiotech.com/cro/altasciences-buys-sinclair-to-boost-preclinical-reach-and-capacity\n",
      "2022-01-06\n",
      "CRO\n",
      "Virtue Diagnostics nets $100M for affordable in vitro testing\n",
      "https://www.fiercebiotech.com/medtech/virtue-diagnostics-racks-up-100m-to-make-vitro-testing-affordable-accessible-china\n",
      "2022-01-06\n",
      "MedTech\n",
      "Amgen chooses AI expert Generate in $1.9B biobucks deal\n",
      "https://www.fiercebiotech.com/biotech/amgen-chooses-generate-for-1-9b-biobucks-deal-to-churn-out-up-to-10-multi-modality-drug\n",
      "2022-01-06\n",
      "Biotech\n",
      "Stryker’s $3B deal for Vocera aims to amp up its communications\n",
      "https://www.fiercebiotech.com/medtech/stryker-lands-3b-deal-for-vocera-to-amp-up-its-digital-communications\n",
      "2022-01-06\n",
      "MedTech\n",
      "With STIs off the charts, California pushes at-home tests\n",
      "https://www.fiercebiotech.com/medtech/sexually-transmitted-infections-off-charts-california-pushes-at-home-tests\n",
      "2022-01-06\n",
      "MedTech\n",
      "Sanofi tears up Sangamo deal in pivot to off-the-shelf approach\n",
      "https://www.fiercebiotech.com/biotech/sanofi-tears-up-sangamo-cell-therapy-deal-pivot-to-off-shelf-approaches\n",
      "2022-01-06\n",
      "Biotech\n",
      "Novartis taps Alnylam for ambitious push to fix liver function\n",
      "https://www.fiercebiotech.com/biotech/novartis-taps-alnylam-for-ambitious-push-to-fix-liver-function\n",
      "2022-01-06\n",
      "Biotech\n",
      "Eikon gins up half-a-billion-dollar series B, bolsters C-suite\n",
      "https://www.fiercebiotech.com/biotech/eikon-therapeutics-snares-500m-series-b-pinning-constellation-biotech-stars-to-its-upper\n",
      "2022-01-06\n",
      "Biotech\n",
      "Lilly, Entos team up to improve nucleic acid delivery\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-taps-entos-delivery-tech-50m-plus-nucleic-acid-pact\n",
      "2022-01-06\n",
      "Biotech\n",
      "Ex-Alnylam CEO Maraganore wants to be a biotech multiplier\n",
      "https://www.fiercebiotech.com/biotech/alnylam-john-maraganore-wants-to-be-a-biotech-multiplier-matchmaker-and-mentor\n",
      "2022-01-06\n",
      "Biotech\n",
      "Annexon shares dip as patient dropouts hit Huntington's trial\n",
      "https://www.fiercebiotech.com/biotech/annexon-shares-dip-30-as-huntington-s-drug-dogged-by-patient-dropouts\n",
      "2022-01-05\n",
      "Biotech\n",
      "GE, Boston Scientific forge heart tech team-up in Southeast Asia\n",
      "https://www.fiercebiotech.com/medtech/ge-boston-scientific-team-up-to-bring-advanced-cardiac-care-tech-to-southeast-asia\n",
      "2022-01-05\n",
      "MedTech\n",
      "Fierce is looking for the biggest Rising Stars in Health Tech\n",
      "https://www.fiercebiotech.com/medtech/fierce-looking-for-next-rising-stars-health-tech\n",
      "2022-01-05\n",
      "MedTech\n",
      "Ultragenyx granted go-ahead to up doses for Angelman therapy\n",
      "https://www.fiercebiotech.com/biotech/ultragenyx-granted-go-ahead-to-up-doses-for-stalled-angelman-therapy-after-safety-issues\n",
      "2022-01-05\n",
      "Biotech\n",
      "Owlet, Kiddo ramp up remote monitoring tech for kids\n",
      "https://www.fiercebiotech.com/medtech/owlet-kiddo-ramp-up-remote-health-monitoring-offerings-for-babies-and-children\n",
      "2022-01-05\n",
      "MedTech\n",
      "Merck takes 4th option on Big Pharma darling F-star's bispecific\n",
      "https://www.fiercebiotech.com/biotech/merck-takes-4th-option-big-pharma-darling-f-star-s-bispecific-immunotherapies\n",
      "2022-01-05\n",
      "Biotech\n",
      "Spectrum trims workforce, R&D to focus on 2 key cancer meds\n",
      "https://www.fiercebiotech.com/biotech/spectrum-cuts-30-its-workforce-to-save-cash-and-focus-key-cancer-meds\n",
      "2022-01-05\n",
      "Biotech\n",
      "Thermo Fisher nets protein producer PeproTech for $1.85B\n",
      "https://www.fiercebiotech.com/medtech/thermo-fisher-nets-protein-producer-peprotech-for-1-85b\n",
      "2022-01-05\n",
      "MedTech\n",
      "Pfizer, BioNTech team up against GSK's Shingrix dominance\n",
      "https://www.fiercebiotech.com/biotech/pfizer-biontech-team-up-again-to-take-a-swing-at-gsk-s-shingrix-dominance\n",
      "2022-01-05\n",
      "Biotech\n",
      "Fighting drug-resistant cancer by blocking an escape route\n",
      "https://www.fiercebiotech.com/research/fighting-drug-resistant-cancer-by-blocking-escape-pathway\n",
      "2022-01-05\n",
      "Research\n",
      "VCs plow $115M into next-gen genetic medicine startup SalioGen\n",
      "https://www.fiercebiotech.com/biotech/vcs-plow-115m-into-next-gen-genetic-medicine-startup-saliogen-teeing-up-work-eye-and-liver\n",
      "2022-01-05\n",
      "Biotech\n",
      "Intellia bags option on Kyverna’s autoimmune CAR-T prospect\n",
      "https://www.fiercebiotech.com/biotech/intellia-bags-option-autoimmune-car-t-prospect-handing-kyverna-rights-to-use-crispr-tech-to\n",
      "2022-01-05\n",
      "Biotech\n",
      "Korro Bio rings in new year with $116M for OPERA RNA editing\n",
      "https://www.fiercebiotech.com/biotech/korro-bio-sings-to-tune-116m-for-its-opera-rna-editing-program\n",
      "2022-01-05\n",
      "Biotech\n",
      "Applied pumps brakes on FDA application after request for data\n",
      "https://www.fiercebiotech.com/biotech/applied-holds-off-drug-approval-request-as-fda-wants-clinical-outcomes-data-for-metabolic\n",
      "2022-01-04\n",
      "Biotech\n",
      "Co-Diagnostics locks down 2 buyouts to debut at-home test device\n",
      "https://www.fiercebiotech.com/medtech/co-diagnostics-completes-two-pronged-acquisition-to-begin-rolling-out-at-home-covid-testing\n",
      "2022-01-04\n",
      "MedTech\n",
      "Desktop DNA printer maker DNA Script adds to 9-digit VC round\n",
      "https://www.fiercebiotech.com/medtech/desktop-dna-printer-maker-dna-script-adds-to-its-9-digit-vc-round\n",
      "2022-01-04\n",
      "MedTech\n",
      "Biogen, Ionis keep formula the same for Spinraza successor\n",
      "https://www.fiercebiotech.com/biotech/biogen-ionis-keep-formula-same-for-spinraza-successor\n",
      "2022-01-04\n",
      "Biotech\n",
      "Avrobio ditches Fabry, eyes 2023 trials for other gene therapies\n",
      "https://www.fiercebiotech.com/biotech/avrobio-bids-adieu-to-fabry-program-adjusts-pipeline-to-focus-other-gene-therapies-multiple\n",
      "2022-01-04\n",
      "Biotech\n",
      "Theranos’ Holmes convicted on 4 counts of fraud\n",
      "https://www.fiercebiotech.com/medtech/ex-theranos-ceo-elizabeth-holmes-found-guilty-four-11-counts-fraud\n",
      "2022-01-04\n",
      "MedTech\n",
      "Helper immune cells help Pfizer's mRNA COVID-19 vax: study\n",
      "https://www.fiercebiotech.com/research/helper-immune-cells-key-to-helping-pfizer-s-mrna-covid-19-vaccine-stave-off-death\n",
      "2022-01-04\n",
      "Research\n",
      "With $415M on the line, Genmab taps Synaffix for ADC technology\n",
      "https://www.fiercebiotech.com/biotech/415m-line-genmab-taps-synaffix-for-antibody-drug-conjugate-technologies\n",
      "2022-01-04\n",
      "Biotech\n",
      "Exelixis recruits Merck's Goodman as CMO\n",
      "https://www.fiercebiotech.com/biotech/exelixis-nabs-merck-veteran-as-chief-medical-officer-quest-to-expand-its-r-d-footprint\n",
      "2022-01-04\n",
      "Biotech\n",
      "Novo powers transatlantic rare disease fund to $124M first close\n",
      "https://www.fiercebiotech.com/biotech/transatlantic-vc-veterans-tap-novo-holdings-to-raise-124m-rare-disease-fund\n",
      "2022-01-04\n",
      "Biotech\n",
      "Ovid lands AstraZeneca in a comeback licensing deal\n",
      "https://www.fiercebiotech.com/biotech/ovid-lands-astrazeneca-a-comeback-licensing-deal-first-a-series\n",
      "2022-01-03\n",
      "Biotech\n",
      "US greenlights Siemens' home COVID test as omicron spreads\n",
      "https://www.fiercebiotech.com/medtech/u-s-greenlights-siemens-rapid-home-covid-test-its-second-a-week-as-omicron-marches\n",
      "2021-12-30\n",
      "MedTech\n",
      "Degrading a protein nexus behind prostate cancer\n",
      "https://www.fiercebiotech.com/research/degrading-a-protein-nexus-oncogenes-rely-to-drive-prostate-cancer\n",
      "2021-12-30\n",
      "Research\n",
      "J&J ships another bispecific off to FDA in multiple myeloma\n",
      "https://www.fiercebiotech.com/biotech/j-j-ships-another-bispecific-off-to-fda-multiple-myeloma\n",
      "2021-12-30\n",
      "Biotech\n",
      "AstraZeneca, Ionis ink $2.9B biobucks deal for heart drug\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-joins-crowd-companies-gunning-for-rare-heart-disease-ionis-deal-worth-billions\n",
      "2021-12-29\n",
      "Biotech\n",
      "Emulate's brain models head to space to study gravity's effects\n",
      "https://www.fiercebiotech.com/medtech/emulate-s-organs-a-chip-head-to-international-space-station-to-study-gravity-s-pull-brain\n",
      "2021-12-29\n",
      "MedTech\n",
      "How strange DNA structures could inspire new cancer drugs\n",
      "https://www.fiercebiotech.com/research/how-strange-dna-structures-could-inspire-development-cancer-drugs\n",
      "2021-12-29\n",
      "Research\n",
      "Roche nets U.S. green light for rapid, home-based COVID test\n",
      "https://www.fiercebiotech.com/medtech/roche-nets-u-s-green-light-for-rapid-home-based-covid-test\n",
      "2021-12-28\n",
      "MedTech\n",
      "BridgeBio CEO calls phase 3 failure of heart drug 'baffling'\n",
      "https://www.fiercebiotech.com/biotech/bridgebio-s-baffling-heart-disease-drug-fail-de-intensifies-competition-and-net-neutral-for\n",
      "2021-12-28\n",
      "Biotech\n",
      "Biogen-Eisai's Aduhelm sequel granted speedy review by FDA\n",
      "https://www.fiercebiotech.com/biotech/biogen-eisai-s-aduhelm-follow-up-granted-speedy-review-by-fda\n",
      "2021-12-27\n",
      "Biotech\n",
      "Quidel scoops up Ortho Clinical Diagnostics for $6B\n",
      "https://www.fiercebiotech.com/medtech/quidel-plots-future-as-global-testing-powerhouse-6b-purchase-ortho-clinical-diagnostics\n",
      "2021-12-27\n",
      "MedTech\n",
      "The top 10 Fierce Medtech stories of 2021\n",
      "https://www.fiercebiotech.com/medtech/fierce-medtech-s-top-10-stories-2021-covid-testing-continues-to-evolve\n",
      "2021-12-23\n",
      "MedTech\n",
      "Fierce Biotech’s top 10 most read stories in 2021\n",
      "https://www.fiercebiotech.com/biotech/editor-s-corner-fierce-biotech-s-top-10-most-read-stories-2021\n",
      "2021-12-23\n",
      "Biotech\n",
      "EU OKs Microsoft's $19.7B Nuance buy after antitrust probe\n",
      "https://www.fiercebiotech.com/medtech/microsoft-s-19-7b-nuance-purchase-secures-eu-sign-off-after-antitrust-investigation\n",
      "2021-12-22\n",
      "MedTech\n",
      "2022 forecast: Blood tests to spur Alzheimer's, Parkinson's R&D\n",
      "https://www.fiercebiotech.com/medtech/blood-test-breakthroughs-aim-to-move-needle-alzheimer-s-parkinson-s-research\n",
      "2021-12-22\n",
      "MedTech\n",
      "Verily CEO steps back from day-to-day duties\n",
      "https://www.fiercebiotech.com/medtech/verily-coo-gillett-tacks-president-title-as-ceo-conrad-steps-back-from-day-to-day-duties\n",
      "2021-12-22\n",
      "MedTech\n",
      "Philips nabs FDA nod for laser-powered blood clot filter removal\n",
      "https://www.fiercebiotech.com/medtech/philips-scores-fda-de-novo-clearance-for-laser-powered-blood-clot-filter-removal\n",
      "2021-12-22\n",
      "MedTech\n",
      "CRISPR cans R&D chief in SEC filing—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-crispr-therapeutics-bids-adieu-to-r-d-head-securities-filing\n",
      "2021-12-22\n",
      "Biotech\n",
      "2022 forecast: How AR, VR will form medtech's next dimension\n",
      "https://www.fiercebiotech.com/medtech/reality-check-ar-and-vr-are-poised-to-send-medtech-into-next-dimension-2022\n",
      "2021-12-22\n",
      "MedTech\n",
      "Novartis inks $800M buyout of eye disease gene therapy biotech\n",
      "https://www.fiercebiotech.com/biotech/novartis-inks-800m-upfront-buyout-gyroscope-to-continue-eye-disease-gene-therapy-m-a-spree\n",
      "2021-12-22\n",
      "Biotech\n",
      "Korify rolls out $100M longevity and mental health venture fund\n",
      "https://www.fiercebiotech.com/biotech/aiming-to-make-70-new-50-korify-rolls-out-100m-longevity-and-mental-health-venture-fund\n",
      "2021-12-22\n",
      "Biotech\n",
      "2022 forecast: Next year could see new data for Alzheimer's meds\n",
      "https://www.fiercebiotech.com/biotech/2021-was-year-alzheimer-s-drug-development-blew-up-2022-may-be-even-better\n",
      "2021-12-22\n",
      "Biotech\n",
      "2022 forecast: Bad news for dealmaking; omicron is coming\n",
      "https://www.fiercebiotech.com/biotech/we-wish-we-had-better-news-for-biotech-dealmaking-2022-but-omicron-coming-anyway\n",
      "2021-12-22\n",
      "Biotech\n",
      "2022 forecast: In biopharma talent wars, everybody has offers\n",
      "https://www.fiercebiotech.com/biotech/2022-talent-war-life-sciences-salary-inflation-c-suite-builds-to-negative-feedback-loop\n",
      "2021-12-22\n",
      "Biotech\n",
      "2022 forecast: Will trials be less white next year?\n",
      "https://www.fiercebiotech.com/biotech/2022-forecast-calls-for-clinical-trial-diversity-aren-t-going-away-as-majority-studies\n",
      "2021-12-22\n",
      "CRO\n",
      "Biden buys up 500M rapid COVID tests to distribute for free\n",
      "https://www.fiercebiotech.com/medtech/biden-buys-up-500m-rapid-at-home-covid-tests-to-distribute-for-free-2022\n",
      "2021-12-21\n",
      "MedTech\n",
      "BD buys smartphone-powered COVID test partner Scanwell Health\n",
      "https://www.fiercebiotech.com/medtech/bd-acquires-smartphone-powered-covid-test-partner-scanwell-health\n",
      "2021-12-21\n",
      "MedTech\n",
      "FDA alerts device makers to Apache Log4j cybersecurity risk\n",
      "https://www.fiercebiotech.com/medtech/fda-alerts-medical-devicemakers-to-cybersecurity-risk-popular-apache-log4j-software-tool\n",
      "2021-12-21\n",
      "MedTech\n",
      "Pfizer halts Duchenne gene therapy trial after patient death\n",
      "https://www.fiercebiotech.com/biotech/pfizer-reports-death-patient-duchenne-trial-halts-enrolment\n",
      "2021-12-21\n",
      "Biotech\n",
      "PhaseBio blames COVID-19 disruption as heart study axed\n",
      "https://www.fiercebiotech.com/biotech/phasebio-blames-covid-19-disruption-as-cardiovascular-treatment-axed\n",
      "2021-12-21\n",
      "Biotech\n",
      "AC Immune CEO says 2021 was a breakthrough year for Alzheimer's\n",
      "https://www.fiercebiotech.com/biotech/alzheimer-s-debate-may-not-seem-positive-but-ac-immune-s-ceo-promises-it-s-been-a\n",
      "2021-12-21\n",
      "Biotech\n",
      "Fierce Biotech's top 10 editor's picks for 2021\n",
      "https://www.fiercebiotech.com/biotech/fierce-biotech-top-10-editor-s-picks-for-2021\n",
      "2021-12-21\n",
      "Biotech\n",
      "Abandoned by Amgen, Cy­to­ki­net­ics lands heart failure deal\n",
      "https://www.fiercebiotech.com/biotech/abandoned-by-amgen-cy-to-ki-net-ics-lands-deal-for-chinese-rights-to-heart-failure-prospect\n",
      "2021-12-21\n",
      "Biotech\n",
      "Lilly's would-be Dupixent rival scores another late-stage win\n",
      "https://www.fiercebiotech.com/biotech/lilly-s-atopic-dermatitis-med-scores-another-late-stage-win-attempt-to-outdo-dupixent\n",
      "2021-12-21\n",
      "Biotech\n",
      "Sanofi gambles $1B upfront on preclinical oncology biotech\n",
      "https://www.fiercebiotech.com/biotech/sanofi-gambles-1b-upfront-preclinical-oncology-biotech-bagging-amunix-for-its-pipeline-t\n",
      "2021-12-21\n",
      "Biotech\n",
      "Ambys adds $47M to series A to test liver cell therapy in 2023\n",
      "https://www.fiercebiotech.com/biotech/ambys-tops-out-series-a-47m-more-to-test-cell-therapy-liver-disease-2023\n",
      "2021-12-21\n",
      "Biotech\n",
      "Senti to go public in $296M SPAC deal before hitting the clinic\n",
      "https://www.fiercebiotech.com/biotech/no-data-no-problem-senti-will-go-public-296m-spac-deal-before-hitting-clinic\n",
      "2021-12-20\n",
      "Biotech\n",
      "Aptose finally ditches APTO-253 after 3-year clinical hold\n",
      "https://www.fiercebiotech.com/biotech/aptose-finally-ditches-apto-253-after-3-year-clinical-hold-phase-1-dud\n",
      "2021-12-20\n",
      "Biotech\n",
      "FDA clears Koios Medical's breast, thyroid cancer-spotting AI\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-koios-medical-s-ultrasound-reading-ai-spots-breast-thyroid-cancer-two-seconds\n",
      "2021-12-20\n",
      "MedTech\n",
      "Spark's gene therapy manufacturing build leaves space for growth\n",
      "https://www.fiercebiotech.com/biotech/just-spark-roche-s-new-gene-therapy-manufacturing-center-leaves-space-for-growth\n",
      "2021-12-20\n",
      "Biotech\n",
      "Edwards grabs FDA nod for upgraded Sapien 3 pulmonary valve\n",
      "https://www.fiercebiotech.com/medtech/edwards-grabs-fda-approval-for-sapien-3-pulmonary-replacement-valve-pre-stent\n",
      "2021-12-20\n",
      "MedTech\n",
      "Roche builds Genentech's ophthalmology program with $670M deal\n",
      "https://www.fiercebiotech.com/biotech/roche-adds-to-genentech-s-ophthalmology-program-720m-biobucks-for-lineage-cell-therapeutics\n",
      "2021-12-20\n",
      "Biotech\n",
      "FDA clears muscle stimulator for boosting blood flow in the legs\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-muscle-stimulator-for-increasing-blood-flow-lower-legs\n",
      "2021-12-20\n",
      "MedTech\n",
      "Novartis nabs first TIGIT through billion-dollar BeiGene deal\n",
      "https://www.fiercebiotech.com/biotech/novartis-brings-1st-ever-tigit-drug-massive-billion-dollar-biobucks-deal-beigene\n",
      "2021-12-20\n",
      "Biotech\n",
      "BD lands CE mark for infectious disease testing instrument\n",
      "https://www.fiercebiotech.com/medtech/bd-lands-ce-marks-for-infectious-disease-testing-instrument-and-tool-s-first-lab-test\n",
      "2021-12-20\n",
      "MedTech\n",
      "Novartis suffers shock setback as Xolair successor fails phase 3\n",
      "https://www.fiercebiotech.com/biotech/novartis-suffers-shock-setback-as-xolair-successor-fails-phase-3\n",
      "2021-12-20\n",
      "Biotech\n",
      "Colon growth hormone could be path to anti-aging treatments\n",
      "https://www.fiercebiotech.com/research/a-colon-growth-hormone-could-pave-way-for-treating-aging-related-disorders\n",
      "2021-12-20\n",
      "Research\n",
      "Armgo bags $35M for phase 2 heart rhythm study\n",
      "https://www.fiercebiotech.com/biotech/forbion-arms-biotech-to-stop-sudden-cardiac-death-leading-35m-round-to-fund-phase-2-trial\n",
      "2021-12-20\n",
      "Biotech\n",
      "Fierce Biotech’s top 10 data readouts in 2022\n",
      "https://www.fiercebiotech.com/special-report/fierce-biotech-s-top-10-data-readouts-2022\n",
      "2021-12-20\n",
      "Special Reports\n",
      "FDA clears Implicity's ECG-analyzing AI algorithm\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-implicity-s-ai-algorithm-to-improve-medtronic-heart-monitors-afib-detection\n",
      "2021-12-17\n",
      "MedTech\n",
      "V-Wave nets $98M for its heart pressure-relieving shunt implant\n",
      "https://www.fiercebiotech.com/medtech/v-wave-nets-98m-for-its-heart-pressure-relieving-shunt-implant\n",
      "2021-12-17\n",
      "MedTech\n",
      "After FDA U-turn, Amylyx heads for IPO to support ALS drug\n",
      "https://www.fiercebiotech.com/biotech/amylyx-wants-wall-street-to-support-als-drug-as-biotech-seeks-fda-canada-europe-approvals\n",
      "2021-12-17\n",
      "Biotech\n",
      "Roche's Spark unit to build $575M gene therapy center in Philly\n",
      "https://www.fiercebiotech.com/biotech/roche-s-spark-unit-to-build-575m-center-excellence-for-gene-therapy-manufacturing-philly\n",
      "2021-12-17\n",
      "Biotech\n",
      "Ipsen ends 2021 deal spree with $543M Genfit tie-up\n",
      "https://www.fiercebiotech.com/biotech/ipsen-ends-2021-deal-spree-543m-biobucks-tie-up-for-genfit-s-liver-disease-drug\n",
      "2021-12-17\n",
      "Biotech\n",
      "Amgen, Owkin study shows AI beats clinicians at cardio risks\n",
      "https://www.fiercebiotech.com/medtech/amgen-owkin-ai-study-identifies-cardiovascular-risk-factors\n",
      "2021-12-17\n",
      "MedTech\n",
      "Allergan completes $550M Soliton buy after FTC probe\n",
      "https://www.fiercebiotech.com/medtech/allergan-aesthetics-completes-550m-soliton-buy-following-ftc-probe\n",
      "2021-12-17\n",
      "MedTech\n",
      "Abbott CEO adds chair to title as White retires—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-abbott-s-ceo-and-president-now-also-medtech-giant-s-chairman\n",
      "2021-12-17\n",
      "Biotech\n",
      "Omega closes 7th fund at $650M to build Boston, Europe biotechs\n",
      "https://www.fiercebiotech.com/biotech/omega-backer-150-plus-biotechs-lands-650m-seventh-fund-more-emphasis-startup-creation\n",
      "2021-12-17\n",
      "Biotech\n",
      "Know Labs turns its AI toward a new moneymaker: NFTs\n",
      "https://www.fiercebiotech.com/medtech/glucose-sensor-developer-know-labs-turns-its-ai-toward-a-potential-new-moneymaker-nfts\n",
      "2021-12-16\n",
      "MedTech\n",
      "Pfizer, Novartis back $119M Anaveon series B for phase 2 trials\n",
      "https://www.fiercebiotech.com/biotech/pfizer-joins-119m-round-for-novartis-backed-cytokines-biotech-anaveon-to-bankroll-phase-2\n",
      "2021-12-16\n",
      "Biotech\n",
      "Precisely targeting liver cancer with logic-gated gene therapy\n",
      "https://www.fiercebiotech.com/research/precisely-targeting-liver-cancer-logic-gated-gene-therapy\n",
      "2021-12-16\n",
      "Research\n",
      "Tasso draws up $100M to advance at-home blood collection devices\n",
      "https://www.fiercebiotech.com/medtech/tasso-draws-up-100m-to-advance-at-home-blood-collection-devices\n",
      "2021-12-16\n",
      "MedTech\n",
      "Neogene taps Gritstone CMO to lead T-cell therapies into clinic\n",
      "https://www.fiercebiotech.com/biotech/neogene-adds-ex-roche-director-as-cmo-after-snagging-bristol-myers-arcellx-vets\n",
      "2021-12-16\n",
      "Biotech\n",
      "Mystery revealed: Mythic lands $103M to take on ADC class\n",
      "https://www.fiercebiotech.com/biotech/mystery-no-more-mythic-therapeutics-emerges-103m-to-test-antibody-drug-conjugates-lung\n",
      "2021-12-16\n",
      "Biotech\n",
      "Up to $1.5B on the Horizon for Alpine in 4-drug biobucks pact\n",
      "https://www.fiercebiotech.com/biotech/its-way-up-alpine-biotech-sees-1-5b-horizon-for-up-to-four-drugs\n",
      "2021-12-16\n",
      "Biotech\n",
      "Valneva, Arcturus add to chorus of COVID-19 vax booster data\n",
      "https://www.fiercebiotech.com/biotech/valneva-arcturus-add-to-bombardment-booster-boasting-for-covid-19-shots\n",
      "2021-12-16\n",
      "Biotech\n",
      "Verge Genomics signs on Merck, Lilly for nearly $100M funding\n",
      "https://www.fiercebiotech.com/biotech/als-drug-discoverer-verge-genomics-signs-merck-lilly-nearly-100m-oversubscribed-funding\n",
      "2021-12-16\n",
      "Biotech\n",
      "NuVasive scoliosis system ends hold with new labeling, CE mark\n",
      "https://www.fiercebiotech.com/medtech/nuvasive-resumes-global-sales-scoliosis-system-reinstated-ce-mark-and-new-labeling\n",
      "2021-12-15\n",
      "MedTech\n",
      "Atea will try to pair failed COVID-19 drug with other compounds\n",
      "https://www.fiercebiotech.com/biotech/after-roche-bails-atea-will-try-to-pair-failed-covid-19-drug-other-compounds\n",
      "2021-12-15\n",
      "Biotech\n",
      "Idera's only asset flounders as biotech, AbbVie end enrollment\n",
      "https://www.fiercebiotech.com/biotech/abbvie-ends-enrollment-idera-collaboration-as-idera-ends-its-own-colorectal-cancer-trial\n",
      "2021-12-15\n",
      "Biotech\n",
      "Route 92 collects $111M for its brain clot-clearing devices\n",
      "https://www.fiercebiotech.com/medtech/route-92-medical-collects-111m-for-its-brain-blood-clot-clearing-devices\n",
      "2021-12-15\n",
      "MedTech\n",
      "Medtronic’s diabetes HQ receives FDA warning letter\n",
      "https://www.fiercebiotech.com/medtech/medtronic-receives-fda-warning-letter-over-quality-control-issues-at-diabetes-hq\n",
      "2021-12-15\n",
      "MedTech\n",
      "Sanofi, GSK push COVID-19 vaccine shot data into 2022\n",
      "https://www.fiercebiotech.com/biotech/sanofi-gsk-push-covid-19-vaccine-shot-data-into-2022-as-strong-booster-data-holds-place\n",
      "2021-12-15\n",
      "Biotech\n",
      "Lilly to begin 2022 with FDA filing for Alzheimer's drug\n",
      "https://www.fiercebiotech.com/biotech/lilly-intends-to-kick-off-2022-completion-much-anticipated-fda-filing-for-alzheimer-s\n",
      "2021-12-15\n",
      "Biotech\n",
      "Lilly packs up UC med for FDA with phase 3 success\n",
      "https://www.fiercebiotech.com/biotech/lilly-to-send-ulcerative-colitis-drug-to-fda-other-regulators-next-year-phase-3-success\n",
      "2021-12-15\n",
      "Biotech\n",
      "Biopharma charts progress in translating CAR-T to solid cancers\n",
      "https://www.fiercebiotech.com/research/biopharma-charts-progress-translating-car-t-cell-therapies-to-solid-cancers\n",
      "2021-12-15\n",
      "Biotech\n",
      "Galera shares rise over 100% as phase 3 flop deemed an error\n",
      "https://www.fiercebiotech.com/biotech/turns-out-galera-s-radiotherapy-drug-did-work-after-all-and-investors-are-thrilled\n",
      "2021-12-14\n",
      "Biotech\n",
      "Boston Scientific to lay off 170 California workers\n",
      "https://www.fiercebiotech.com/medtech/boston-scientific-to-lay-off-170-workers-close-silicon-valley-manufacturing-plant\n",
      "2021-12-14\n",
      "MedTech\n",
      "Generation Bio shares halved on hemophilia gene therapy setback\n",
      "https://www.fiercebiotech.com/biotech/generation-bio-shares-halve-as-hemophilia-gene-therapy-hunt-goes-back-to-square-one\n",
      "2021-12-14\n",
      "Biotech\n",
      "Novartis severs ties to Mesoblast's failed COVID-19 drug\n",
      "https://www.fiercebiotech.com/biotech/novartis-cuts-ties-mesoblast-s-failed-covid-19-cell-therapy-as-biotech-looks-to-start\n",
      "2021-12-14\n",
      "Biotech\n",
      "Philips gets the blood flowing with Vesper Medical tuck-in buy\n",
      "https://www.fiercebiotech.com/medtech/philips-gets-blood-flowing-vesper-medical-vascular-tuck-buy\n",
      "2021-12-14\n",
      "MedTech\n",
      "Novartis tags Molecular Partners for $580M radioligand deal\n",
      "https://www.fiercebiotech.com/biotech/novartis-tags-molecular-partners-for-next-radioligand-play-560m-biobucks-deal\n",
      "2021-12-14\n",
      "Biotech\n",
      "Sanofi's hemophilia drug reduced bleeding in phase 3 studies\n",
      "https://www.fiercebiotech.com/biotech/sanofi-s-hemophilia-drug-hopeful-shows-signs-stopping-bleeding-but-adverse-events-not-gone\n",
      "2021-12-14\n",
      "Biotech\n",
      "Pfizer's COVID-19 antiviral is expected to work against omicron\n",
      "https://www.fiercebiotech.com/biotech/pfizer-s-covid-19-antiviral-expected-to-work-against-omicron-variant\n",
      "2021-12-14\n",
      "Biotech\n",
      "FDA panel rejects BrainsGate neurostim implant for stroke\n",
      "https://www.fiercebiotech.com/medtech/fda-panel-rejects-brainsgate-neurostimulation-implant-for-ischemic-stroke\n",
      "2021-12-14\n",
      "MedTech\n",
      "Merck's HIV program suffers 13 clinical holds from FDA\n",
      "https://www.fiercebiotech.com/biotech/merck-s-hiv-program-suffers-6-full-7-partial-clinical-holds-from-fda\n",
      "2021-12-14\n",
      "Biotech\n",
      "Bristol Myers, Immatics collaborate again in $770M biobucks deal\n",
      "https://www.fiercebiotech.com/biotech/immatics-inks-new-770m-biobucks-collab-bristol-myers-for-preclinical-solid-tumor-bispecific\n",
      "2021-12-14\n",
      "Biotech\n",
      "Takeda previews early data for 'Wave 2' multiple myeloma med\n",
      "https://www.fiercebiotech.com/biotech/takeda-s-early-stage-multiple-myeloma-treatment-leads-to-response-38-patients\n",
      "2021-12-13\n",
      "Biotech\n",
      "ASH: Novartis posts early clinical data on next-gen CAR-Ts\n",
      "https://www.fiercebiotech.com/biotech/ash-novartis-posts-early-clinical-data-next-gen-car-ts-sets-sights-2022-registration-trials\n",
      "2021-12-13\n",
      "Biotech\n",
      "Pfizer executives lay out M&A priorities for COVID cash\n",
      "https://www.fiercebiotech.com/biotech/tidy-up-your-labs-biotech-pfizer-coming-significant-firepower-and-cash-to-burn\n",
      "2021-12-13\n",
      "Biotech\n",
      "Roche’s new Avenio system automates sequencing sample prep\n",
      "https://www.fiercebiotech.com/medtech/roche-unveils-new-avenio-system-to-automate-dna-sequencing-sample-preparation\n",
      "2021-12-13\n",
      "MedTech\n",
      "Former Iterum VP returns as medical lead to test UTI drug again\n",
      "https://www.fiercebiotech.com/biotech/former-iterum-vp-returns-as-medical-chief-to-give-ex-pfizer-antibiotic-another-shot-at\n",
      "2021-12-13\n",
      "Biotech\n",
      "Preventing metastasis by keeping dormant cancer cells asleep\n",
      "https://www.fiercebiotech.com/research/preventing-cancer-metastasis-by-keeping-dormant-tumor-cells-asleep-collagen\n",
      "2021-12-13\n",
      "Research\n",
      "FDA seeks input on 3D-printing devices at the point of care\n",
      "https://www.fiercebiotech.com/medtech/fda-seeks-input-regulating-3d-printed-implants-devices-made-at-point-care\n",
      "2021-12-13\n",
      "MedTech\n",
      "Intellia's HAE gene editing therapy lands in clinic\n",
      "https://www.fiercebiotech.com/biotech/intellia-doses-first-patient-as-hereditary-angioedema-gene-editing-therapy-lands-clinic\n",
      "2021-12-13\n",
      "Biotech\n",
      "Abbott CEO Ford elected chairman of the board\n",
      "https://www.fiercebiotech.com/medtech/abbott-ceo-ford-elected-chairman-board-as-predecessor-white-retires-after-40-years\n",
      "2021-12-13\n",
      "MedTech\n",
      "Pfizer books Arena for immuno-inflammatory drugs in $6.7B deal\n",
      "https://www.fiercebiotech.com/biotech/pfizer-books-arena-for-immuno-inflammatory-portfolio-6-7b-deal\n",
      "2021-12-13\n",
      "Biotech\n",
      "Eli Lilly dishes out $380M to Foghorn to tackle 5% of all tumors\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-dishes-out-380m-to-foghorn-to-tackle-5-all-tumors-via-multiple-oncology-programs\n",
      "2021-12-13\n",
      "Biotech\n",
      "The top 10 M&A targets in medtech for 2022\n",
      "https://www.fiercebiotech.com/special-report/top-10-m-a-targets-medtech-for-2022\n",
      "2021-12-13\n",
      "Special Reports\n",
      "ASH: Survival data on J&J's BCMA cell therapy keep on growing\n",
      "https://www.fiercebiotech.com/biotech/ash-two-years-survival-data-j-j-s-rival-to-bristol-myers-bcma-cell-therapy-still-growing\n",
      "2021-12-12\n",
      "Biotech\n",
      "Medtronic's Covidien faces another Class I ventilator recall\n",
      "https://www.fiercebiotech.com/medtech/medtronic-s-covidien-faces-another-class-i-recall-beleaguered-puritan-bennett-ventilators\n",
      "2021-12-10\n",
      "MedTech\n",
      "Moderna taps Carnegie Mellon for in-house AI training academy\n",
      "https://www.fiercebiotech.com/medtech/moderna-taps-carnegie-mellon-for-house-ai-training-academy\n",
      "2021-12-10\n",
      "MedTech\n",
      "Elizabeth Holmes' defense rests in Theranos fraud trial\n",
      "https://www.fiercebiotech.com/medtech/elizabeth-holmes-defense-rests-after-7-days-revealing-testimony-from-ex-theranos-ceo\n",
      "2021-12-10\n",
      "MedTech\n",
      "Ex-FDA head Hahn now CEO of Harbinger Health—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-former-fda-leader-hahn-lands-at-cancer-blood-test-maker-harbinger-health\n",
      "2021-12-10\n",
      "Biotech\n",
      "Super-fit mice reveal anti-inflammatory brain protein\n",
      "https://www.fiercebiotech.com/research/super-fit-mice-reveal-anti-inflammatory-protein-could-boost-search-for-alzheimer-s-drugs\n",
      "2021-12-10\n",
      "Research\n",
      "Moderna posts early peek at mRNA flu shot hopeful\n",
      "https://www.fiercebiotech.com/biotech/moderna-hoping-to-prove-it-s-no-one-trick-covid-pony-posts-early-peek-at-mrna-flu-shot\n",
      "2021-12-10\n",
      "Biotech\n",
      "Eli Lilly pens $1.5B biobucks pact with China's Regor\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-pens-1-5b-biobucks-pact-china-s-regor-for-metabolic-disease-work\n",
      "2021-12-10\n",
      "Biotech\n",
      "Novartis poaches Roche's neuro and rare disease R&D lead\n",
      "https://www.fiercebiotech.com/biotech/novartis-poaches-roche-s-neuro-and-rare-disease-r-d-lead-replacing-shanker\n",
      "2021-12-10\n",
      "Biotech\n",
      "Roche posts 'impressive' TIGIT combo lung cancer data\n",
      "https://www.fiercebiotech.com/biotech/roche-posts-impressive-tigit-combo-lung-cancer-data-as-jefferies-read-blockbuster-sales-tea\n",
      "2021-12-10\n",
      "Biotech\n",
      "ALS organizations call on Senate to pass $500M neuro R&D bill\n",
      "https://www.fiercebiotech.com/cro/als-organizations-call-for-senate-to-follow-house-s-suit-passing-500m-r-d-bill\n",
      "2021-12-09\n",
      "CRO\n",
      "Albireo CMO Horn exits 5 months after US, EU approvals\n",
      "https://www.fiercebiotech.com/biotech/albireo-cmo-horn-out-doors-five-months-after-u-s-eu-approvals-rare-liver-disease-drug\n",
      "2021-12-09\n",
      "Biotech\n",
      "How a nanomedicine could treat complications of vascular disease\n",
      "https://www.fiercebiotech.com/research/new-nanomedicine-reduces-vascular-lesions-could-pave-path-for-new-vascular-treatments\n",
      "2021-12-09\n",
      "Research\n",
      "Chan Zuckerberg Initiative pours $3.4B into new biomedical tech\n",
      "https://www.fiercebiotech.com/medtech/chan-zuckerberg-initiative-pours-3-4b-into-ai-imaging-and-other-tech-to-unravel-biomedical\n",
      "2021-12-09\n",
      "MedTech\n",
      "BD seals the deal to acquire surgical sealant maker Tissuemed\n",
      "https://www.fiercebiotech.com/medtech/bd-seals-deal-to-acquire-u-k-based-surgical-sealant-maker-tissuemed\n",
      "2021-12-09\n",
      "MedTech\n",
      "K36 begins with $30M to test multiple myeloma drug from Novartis\n",
      "https://www.fiercebiotech.com/biotech/k36-emerges-30m-to-bankroll-multiple-myeloma-drug-licensed-from-novartis\n",
      "2021-12-09\n",
      "Biotech\n",
      "ASH: Senti Bio's CAR-NK therapy shows promise in leukemia\n",
      "https://www.fiercebiotech.com/research/senti-bio-s-gene-circuit-car-nk-cell-therapy-enhances-cancer-killing-and-safety-leukemia\n",
      "2021-12-09\n",
      "Research\n",
      "Totus tots up $40M round to go after competitive cancer space\n",
      "https://www.fiercebiotech.com/biotech/totus-tots-up-40m-series-a-funding-to-go-after-competitive-cancer-space\n",
      "2021-12-09\n",
      "Biotech\n",
      "FDA clears Philips patient monitors a year after pandemic EUA\n",
      "https://www.fiercebiotech.com/medtech/philips-clinches-fda-clearance-for-patient-monitors-garnered-emergency-ok-amid-pandemic\n",
      "2021-12-09\n",
      "MedTech\n",
      "Novartis works on pan-coronavirus pill, eyes 2022 trial\n",
      "https://www.fiercebiotech.com/biotech/novartis-working-pan-coronavirus-pill-eyes-2022-human-testing\n",
      "2021-12-09\n",
      "Biotech\n",
      "Eir raises $138M fund to fill gap in Nordic life science scene\n",
      "https://www.fiercebiotech.com/biotech/science-talent-money-eir-raises-138m-vc-fund-to-fill-gap-nordic-life-science-scene\n",
      "2021-12-09\n",
      "Biotech\n",
      "FDA advisers unanimously reject Reata's kidney disease drug\n",
      "https://www.fiercebiotech.com/biotech/fda-advisors-unanimously-agree-reata-s-kidney-drug-not-effective-at-slowing-disease\n",
      "2021-12-08\n",
      "Biotech\n",
      "Microsoft's $19.7B Nuance buy snags on EU antitrust probe\n",
      "https://www.fiercebiotech.com/medtech/microsoft-s-19-7b-nuance-buy-hits-a-snag-eu-antitrust-probe\n",
      "2021-12-08\n",
      "MedTech\n",
      "Nomic nets $17M to advance its automated, high-speed ELISA test\n",
      "https://www.fiercebiotech.com/medtech/nomic-collects-17m-to-advance-its-automated-high-throughput-elisa-platform\n",
      "2021-12-08\n",
      "MedTech\n",
      "Ophthalmic Sciences debuts AI device to monitor glaucoma\n",
      "https://www.fiercebiotech.com/medtech/israeli-startup-debuts-contactless-ai-device-to-track-glaucoma-related-eye-pressure\n",
      "2021-12-08\n",
      "MedTech\n",
      "MIT scientist claims Sabatini 'coerced' sex, led 'offensive' lab\n",
      "https://www.fiercebiotech.com/biotech/mit-assistant-professor-alleges-sabatini-coerced-her-into-sex-led-highly-sexualized-lab\n",
      "2021-12-08\n",
      "Biotech\n",
      "Fresh from $316M raise, Sotio inks Merck deal for Keytruda trial\n",
      "https://www.fiercebiotech.com/biotech/fresh-from-316m-raise-sotio-inks-merck-deal-for-keytruda-combo-trial\n",
      "2021-12-08\n",
      "Biotech\n",
      "OncoMyx nabs $50M to jump into the clinic\n",
      "https://www.fiercebiotech.com/biotech/oncomyx-nabs-50m-to-jump-into-clinic-its-rabbit-pox-virus-cancer-drug\n",
      "2021-12-08\n",
      "Biotech\n",
      "Merck KGaA steps up VC activity with $677M for M Ventures\n",
      "https://www.fiercebiotech.com/biotech/merck-kgaa-steps-up-vc-activity-677m-investment-positioning-m-ventures-to-keep-pace\n",
      "2021-12-08\n",
      "Biotech\n",
      "Science 37 enters hybrid trial landscape in China, Russia\n",
      "https://www.fiercebiotech.com/cro/science-37-s-biopharma-clients-can-test-treatments-china-and-russia-months-after-expansion-into\n",
      "2021-12-08\n",
      "CRO\n",
      "Avistone nabs $200M cancer platform funding drive\n",
      "https://www.fiercebiotech.com/biotech/avistone-nabs-200m-cancer-platform-funding-drive-from-leading-vcs-as-it-combines-pearl\n",
      "2021-12-08\n",
      "Biotech\n",
      "'Day job and a gay job': LGBTQ+ leaders bring biopharma together\n",
      "https://www.fiercebiotech.com/biotech/day-job-and-a-gay-job-lgbtq-leaders-biopharma-want-those-who-look-talk-and-love-like-them\n",
      "2021-12-08\n",
      "Biotech\n",
      "After Chroma and Prime, Newpath lines up $350M for 8-12 biotechs\n",
      "https://www.fiercebiotech.com/biotech/newpath-en-route-to-backing-8-to-12-more-biotechs-350m-second-fund\n",
      "2021-12-08\n",
      "Biotech\n",
      "Ex-FDA head Hahn finds new gig with cancer test maker Harbinger\n",
      "https://www.fiercebiotech.com/medtech/former-fda-head-hahn-takes-helm-cancer-blood-test-maker-harbinger-health\n",
      "2021-12-07\n",
      "MedTech\n",
      "Freenome tacks on $300M to expand cancer blood test platform\n",
      "https://www.fiercebiotech.com/medtech/freenome-one-ups-itself-300m-from-gv-roche-and-more-to-expand-cancer-blood-test-platform\n",
      "2021-12-07\n",
      "MedTech\n",
      "Corbus snags Takeda's cancer leader to boost early-stage assets\n",
      "https://www.fiercebiotech.com/biotech/corbus-poaches-takeda-s-oncology-leader-as-it-beefs-up-early-stage-pipeline-following-three\n",
      "2021-12-07\n",
      "Biotech\n",
      "Recursion loops in Roche, Genentech for multibillion AI deal\n",
      "https://www.fiercebiotech.com/medtech/recursion-loops-roche-genentech-for-multibillion-dollar-ai-drug-discovery-deal\n",
      "2021-12-07\n",
      "MedTech\n",
      "Harvard's Nabla Bio nabs $11M for AI-driven antibody design\n",
      "https://www.fiercebiotech.com/medtech/ai-driven-antibody-designer-nabla-bio-raises-11m-seed-funding\n",
      "2021-12-07\n",
      "MedTech\n",
      "J&J squares up to Big Pharma rivals with extra RSV vaccine data\n",
      "https://www.fiercebiotech.com/biotech/j-j-squares-up-to-big-pharma-rivals-extra-rsv-vaccine-data\n",
      "2021-12-07\n",
      "Biotech\n",
      "Merck pauses 2 more trials of backbone HIV drug over red flag\n",
      "https://www.fiercebiotech.com/biotech/merck-pauses-2-more-trials-backbone-hiv-drug-over-red-flag-raising-doubts-about-multi\n",
      "2021-12-07\n",
      "Biotech\n",
      "'Leadership is showing': Biotech execs detail being openly LGBTQ\n",
      "https://www.fiercebiotech.com/biotech/don-t-check-yourself-when-you-come-to-work-being-openly-lgbtq-a-scientist-led-industry\n",
      "2021-12-07\n",
      "Biotech\n",
      "GlaxoSmithKline, Medicago hit 75% efficacy against delta\n",
      "https://www.fiercebiotech.com/biotech/glaxosmithkline-medicago-hit-75-efficacy-against-delta-covid-strain-but-omicron-muddies\n",
      "2021-12-07\n",
      "Biotech\n",
      "Gary Glick's Odyssey begins with $218M for 7 assets\n",
      "https://www.fiercebiotech.com/biotech/odyssey-starts-journey-218m-for-7-assets-across-cancer-inflammation-ifm-scorpion-founder-at\n",
      "2021-12-07\n",
      "Biotech\n",
      "Metis debuts with $86M to bankroll 2022 trial, gene therapy push\n",
      "https://www.fiercebiotech.com/biotech/metis-therapeutics-emerges-86m-for-2022-clinic-entry-push-into-gene-therapy\n",
      "2021-12-07\n",
      "Biotech\n",
      "ATP launches in UK with Adendra Therapeutics\n",
      "https://www.fiercebiotech.com/biotech/apple-tree-partners-breaks-into-uk-biotech-adendra-therapeutics-launch-raises-53m-series-a\n",
      "2021-12-07\n",
      "Biotech\n",
      "FDA lists 26 COVID tests that need to confirm omicron detection\n",
      "https://www.fiercebiotech.com/medtech/fda-lists-26-covid-19-tests-potentially-impacted-by-omicron-variant\n",
      "2021-12-06\n",
      "MedTech\n",
      "Aslan partners with IQVIA for midstage dermatitis med\n",
      "https://www.fiercebiotech.com/cro/aslan-teams-up-iqvia-to-test-atopic-dermatitis-drug-international-phase-2b-trial\n",
      "2021-12-06\n",
      "CRO\n",
      "Roche launches 3 omicron test kits following TIB Molbiol buy\n",
      "https://www.fiercebiotech.com/medtech/roche-tib-molbiol-covid-19-omicron-variant-research-tests-diagnostics\n",
      "2021-12-06\n",
      "MedTech\n",
      "RefleXion’s lung cancer radiotherapy wins FDA breakthrough label\n",
      "https://www.fiercebiotech.com/medtech/reflexion-snags-fda-breakthrough-status-for-cancer-guided-radiotherapy-to-treat-lung-tumors\n",
      "2021-12-06\n",
      "MedTech\n",
      "Could Viagra prevent and treat Alzheimer's?\n",
      "https://www.fiercebiotech.com/research/could-viagra-prevent-and-treat-alzheimer-s-cleveland-clinic-team-shows-its-potential\n",
      "2021-12-06\n",
      "Research\n",
      "BD dubs diabetes spinoff embecta and finalizes leadership\n",
      "https://www.fiercebiotech.com/medtech/bd-dubs-billion-dollar-diabetes-spin-off-embecta-finalizes-leadership\n",
      "MedTech\n",
      "Goldfinch nabs 13-year Ardelyx vet as CSO to advance kidney drug\n",
      "https://www.fiercebiotech.com/biotech/gilead-partnered-goldfinch-bio-snags-13-year-ardelyx-vet-to-lead-scientific-operations\n",
      "2021-12-06\n",
      "Biotech\n",
      "Biohaven pain spray aces test amid C-suite shake-up\n",
      "https://www.fiercebiotech.com/biotech/biohaven-pain-spray-aces-test-as-c-suite-shake-up-sees-incoming-cfo-as-chief-takes-chairman\n",
      "2021-12-06\n",
      "Biotech\n",
      "BenevolentAI to go public in EU's largest SPAC deal\n",
      "https://www.fiercebiotech.com/medtech/benevolentai-to-take-drug-discovery-tech-public-europe-s-largest-spac-deal-valued-at-eu1-5b\n",
      "2021-12-06\n",
      "MedTech\n",
      "Investors punish Aeglea for missed rare disease secondaries\n",
      "https://www.fiercebiotech.com/biotech/investors-punish-aeglea-for-missed-rare-disease-secondaries-sending-stock-spiraling-down\n",
      "2021-12-06\n",
      "Biotech\n",
      "Amish-linked gene variant reduces risk of heart disease\n",
      "https://www.fiercebiotech.com/research/genetic-variant-linked-to-amish-community-could-pave-way-for-new-heart-disease-therapies\n",
      "2021-12-06\n",
      "Research\n",
      "Adicet soars on early responses to gamma delta CAR-T therapy\n",
      "https://www.fiercebiotech.com/biotech/adicet-soars-early-responses-to-gamma-delta-car-t-therapy\n",
      "2021-12-06\n",
      "Biotech\n",
      "Trials increase Black patient inclusion, falter for other races\n",
      "https://www.fiercebiotech.com/cro/black-patient-inclusion-clinical-trials-improves-but-asian-latino-and-other-groups\n",
      "2021-12-06\n",
      "CRO\n",
      "LGBTQ+ progress in biotech lingers in the 'diagnose' stage\n",
      "https://www.fiercebiotech.com/biotech/we-re-getting-there-lgbtq-progress-biotech-lingers-diagnose-stage\n",
      "2021-12-06\n",
      "Biotech\n",
      "IQVIA connects nurses, phlebotomists with trial patients at home\n",
      "https://www.fiercebiotech.com/cro/iqvia-releases-tool-to-connect-nurses-phlebotomists-home-clinical-trial-patients\n",
      "2021-12-03\n",
      "CRO\n",
      "Improving CAR-T cells for cancer by targeting a protein 'brake'\n",
      "https://www.fiercebiotech.com/research/designing-better-car-t-cell-therapy-by-targeting-a-protein-brake\n",
      "2021-12-03\n",
      "Research\n",
      "Boston Scientific to test modular, leadless pacemaker-ICD system\n",
      "https://www.fiercebiotech.com/medtech/boston-scientific-launches-trial-modular-leadless-pacemaker-defibrillator-system\n",
      "2021-12-03\n",
      "MedTech\n",
      "Insightec lands FDA nod for prostate cancer treatment\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-insightec-s-mri-guided-sound-wave-technology-to-treat-prostate-cancer\n",
      "2021-12-03\n",
      "MedTech\n",
      "FDA OKs Sound Life Sciences’ sonar-based respiratory monitor\n",
      "https://www.fiercebiotech.com/medtech/hear-hear-sound-life-sciences-wins-fda-ok-for-app-uses-sonar-to-measure-breathing\n",
      "2021-12-03\n",
      "MedTech\n",
      "GlaxoSmithKline hires Pfizer vax lead Dormitzer—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-glaxosmithkline-snags-pfizer-vax-leader-phil-dormitzer\n",
      "2021-12-03\n",
      "Biotech\n",
      "Gene therapy startup bursts forth from J&J and F-Prime incubator\n",
      "https://www.fiercebiotech.com/biotech/gene-therapy-startup-bursts-forth-from-incubation-at-j-j-and-f-prime-graduating-80m-and-a\n",
      "2021-12-03\n",
      "Biotech\n",
      "Little European biotech Sotio nabs a super $316M funding round\n",
      "https://www.fiercebiotech.com/biotech/little-european-biotech-sotio-nabs-a-super-316m-funding-round-for-its-superagonist-work\n",
      "2021-12-03\n",
      "Biotech\n",
      "BeyondSpring lurches down as FDA rejects plinabulin\n",
      "https://www.fiercebiotech.com/biotech/beyondspring-lurches-down-as-fda-rejects-plinabulin-raising-questions-about-lung-cancer\n",
      "2021-12-03\n",
      "Biotech\n",
      "Ex-Immunomedics CFO Malik charged with insider trading\n",
      "https://www.fiercebiotech.com/biotech/fore-fires-ceo-usama-malik-after-sec-insider-trading-charges-during-his-time-as\n",
      "2021-12-02\n",
      "Biotech\n",
      "Biden tees up reimbursable home tests to take on omicron\n",
      "https://www.fiercebiotech.com/medtech/biden-s-omicron-battle-plan-includes-private-insurance-reimbursement-for-at-home-covid\n",
      "2021-12-02\n",
      "MedTech\n",
      "BD enters varicose vein market with Venclose buy\n",
      "https://www.fiercebiotech.com/medtech/bd-enters-varicose-vein-treatment-market-venclose-buy\n",
      "2021-12-02\n",
      "MedTech\n",
      "Janssen taps Tempus' AI for cancer drug discovery\n",
      "https://www.fiercebiotech.com/medtech/janssen-taps-tempus-ai-and-real-world-data-library-for-cancer-drug-discovery\n",
      "2021-12-02\n",
      "MedTech\n",
      "Acepodia lines pockets with $109M for oncology cell therapies\n",
      "https://www.fiercebiotech.com/biotech/acepodia-secures-109m-series-c-to-bankroll-cell-therapy-for-her2-cancers\n",
      "2021-12-02\n",
      "Biotech\n",
      "Novartis pays UCB $150M to join Roche in Parkinson's race\n",
      "https://www.fiercebiotech.com/biotech/alpha-challenger-novartis-pays-ucb-150m-to-join-roche-astrazeneca-parkinson-s-race\n",
      "2021-12-02\n",
      "Biotech\n",
      "GlaxoSmithKline, University of Oxford join forces into neuro\n",
      "https://www.fiercebiotech.com/biotech/glaxosmithkline-and-oxford-university-join-forces-40m-digital-deep-dive-neuro\n",
      "2021-12-02\n",
      "Biotech\n",
      "Music to its ears: Tune bags $40M to alter gene expression\n",
      "https://www.fiercebiotech.com/biotech/up-down-tune-therapeutics-snags-40m-to-leverage-epigenome-to-dial-gene-expression\n",
      "2021-12-02\n",
      "Biotech\n",
      "Astellas inks $1.6B pact with Dyno to continue gene therapy play\n",
      "https://www.fiercebiotech.com/biotech/astellas-becomes-latest-dyno-gene-therapy-partner-1-6b-biobucks-pact-to-join-roche-novartis\n",
      "2021-12-01\n",
      "Biotech\n",
      "Ember to swap heated mugs for pharma cold-chain tech\n",
      "https://www.fiercebiotech.com/medtech/ember-plots-shift-from-smart-mugs-to-pharma-cold-chain-tech-23m-vc-raise\n",
      "2021-12-01\n",
      "MedTech\n",
      "Aclaris' RA candidate bolsters chemo in pancreatic cancer models\n",
      "https://www.fiercebiotech.com/research/aclaris-experimental-rheumatoid-arthritis-drug-bolsters-chemo-pancreatic-cancer-models\n",
      "2021-12-01\n",
      "Research\n",
      "Virtual Incision nets $46M after mini-robot makes surgical debut\n",
      "https://www.fiercebiotech.com/medtech/virtual-incision-garners-46m-after-mini-robot-makes-surgical-debut\n",
      "2021-12-01\n",
      "MedTech\n",
      "Freenome, Siemens link up to develop breast cancer blood test\n",
      "https://www.fiercebiotech.com/medtech/freenome-siemens-join-forces-to-develop-blood-test-for-breast-cancer\n",
      "2021-12-01\n",
      "MedTech\n",
      "PrecisionOS lands FDA OK for surgical planning VR tool\n",
      "https://www.fiercebiotech.com/medtech/precisionos-gears-up-for-2022-launch-newly-fda-cleared-surgical-planning-vr-tool\n",
      "2021-12-01\n",
      "MedTech\n",
      "Ex-Ra Pharma execs snag $75M for Curie's radiopharmaceuticals\n",
      "https://www.fiercebiotech.com/biotech/curie-therapeutics-lines-up-75m-to-tackle-radiopharmaceuticals-former-ra-pharma-execs\n",
      "2021-12-01\n",
      "Biotech\n",
      "Submit your nominations now for 2021's Fierce 15\n",
      "https://www.fiercebiotech.com/medtech/who-s-fierce-medtech-submit-your-nominations-now-for-2021-s-fierce-15\n",
      "2021-12-01\n",
      "MedTech\n",
      "Vertex again talks up a tiny trial, this time: Kidney disease\n",
      "https://www.fiercebiotech.com/biotech/vertex-once-again-talks-up-a-tiny-trial-positive-read-throughs-time-for-a-genetically\n",
      "2021-12-01\n",
      "Biotech\n",
      "J&J cell therapy head exits to take up post at fledgling biotech\n",
      "https://www.fiercebiotech.com/biotech/j-j-cell-therapy-head-exits-to-take-up-post-at-fledgling-biotech\n",
      "2021-12-01\n",
      "Biotech\n",
      "Apollo's mission to extend human health span gets $180M boost\n",
      "https://www.fiercebiotech.com/biotech/apollo-s-mission-to-extend-human-health-span-gets-180m-boost-giving-vc-fund-a-launchpad-for\n",
      "2021-12-01\n",
      "Biotech\n",
      "Britain led the way in COVID studies, but trial work lagging\n",
      "https://www.fiercebiotech.com/cro/britain-led-way-covid-trials-but-overall-clinical-study-activity-still-lags-report\n",
      "2021-12-01\n",
      "CRO\n",
      "'What it takes': Genentech has 'never wavered' on Alzheimer's\n",
      "https://www.fiercebiotech.com/biotech/what-it-takes-genentech-s-rachelle-doody-looks-back-great-sadness-alzheimer-s-failures-but\n",
      "2021-12-01\n",
      "Biotech\n",
      "Sanofi snaps up Origimm for acne vaccine, plans mRNA prospect\n",
      "https://www.fiercebiotech.com/biotech/sanofi-snaps-up-origimm-for-early-phase-acne-vaccine-opening-new-front-mrna-strategy\n",
      "2021-12-01\n",
      "Biotech\n",
      "Insilico begins first human trial of AI-designed fibrosis drug\n",
      "https://www.fiercebiotech.com/medtech/insilico-medicine-begins-first-human-trial-its-ai-designed-drug-for-pulmonary-fibrosis\n",
      "2021-11-30\n",
      "MedTech\n",
      "Hyperfine's portable MRI nets FDA OK for deep-learning imaging\n",
      "https://www.fiercebiotech.com/medtech/hyperfine-s-portable-mri-nets-fda-clearance-for-deep-learning-powered-imaging\n",
      "2021-11-30\n",
      "MedTech\n",
      "FDA orders advisory meeting for TG's U2 leukemia combo\n",
      "https://www.fiercebiotech.com/biotech/fda-not-findings-what-it-s-looking-for-orders-adcomm-for-tg-s-u2-leukemia-combo\n",
      "2021-11-30\n",
      "Biotech\n",
      "Mei, with Bayer and Gilead in its sights, posts pivotal data\n",
      "https://www.fiercebiotech.com/biotech/mei-bayer-and-gilead-its-sights-posts-pivotal-data-blood-cancer-prospect\n",
      "2021-11-30\n",
      "Biotech\n",
      "GlaxoSmithKline poaches Pfizer vax leader Dormitzer\n",
      "https://www.fiercebiotech.com/biotech/glaxosmithkline-poaches-pfizer-vax-leader-phil-dormitzer-after-hemorrhaging-vaccine-r-d\n",
      "2021-11-30\n",
      "Biotech\n",
      "ImmunoGen lines up FDA filing as ADC shrinks tumors in trial\n",
      "https://www.fiercebiotech.com/biotech/immunogen-lines-up-fda-filing-as-antibody-drug-conjugate-shrinks-tumors-pivotal-trial\n",
      "2021-11-30\n",
      "Biotech\n",
      "Chinook launches a new biotech with major VCs in China\n",
      "https://www.fiercebiotech.com/biotech/chinook-launches-a-new-biotech-major-vcs-china-to-double-down-kidney-disease-r-d\n",
      "2021-11-30\n",
      "Biotech\n",
      "'What it takes': Lilly's Alzheimer's drug launch leader\n",
      "https://www.fiercebiotech.com/biotech/what-it-takes-as-lilly-s-alzheimer-s-drug-approaches-fda-drug-launch-leader-feels-amplified\n",
      "2021-11-30\n",
      "Biotech\n",
      "Owlet pulls baby-monitoring Smart Sock after FDA warning\n",
      "https://www.fiercebiotech.com/medtech/owlet-pulls-baby-monitoring-smart-sock-from-market-after-fda-warning\n",
      "2021-11-29\n",
      "MedTech\n",
      "Novel drug tamps down diabetes tissue damage in mice\n",
      "https://www.fiercebiotech.com/research/rage-against-diabetes-complications-novel-drug-tamps-down-tissue-damage-mice\n",
      "2021-11-29\n",
      "Research\n",
      "Ocugen COVID shot will have to wait for US market after FDA hold\n",
      "https://www.fiercebiotech.com/biotech/fda-stops-ocugen-from-starting-phase-3-trial-covid-19-vaccine-already-authorized-17\n",
      "2021-11-29\n",
      "Biotech\n",
      "BD ramps up tech development with new science chief\n",
      "https://www.fiercebiotech.com/medtech/bd-ramps-up-tech-development-new-science-chief-scientific-advisory-board\n",
      "2021-11-29\n",
      "MedTech\n",
      "COVID-19 test makers prepare for oncoming omicron variant\n",
      "https://www.fiercebiotech.com/medtech/thermo-fisher-qiagen-and-other-covid-19-test-makers-prepare-for-oncoming-omicron-variant\n",
      "2021-11-29\n",
      "MedTech\n",
      "Black tech founders aim to change the culture of healthcare\n",
      "https://www.fiercebiotech.com/medtech/black-tech-founders-want-to-change-culture-healthcare-one-click-at-a-time\n",
      "2021-11-29\n",
      "MedTech\n",
      "Blueprint drops $250M on Lengo for preclinical lung cancer med\n",
      "https://www.fiercebiotech.com/biotech/blueprint-has-approved-lung-cancer-drug-it-wants-to-make-another-250m-acquisition-lengo\n",
      "2021-11-29\n",
      "Biotech\n",
      "GE Healthcare doubles down on AI with new products, partnerships\n",
      "https://www.fiercebiotech.com/medtech/ge-healthcare-doubles-down-ai-new-product-launches-partnerships-optellum-and-cambridge\n",
      "2021-11-29\n",
      "MedTech\n",
      "Could antihistamines boost I-O treatments?\n",
      "https://www.fiercebiotech.com/research/could-common-antihistamines-be-key-to-boosting-immuno-oncology-treatments\n",
      "2021-11-29\n",
      "Research\n",
      "'What it takes': In the eye of Aduhelm storm is Biogen's CMO\n",
      "https://www.fiercebiotech.com/biotech/what-it-takes-eye-aduhelm-storm-biogen-s-cmo-tries-to-keep-patients-from-getting-lost\n",
      "2021-11-29\n",
      "Biotech\n",
      "'What it takes': The women pushing Alzheimer's R&D forward\n",
      "https://www.fiercebiotech.com/biotech/what-it-takes-beyond-headlines-women-are-pushing-groundbreaking-new-alzheimer-s-treatments\n",
      "2021-11-29\n",
      "Biotech\n",
      "Turnstone, Moffitt ally to take cell therapies into the clinic\n",
      "https://www.fiercebiotech.com/biotech/turnstone-teams-up-moffitt-to-race-til-cell-therapies-into-clinic\n",
      "2021-11-29\n",
      "Biotech\n",
      "Next-gen CAR player Quell Therapeutics drives into the fast lane\n",
      "https://www.fiercebiotech.com/biotech/next-gen-car-player-quell-therapeutics-drives-into-fast-lane-major-156m-round\n",
      "2021-11-29\n",
      "Biotech\n",
      "HotSpot collects $100M to bankroll trials of allosteric drugs\n",
      "https://www.fiercebiotech.com/biotech/hotspot-therapeutics-snags-100m-series-c-to-bring-allosteric-meds-into-clinic\n",
      "2021-11-29\n",
      "Biotech\n",
      "Is molnupiravir a turkey? Merck posts drop in antiviral efficacy\n",
      "https://www.fiercebiotech.com/biotech/molnupiravir-a-turkey-merck-slips-out-drop-efficacy-covid-19-antiviral-over-thanksgiving\n",
      "2021-11-29\n",
      "Biotech\n",
      "BD snags new SVP of investor relations from Medtronic\n",
      "https://www.fiercebiotech.com/medtech/bd-snags-new-senior-vp-investor-relations-from-medtronic\n",
      "2021-11-24\n",
      "MedTech\n",
      "Philips debuts AI-equipped MRI, spectral angio-CT combo scanners\n",
      "https://www.fiercebiotech.com/medtech/philips-debuts-ai-equipped-mri-machines-plus-spectral-angio-ct-combination-scanners\n",
      "2021-11-24\n",
      "MedTech\n",
      "Elizabeth Holmes admits to OK'ing shady practices at Theranos\n",
      "https://www.fiercebiotech.com/medtech/theranos-trial-elizabeth-holmes-admits-to-using-altered-siemens-analyzers-for-blood-tests\n",
      "2021-11-24\n",
      "MedTech\n",
      "Potential new target for arthritis treatment pinpointed\n",
      "https://www.fiercebiotech.com/research/researchers-find-regulatory-interaction-could-point-to-new-pathway-for-treating\n",
      "2021-11-24\n",
      "Research\n",
      "FDA stops Kura's early-phase leukemia trial after patient dies\n",
      "https://www.fiercebiotech.com/biotech/fda-halts-phase-1b-kura-oncology-trial-acute-myeloid-leukemia-following-patient-death\n",
      "2021-11-24\n",
      "Biotech\n",
      "Kymera’s protein degrader shows potential to boost I-O\n",
      "https://www.fiercebiotech.com/research/kymera-first-class-protein-degrader-shows-potential-to-boost-cancer-immunotherapy-pd-1\n",
      "2021-11-24\n",
      "Research\n",
      "Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet\n",
      "https://www.fiercebiotech.com/biotech/chasing-regeneron-pfizer-posts-data-250m-cardiovascular-bet\n",
      "2021-11-24\n",
      "Biotech\n",
      "Acorda CMO hits the exit, landing Pharnext job\n",
      "https://www.fiercebiotech.com/biotech/acorda-cmo-hits-exit-landing-pharnext-job-oversight-phase-3-neurological-disorder-trial\n",
      "2021-11-24\n",
      "Biotech\n",
      "Merck taps 2nd asset in $700M Dragonfly pact, bio abuzz with BMS\n",
      "https://www.fiercebiotech.com/biotech/merck-buzzes-dragonfly-for-second-immunotherapy-candidate-700m-pact-month-after-bristol\n",
      "2021-11-24\n",
      "Biotech\n",
      "Medtronic's surgery robot rollout hits supply chain speed bumps\n",
      "https://www.fiercebiotech.com/medtech/medtronic-s-surgery-robot-rollout-hits-supply-chain-speed-bumps\n",
      "2021-11-23\n",
      "MedTech\n",
      "Reify Health launches tool to improve clinical trial diversity\n",
      "https://www.fiercebiotech.com/cro/reify-health-releases-tool-to-give-drug-sponsors-insight-trial-diversity\n",
      "2021-11-23\n",
      "CRO\n",
      "Data manipulation scientist Elisabeth Bik on Cassava, Athira\n",
      "https://www.fiercebiotech.com/biotech/data-manipulation-scientist-elizabeth-bik-cassava-athira-alzheimer-s-data-manipulation\n",
      "2021-11-23\n",
      "Biotech\n",
      "Cardiologs scores pediatric heart Dx nod ahead of Philips buyout\n",
      "https://www.fiercebiotech.com/medtech/cardiologs-scores-pediatric-heart-ai-clearance-from-fda-ahead-philips-buyout\n",
      "2021-11-23\n",
      "MedTech\n",
      "When the eye on older patients is a camera\n",
      "https://www.fiercebiotech.com/medtech/when-eye-older-patients-a-camera\n",
      "2021-11-23\n",
      "MedTech\n",
      "Rafael resets after phase 3 flop, parting ways with 5 execs\n",
      "https://www.fiercebiotech.com/biotech/rafael-resets-after-phase-3-flop-parting-ways-5-execs-and-reinstating-telecom-tycoon-as-ceo\n",
      "2021-11-23\n",
      "Biotech\n",
      "Nykode, celebrates new name with Regeneron deal\n",
      "https://www.fiercebiotech.com/biotech/vaccibody-now-nykode-celebrates-new-name-a-new-regeneron-deal-worth-900m-plus\n",
      "2021-11-23\n",
      "Biotech\n",
      "Founder-led biotech makes space for ideas—and diverse leaders\n",
      "https://www.fiercebiotech.com/biotech/founder-led-biotech-making-space-for-ideas-and-diverse-leaders-where-it-didn-t-exist-before\n",
      "2021-11-23\n",
      "Biotech\n",
      "AstraZeneca, after years of delays, opens Cambridge R&D site\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-after-years-delays-and-spiraling-costs-opens-cambridge-r-d-site-will-bet-pay\n",
      "2021-11-23\n",
      "Biotech\n",
      "GSK takes a $1B dive into NASH, penning an RNAi pact\n",
      "https://www.fiercebiotech.com/biotech/gsk-takes-a-1b-dive-into-nash-penning-rnai-pact-target-arrowhead-pharmaceuticals\n",
      "2021-11-22\n",
      "Biotech\n",
      "UK launches review of racial, gender biases in medical devices\n",
      "https://www.fiercebiotech.com/medtech/uk-launches-review-racial-gender-bias-medical-devices-sparked-by-disproportionate-covid\n",
      "2021-11-22\n",
      "MedTech\n",
      "Pear nabs FDA breakthrough tag for alcoholism digital therapy\n",
      "https://www.fiercebiotech.com/medtech/pear-s-digital-therapeutic-for-alcohol-use-disorder-bears-fruit-fda-breakthrough-tag\n",
      "2021-11-22\n",
      "MedTech\n",
      "FDA unlocks faster clearances for future hepatitis C diagnostics\n",
      "https://www.fiercebiotech.com/medtech/fda-unlocks-faster-clearances-for-future-hepatitis-c-diagnostics\n",
      "2021-11-22\n",
      "MedTech\n",
      "COVID antiviral success hinges on access to fast, accurate tests\n",
      "https://www.fiercebiotech.com/medtech/success-covid-antiviral-pills-hinges-access-to-speedy-and-accurate-tests\n",
      "2021-11-22\n",
      "MedTech\n",
      "Roche, Genentech tap Flywheel to spin up AI-based drug discovery\n",
      "https://www.fiercebiotech.com/medtech/roche-genentech-tap-flywheel-to-spin-up-ai-based-drug-discovery-research\n",
      "2021-11-22\n",
      "MedTech\n",
      "BD upsizes San Diego presence with 220K-square-foot facility\n",
      "https://www.fiercebiotech.com/medtech/bd-upsizes-san-diego-presence-new-220k-square-foot-biosciences-r-d-facility\n",
      "2021-11-22\n",
      "MedTech\n",
      "Neurocrine pens $2.6B biobucks pact with Sosei Heptares\n",
      "https://www.fiercebiotech.com/biotech/neurocrine-pens-2-6b-biobucks-pact-sosei-heptares-for-next-gen-neuro-targets\n",
      "2021-11-22\n",
      "Biotech\n",
      "Xencor sells ex-lead drug to Tesaro founder in backloaded deal\n",
      "https://www.fiercebiotech.com/biotech/xencor-finally-finds-buyer-for-one-time-lead-drug-offloading-autoimmune-asset-to-tesaro\n",
      "2021-11-22\n",
      "Biotech\n",
      "Twist nabs antibody discovery biotech Abveris for $190M\n",
      "https://www.fiercebiotech.com/biotech/twist-nabs-antibody-discovery-biotech-abveris-for-190m-a-week-after-spinning-out-covid-unit\n",
      "2021-11-22\n",
      "Biotech\n",
      "Sanifit lands $231M Vifor buyout ahead of phase 3 data\n",
      "https://www.fiercebiotech.com/biotech/sanifit-having-put-spain-s-biotech-scene-map-lands-231m-vifor-buyout-ahead-phase-3-data\n",
      "2021-11-22\n",
      "Biotech\n",
      "Connect Biopharma touts positive data for Dupixent rival\n",
      "https://www.fiercebiotech.com/biotech/connect-biopharma-touts-positive-data-for-dupixent-rival-but-shares-slashed-half-as\n",
      "2021-11-22\n",
      "Biotech\n",
      "Roche launches more compact cobas analyzer for smaller labs\n",
      "https://www.fiercebiotech.com/medtech/roche-launches-more-compact-cobas-5800-analyzer-for-smaller-european-diagnostic-labs\n",
      "2021-11-19\n",
      "MedTech\n",
      "Benchling rakes in 2nd 9-figure VC haul this year\n",
      "https://www.fiercebiotech.com/medtech/cloud-r-d-developer-benchling-picks-up-second-nine-figure-venture-capital-haul-year\n",
      "2021-11-19\n",
      "MedTech\n",
      "FDA Califf, Biogen exec Sandrock, Pfizer CFO—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-robert-califf-nominated-to-lead-fda-again-after-woodcock-s-lengthy-interim\n",
      "2021-11-19\n",
      "Biotech\n",
      "Insights into how cancer cripples immune cells could fuel I-O\n",
      "https://www.fiercebiotech.com/research/new-insights-into-how-cancer-cripples-immune-cells-could-fuel-fresh-i-o-approaches\n",
      "2021-11-19\n",
      "Research\n",
      "BMS heart drug delayed as risk mitigation program worked out\n",
      "https://www.fiercebiotech.com/biotech/bms-heart-drug-delayed-at-fda-as-risk-mitigation-program-worked-out\n",
      "2021-11-19\n",
      "Biotech\n",
      "Enanta dumps oral hep B program after safety warnings\n",
      "https://www.fiercebiotech.com/biotech/enanta-dumps-oral-hep-b-program-after-safety-warnings-early-test\n",
      "2021-11-19\n",
      "Biotech\n",
      "BridgeBio, Helsinn expand collaboration to cover cancer assets\n",
      "https://www.fiercebiotech.com/biotech/fresh-from-2-5b-pact-bridgebio-helsinn-expand-collaboration-to-cover-preclinical-cancer\n",
      "2021-11-19\n",
      "Biotech\n",
      "Merck pauses 'very important' HIV program after seeing red flag\n",
      "https://www.fiercebiotech.com/biotech/merck-pauses-very-important-hiv-program-after-seeing-red-flag-phase-2-trial-once-weekly\n",
      "2021-11-19\n",
      "Biotech\n",
      "J&J previews $60B future with plans to go after evasive viruses\n",
      "https://www.fiercebiotech.com/biotech/j-j-previews-60b-future-plans-to-go-after-viruses-have-long-evaded-vaccine-makers\n",
      "2021-11-18\n",
      "Biotech\n",
      "Personalized T cells could open I-O to kids with brain tumors\n",
      "https://www.fiercebiotech.com/research/personalized-t-cells-could-offer-immunotherapy-option-to-children-brain-tumors\n",
      "2021-11-18\n",
      "Research\n",
      "FDA reemphasizes heart perforation risks of leadless pacemakers\n",
      "https://www.fiercebiotech.com/medtech/fda-highlights-heart-perforation-risks-leadless-pacemakers-market-set-to-grow\n",
      "2021-11-18\n",
      "MedTech\n",
      "Labcorp grows drug, device development services with Toxikon buy\n",
      "https://www.fiercebiotech.com/medtech/labcorp-adds-to-drug-development-device-testing-services-toxikon-purchase\n",
      "2021-11-18\n",
      "MedTech\n",
      "Cassava starts another Alzheimer's med trial amid fed inquiries\n",
      "https://www.fiercebiotech.com/biotech/federal-investigation-doesn-t-deter-cassava-from-starting-a-second-phase-3-trial-criticized\n",
      "2021-11-18\n",
      "Biotech\n",
      "Bristol Myers becomes latest victim of unforgiving NASH\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-becomes-latest-victim-unforgiving-nash-as-mid-stage-asset-shelved\n",
      "2021-11-18\n",
      "Biotech\n",
      "Pfizer invests $15M in Cardiff to bankroll Amgen KRAS challenger\n",
      "https://www.fiercebiotech.com/biotech/pfizer-doles-out-15m-to-cardiff-to-advance-a-challenger-to-amgen-s-kras-winner-lumakras\n",
      "2021-11-18\n",
      "Biotech\n",
      "Blackrock Neurotech’s mind-reading tech named FDA breakthrough\n",
      "https://www.fiercebiotech.com/medtech/blackrock-neurotech-nabs-fda-breakthrough-nod-for-system-uses-thoughts-to-control-devices\n",
      "2021-11-18\n",
      "MedTech\n",
      "Psilocybin shows promise in rat models of alcohol use disorder\n",
      "https://www.fiercebiotech.com/research/magic-mushrooms-might-be-next-treatment-tested-for-alcohol-addiction\n",
      "2021-11-18\n",
      "Research\n",
      "Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna\n",
      "https://www.fiercebiotech.com/biotech/novo-nordisk-bets-big-rnai-paying-3-3b-to-buy-dicerna\n",
      "2021-11-18\n",
      "Biotech\n",
      "Gilead hits go on a host of Arcus cancer programs\n",
      "https://www.fiercebiotech.com/biotech/gilead-hits-go-a-host-arcus-cancer-programs-but-forgoes-rumored-buyout-a-725m-pact-as-tigit\n",
      "2021-11-18\n",
      "Biotech\n",
      "J&J's Heaton becomes face of COVID-19 booster debate\n",
      "https://www.fiercebiotech.com/biotech/j-j-s-penny-heaton-becomes-face-covid-19-booster-debate-first-months-as-janssen-vaccine\n",
      "2021-11-18\n",
      "Biotech\n",
      "AstraZeneca shows durability of its COVID-preventing antibodies\n",
      "https://www.fiercebiotech.com/biotech/fda-scrutinizing-its-data-astrazeneca-shows-durability-its-covid-preventing-antibodies\n",
      "2021-11-18\n",
      "Biotech\n",
      "Flagship-incubated Generate reels in $370M for protein therapies\n",
      "https://www.fiercebiotech.com/biotech/flagship-founded-generate-snags-370m-to-generate-medicines-based-proteins-building-blocks\n",
      "2021-11-18\n",
      "Biotech\n",
      "Sanofi inks $270M cancer AI deal with developer Owkin\n",
      "https://www.fiercebiotech.com/medtech/sanofi-inks-270m-cancer-ai-deal-r-d-platform-developer-owkin\n",
      "2021-11-18\n",
      "MedTech\n",
      "Fine-tuning multiple myeloma treatments with 'multi-omics' data\n",
      "https://www.fiercebiotech.com/research/mount-sinai-tailored-treatment-precision-medicine-multiple-myeloma-subtypes-multiomics\n",
      "2021-11-17\n",
      "Research\n",
      "COVID test maker Sense pads venture round with another $15M\n",
      "https://www.fiercebiotech.com/medtech/sense-biodetection-pads-series-b-another-15m-amid-fda-submission-covid-test-platform\n",
      "2021-11-17\n",
      "MedTech\n",
      "Cala Health nets $77M to expand on its tremor-fighting wearable\n",
      "https://www.fiercebiotech.com/medtech/cala-health-scores-77m-to-expand-use-its-tremor-fighting-wearable\n",
      "2021-11-17\n",
      "MedTech\n",
      "Hybrid trial growth could outpace site-based in 2022: study\n",
      "https://www.fiercebiotech.com/cro/nearly-80-clinical-research-execs-expect-to-run-decentralized-trials-next-12-months-survey\n",
      "2021-11-17\n",
      "CRO\n",
      "Provention hires 3rd exec as it awaits FDA meeting for lead drug\n",
      "https://www.fiercebiotech.com/biotech/provention-bio-hires-third-exec-as-many-weeks-as-it-awaits-fda-meeting-for-rejected-drug\n",
      "2021-11-17\n",
      "Biotech\n",
      "AppliedVR nets FDA’s first approval for VR back pain device\n",
      "https://www.fiercebiotech.com/medtech/appliedvr-nets-fda-s-first-approval-for-a-vr-system-to-treat-chronic-low-back-pain\n",
      "2021-11-17\n",
      "MedTech\n",
      "Valo blames 'market conditions' for end of $750M Khosla deal\n",
      "https://www.fiercebiotech.com/biotech/valo-whacks-spac-merger-blaming-market-conditions-for-end-750m-khosla-deal\n",
      "2021-11-17\n",
      "Biotech\n",
      "Eloxx ends long wait for cystic fibrosis data. Market shrugs\n",
      "https://www.fiercebiotech.com/biotech/eloxx-ends-long-wait-for-phase-2-cystic-fibrosis-data-market-shrugs\n",
      "2021-11-17\n",
      "Biotech\n",
      "Roche culls pandemic ties with Atea\n",
      "https://www.fiercebiotech.com/biotech/as-merck-and-pfizer-predict-incoming-billions-from-their-covid-drugsas-merck-and-pfizer\n",
      "2021-11-17\n",
      "Biotech\n",
      "Software for the DNA hardware: Chroma snags $125M for epigenome\n",
      "https://www.fiercebiotech.com/biotech/gene-gene-off-chroma-medicine-turns-lights-125m-to-control-gene-expression-ex-editas\n",
      "2021-11-17\n",
      "Biotech\n",
      "HHS reinstates FDA authority over lab-developed tests\n",
      "https://www.fiercebiotech.com/medtech/hhs-reinstates-fda-authority-over-lab-developed-tests-covid-diagnostics\n",
      "2021-11-16\n",
      "MedTech\n",
      "Spine surgery tech maker Accelus sizes up $482M SPAC deal\n",
      "https://www.fiercebiotech.com/medtech/accelus-sizes-up-482m-spac-deal-to-take-its-minimally-invasive-spinal-surgery-tech-public\n",
      "2021-11-16\n",
      "MedTech\n",
      "Medtronic nets capsule camera clearance for at-home screenings\n",
      "https://www.fiercebiotech.com/medtech/medtronic-nets-fda-capsule-camera-clearance-for-at-home-gi-screenings\n",
      "2021-11-16\n",
      "MedTech\n",
      "AavantiBio poaches another bluebird bio VP as scientific leader\n",
      "https://www.fiercebiotech.com/biotech/aavantibio-snags-another-bluebird-bio-vp-gene-therapy-chops-as-sixth-executive-hire-year\n",
      "2021-11-16\n",
      "Biotech\n",
      "Geneoscopy nabs $105M to advance gut tests for colorectal cancer\n",
      "https://www.fiercebiotech.com/medtech/geneoscopy-nabs-105m-to-advance-rna-based-gut-tests-for-early-colorectal-cancer-screening\n",
      "2021-11-16\n",
      "MedTech\n",
      "Novartis-partnered DARPin flames out in COVID-19 study\n",
      "https://www.fiercebiotech.com/biotech/novartis-partnered-darpin-flames-out-covid-19-study-sending-molecular-partners-stock-into\n",
      "2021-11-16\n",
      "Biotech\n",
      "Ncardia snags $60M to boost production of pluripotent stem cells\n",
      "https://www.fiercebiotech.com/cro/ncardia-inks-60m-funding-deal-to-expand-discovery-and-commercial-production-services-for-stem\n",
      "2021-11-16\n",
      "CRO\n",
      "Sandrock retires as Biogen R&D chief amid Aduhelm fallout\n",
      "https://www.fiercebiotech.com/biotech/sandrock-makes-a-sharp-exit-retiring-as-biogen-r-d-chief-amid-fallout-from-aduhelm-approval\n",
      "2021-11-16\n",
      "Biotech\n",
      "Acelyrin snags $250M, licenses Affibody IL-17 asset for 3 trials\n",
      "https://www.fiercebiotech.com/biotech/acelyrin-reels-250m-to-fund-three-late-stage-trials-inflammatory-disease-antibody-licensed\n",
      "2021-11-16\n",
      "Biotech\n",
      "Medidata co-founder Glen de Vries dies in plane crash\n",
      "https://www.fiercebiotech.com/cro/medidata-co-founder-glen-de-vries-dies-plane-crash-less-than-a-month-after-blue-origin-flight\n",
      "2021-11-15\n",
      "CRO\n",
      "BMS, Janssen blood clot med aces proof-of-concept study\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-janssen-look-to-phase-3-as-anticoagulant-med-aces-proof-concept-study\n",
      "2021-11-15\n",
      "Biotech\n",
      "PhaseBio shows Brilinta reversal agent can work in an emergency\n",
      "https://www.fiercebiotech.com/biotech/phasebio-boasts-emergency-results-needed-phase-3-trial-brilinta-reversal-agent\n",
      "2021-11-15\n",
      "Biotech\n",
      "FDA flags safety issue in fix for recalled Philips ventilators\n",
      "https://www.fiercebiotech.com/medtech/fda-flags-safety-issue-replacement-material-for-recalled-philips-ventilators\n",
      "2021-11-15\n",
      "MedTech\n",
      "Fitbit shows it can track down afib in 450,000-strong study\n",
      "https://www.fiercebiotech.com/medtech/fitbit-shows-it-can-track-down-atrial-fibrillation-450-000-strong-heart-study\n",
      "2021-11-15\n",
      "MedTech\n",
      "FDA clears ALung's 'respiratory dialysis' machine\n",
      "https://www.fiercebiotech.com/medtech/fda-grants-de-novo-clearance-to-alung-s-respiratory-dialysis-machine\n",
      "2021-11-15\n",
      "MedTech\n",
      "Medtronic builds out executive team with 4 new hires\n",
      "https://www.fiercebiotech.com/medtech/medtronic-adds-two-new-neuroscience-execs-plus-strategy-and-digital-innovation-heads\n",
      "2021-11-15\n",
      "MedTech\n",
      "Injected 'dancing molecules' restore mobility in paralyzed mice\n",
      "https://www.fiercebiotech.com/research/injectable-dancing-molecules-repair-spinal-cord-injury-and-restore-mobility-paralyzed-mice\n",
      "2021-11-15\n",
      "Research\n",
      "Protagonist posts hormone replacement data in iron disease\n",
      "https://www.fiercebiotech.com/biotech/protagonist-posts-phase-2-hormone-replacement-data-pitching-for-lead-role-genetic-iron\n",
      "2021-11-15\n",
      "Biotech\n",
      "AZ, Moderna shine early light on mRNA potential in heart failure\n",
      "https://www.fiercebiotech.com/biotech/aha-astrazeneca-moderna-shine-early-light-mrna-potential-heart-failure\n",
      "2021-11-15\n",
      "Biotech\n",
      "Twist spins out COVID-19 antibody program to form startup\n",
      "https://www.fiercebiotech.com/biotech/twist-spins-out-covid-19-antibody-program-forming-startup-to-advance-variant-busting\n",
      "2021-11-15\n",
      "Biotech\n",
      "Recludix emerges with $60M, Seagen exec Nancy Whiting at helm\n",
      "https://www.fiercebiotech.com/biotech/scientific-cofounder-blueprint-medicines-launches-recludix-60m-15-year-seagen-exec-steering\n",
      "2021-11-15\n",
      "Biotech\n",
      "BMS' $13B MyoKardia heart drug gets along with beta blockers\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-13b-myokardia-heart-drug-gets-along-beta-blockers-as-clock-ticks-down-to-fda\n",
      "2021-11-13\n",
      "Biotech\n",
      "Abbott's leadless pacemaker clears clinical trial hurdle\n",
      "https://www.fiercebiotech.com/medtech/abbott-s-retrievable-leadless-pacemaker-clears-trial-hurdle-as-fda-continues-review\n",
      "2021-11-12\n",
      "MedTech\n",
      "Olympus launches medtech VC fund with $50M\n",
      "https://www.fiercebiotech.com/medtech/olympus-launches-vc-fund-50m-to-back-new-surgical-devices-diagnostics\n",
      "2021-11-12\n",
      "MedTech\n",
      "SITC: Cellectis off-the-shelf CAR-T active in solid tumor models\n",
      "https://www.fiercebiotech.com/research/sitc-cellectis-off-shelf-car-t-for-pancreatic-cancer-and-mesothelioma-shows-activity-mice\n",
      "2021-11-12\n",
      "Research\n",
      "At the eleventh hour, Califf becomes FDA commish nominee\n",
      "https://www.fiercebiotech.com/biotech/at-eleventh-hour-woodcock-shunned-by-biden-as-recycled-pick-califf-becomes-fda-commish\n",
      "2021-11-12\n",
      "Biotech\n",
      "Cortexyme picks a lower dose for nebulous Alzheimer's drug\n",
      "https://www.fiercebiotech.com/biotech/cortexyme-picks-a-lower-dose-for-alzheimer-s-drug-after-phase-2-3-flop\n",
      "2021-11-12\n",
      "Biotech\n",
      "Recall of Ellume COVID tests grows to more than 2.2M kits\n",
      "https://www.fiercebiotech.com/medtech/recall-ellume-at-home-covid-antigen-tests-grows-to-more-than-2-2-million-kits\n",
      "2021-11-12\n",
      "MedTech\n",
      "Before exiting J&J, Gorsky lands on Apple board—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-j-j-s-outgoing-ceo-already-has-a-new-role-apple-board-member\n",
      "2021-11-12\n",
      "Biotech\n",
      "Gerngross biotech Ankyra Therapeutics nabs $45M series B\n",
      "https://www.fiercebiotech.com/biotech/gerngross-biotech-ankyra-therapeutics-nabs-45m-series-b-to-jump-into-clinic-hires-new-cmo\n",
      "2021-11-12\n",
      "Biotech\n",
      "CRISPR pinpoints a new anti-inflammatory drug target\n",
      "https://www.fiercebiotech.com/research/using-crispr-screening-to-find-a-new-drug-target-for-multiple-sclerosis-inflammatory-bowel\n",
      "2021-11-12\n",
      "Research\n",
      "AstraZeneca scraps midphase drugs from $1B buyout, Heptares pact\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-wields-ax-scrapping-midphase-programs-from-1b-takeover-heptares-pact-latest\n",
      "2021-11-12\n",
      "Biotech\n",
      "Adaptimmune's T-cell therapy clears efficacy bar in solid tumors\n",
      "https://www.fiercebiotech.com/biotech/adaptimmune-s-tcr-t-cell-therapy-clears-efficacy-bar-rare-cancers-teeing-up-landmark-solid\n",
      "2021-11-12\n",
      "Biotech\n",
      "C2N's Alzheimer's risk blood test matches up to PET scans\n",
      "https://www.fiercebiotech.com/medtech/c2n-s-alzheimer-s-blood-test-to-help-unlock-clinical-studies-into-memory-loss-cognitive\n",
      "2021-11-11\n",
      "MedTech\n",
      "Viome hauls in $54M to grow microbiome-sequencing platform\n",
      "https://www.fiercebiotech.com/medtech/viome-passes-gut-check-54m-haul-to-grow-microbiome-sequencing-platform\n",
      "2021-11-11\n",
      "MedTech\n",
      "Siemens, UCSF team up to build carbon-neutral imaging tech\n",
      "https://www.fiercebiotech.com/medtech/siemens-healthineers-ucsf-team-up-to-build-carbon-neutral-imaging-tech\n",
      "2021-11-11\n",
      "MedTech\n",
      "Vaxxinity makes a subdued Wall Street debut\n",
      "https://www.fiercebiotech.com/biotech/vaxxinity-hoping-to-turn-bodies-into-their-own-drug-factories-makes-a-subdued-wall-street\n",
      "2021-11-11\n",
      "Biotech\n",
      "Organon buys Forendo in 3rd deal since spinning out of Merck\n",
      "https://www.fiercebiotech.com/biotech/organon-keeps-pedal-to-metal-buying-up-forendo-3rd-deal-since-spinning-out-merck\n",
      "2021-11-11\n",
      "Biotech\n",
      "Genentech inks deal for seaweed-controlled oral cell therapies\n",
      "https://www.fiercebiotech.com/biotech/genentech-novome-team-up-to-study-seaweed-controlled-oral-cell-therapies-ibd\n",
      "2021-11-11\n",
      "Biotech\n",
      "Acrivon snags $100M to bring Lilly cancer drug into 19th study\n",
      "https://www.fiercebiotech.com/biotech/acrivon-therapeutics-secures-100m-to-give-eli-lilly-cancer-drug-another-try-fund-2-solid\n",
      "2021-11-11\n",
      "Biotech\n",
      "Shasqi snatches $50M for chemotherapy-boosting treatments\n",
      "https://www.fiercebiotech.com/biotech/shasqi-snatches-50m-series-b-sum-to-take-its-lead-program-to-clinic\n",
      "2021-11-11\n",
      "Biotech\n",
      "Non-opioid pain drug indirectly blocks a key ion channel\n",
      "https://www.fiercebiotech.com/research/university-arizona-non-opioid-painkiller-reducing-pain-by-indirectly-blocking-ion-channel\n",
      "2021-11-10\n",
      "Research\n",
      "J&J’s Gorsky finds exit strategy in Apple board appointment\n",
      "https://www.fiercebiotech.com/medtech/outgoing-j-j-ceo-gorsky-takes-health-tech-talents-to-apple\n",
      "2021-11-10\n",
      "MedTech\n",
      "FDA clears arrhythmia mapping system that uses a 12-lead ECG\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-heart-mapping-system-hunts-down-arrhythmias-using-only-a-12-lead-ecg\n",
      "2021-11-10\n",
      "MedTech\n",
      "Color triples valuation with $100M funding boost\n",
      "https://www.fiercebiotech.com/medtech/color-triples-valuation-100m-funding-to-expand-population-level-testing-and-treatment\n",
      "2021-11-10\n",
      "MedTech\n",
      "Intima snags Gilead's former Yescarta leader for cell Tx chops\n",
      "https://www.fiercebiotech.com/biotech/intima-bioscience-poaches-ex-ichnos-ceo-gilead-novartis-resume-to-lead-phase-1-2-asset\n",
      "2021-11-10\n",
      "Biotech\n",
      "EQT doubles down on healthcare with Life Science Partners buyout\n",
      "https://www.fiercebiotech.com/biotech/after-snapping-up-parexel-goldman-sachs-eqt-doubles-down-healthcare-life-science-vc-buyout\n",
      "2021-11-10\n",
      "Biotech\n",
      "Immatics' cell therapy blasts solid tumors, but questions remain\n",
      "https://www.fiercebiotech.com/biotech/immatics-cell-therapy-blasts-solid-tumors-phase-1-but-durability-spooks-investors-will\n",
      "2021-11-10\n",
      "Biotech\n",
      "Psilocybin clears biggest test yet, easing depression in phase 2\n",
      "https://www.fiercebiotech.com/biotech/psilocybin-clears-biggest-test-yet-improving-depression-phase-2b-but-compass-stock-falls\n",
      "2021-11-10\n",
      "Biotech\n",
      "Takeda-backed Poseida puts off-the-shelf CAR-T in its basket\n",
      "https://www.fiercebiotech.com/biotech/takeda-backed-poseida-puts-off-shelf-car-t-its-basket-places-autologous-therapy-back-shelf\n",
      "2021-11-10\n",
      "Biotech\n",
      "Coloplast picks up voice box maker Atos Medical in €2B deal\n",
      "https://www.fiercebiotech.com/medtech/coloplast-picks-up-voice-box-maker-atos-medical-eu2b-deal\n",
      "2021-11-09\n",
      "MedTech\n",
      "GE spins off healthcare business into standalone public company\n",
      "https://www.fiercebiotech.com/medtech/ge-healthcare-to-become-standalone-public-company-after-ge-completes-three-way-split\n",
      "2021-11-09\n",
      "MedTech\n",
      "Novartis-backed Mekonos nets $25M for cell engineering platform\n",
      "https://www.fiercebiotech.com/medtech/mekonos-closes-novartis-backed-25m-series-a-for-cell-engineering-platform\n",
      "2021-11-09\n",
      "MedTech\n",
      "Cue kicks off DTC COVID test launch with new telehealth platform\n",
      "https://www.fiercebiotech.com/medtech/cue-health-to-kick-off-direct-to-consumer-covid-test-launch-new-telehealth-platform\n",
      "2021-11-09\n",
      "MedTech\n",
      "Arthrex fined $16M over kickback allegations\n",
      "https://www.fiercebiotech.com/medtech/surgical-device-maker-arthrex-fined-16m-over-alleged-kickback-scheme\n",
      "2021-11-09\n",
      "MedTech\n",
      "Clinical Ink acquires Digital Artefacts to boost study data\n",
      "https://www.fiercebiotech.com/cro/clinical-ink-pens-data-acquisition-digital-artefacts-to-enhance-wearables-sensors-data\n",
      "2021-11-09\n",
      "CRO\n",
      "Novartis dumps 2nd bispecific from $2.6B Xencor pact\n",
      "https://www.fiercebiotech.com/biotech/novartis-dumps-second-bispecific-from-2-6b-xencor-pact-dealing-further-blow-to-hopes-for\n",
      "2021-11-09\n",
      "Biotech\n",
      "Mirati cuts KRAS dose in Keytruda combo to improve tolerability\n",
      "https://www.fiercebiotech.com/biotech/seeking-edge-over-amgen-mirati-advances-lower-kras-dose-keytruda-combo-to-improve\n",
      "2021-11-09\n",
      "Biotech\n",
      "Feng Zhang's Arbor Bio snags $215M for liver, CNS diseases\n",
      "https://www.fiercebiotech.com/biotech/arbor-s-autumn-a-1-2b-vertex-pact-now-a-215m-series-b-for-liver-cns-diseases\n",
      "2021-11-09\n",
      "Biotech\n",
      "After Moderna success, Flagship's next RNA bet: $50M for Alltrna\n",
      "https://www.fiercebiotech.com/biotech/flagship-unveils-its-next-rna-bet-50m-for-alltrna-to-explore-thousands-genetic-diseases\n",
      "2021-11-09\n",
      "Biotech\n",
      "With ex-Allergan CEO on board, OcuTerra nabs $35M for eye drops\n",
      "https://www.fiercebiotech.com/biotech/ocuterra-snags-35m-for-phase-2-trial-eye-drop-former-allergan-ceo-as-chair\n",
      "2021-11-09\n",
      "Biotech\n",
      "NHS lands £250M in government funds to digitize diagnostics\n",
      "https://www.fiercebiotech.com/medtech/nhs-lands-ps250m-government-funding-to-update-diagnostic-technologies\n",
      "2021-11-08\n",
      "MedTech\n",
      "Philips augments cardiac AI programs with Cardiologs acquisition\n",
      "https://www.fiercebiotech.com/medtech/philips-augments-cardiac-ai-diagnostic-programs-cardiologs-acquisition\n",
      "2021-11-08\n",
      "MedTech\n",
      "Joe Jimenez's Ancora Bio poaches Sage CMO to revive Taisho drug\n",
      "https://www.fiercebiotech.com/biotech/he-got-first-postpartum-depression-drug-to-market-now-ex-sage-cmo-takes-helm-at-ancora-to\n",
      "2021-11-08\n",
      "Biotech\n",
      "Alcon scopes out $475M acquisition of Ivantis\n",
      "https://www.fiercebiotech.com/medtech/alcon-scopes-out-475m-acquisition-glaucoma-stent-maker-ivantis\n",
      "2021-11-08\n",
      "MedTech\n",
      "Once-failed cancer drug ramps up I-O in pancreatic cancer models\n",
      "https://www.fiercebiotech.com/research/once-failed-cancer-drug-from-bioxcel-ramps-up-immunotherapy-mouse-models-pancreatic-cancer\n",
      "2021-11-08\n",
      "Research\n",
      "Blade runs to Wall St. at $353M SPAC deal for 2 trials in 2022\n",
      "https://www.fiercebiotech.com/biotech/blade-runs-toward-nasdaq-at-353m-spac-deal-for-two-clinical-trials-2022\n",
      "2021-11-08\n",
      "Biotech\n",
      "Gyroscope spins the wheel again as it taps Sanofi for $60M\n",
      "https://www.fiercebiotech.com/biotech/gyroscope-spins-wheel-again-as-it-taps-sanofi-for-60m-months-after-ditching-ipo-attempt\n",
      "2021-11-08\n",
      "Biotech\n",
      "Marengo's $80M cancer battle led by ex-Merck KGaA oncology exec\n",
      "https://www.fiercebiotech.com/biotech/atp-fuels-marengo-80m-for-battle-against-cancers-former-merck-kgaa-oncology-head-driver-s\n",
      "2021-11-08\n",
      "Biotech\n",
      "GSK pulls off clean sweep of endpoint hits in anemia phase 3\n",
      "https://www.fiercebiotech.com/biotech/gsk-pulls-off-clean-sweep-endpoint-hits-anemia-phase-3-positioning-it-to-leapfrog\n",
      "2021-11-08\n",
      "Biotech\n",
      "Blackstone bets on Autolus' CD19 CAR-T in $250M deal\n",
      "https://www.fiercebiotech.com/biotech/blackstone-bets-autolus-cd19-car-t-250m-deal-clearing-path-to-pivotal-readout-2022\n",
      "2021-11-08\n",
      "Biotech\n",
      "Provention Bio hires early research exec from Gossamer\n",
      "https://www.fiercebiotech.com/biotech/provention-bio-hit-by-adcomm-rejection-for-lead-drug-hires-new-early-research-exec-from\n",
      "2021-11-08\n",
      "Biotech\n",
      "iRhythm picks up the tempo with 19% revenue boost in Q3\n",
      "https://www.fiercebiotech.com/medtech/irhythm-picks-up-tempo-19-revenue-boost-despite-medicare-pricing-letdown\n",
      "2021-11-05\n",
      "MedTech\n",
      "TCT: Medtronic's TAVR valve on par with surgery after 5 years\n",
      "https://www.fiercebiotech.com/medtech/tct-2021-medtronic-s-tavr-valve-safety-par-open-surgery-after-5-years\n",
      "2021-11-05\n",
      "MedTech\n",
      "ReWalk’s ReBoot ankle exo-suit lands FDA breakthrough label\n",
      "https://www.fiercebiotech.com/medtech/rewalk-lands-fda-breakthrough-label-for-at-home-exoskeleton-device-to-restore-post-stroke\n",
      "2021-11-05\n",
      "MedTech\n",
      "Treating resistant prostate cancer via tumor-suppressing RNA\n",
      "https://www.fiercebiotech.com/research/treating-drug-resistant-prostate-cancer-by-exploiting-tumor-suppressing-rna\n",
      "2021-11-05\n",
      "Research\n",
      "Mirati CMO, COO booted as request to FDA looms—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-mirati-therapeutics-cmo-coo-given-boot-as-fda-filing-looms\n",
      "2021-11-05\n",
      "Biotech\n",
      "Researchers find a potential gene therapy target in Parkinson's\n",
      "https://www.fiercebiotech.com/research/researchers-find-target-for-potential-parkinson-s-gene-therapy-way-to-diagnose-disease\n",
      "2021-11-05\n",
      "Research\n",
      "HitGen taps Cambridge Molecular for 'deep learning' work\n",
      "https://www.fiercebiotech.com/biotech/hitgen-taps-cambridge-molecular-for-deep-learning-drug-discovery-collab\n",
      "2021-11-05\n",
      "Biotech\n",
      "Moderna scraps lead mRNA chikungunya candidate after phase 1\n",
      "https://www.fiercebiotech.com/biotech/moderna-scraps-lead-mrna-antibody-candidate-after-phase-1-slowing-push-beyond-prophylactic\n",
      "2021-11-05\n",
      "Biotech\n",
      "Pfizer's oral COVID antiviral cuts hospitalization, death by 89%\n",
      "https://www.fiercebiotech.com/biotech/pfizer-s-oral-covid-19-antiviral-cuts-hospitalization-death-by-85-sending-team-barreling-to\n",
      "2021-11-05\n",
      "Biotech\n",
      "Veterans from GSK's GlycoVaxyn rally up $49M for new biotech\n",
      "https://www.fiercebiotech.com/biotech/veterans-from-gsk-s-glycovaxyn-rally-up-49m-to-advance-swiss-biotech-glycoera-and-custom\n",
      "2021-11-05\n",
      "Biotech\n",
      "Alphabet unveils AI drug venture built on DeepMind protein work\n",
      "https://www.fiercebiotech.com/medtech/alphabet-google-ai-drug-discovery-deepmind-protein-folding\n",
      "2021-11-04\n",
      "MedTech\n",
      "Hologic launches AI-powered cervical cancer screening in EU\n",
      "https://www.fiercebiotech.com/medtech/hologic-begins-european-rollout-ai-powered-cervical-cancer-screening-system\n",
      "2021-11-04\n",
      "MedTech\n",
      "Amgen targets 'multi-specifics' in drug development's 4th wave\n",
      "https://www.fiercebiotech.com/biotech/amgen-has-loaded-early-pipeline-multi-specifics-quest-to-tackle-undruggable\n",
      "2021-11-04\n",
      "Biotech\n",
      "Siemens posts record year following Varian megadeal\n",
      "https://www.fiercebiotech.com/medtech/siemens-posts-record-year-backs-varian-acquisition-covid-antigen-test-sales\n",
      "2021-11-04\n",
      "MedTech\n",
      "Aptose to pay Hanmi up to $420M for myeloid inhibitor\n",
      "https://www.fiercebiotech.com/biotech/aptose-inks-408m-biobucks-deal-hanmi-for-access-to-phase-1-2-myeloid-inhibitor\n",
      "2021-11-04\n",
      "Biotech\n",
      "Section 32 closes $740M VC fund to back health tech startups\n",
      "https://www.fiercebiotech.com/medtech/section-32-closes-740m-vc-fund-to-back-startups-at-intersection-technology-and-healthcare\n",
      "2021-11-04\n",
      "MedTech\n",
      "Sangamo's Fabry gene therapy clears early clinical test\n",
      "https://www.fiercebiotech.com/biotech/sangamo-s-fabry-gene-therapy-clears-early-clinical-test-firing-starting-gun-preparations\n",
      "2021-11-04\n",
      "Biotech\n",
      "Bayer poaches Otsuka's chief medical officer Koenen\n",
      "https://www.fiercebiotech.com/biotech/bayer-poaches-otsuka-s-chief-medical-officer-koenen-to-head-up-its-clinical-operations\n",
      "2021-11-04\n",
      "Biotech\n",
      "Ironwood starts pipeline rebuild with liver disease deal\n",
      "https://www.fiercebiotech.com/biotech/after-flops-ironwood-starts-pipeline-rebuild-liver-disease-deal\n",
      "2021-11-04\n",
      "Biotech\n",
      "VC firm Mission BioCapital snags $275M to launch new biotechs\n",
      "https://www.fiercebiotech.com/biotech/vc-shop-mission-biocapital-raises-275m-fifth-fund-focus-incubating-startups\n",
      "2021-11-04\n",
      "Biotech\n",
      "Allara launches at-home test for polycystic ovary syndrome\n",
      "https://www.fiercebiotech.com/medtech/allara-launches-at-home-hormone-test-for-diagnosing-pcos\n",
      "2021-11-03\n",
      "MedTech\n",
      "Heru adds 3 more eye exams to VR headset-based platform\n",
      "https://www.fiercebiotech.com/medtech/heru-adds-3-more-diagnostics-to-vr-headset-based-vision-testing-platform\n",
      "2021-11-03\n",
      "MedTech\n",
      "Pfizer adds to $65M Parthenon war chest for tumor barrier battle\n",
      "https://www.fiercebiotech.com/biotech/pfizer-ventures-backed-biotech-parthenon-therapeutics-snags-65m-series-a-to-advance-its\n",
      "2021-11-03\n",
      "Biotech\n",
      "Novel CAR-T for solid tumors targets proteins in cancer cells\n",
      "https://www.fiercebiotech.com/research/chop-car-t-therapy-solid-tumor-target-fragments-proteins-inside-cancer-cells\n",
      "2021-11-03\n",
      "Research\n",
      "After securing first FDA nod in 17-year stint, Cara CEO departs\n",
      "https://www.fiercebiotech.com/biotech/cara-ceo-hands-keys-to-leo-head-3-months-after-first-approval-17-year-stint\n",
      "2021-11-03\n",
      "Biotech\n",
      "PhaseBio's Brilinta reversal agent wins midstage test\n",
      "https://www.fiercebiotech.com/biotech/phasebio-s-brilinta-reversal-agent-wins-midstage-test-as-biotech-awaits-key-interim-read\n",
      "2021-11-03\n",
      "Biotech\n",
      "Boston Scientific wins $20M from Nevro in patent case\n",
      "https://www.fiercebiotech.com/medtech/boston-scientific-wins-20m-patent-infringement-case-against-nevro-over-spinal-cord\n",
      "2021-11-03\n",
      "MedTech\n",
      "Antios raises a further $75M to fuel pursuit of hepatitis B cure\n",
      "https://www.fiercebiotech.com/biotech/antios-months-after-series-b-raises-a-further-75m-to-fuel-pursuit-hepatitis-b-cure\n",
      "2021-11-03\n",
      "Biotech\n",
      "Pfizer reveals series of delays to pivotal gene therapy readouts\n",
      "https://www.fiercebiotech.com/biotech/pfizer-tears-up-gene-therapy-timelines-revealing-a-series-phase-3-delays-end-vision-a\n",
      "2021-11-03\n",
      "Biotech\n",
      "Patient's race 'highly' correlates with trial site staff: study\n",
      "https://www.fiercebiotech.com/cro/race-ethnicity-trial-patients-highly-correlated-staff-site-investigators-study\n",
      "2021-11-03\n",
      "CRO\n",
      "Intuity launches all-in-one, push-button blood glucose monitor\n",
      "https://www.fiercebiotech.com/medtech/intuity-launches-all-one-push-button-blood-glucose-monitor\n",
      "2021-11-03\n",
      "MedTech\n",
      "Flagship startups snag up to $110M from Cystic Fibrosis org\n",
      "https://www.fiercebiotech.com/biotech/cohort-flagship-biotechs-snag-100m-to-make-cystic-fibrosis-treatments\n",
      "2021-11-03\n",
      "Biotech\n",
      "Bristol Myers Squibb-backed Clade nabs a meaty $87M series A\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-squibb-backed-clade-nabs-a-meaty-87m-series-a-for-cell-therapy-2-0\n",
      "2021-11-03\n",
      "Biotech\n",
      "Biolinq amasses $100M for its painless glucose sensor patch\n",
      "https://www.fiercebiotech.com/medtech/biolinq-amasses-100m-for-its-painless-glucose-sensor-patch\n",
      "2021-11-02\n",
      "MedTech\n",
      "LightForce Orthodontics nets $50M for 3D-printed braces system\n",
      "https://www.fiercebiotech.com/medtech/3d-printed-braces-maker-lightforce-orthodontics-sinks-its-teeth-into-50m-vc-round\n",
      "2021-11-02\n",
      "MedTech\n",
      "Sage tweaks primary endpoint for zuranolone depression trial\n",
      "https://www.fiercebiotech.com/biotech/sage-tweaks-primary-endpoint-for-zuranolone-depression-trial-leaving-key-durability\n",
      "2021-11-02\n",
      "Biotech\n",
      "Aldeyra dry eye drug helps with redness, misses secondary goals\n",
      "https://www.fiercebiotech.com/biotech/aldeyra-s-dry-eye-drug-helps-redness-but-misses-other-phase-2-goals-important-measures\n",
      "2021-11-02\n",
      "Biotech\n",
      "Cambridge Epigenetix lines up $88M for genetic sequencing tech\n",
      "https://www.fiercebiotech.com/medtech/gv-backed-cambridge-epigenetix-lines-up-88m-to-roll-out-genetic-sequencing-technology\n",
      "2021-11-02\n",
      "MedTech\n",
      "Why public health lab workers are fleeing the field\n",
      "https://www.fiercebiotech.com/medtech/labs-no-one-to-run-them-why-public-health-workers-are-fleeing-field\n",
      "2021-11-02\n",
      "MedTech\n",
      "Pfizer sells midphase inflammatory drugs to mystery startup\n",
      "https://www.fiercebiotech.com/biotech/pfizer-sells-midphase-inflammatory-drugs-to-mystery-startup-exiting-race-against-bristol\n",
      "2021-11-02\n",
      "Biotech\n",
      "BMS tops AbbVie-backed Nitrase's $45M series A, snags Nurix exec\n",
      "https://www.fiercebiotech.com/biotech/abbvie-backed-nitrome-adds-bms-as-investor-snags-nurix-cbo-as-ceo-and-rebrands-to-nitrase\n",
      "2021-11-02\n",
      "Biotech\n",
      "Moderna finally cracks into gene editing with Metagenomi pact\n",
      "https://www.fiercebiotech.com/biotech/moderna-finally-cracks-into-gene-editing-metagenomi-pact-thanks-irresistible-data\n",
      "2021-11-02\n",
      "Biotech\n",
      "Novartis inks protein degrader deal with new British startup\n",
      "https://www.fiercebiotech.com/biotech/novartis-makes-protein-degrader-play-inking-deal-new-british-startup-to-access-fruits-novel\n",
      "2021-11-02\n",
      "Biotech\n",
      "FDA delays Legend, Janssen-partnered CAR-T cilta-cel\n",
      "https://www.fiercebiotech.com/biotech/legend-s-status-put-hold-as-fda-delays-janssen-partnered-car-t-decision\n",
      "2021-11-02\n",
      "Biotech\n",
      "The top 10 highest-paid medtech CEOs\n",
      "https://www.fiercebiotech.com/special-report/top-10-highest-paid-medtech-ceos\n",
      "2021-11-02\n",
      "Special Reports\n",
      "TriNetX hires Harvard professor as chief scientific officer\n",
      "https://www.fiercebiotech.com/cro/trials-network-provider-life-sciences-data-company-trinetx-snags-harvard-prof-as-chief\n",
      "2021-11-01\n",
      "CRO\n",
      "'The year of RSV': Pfizer, GSK present dueling maternal vax data\n",
      "https://www.fiercebiotech.com/biotech/year-rsv-ahead-as-pfizer-gsk-present-dueling-maternal-vax-data\n",
      "2021-11-01\n",
      "Biotech\n",
      "Boehringer joins $20M series A for Alzheimer's test maker Optina\n",
      "https://www.fiercebiotech.com/medtech/optina-diagnostics-nabs-boehringer-s-support-20m-vc-round-for-retina-based-alzheimer-s-test\n",
      "2021-11-01\n",
      "MedTech\n",
      "Mirati KRAS concerns as key adagrasib lead, COO suddenly exit\n",
      "https://www.fiercebiotech.com/biotech/kras-race-against-amgen-mirati-cmo-and-coo-shown-exit-ahead-fda-drug-approval-request\n",
      "2021-11-01\n",
      "Biotech\n",
      "Inovio falls victim to AstraZeneca's 'usual pipeline pruning'\n",
      "https://www.fiercebiotech.com/biotech/inovio-falls-victim-to-astrazeneca-s-usual-pipeline-pruning-as-human-papillomavirus-cancer\n",
      "2021-11-01\n",
      "Biotech\n",
      "Zimmer Biomet recalls Rosa One robotic neurosurgery platform\n",
      "https://www.fiercebiotech.com/medtech/zimmer-biomet-issues-class-i-recall-rosa-one-robotic-neurosurgery-platform-due-to-software\n",
      "2021-11-01\n",
      "MedTech\n",
      "LianBio inks $325M IPO for pipeline with BMS, BridgeBio, Lyra\n",
      "https://www.fiercebiotech.com/biotech/lianbio-snags-325m-ipo-slightly-bigger-than-multi-partnered-biotech-s-2020-series-a\n",
      "2021-11-01\n",
      "Biotech\n",
      "How differences in T cells govern I-O resistance in NSCLC\n",
      "https://www.fiercebiotech.com/research/mit-team-uncovers-differences-t-cells-drive-immuno-oncology-resistance-lung-cancer\n",
      "2021-11-01\n",
      "Research\n",
      "Lengo's hiring spree continues with Pfizer vet\n",
      "https://www.fiercebiotech.com/biotech/lengo-s-hiring-spree-shows-no-signs-slowing-as-it-hires-pfizer-veteran-murray-as-vp\n",
      "2021-11-01\n",
      "Biotech\n",
      "Ex-Moderna CMO Zaks takes venture partner post at OrbiMed\n",
      "https://www.fiercebiotech.com/biotech/zaks-fresh-from-making-millions-at-moderna-takes-venture-partner-post-at-orbimed\n",
      "2021-11-01\n",
      "Biotech\n",
      "Gilead bought his last biotech. Now, Helin has a new startup\n",
      "https://www.fiercebiotech.com/biotech/gilead-bought-his-last-biotech-now-helin-back-another-cancer-startup\n",
      "2021-11-01\n",
      "Biotech\n",
      "Merck inks $525M biobucks pact for Synthekine's cytokine target\n",
      "https://www.fiercebiotech.com/biotech/as-covid-takes-center-stage-at-merck-pharma-signs-525m-biobucks-pact-synthekine-for\n",
      "2021-11-01\n",
      "Biotech\n",
      "BD inks BARDA contract to develop tests for COVID’s long future\n",
      "https://www.fiercebiotech.com/medtech/bd-inks-barda-contract-to-develop-covid-tests-for-long-future-pandemic\n",
      "2021-11-01\n",
      "MedTech\n",
      "Detect nets FDA green light for home-based molecular COVID test\n",
      "https://www.fiercebiotech.com/medtech/detect-nets-fda-green-light-to-bring-routine-molecular-covid-testing-to-home\n",
      "2021-11-01\n",
      "MedTech\n",
      "A COVID-19 vaccine in a patch rivals shots in mice\n",
      "https://www.fiercebiotech.com/research/a-covid-19-vaccine-delivered-as-a-patch-shows-promise-against-virus-mice\n",
      "2021-10-29\n",
      "Research\n",
      "Magnus Medical debuts with $25M to target severe depression\n",
      "https://www.fiercebiotech.com/medtech/magnus-medical-debuts-25m-to-target-drug-resistant-depression-personalized-therapy\n",
      "2021-10-29\n",
      "MedTech\n",
      "Spooky SPAC season and a $180M Entrada onto Wall Street\n",
      "https://www.fiercebiotech.com/biotech/spactacular-spooky-season-for-arbor-rapha-s-blank-check-and-entrada-entrance-onto-wall\n",
      "2021-10-29\n",
      "Biotech\n",
      "Alnylam CEO to pass baton to president by 2022—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-medivir-poaches-astrazeneca-veteran-to-be-fourth-ceo-past-2-years\n",
      "2021-10-29\n",
      "Biotech\n",
      "DNA Script tallies $165M to help launch its desktop DNA printer\n",
      "https://www.fiercebiotech.com/medtech/dna-script-tallies-up-165m-to-help-launch-its-desktop-dna-printer\n",
      "2021-10-29\n",
      "MedTech\n",
      "Signet Therapeutics gets a $10M top-up for next-gen cancer bets\n",
      "https://www.fiercebiotech.com/biotech/signet-therapeutics-gets-a-10m-top-up-for-next-gen-cancer-bets\n",
      "2021-10-29\n",
      "Biotech\n",
      "Daiichi jettisons ADC after flunking early solid tumor test\n",
      "https://www.fiercebiotech.com/biotech/daiichi-jettisons-adc-after-flunking-early-solid-tumor-test\n",
      "2021-10-29\n",
      "Biotech\n",
      "Gilead taps brakes on $4.9B bet after rival's failure\n",
      "https://www.fiercebiotech.com/biotech/gilead-dabs-brakes-4-9b-bet-after-rival-s-failure-pushing-blood-cancer-data-out-to-22\n",
      "2021-10-29\n",
      "Biotech\n",
      "NIH deals out $75M for health data science research in Africa\n",
      "https://www.fiercebiotech.com/medtech/nih-deals-out-nearly-75m-for-new-program-focusing-data-science-research-and-critical-health\n",
      "2021-10-29\n",
      "MedTech\n",
      "Science 37 taps 2 CROs in Japan for virtual trials expansion\n",
      "https://www.fiercebiotech.com/cro/science-37-partners-two-cros-japan-as-part-decentralized-trials-push\n",
      "2021-10-28\n",
      "CRO\n",
      "FDA adds new restrictions, warning labels for breast implants\n",
      "https://www.fiercebiotech.com/medtech/fda-adds-new-restrictions-warning-labels-for-breast-implants-following-reports-cancer-cases\n",
      "2021-10-28\n",
      "MedTech\n",
      "Checkmate CEO exits one-asset biotech, board member fills post\n",
      "https://www.fiercebiotech.com/biotech/checkmate-begins-search-for-new-ceo-as-board-member-biotech-cfo-veteran-alan-fuhrman-takes\n",
      "2021-10-28\n",
      "Biotech\n",
      "FDA outlines best AI practices alongside Canada, UK\n",
      "https://www.fiercebiotech.com/medtech/healthcare-ai-ml-artificial-intelligence-machine-learning-fda-uk-mhra-health-canada\n",
      "2021-10-28\n",
      "MedTech\n",
      "Pfizer, J&J sign on to streamline gene therapy development\n",
      "https://www.fiercebiotech.com/biotech/pfizer-j-j-among-pharmas-and-biotechs-signing-to-us-agencies-new-rare-disease-gene-therapy\n",
      "2021-10-28\n",
      "Biotech\n",
      "Telecom tycoon's phase 3 pancreatic cancer bet flames out\n",
      "https://www.fiercebiotech.com/biotech/telecom-tycoon-s-phase-3-pancreatic-cancer-bet-flames-out-sending-stock-to-basement\n",
      "2021-10-28\n",
      "Biotech\n",
      "Frazier raises $830M for first public life science fund\n",
      "https://www.fiercebiotech.com/biotech/frazier-has-raised-830m-public-life-science-fund-here-s-how-it-plans-to-invest-cash\n",
      "2021-10-28\n",
      "Biotech\n",
      "Sanofi hit by filing delays for key drugs\n",
      "https://www.fiercebiotech.com/biotech/sanofi-hit-by-filing-delays-for-key-drugs-drops-early-sangamo-thalassemia-asset\n",
      "2021-10-28\n",
      "Biotech\n",
      "Boosting I-O by targeting a cellular stress pathway\n",
      "https://www.fiercebiotech.com/research/genetic-signature-behind-drugs-astrazeneca-bayer-eli-lilly-boost-cancer-immunotherapy\n",
      "2021-10-27\n",
      "Research\n",
      "Merck HIV combo pill compares to existing meds in phase 3 trials\n",
      "https://www.fiercebiotech.com/biotech/merck-close-to-regulatory-filings-for-hiv-treatment-combo-shows-comparable-efficacy-to\n",
      "2021-10-27\n",
      "Biotech\n",
      "Takeda-backed cardiovascular biotech nabs $300M from Bain\n",
      "https://www.fiercebiotech.com/biotech/takeda-backed-cardiovascular-biotech-nabs-300m-investment-from-bain\n",
      "2021-10-27\n",
      "Biotech\n",
      "Immunai adds $215M to bank to help discovery drug targets\n",
      "https://www.fiercebiotech.com/cro/immunai-secures-215m-for-immune-system-map-fuel-more-acquisitions\n",
      "2021-10-27\n",
      "CRO\n",
      "NuVasive to launch global VR training program for spine surgery\n",
      "https://www.fiercebiotech.com/medtech/nuvasive-to-launch-international-vr-training-program-for-spine-surgery\n",
      "2021-10-27\n",
      "MedTech\n",
      "Takeda buys partner GammaDelta for cancer T-cell therapies\n",
      "https://www.fiercebiotech.com/biotech/takeda-buys-out-collaborator-gammadelta-therapeutics-for-solid-tumor-pipeline\n",
      "2021-10-27\n",
      "Biotech\n",
      "Novavax asks UK for COVID-19 vaccine approval, FDA by year-end\n",
      "https://www.fiercebiotech.com/biotech/novavax-completes-uk-filing-for-covid-19-vaccine-expects-to-finish-fda-filing-by-year-s-end\n",
      "2021-10-27\n",
      "Biotech\n",
      "Potential pain remedy emerges from 'junkyard of cancer drugs'\n",
      "https://www.fiercebiotech.com/research/duke-and-uc-scientists-find-a-potential-remedy-for-chronic-pain-from-a-junkyard-cancer\n",
      "2021-10-27\n",
      "Research\n",
      "One Drop launches Bayer-boosted heart disease prevention program\n",
      "https://www.fiercebiotech.com/medtech/one-drop-launches-bayer-boosted-ai-program-for-preventing-heart-disease\n",
      "2021-10-27\n",
      "MedTech\n",
      "GSK, after pushing past fail, ends work on otilimab in COVID-19\n",
      "https://www.fiercebiotech.com/biotech/gsk-after-pushing-past-midphase-fail-ends-development-otilimab-covid-19\n",
      "2021-10-27\n",
      "Biotech\n",
      "ElevateBio buys editing tech to support gene therapy pipeline\n",
      "https://www.fiercebiotech.com/biotech/elevatebio-cuts-a-deal-for-life-edit-adding-genome-engineering-tech-to-support-gene-therapy\n",
      "2021-10-27\n",
      "Biotech\n",
      "After COVID flop, Angion's leading med fails again\n",
      "https://www.fiercebiotech.com/biotech/after-covid-flop-angion-s-leading-med-fails-again-time-kidney-transplant-patients-as-shares\n",
      "2021-10-27\n",
      "Biotech\n",
      "Cortexyme will forge ahead with failed Alzheimer's drug\n",
      "https://www.fiercebiotech.com/biotech/cortexyme-will-forge-ahead-failed-alzheimer-s-drug-just-like-everyone-else\n",
      "2021-10-26\n",
      "Biotech\n",
      "FDA clears Trice Medical’s 25-degree disposable arthroscope\n",
      "https://www.fiercebiotech.com/medtech/trice-medical-nabs-first-fda-clearance-for-disposable-needle-arthroscope-25-degree-view\n",
      "2021-10-26\n",
      "MedTech\n",
      "Medable's virtual trials push gets $304M bet to edge out others\n",
      "https://www.fiercebiotech.com/cro/medable-adds-304m-to-treasure-chest-fourth-raise-18-months-for-virtual-trials\n",
      "2021-10-26\n",
      "CRO\n",
      "Stroke trials don't match prevalence of disease in women: study\n",
      "https://www.fiercebiotech.com/cro/stroke-trials-since-1990-have-a-10-gap-inclusion-women-versus-prevalence-group-study\n",
      "2021-10-26\n",
      "CRO\n",
      "Lilly, Bayer, Merck catch classical buzz with $55M for Mozart Tx\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-bayer-merck-join-symphony-no-55-as-mozart-launches-into-allegro-phase\n",
      "2021-10-26\n",
      "Biotech\n",
      "BD primes Amazon rollout of smartphone COVID test\n",
      "https://www.fiercebiotech.com/medtech/bd-primes-rollout-smartphone-based-rapid-covid-19-test-amazon-launch\n",
      "2021-10-26\n",
      "MedTech\n",
      "MIT nanotube sensor detects COVID in 5 minutes\n",
      "https://www.fiercebiotech.com/medtech/mit-researchers-develop-nanotube-based-sensor-can-detect-covid-within-five-minutes\n",
      "2021-10-26\n",
      "MedTech\n",
      "Lilly, Pfizer stop study of arthritis drug after FDA rejection\n",
      "https://www.fiercebiotech.com/biotech/lilly-pfizer-stop-development-osteoarthritis-drug-after-fda-rejection-extending-bleak-run\n",
      "2021-10-26\n",
      "Biotech\n",
      "Mammoth, Vertex ink $650M biobucks deal for CRISPR gene editing\n",
      "https://www.fiercebiotech.com/biotech/mammoth-sized-crispr-deal-mammoth-vertex-sign-650m-biobucks-collab-for-two-genetic-diseases\n",
      "2021-10-26\n",
      "Biotech\n",
      "Novartis dumps Rett gene therapy caught up in Zolgensma scandal\n",
      "https://www.fiercebiotech.com/biotech/novartis-dumps-rett-gene-therapy-caught-up-zolgensma-scandal-cull-pipeline-prospects\n",
      "2021-10-26\n",
      "Biotech\n",
      "Cambrian snags $100M for 14 assets, 3-5 trials within 18 months\n",
      "https://www.fiercebiotech.com/biotech/cambrian-secures-100m-series-c-for-atai-roivant-like-approach-to-building-up-biotechs-14\n",
      "2021-10-26\n",
      "Biotech\n",
      "Axcella jumps into long COVID with phase 2 of midstage NASH drug\n",
      "https://www.fiercebiotech.com/biotech/flagship-founded-axcella-to-test-midstage-nash-drug-for-long-covid-phase-2a-trial\n",
      "2021-10-26\n",
      "Biotech\n",
      "Eli Lilly kick-starts speedy FDA review for Alzheimer's hopeful\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-kickstarts-speedy-fda-review-for-alzheimer-s-hopeful-donanemab-plots-aduhelm-head\n",
      "2021-10-26\n",
      "Biotech\n",
      "Guardant blood test spots 96% of early colon cancers: study\n",
      "https://www.fiercebiotech.com/medtech/guardant-s-liquid-biopsy-detects-96-early-stage-colorectal-cancer-cases-a-single-blood-draw\n",
      "2021-10-25\n",
      "MedTech\n",
      "Roche, Foundation Medicine unveil genomic profiling kit for labs\n",
      "https://www.fiercebiotech.com/medtech/roche-foundation-medicine-begin-global-launch-genomic-profiling-kit-for-cancer-research\n",
      "2021-10-25\n",
      "MedTech\n",
      "Erytech's eryaspase flunks late-stage pancreatic cancer trial\n",
      "https://www.fiercebiotech.com/biotech/erytech-s-eryaspase-drops-pancreatic-cancer-phase-3-trial\n",
      "2021-10-25\n",
      "Biotech\n",
      "Intellia, LogicBio fuel hope for in vivo gene editing: report\n",
      "https://www.fiercebiotech.com/research/intellia-logicbio-fuel-hope-for-vivo-gene-editing-new-animal-data-rare-diseases-report\n",
      "2021-10-25\n",
      "Research\n",
      "HHS invests $560M to boost COVID-19 test supply\n",
      "https://www.fiercebiotech.com/medtech/biden-administration-infuses-more-than-560m-to-strengthen-covid-19-testing-supply-chain\n",
      "2021-10-25\n",
      "MedTech\n",
      "Gilead's Immunomedics CMO exits to Aadi as it nears FDA decision\n",
      "https://www.fiercebiotech.com/biotech/gilead-s-immunomedics-cmo-jumps-to-aadi-as-biotech-looks-for-first-fda-approval-next-month\n",
      "2021-10-25\n",
      "Biotech\n",
      "Juventas Cell Therapy closes a $63M funding round\n",
      "https://www.fiercebiotech.com/biotech/juventas-cell-therapy-closes-a-63m-funding-round-as-it-eyes-a-big-push-for-blood-cancer\n",
      "2021-10-25\n",
      "Biotech\n",
      "AstraZeneca veteran takes up CEO post at Medivir\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-veteran-takes-up-ceo-post-at-medivir-become-fourth-person-to-hold-post-quick\n",
      "2021-10-25\n",
      "Biotech\n",
      "EMA starts rolling review of Merck's COVID-19 antiviral\n",
      "https://www.fiercebiotech.com/biotech/ema-starts-rolling-review-merck-s-molnupiravir-continuing-rapid-regulatory-response-to\n",
      "2021-10-25\n",
      "Biotech\n",
      "Cedilla adds $25M to series B to test two cancer drugs in trials\n",
      "https://www.fiercebiotech.com/biotech/cedilla-tops-off-series-b-additional-25m-to-test-drugs-mesothelioma-certain-breast-cancers\n",
      "2021-10-25\n",
      "Biotech\n",
      "Sanofi joins $52M series B for digital therapeutics maker Click\n",
      "https://www.fiercebiotech.com/medtech/sanofi-joins-click-therapeutics-52m-series-b-to-advance-digital-therapeutics-for-depression\n",
      "2021-10-22\n",
      "MedTech\n",
      "Ocular's drug-eluting insert for dry eye disease misses endpoint\n",
      "https://www.fiercebiotech.com/medtech/ocular-s-insert-for-dry-eye-disease-misses-primary-endpoint-phase-2-trial\n",
      "2021-10-22\n",
      "MedTech\n",
      "MIT prof, biotech founder Sabatini sues accuser, institute\n",
      "https://www.fiercebiotech.com/biotech/biotech-founder-mit-researcher-david-sabatini-alleges-false-sexual-harrassment-claims\n",
      "2021-10-22\n",
      "Biotech\n",
      "Medtronic taps TikTok-famous doc as first-ever CMO of GI segment\n",
      "https://www.fiercebiotech.com/medtech/medtronic-taps-tiktok-famous-physician-as-first-chief-medical-officer-gi-business\n",
      "2021-10-22\n",
      "MedTech\n",
      "Athira CEO resigns after investigation—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-vtv-therapeutics-names-deepa-prasad-ceo-and-president\n",
      "2021-10-22\n",
      "Biotech\n",
      "Egle Therapeutics nabs $46M for pipeline push\n",
      "https://www.fiercebiotech.com/biotech/egle-therapeutics-nabs-46m-as-it-looks-to-push-into-clinic-its-next-gen-tregs-platform\n",
      "2021-10-22\n",
      "Biotech\n",
      "2 cancer drugs show promise in a hard-to-treat lung disease\n",
      "https://www.fiercebiotech.com/research/investigational-cancer-drugs-might-be-tools-for-fighting-rare-lung-disease-too-researchers\n",
      "2021-10-22\n",
      "Research\n",
      "Agenus withdraws cervical cancer application for balstilimab\n",
      "https://www.fiercebiotech.com/biotech/agenus-withdraws-cervical-cancer-application-for-balstilimab-after-fda-fully-authorizes\n",
      "2021-10-22\n",
      "Biotech\n",
      "Metacrine shares halved as NASH work thrown out\n",
      "https://www.fiercebiotech.com/biotech/metacrine-shares-halved-as-it-throws-out-its-mixed-bag-nash-program-investigates-potential\n",
      "2021-10-22\n",
      "Biotech\n",
      "Athira CEO Kawas out after findings confirm she altered research\n",
      "https://www.fiercebiotech.com/biotech/athira-ceo-leen-kawas-officially-out-after-investigation-found-she-did-alter-grad-research\n",
      "2021-10-21\n",
      "Biotech\n",
      "Zerigo Health beams up $43M for at-home psoriasis treatment\n",
      "https://www.fiercebiotech.com/medtech/zerigo-health-beams-up-43m-from-bayer-cigna-and-more-for-at-home-psoriasis-uv-light-therapy\n",
      "2021-10-21\n",
      "MedTech\n",
      "FDA approves Luminopia’s VR system to treat kids with lazy eye\n",
      "https://www.fiercebiotech.com/medtech/fda-approves-luminopia-s-vr-based-digital-therapeutic-to-treat-children-lazy-eye\n",
      "2021-10-21\n",
      "MedTech\n",
      "Ventyx nabs an upsized IPO to challenge BMS' Zeposia\n",
      "https://www.fiercebiotech.com/biotech/ventyx-nabs-upsized-ipo-to-challenge-bristol-s-zeposia-and-a-backer-intimate-knowledge-its\n",
      "2021-10-21\n",
      "Biotech\n",
      "VCs back Leucid to trial CAR-T twist in ovarian cancer patients\n",
      "https://www.fiercebiotech.com/biotech/vcs-back-leucid-to-trial-car-t-twist-ovarian-cancer-patients\n",
      "2021-10-21\n",
      "Biotech\n",
      "Atreca, Gates Research Institute ink pact on malaria antibody\n",
      "https://www.fiercebiotech.com/biotech/atreca-inks-license-gates-medical-research-institute-for-malaria-asset\n",
      "2021-10-21\n",
      "Biotech\n",
      "ReCode snags $80M from Pfizer, Sanofi for mRNA work in CF, lungs\n",
      "https://www.fiercebiotech.com/biotech/another-80m-mrna-biotech-recode-matches-2020-series-a-for-trials-cystic-fibrosis-other-lung\n",
      "2021-10-21\n",
      "Biotech\n",
      "Menarini, chased by 3 Big Pharmas, records breast cancer win\n",
      "https://www.fiercebiotech.com/biotech/menarini-chased-by-three-big-pharmas-records-win-breast-cancer-phase-3-plots-path-to-fda\n",
      "2021-10-21\n",
      "Biotech\n",
      "Charles River expands development lab space in Cambridge\n",
      "https://www.fiercebiotech.com/cro/charles-river-expands-development-lab-space-cambridge\n",
      "2021-10-20\n",
      "CRO\n",
      "Medtronic issues EU safety warning for Percept PC brain implant\n",
      "https://www.fiercebiotech.com/medtech/medtronic-issues-eu-safety-warning-for-percept-pc-deep-brain-stimulation-implant\n",
      "2021-10-20\n",
      "MedTech\n",
      "FDA slaps clinical hold on AstraZeneca cancer drug\n",
      "https://www.fiercebiotech.com/biotech/fda-slaps-clinical-hold-astrazeneca-cancer-drug-amid-heart-safety-scare-combo-test\n",
      "2021-10-20\n",
      "Biotech\n",
      "Medtronic's newest insulin pump effective in kids: study\n",
      "https://www.fiercebiotech.com/medtech/medtronic-s-newest-minimed-insulin-pump-improves-glycemic-control-children-study\n",
      "2021-10-20\n",
      "MedTech\n",
      "Princeton and MIT team uncovers clues for improving gene editing\n",
      "https://www.fiercebiotech.com/research/improving-gene-editing-tools-david-liu-mit-and-princeton-scientists-uncover-clues\n",
      "2021-10-20\n",
      "Research\n",
      "Abbott's COVID test sales make comeback with delta-driven demand\n",
      "https://www.fiercebiotech.com/medtech/covid-test-demand-returns-to-buoy-abbott-s-quarterly-sales\n",
      "2021-10-20\n",
      "MedTech\n",
      "F-Star's J&J deal is largest yet with $1.35B in biobucks\n",
      "https://www.fiercebiotech.com/biotech/again-again-again-f-star-s-latest-big-pharma-partner-janssen-17-5m-upfront-1-35b-biobucks\n",
      "2021-10-20\n",
      "Biotech\n",
      "NYU surgeons transplant gene-edited pig kidney into a human\n",
      "https://www.fiercebiotech.com/medtech/nyu-surgeons-successfully-transplant-kidney-from-genetically-modified-pig-into-human\n",
      "2021-10-20\n",
      "MedTech\n",
      "Stealth rare disease drug denied by FDA in I told you so moment\n",
      "https://www.fiercebiotech.com/biotech/stealth-s-not-so-sneaky-strategy-to-file-unprepared-drug-application-foiled-by-fda\n",
      "2021-10-20\n",
      "Biotech\n",
      "Chase gets cash for pivotal trials in depression, Parkinson's\n",
      "https://www.fiercebiotech.com/biotech/chase-after-selling-last-biotech-to-allergan-gets-cash-to-start-pivotal-trials-depression\n",
      "2021-10-20\n",
      "Biotech\n",
      "Merck KGaA taps CytoReason AI to profile immuno-oncology drug\n",
      "https://www.fiercebiotech.com/medtech/merck-kgaa-taps-cytoreason-s-machine-learning-platform-to-profile-immuno-oncology-drug\n",
      "2021-10-20\n",
      "MedTech\n",
      "Takeda crashes out of Wave discovery pact at cost of $23M\n",
      "https://www.fiercebiotech.com/biotech/takeda-crashes-out-wave-discovery-pact-at-cost-23m\n",
      "2021-10-20\n",
      "Biotech\n",
      "ShouTi snags $100M for oral drugs to treat chronic diseases\n",
      "https://www.fiercebiotech.com/biotech/receptos-founder-returns-shoutti-and-100m-for-chronic-diseases\n",
      "2021-10-20\n",
      "Biotech\n",
      "AstraZeneca slams the brakes on MCL-1 blood cancer drug\n",
      "https://www.fiercebiotech.com/biotech/amid-amgen-s-similar-struggles-astrazeneca-slams-brakes-mcl-1-blood-cancer-drug\n",
      "2021-10-20\n",
      "Biotech\n",
      "Injured tumor cells activate I-O drugs in cancer models\n",
      "https://www.fiercebiotech.com/research/injured-tumor-cells-activate-immuno-oncology-drugs-to-combat-breast-cancer-and-melanoma\n",
      "2021-10-19\n",
      "Research\n",
      "Castle Bio taps into Cernostics' GI franchise with $80M deal\n",
      "https://www.fiercebiotech.com/medtech/castle-biosciences-taps-into-cernostics-gi-cancer-test-franchise-80m-deal\n",
      "2021-10-19\n",
      "MedTech\n",
      "Intrivo launches at-home COVID test powered by an AI app\n",
      "https://www.fiercebiotech.com/medtech/intrivo-launches-at-home-covid-test-returns-results-10-minutes-via-ai-powered-app\n",
      "2021-10-19\n",
      "MedTech\n",
      "Galera shares slide as radiotherapy complication drug fails\n",
      "https://www.fiercebiotech.com/biotech/galera-shares-slide-nearly-70-as-radiotherapy-complication-drug-flunks-out-phase-3\n",
      "2021-10-19\n",
      "Biotech\n",
      "Not for sale: Intellia CEO Leonard talks dealmaking\n",
      "https://www.fiercebiotech.com/biotech/intellia-ceo-john-loenard-potential-m-a-dealmaking-gene-editing-fierce-biotech-cell-gene\n",
      "2021-10-19\n",
      "Biotech\n",
      "FDA opens doors to over-the-counter hearing aids\n",
      "https://www.fiercebiotech.com/medtech/fda-opens-doors-to-a-new-class-over-counter-hearing-aids\n",
      "2021-10-19\n",
      "MedTech\n",
      "Struggling Calithera nabs 2 cheap cancer assets from Takeda\n",
      "https://www.fiercebiotech.com/biotech/struggling-calithera-nabs-two-cheap-cancer-assets-from-takeda-for-just-10m-upfront\n",
      "2021-10-19\n",
      "Biotech\n",
      "Entasis antibiotic beats last resort treatment in phase 3 trial\n",
      "https://www.fiercebiotech.com/biotech/entasis-zai-labs-antibiotic-sul-dur-beats-comparator-phase-3-trial\n",
      "2021-10-19\n",
      "Biotech\n",
      "SPR Therapeutics nabs $37M funding for Sprint pain relief device\n",
      "https://www.fiercebiotech.com/medtech/spr-therapeutics-runs-up-37m-vc-funding-for-sprint-pain-relief-device\n",
      "2021-10-19\n",
      "MedTech\n",
      "Dicerna flops efficacy endpoint on nedosiran in PH2\n",
      "https://www.fiercebiotech.com/biotech/dicerna-flops-efficacy-endpoint-nedosiran-ph2-but-will-file-for-fda-approval-just-ph1-after\n",
      "2021-10-19\n",
      "Biotech\n",
      "Atea and Roche's COVID-19 antiviral flunks phase 2\n",
      "https://www.fiercebiotech.com/biotech/atea-and-roche-s-covid-19-antiviral-flunks-phase-2-prompting-switch-will-delay-pivotal-data\n",
      "2021-10-19\n",
      "Biotech\n",
      "Biogen, Sage plot 2022 filing for zuranolone approval\n",
      "https://www.fiercebiotech.com/biotech/biogen-sage-plot-2022-filing-for-zuranolone-approval-furthering-turnaround-depression-drug\n",
      "2021-10-19\n",
      "Biotech\n",
      "D&D Pharma nabs $51M before Korean IPO for Alzheimer's\n",
      "https://www.fiercebiotech.com/biotech/d-d-pharma-snags-51m-ahead-1q22-korean-ipo-for-alzheimer-s-parkinson-s\n",
      "2021-10-19\n",
      "Biotech\n",
      "Sofinnova bulks out VC shop with a hefty $548M\n",
      "https://www.fiercebiotech.com/biotech/sofinnova-bulks-out-vc-shop-a-hefty-548m-as-it-zeroes-early-stage-european-biotechs\n",
      "2021-10-19\n",
      "Biotech\n",
      "Crinetics creates Radionetics with $30M for 10 cancer candidates\n",
      "https://www.fiercebiotech.com/biotech/crinetics-forms-radionetics-initial-30m-1b-plus-biobucks-for-radiopharmaceuticals\n",
      "2021-10-18\n",
      "Biotech\n",
      "Phathom's erosive esophagitis drug bests Prevacid in phase 3\n",
      "https://www.fiercebiotech.com/biotech/phathom-pharmaceuticals-study-shows-its-erosive-esophogitis-drug-bests-prevacid-head-to\n",
      "2021-10-18\n",
      "Biotech\n",
      "Natera launches lung DNA test for catching transplant rejections\n",
      "https://www.fiercebiotech.com/medtech/natera-launches-lung-dna-test-for-catching-transplant-rejections\n",
      "2021-10-18\n",
      "MedTech\n",
      "Vertex reports success in 1 patient after islet cell therapy\n",
      "https://www.fiercebiotech.com/biotech/vertex-diabetes-cell-therapy-vx-880-restores-islet-cell-function-single-patient\n",
      "2021-10-18\n",
      "Biotech\n",
      "ReCor's renal denervation device misses blood pressure endpoint\n",
      "https://www.fiercebiotech.com/medtech/recor-medical-s-renal-denervation-device-misses-blood-pressure-endpoint-after-european\n",
      "2021-10-18\n",
      "MedTech\n",
      "Philips CPAP recall still chips away at quarterly earnings\n",
      "https://www.fiercebiotech.com/medtech/philips-cpap-recall-still-chipping-away-at-earnings-nearly-40-drop-q3-connected-care-sales\n",
      "2021-10-18\n",
      "MedTech\n",
      "TAK1 blocker teams up with chemo to kill myeloma cells: study\n",
      "https://www.fiercebiotech.com/research/a-new-target-multiple-myeloma-tak1-blocker-boosts-chemo-s-cancer-killing-power-preclinical\n",
      "2021-10-18\n",
      "Research\n",
      "Valneva tops AstraZeneca's COVID-19 vax, preps for filing in EU\n",
      "https://www.fiercebiotech.com/biotech/valneva-tops-astrazeneca-s-covid-19-vaccine-prepping-for-conditional-ema-approval\n",
      "2021-10-18\n",
      "Biotech\n",
      "FDA rejects Omeros drug over difficulties estimating its effect\n",
      "https://www.fiercebiotech.com/biotech/fda-rejects-omeros-transplant-drug-over-difficulties-estimating-its-effect\n",
      "2021-10-18\n",
      "Biotech\n",
      "Quris launches with $9M for AI to predict drug success, safety\n",
      "https://www.fiercebiotech.com/cro/ai-drug-discovery-startup-quris-launches-9m-to-predict-drug-success-starting-rare-diseases\n",
      "2021-10-18\n",
      "CRO\n",
      "Sensyne, OMNY team up on 22M patient records for research\n",
      "https://www.fiercebiotech.com/cro/sensyne-teams-up-omny-for-22-million-patient-records-for-clinical-research\n",
      "2021-10-18\n",
      "CRO\n",
      "Biogen's ALS drug has failed phase 3. Will FDA approve anyway?\n",
      "https://www.fiercebiotech.com/biotech/biogen-s-als-drug-has-failed-phase-3-will-fda-approve-anyway\n",
      "2021-10-18\n",
      "Biotech\n",
      "Medtronic sizing up $300M insulin pump patch buy: report\n",
      "https://www.fiercebiotech.com/medtech/medtronic-to-leap-ahead-diabetes-tech-race-300m-triple-jump-purchase-report\n",
      "2021-10-18\n",
      "MedTech\n",
      "Agenus cell therapy spinout MiNK inks $40M IPO for cancer, COVID\n",
      "https://www.fiercebiotech.com/biotech/agenus-cell-therapy-spin-off-mink-inks-mark-wall-street-low-end-40m-ipo-for-cancer-covid-19\n",
      "2021-10-15\n",
      "Biotech\n",
      "NIH deals out $77M to develop 12 new rapid COVID tests\n",
      "https://www.fiercebiotech.com/medtech/nih-deals-out-77-7m-to-develop-12-new-rapid-covid-diagnostics-from-bd-quidel-and-more\n",
      "2021-10-15\n",
      "MedTech\n",
      "Roche welcomes PathAI into its open digital pathology initiative\n",
      "https://www.fiercebiotech.com/medtech/roche-pathai-digital-pathology-cancer-artificial-intelligence\n",
      "2021-10-15\n",
      "MedTech\n",
      "Greenwood takes the top job at Kojin Therapeutics\n",
      "https://www.fiercebiotech.com/biotech/luba-greenwood-takes-top-job-at-kojin-therapeutics-leading-all-woman-biotech-c-suite\n",
      "2021-10-15\n",
      "Biotech\n",
      "FDA recalls Abbott COVID tests at risk of false positives\n",
      "https://www.fiercebiotech.com/medtech/fda-adds-class-i-recall-label-to-abbott-alinity-covid-tests-high-risk-false-positives\n",
      "2021-10-15\n",
      "MedTech\n",
      "Hologic dreams bigger for Bolder Surgical with $160M acquisition\n",
      "https://www.fiercebiotech.com/medtech/hologic-bolder-surgical-160-million-acquisition-laparoscopic-surgery\n",
      "2021-10-15\n",
      "MedTech\n",
      "J&J science chief Stoffels latest exec to exit—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-j-j-science-chief-paul-stoffels-latest-c-suite-leader-to-retire\n",
      "2021-10-15\n",
      "Biotech\n",
      "Resilience commits $30M to form new biotechs out of Harvard labs\n",
      "https://www.fiercebiotech.com/biotech/first-moderna-then-intergalactic-and-now-harvard-resilience-commits-30m-forms-circle\n",
      "2021-10-15\n",
      "Biotech\n",
      "Inhalable antibody tamps down COVID-19 in hamsters\n",
      "https://www.fiercebiotech.com/research/inhalable-anti-covid-19-antibody-from-tff-and-augmenta-tamps-down-viral-load-hamsters\n",
      "2021-10-15\n",
      "Research\n",
      "AstraZeneca posts rare cancer win for treme, beating Nexavar\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-delivers-rare-win-for-treme-liver-cancer-bouncing-back-from-flops-to-beat-bayer\n",
      "2021-10-15\n",
      "Biotech\n",
      "Chinese powerhouse continues charge into siRNA with Silence pact\n",
      "https://www.fiercebiotech.com/biotech/chinese-biopharma-powerhouse-continues-charge-into-sirna-silence-r-d-pact\n",
      "2021-10-15\n",
      "Biotech\n",
      "Seasoned executive team launches Tentarix with $50M\n",
      "https://www.fiercebiotech.com/biotech/stacked-cohort-industry-vets-set-to-launch-biotech-tentarix-biotherapeutics-50m-series-a\n",
      "2021-10-14\n",
      "Biotech\n",
      "Cue Health reups NBA COVID testing contract\n",
      "https://www.fiercebiotech.com/medtech/cue-health-snags-rebound-re-upping-nba-covid-testing-contract-for-another-season\n",
      "2021-10-14\n",
      "MedTech\n",
      "Exscientia AI spots which therapies work in blood cancer study\n",
      "https://www.fiercebiotech.com/medtech/exscientia-ai-artificial-intelligence-study-results-blood-cancer-hematology-oncology\n",
      "2021-10-14\n",
      "MedTech\n",
      "Laborie acquires Pelvalon and its fecal incontinence device\n",
      "https://www.fiercebiotech.com/medtech/laborie-expands-gi-profile-acquisition-pelvalon-and-its-female-fecal-incontinence-device\n",
      "2021-10-14\n",
      "MedTech\n",
      "Protein that manipulates gene expression could steer RSV drugs\n",
      "https://www.fiercebiotech.com/research/protein-manipulates-gene-expression-inside-nucleus-could-steer-new-rsv-drugs-vaccines\n",
      "2021-10-14\n",
      "Research\n",
      "Sanofi tries to quiet naysayers with data on Principia MS drug\n",
      "https://www.fiercebiotech.com/biotech/sanofi-tolebrutinib-extension-data-analyst-reaction-multiple-sclerosis-candidate\n",
      "2021-10-14\n",
      "Biotech\n",
      "COVID testing, turnarounds still uneven this far into pandemic\n",
      "https://www.fiercebiotech.com/medtech/covid-testing-turnaround-times-are-still-uneven-far-into-pandemic\n",
      "2021-10-14\n",
      "MedTech\n",
      "Omega taps Stanford to find targets for genome-tuning tech\n",
      "https://www.fiercebiotech.com/biotech/omega-eyeing-new-uses-for-genome-tuning-tech-taps-stanford-to-find-ocular-disease-targets\n",
      "2021-10-14\n",
      "Biotech\n",
      "OnKure sets Diamond in C-suite ahead of Pfizer drug combo trial\n",
      "https://www.fiercebiotech.com/biotech/onkure-sets-diamond-c-suite-ahead-pfizer-drug-combo-trial\n",
      "2021-10-14\n",
      "Biotech\n",
      "Digital trials peaked amid COVID, but benefits mixed bag: survey\n",
      "https://www.fiercebiotech.com/cro/decentralized-clinical-trials-skyrocketed-during-pandemic-but-patient-experience-mixed-bag\n",
      "2021-10-14\n",
      "CRO\n",
      "Malek jumps ship to run Novartis' NIBR oncology unit\n",
      "https://www.fiercebiotech.com/biotech/after-15-years-helping-lead-early-cancer-research-at-genentech-shiva-malek-jumps-ship-to\n",
      "2021-10-14\n",
      "Biotech\n",
      "Restore your ABCs: Rectify nabs $100M, Vertex founding scientist\n",
      "https://www.fiercebiotech.com/biotech/rectify-s-work-abcs-lands-100m-series-a-vertex-founding-scientist\n",
      "2021-10-14\n",
      "Biotech\n",
      "Charles River dumps research model site, Swedish CDMO for $115M\n",
      "https://www.fiercebiotech.com/cro/charles-river-offloads-japan-research-model-site-swedish-gene-therapy-cdmo-for-115m\n",
      "2021-10-13\n",
      "CRO\n",
      "Protein degrader against 'undruggable' target blocks cancer\n",
      "https://www.fiercebiotech.com/research/novel-protein-degrader-against-undruggable-cancer-target-inhibits-tumors-mice\n",
      "2021-10-13\n",
      "Research\n",
      "Olympus investigating 2nd cybersecurity incident in a month\n",
      "https://www.fiercebiotech.com/medtech/olympus-investigating-potential-cybersecurity-incident-american-it-systems-its-second\n",
      "2021-10-13\n",
      "MedTech\n",
      "Regulus again reprioritizes in attempt to turn ship around\n",
      "https://www.fiercebiotech.com/biotech/microrna-biotech-regulus-therapeutics-drops-first-generation-adpkd-candidate-focuses-next\n",
      "2021-10-13\n",
      "Biotech\n",
      "Dexcom brings real-time diabetes data to Garmin fitness devices\n",
      "https://www.fiercebiotech.com/medtech/dexcom-garmin-diabetes-fitness-smartwatch-blood-sugar-glucose-tracking\n",
      "2021-10-13\n",
      "MedTech\n",
      "FDA OKs Cochlear's remote programming tool for hearing implants\n",
      "https://www.fiercebiotech.com/medtech/cochlear-secures-two-fda-nods-for-telehealth-solution-to-program-hearing-implants-from-afar\n",
      "2021-10-13\n",
      "MedTech\n",
      "Aum bags $27M to hit cancer targets pursued by Bayer, Roche\n",
      "https://www.fiercebiotech.com/biotech/aum-bags-27m-to-hit-cancer-targets-pursued-by-bayer-roche\n",
      "2021-10-13\n",
      "Biotech\n",
      "Takeda inks another biobucks pact: $900M for Immusoft's B cells\n",
      "https://www.fiercebiotech.com/biotech/takeda-bets-up-to-900m-immusoft-s-cell-therapies-for-neurometabolic-disorders\n",
      "2021-10-13\n",
      "Biotech\n",
      "More diversity needed in breast cancer clinical trials: report\n",
      "https://www.fiercebiotech.com/cro/barriers-exist-but-participation-urgent-breast-cancer-clinical-trials-report\n",
      "2021-10-13\n",
      "CRO\n",
      "UPDATE: CRISPR hails safety, efficacy of off-the-shelf CAR-Ts\n",
      "https://www.fiercebiotech.com/biotech/crispr-hails-safety-efficacy-off-shelf-car-t-but-stock-slides-amid-durability-doubts\n",
      "2021-10-13\n",
      "Biotech\n",
      "Apnimed sees positives in new sleep apnea drug data\n",
      "https://www.fiercebiotech.com/biotech/apnimed-sees-positives-midstage-data-for-its-attempt-at-drugging-sleep-apnea-problem\n",
      "2021-10-13\n",
      "Biotech\n",
      "Axial tops up funding for phase 2 autism trial with $37M round\n",
      "https://www.fiercebiotech.com/biotech/axial-therapeutics-secures-37m-for-mid-stage-trial-autism-work-neurological-diseases\n",
      "2021-10-13\n",
      "Biotech\n",
      "Intellia expands ocular pipeline with 10% stake in SparingVision\n",
      "https://www.fiercebiotech.com/biotech/after-a-gene-editing-first-intellia-grabs-10-stake-sparingvision-for-collab-eye-gene\n",
      "2021-10-13\n",
      "Biotech\n",
      "FDA clears Withings’ smartwatch to detect afib, sleep apnea\n",
      "https://www.fiercebiotech.com/medtech/withings-goes-head-to-head-apple-nabbing-fda-ok-for-smartwatch-to-detect-afib-sleep-apnea\n",
      "2021-10-12\n",
      "MedTech\n",
      "Mayo Clinic taps Personalis for cancer genomic testing efforts\n",
      "https://www.fiercebiotech.com/medtech/mayo-clinic-taps-personalis-for-comprehensive-genomic-testing-for-cancer\n",
      "2021-10-12\n",
      "MedTech\n",
      "BioNova adds to blood cancer portfolio with $200M Sutro deal\n",
      "https://www.fiercebiotech.com/biotech/bionova-signs-204m-collab-for-sutro-s-early-stage-hematologic-cancer-asset-china\n",
      "2021-10-12\n",
      "Biotech\n",
      "To ease children through an MRI, Philips makes scans into games\n",
      "https://www.fiercebiotech.com/medtech/to-ease-children-through-a-scary-mri-philips-makes-scanner-a-playground\n",
      "2021-10-12\n",
      "MedTech\n",
      "Roche's Spark adds epilepsy asset to pipeline with $328M deal\n",
      "https://www.fiercebiotech.com/biotech/roche-s-spark-adds-epilepsy-asset-to-pipeline-328m-combigene-licensing-deal\n",
      "2021-10-12\n",
      "Biotech\n",
      "MindMaze finds its way to $125M for neuro-rehab game platform\n",
      "https://www.fiercebiotech.com/medtech/mindmaze-finds-its-way-to-125m-for-neuro-rehabilitation-video-game-platform\n",
      "2021-10-12\n",
      "MedTech\n",
      "Broad Institute, Intel upgrade genomic data collab with Google\n",
      "https://www.fiercebiotech.com/medtech/broad-institute-looks-to-intel-google-cloud-to-upgrade-genomic-data-processing\n",
      "2021-10-12\n",
      "MedTech\n",
      "Poseida, Takeda ink $3.6B pact for 8 non-viral gene therapies\n",
      "https://www.fiercebiotech.com/biotech/billions-club-takeda-taps-poseida-for-second-1b-plus-gene-therapy-pact-2-weeks\n",
      "2021-10-12\n",
      "Biotech\n",
      "J&J science chief Stoffels to retire, adding to C-suite changes\n",
      "https://www.fiercebiotech.com/biotech/j-j-science-chief-stoffels-to-retire-after-decade-at-top-adding-to-c-suite-changes\n",
      "2021-10-12\n",
      "Biotech\n",
      "Biotech backers quit Dana-Farber board after policy U-turn\n",
      "https://www.fiercebiotech.com/biotech/boston-biotech-backers-quit-dana-farber-board-after-u-turn-investment-policy\n",
      "2021-10-12\n",
      "Biotech\n",
      "CureVac giving up on first COVID mRNA vaccine\n",
      "https://www.fiercebiotech.com/biotech/curevac-giving-up-first-covid-mrna-vax-focusing-gsk-partnered-second-attempt\n",
      "2021-10-12\n",
      "Biotech\n",
      "Gossamer unveils 2 new therapies after midstage failures\n",
      "https://www.fiercebiotech.com/biotech/gossamer-unveils-2-new-pipeline-candidates-a-year-after-lead-program-fizzled-out-phase-2\n",
      "2021-10-11\n",
      "Biotech\n",
      "FDA warns against using needle-free devices for facial fillers\n",
      "https://www.fiercebiotech.com/medtech/fda-warns-against-using-over-counter-lip-and-facial-fillers-unauthorized-needle-free\n",
      "2021-10-11\n",
      "MedTech\n",
      "Veracyte begins limited release of nasal swab lung cancer test\n",
      "https://www.fiercebiotech.com/medtech/veracyte-kicks-off-limited-release-its-nasal-swab-lung-cancer-test-as-it-gears-up-for-full\n",
      "2021-10-11\n",
      "MedTech\n",
      "Protalix sees a path for Fabry resubmission down the line\n",
      "https://www.fiercebiotech.com/biotech/protalix-biotherapeutics-fabry-disease-drug-complete-response-letter-fda-update\n",
      "2021-10-11\n",
      "Biotech\n",
      "Mount Sinai unveils department to enhance AI in healthcare\n",
      "https://www.fiercebiotech.com/medtech/mount-sinai-unveils-first-its-kind-department-to-develop-ai-tools-for-healthcare\n",
      "2021-10-11\n",
      "MedTech\n",
      "Medtronic's Hugo surgical robot heads to Europe with new CE mark\n",
      "https://www.fiercebiotech.com/medtech/medtronic-s-hugo-surgical-robot-heads-to-europe-regulatory-green-light\n",
      "2021-10-11\n",
      "MedTech\n",
      "Brain atlas unveils dozens of cell types that control movement\n",
      "https://www.fiercebiotech.com/research/brain-atlas-study-from-uc-berkeley-unveils-dozens-cell-types-control-movement-and-could\n",
      "2021-10-11\n",
      "Research\n",
      "Idorsi's Fabry drug fails to relieve pain in phase 3 test\n",
      "https://www.fiercebiotech.com/biotech/idorsia-s-fabry-med-fails-phase-3-clinical-trial-does-not-relieve-neuropathic-pain\n",
      "2021-10-11\n",
      "Biotech\n",
      "Protagonist's story gets a happy ending as FDA's hold lifted\n",
      "https://www.fiercebiotech.com/biotech/protagonist-s-story-gets-a-happy-ending-as-fda-s-hold-swiftly-lifted-rusfertide-program\n",
      "2021-10-11\n",
      "Biotech\n",
      "Merck seeks FDA nod for COVID antiviral 10 days after data drop\n",
      "https://www.fiercebiotech.com/biotech/merck-makes-beeline-to-fda-seeking-approval-for-covid-19-antiviral-10-days-after-reporting\n",
      "2021-10-11\n",
      "Biotech\n",
      "AstraZeneca's COVID trial hits goal, but efficacy falls short\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-s-covid-19-therapy-hits-goal-phase-3-but-efficacy-falls-short-rivals\n",
      "2021-10-11\n",
      "Biotech\n",
      "Senate to cull Biden's biomedical research agency\n",
      "https://www.fiercebiotech.com/biotech/senate-to-cull-biden-s-biomedical-research-agency-from-social-care-bill-report\n",
      "2021-10-11\n",
      "Biotech\n",
      "Ensoma nabs Bayer's $1B Parkinson's head Nuwaysir for gene meds\n",
      "https://www.fiercebiotech.com/biotech/he-led-bayer-s-1b-parkinson-s-bet-via-bluerock-now-emile-nuwaysir-will-helm-ensoma\n",
      "2021-10-11\n",
      "Biotech\n",
      "Caris Life Sciences finds new finance head in ex-Medtronic SVP\n",
      "https://www.fiercebiotech.com/medtech/caris-life-sciences-taps-former-medtronic-svp-mike-weinstein-as-cfo\n",
      "2021-10-08\n",
      "MedTech\n",
      "Schrödinger ropes MD Anderson into its cancer inhibitor program\n",
      "https://www.fiercebiotech.com/medtech/schrodinger-ropes-md-anderson-into-its-development-program-for-wee1-inhibitors\n",
      "2021-10-08\n",
      "MedTech\n",
      "DreaMed Diabetes' clinical support AI expands to Type 2 diabetes\n",
      "https://www.fiercebiotech.com/medtech/dreamed-diabetes-digital-endocrinologist-ai-expands-to-type-2-diabetes-fda-green-light\n",
      "2021-10-08\n",
      "MedTech\n",
      "Novel vaccine shields mice from COVID-19 and 4 related viruses\n",
      "https://www.fiercebiotech.com/research/novel-vaccine-strategy-protects-mice-from-covid-19-and-4-related-coronaviruses\n",
      "2021-10-08\n",
      "Research\n",
      "Pfizer development head Rod MacKenzie retiring—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-pfizer-s-development-leader-retiring-early-next-year\n",
      "2021-10-08\n",
      "Biotech\n",
      "Pfizer, Bayer-backed Pyxis ups IPO price\n",
      "https://www.fiercebiotech.com/biotech/pfizer-bayer-backed-pyxis-ups-ipo-price-as-biotech-s-public-run-continues-unabated\n",
      "2021-10-08\n",
      "Biotech\n",
      "Takeda's transplant drug gets unanimous support of FDA AdComm\n",
      "https://www.fiercebiotech.com/biotech/takeda-s-transplant-drug-gets-unanimous-support-fda-adcomm-despite-concerns-over-diversity\n",
      "2021-10-08\n",
      "Biotech\n",
      "Mirati, Sanofi join forces in lung cancer with a KRAS-SHP2 combo\n",
      "https://www.fiercebiotech.com/biotech/mirati-sanofi-join-forces-lung-cancer-a-kras-shp2-combo-approach\n",
      "2021-10-08\n",
      "Biotech\n",
      "FDA stops all Allogene's CAR-T trials over safety scare\n",
      "https://www.fiercebiotech.com/biotech/fda-stops-all-allogene-s-car-t-trials-over-safety-scare-raising-questions-about-future-gene\n",
      "2021-10-08\n",
      "Biotech\n",
      "FDA tightens regulations for surgical staplers and staples\n",
      "https://www.fiercebiotech.com/medtech/fda-tightens-regulations-broadens-oversight-surgical-staplers-implantable-staples\n",
      "2021-10-07\n",
      "MedTech\n",
      "No sweat for Brickell to submit to FDA with 2 phase 3 trials\n",
      "https://www.fiercebiotech.com/biotech/no-more-sweat-for-brickell-biotech-will-submit-for-fda-approval-its-sweat-gel-2-phase-3\n",
      "2021-10-07\n",
      "Biotech\n",
      "White House funnels another $1B into at-home COVID test makers\n",
      "https://www.fiercebiotech.com/medtech/white-house-funnels-1b-into-at-home-covid-test-makers-quadrupling-monthly-supply-by\n",
      "2021-10-07\n",
      "MedTech\n",
      "Oculis improves its vision with CMO Chang from Novartis\n",
      "https://www.fiercebiotech.com/biotech/oculis-snags-novartis-head-ophthalmology-joanne-chang-for-cmo-role\n",
      "2021-10-07\n",
      "Biotech\n",
      "Cue Health taps Google Cloud to connect its portable COVID tests\n",
      "https://www.fiercebiotech.com/medtech/to-track-down-covid-variants-cue-health-taps-google-cloud-to-connect-its-portable-tests\n",
      "2021-10-07\n",
      "MedTech\n",
      "Ellume COVID tests recalled over false positive risk\n",
      "https://www.fiercebiotech.com/medtech/ellume-at-home-covid-tests-recalled-over-false-positive-risk-caused-by-manufacturing-issue\n",
      "2021-10-07\n",
      "MedTech\n",
      "Twin Health doubles down with $140M for 'digital twin' tech\n",
      "https://www.fiercebiotech.com/medtech/twin-health-doubles-down-digital-twin-technology-for-diabetes-reversal-140m-series-c\n",
      "2021-10-07\n",
      "MedTech\n",
      "Yale spinout targets cancer's acidic environment to boost I-O\n",
      "https://www.fiercebiotech.com/research/yale-spinout-shows-targeting-cancer-cells-acidic-environment-might-enhance-immunotherapy\n",
      "2021-10-07\n",
      "Research\n",
      "BMS' deucravacitinib flunks midphase IBD trial\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-deucravacitinib-flunks-midphase-ibd-trial-raising-questions-about-potential\n",
      "2021-10-07\n",
      "Biotech\n",
      "AffyImmune snags $30M for 'tune and track' platform for CAR-T\n",
      "https://www.fiercebiotech.com/biotech/affyimmune-raises-30m-to-reduce-toxicity-increase-longevity-car-t-cells-solid-tumors\n",
      "2021-10-07\n",
      "Biotech\n",
      "Denali makes ALS play, hustling Sanofi-allied drug into phase 2\n",
      "https://www.fiercebiotech.com/biotech/denali-makes-als-play-hustling-sanofi-partnered-drug-into-phase-2-and-sharing-early-data\n",
      "2021-10-07\n",
      "Biotech\n",
      "Intergalactic nabs $75M to rocket eye gene therapy to the clinic\n",
      "https://www.fiercebiotech.com/biotech/intergalactic-shoots-for-non-viral-gene-therapy-stars-75m-rocket-fuel\n",
      "2021-10-07\n",
      "Biotech\n",
      "Arch unveils $500M, Amgen-allied bet on neuroscience's future\n",
      "https://www.fiercebiotech.com/biotech/meet-neumora-arch-s-500m-amgen-partnered-play-for-targeted-future-neuroscience-r-d\n",
      "2021-10-07\n",
      "Biotech\n",
      "Venture banks on virtual trials: Lightship, Slope nab funding\n",
      "https://www.fiercebiotech.com/cro/lightship-lures-40m-slope-snags-20m-for-virtual-decentralized-clinical-trials\n",
      "2021-10-06\n",
      "CRO\n",
      "Pfizer development head MacKenzie to retire in early 2022\n",
      "https://www.fiercebiotech.com/biotech/pfizer-s-development-leader-becomes-second-executive-to-retire-early-2022\n",
      "2021-10-06\n",
      "Biotech\n",
      "Ginkgo bowled over as short seller dubs it 'a hoax for the ages'\n",
      "https://www.fiercebiotech.com/medtech/ginkgo-bioworks-suffers-short-attack-firm-calling-it-a-hoax-for-ages\n",
      "2021-10-06\n",
      "MedTech\n",
      "SyncThink clocks FDA nod for AI-powered concussion test\n",
      "https://www.fiercebiotech.com/medtech/syncthink-clocks-fda-nod-for-concussion-test-based-ai-powered-eye-tracking\n",
      "2021-10-06\n",
      "MedTech\n",
      "Dengue compound backed by J&J shows potency in mice\n",
      "https://www.fiercebiotech.com/research/dengue-pill-backed-by-j-j-shows-potency-against-virus-and-all-known-variants-mice\n",
      "2021-10-06\n",
      "Research\n",
      "Boston Scientific puts down $1.7B to scoop up Baylis Medical\n",
      "https://www.fiercebiotech.com/medtech/boston-scientific-puts-down-1-75b-to-team-up-its-cardiac-devices-baylis-medical-s-heart\n",
      "2021-10-06\n",
      "MedTech\n",
      "Medtronic expands 2 Class I recalls of MiniMed insulin pumps\n",
      "https://www.fiercebiotech.com/medtech/medtronic-expands-two-class-i-recalls-minimed-insulin-pumps-spanning-nearly-500k-devices\n",
      "2021-10-06\n",
      "MedTech\n",
      "Acquisition autumn: Syneos pens another deal, for RxDataScience\n",
      "https://www.fiercebiotech.com/cro/fresh-off-september-buy-syneos-inks-another-deal-for-ai-firm-rxdatascience\n",
      "2021-10-06\n",
      "CRO\n",
      "EQRx's affordable drug drive leads to Absci discovery pact\n",
      "https://www.fiercebiotech.com/biotech/eqrx-s-affordable-drug-drive-leads-to-absci-discovery-pact\n",
      "2021-10-06\n",
      "Biotech\n",
      "Sanofi poaches Gilead cancer exec to run its cancer R&D\n",
      "https://www.fiercebiotech.com/biotech/sanofi-poaches-gilead-cancer-exec-valeria-fantin-to-run-its-oncology-research\n",
      "2021-10-06\n",
      "Biotech\n",
      "Retrotope misses mark but boosts survival in rare child disorder\n",
      "https://www.fiercebiotech.com/biotech/retrotope-misses-main-endpoint-but-improves-survival-late-stage-trial-ultrarare-disorder\n",
      "2021-10-06\n",
      "Biotech\n",
      "Voyager pens Pfizer gene therapy pact worth $630M\n",
      "https://www.fiercebiotech.com/biotech/voyager-therapeutics-looks-to-shake-off-a-tough-year-as-it-pens-pfizer-gene-therapy-pact\n",
      "2021-10-06\n",
      "Biotech\n",
      "Takeda stops narcolepsy clinical trials because of safety signal\n",
      "https://www.fiercebiotech.com/biotech/takeda-slams-brakes-narcolepsy-program-stopping-2-studies-early-response-to-safety-signal\n",
      "2021-10-06\n",
      "Biotech\n",
      "Inotiv inks $15M acquisition of drug discovery company Plato\n",
      "https://www.fiercebiotech.com/cro/inotiv-acquires-drug-discovery-company-plato-biopharma-15m-deal\n",
      "2021-10-05\n",
      "CRO\n",
      "Henrietta Lacks' estate sues Thermo Fisher for selling her cells\n",
      "https://www.fiercebiotech.com/medtech/henrietta-lacks-estate-sues-thermo-fisher-for-continued-sale-hela-cells-without-family\n",
      "2021-10-05\n",
      "MedTech\n",
      "FDA clears thumb-sized robot for placing cochlear implants\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-thumb-sized-robot-for-placing-cochlear-implants\n",
      "2021-10-05\n",
      "MedTech\n",
      "GraphWear nabs $20M for needle-free wearable glucose monitor\n",
      "https://www.fiercebiotech.com/medtech/graphwear-tallies-up-20m-vc-funding-for-needle-free-wearable-glucose-monitor\n",
      "2021-10-05\n",
      "MedTech\n",
      "Hologic begins European launch of its tabletop Novodiag tester\n",
      "https://www.fiercebiotech.com/medtech/hologic-begins-broad-european-launch-its-tabletop-novodiag-tester-after-its-795m\n",
      "2021-10-05\n",
      "MedTech\n",
      "Parexel poaches former GSK executive to ramp up digital strategy\n",
      "https://www.fiercebiotech.com/cro/parexel-snags-former-gsk-executive-stephen-pyke-to-boost-digital-strategy-clinical-data\n",
      "2021-10-05\n",
      "CRO\n",
      "Collins, after 12 years at the NIH helm, will exit\n",
      "https://www.fiercebiotech.com/biotech/francis-collins-after-12-years-at-nih-helm-to-exit-by-year-s-end\n",
      "2021-10-05\n",
      "Biotech\n",
      "Gemini axes CSO and 20% of staff to focus on late-phase plans\n",
      "https://www.fiercebiotech.com/biotech/gemini-axes-cso-and-20-staff-to-focus-late-phase-asset\n",
      "2021-10-05\n",
      "Biotech\n",
      "AstraZeneca files for EUA for COVID-preventing antibody\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-files-for-fda-approval-covid-preventing-antibody\n",
      "2021-10-05\n",
      "Biotech\n",
      "Eli Lilly-backed IpiNovyx Bio snags $10M for 2023 clinical entry\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-backed-ipinovyx-bio-emerges-10m-for-2023-clinical-entry\n",
      "2021-10-05\n",
      "Biotech\n",
      "Novartis-backed Exo says 'XO' to investors for $78M series B\n",
      "https://www.fiercebiotech.com/biotech/novartis-backed-exo-therapeutics-secures-78m-to-reprogram-enzymes-sans-side-effects\n",
      "2021-10-05\n",
      "Biotech\n",
      "UCSF develops custom brain implant for severe depression\n",
      "https://www.fiercebiotech.com/medtech/ucsf-health-s-customized-pacemaker-for-brain-successfully-treats-severe-depression\n",
      "2021-10-04\n",
      "MedTech\n",
      "MoonLake inks $230M SPAC deal for llama-derived Cosentyx rival\n",
      "https://www.fiercebiotech.com/biotech/moonlake-over-moon-230m-spac-deal-for-llama-antibodies-to-challenge-novartis-cosentyx\n",
      "2021-10-04\n",
      "Biotech\n",
      "Anatara, ObvioHealth partner for virtual trials in Australia\n",
      "https://www.fiercebiotech.com/biotech/anatara-partners-virtual-trials-company-obviohealth-for-siteless-study-ibs-australia\n",
      "2021-10-04\n",
      "CRO\n",
      "Beyeonics eyes $36M for head-mounted surgical camera tech\n",
      "https://www.fiercebiotech.com/medtech/beyeonics-eyes-36m-funding-for-head-mounted-surgical-visualization-system\n",
      "2021-10-04\n",
      "MedTech\n",
      "BioMarin picks up Vertex VP for CMO post month after trial hold\n",
      "https://www.fiercebiotech.com/biotech/biomarin-snags-vertex-vp-as-cmo-a-month-after-clinical-snag-gene-therapy-trial\n",
      "2021-10-04\n",
      "Biotech\n",
      "FDA greenlights combination at-home test for COVID, influenza\n",
      "https://www.fiercebiotech.com/medtech/fda-greenlights-combination-at-home-test-for-covid-and-influenza-children-as-flu-season\n",
      "2021-10-04\n",
      "MedTech\n",
      "MSU team reveals new insights into the 'second brain' in the gut\n",
      "https://www.fiercebiotech.com/research/new-insights-into-second-brain-gut-could-inspire-treatments-for-intestinal-diseases-msu\n",
      "2021-10-04\n",
      "Research\n",
      "Magenta nabs Constellation CMO after 5-month search, trial snag\n",
      "https://www.fiercebiotech.com/biotech/magenta-poaches-constellation-cmo-jeffrey-humphrey-after-five-month-search-setback-to-blood\n",
      "2021-10-04\n",
      "Biotech\n",
      "Takeda taps Selecta for $1.1B gene therapy research pact\n",
      "https://www.fiercebiotech.com/biotech/takeda-reeling-from-audentes-safety-issues-taps-selecta-for-1-1b-gene-therapy-research-pact\n",
      "2021-10-04\n",
      "Biotech\n",
      "OraSure nabs $109M in DOD funding to churn out COVID tests\n",
      "https://www.fiercebiotech.com/medtech/orasure-tacks-another-109m-dod-funding-to-churn-out-rapid-covid-tests\n",
      "2021-10-04\n",
      "MedTech\n",
      "FDA approves Abbott's latest Amplatzer Talisman heart implant\n",
      "https://www.fiercebiotech.com/medtech/fda-approves-abbott-s-latest-implant-for-closing-holes-heart-leftover-from-childbirth\n",
      "2021-10-04\n",
      "MedTech\n",
      "Enanta pulls plug on NASH, seeks to offload assets for combos\n",
      "https://www.fiercebiotech.com/biotech/enanta-pulls-plug-nash-seeks-to-offload-assets-for-combos\n",
      "2021-10-04\n",
      "Biotech\n",
      "J&J spends $100M to join Roche, Regeneron in blood cancer race\n",
      "https://www.fiercebiotech.com/biotech/j-j-spends-100m-to-join-roche-and-regeneron-bispecific-blood-cancer-race\n",
      "2021-10-04\n",
      "Biotech\n",
      "Amgen reveals midphase eczema data behind its $400M bet\n",
      "https://www.fiercebiotech.com/biotech/amgen-reveals-midphase-eczema-data-behind-its-400m-bet\n",
      "2021-10-04\n",
      "Biotech\n",
      "J&J offers 80% efficacy for RSV vaccine in Big Pharma race\n",
      "https://www.fiercebiotech.com/biotech/janssen-johnson-johnson-rsv-vaccine-shows-80-efficacy-phase-2-trial-at-idweek\n",
      "2021-10-02\n",
      "Biotech\n",
      "Medtronic expands minimally invasive spine surgery portfolio\n",
      "https://www.fiercebiotech.com/medtech/medtronic-expands-minimally-invasive-spine-surgery-portfolio-three-additions\n",
      "2021-10-01\n",
      "MedTech\n",
      "Sophia Genetics, OncoDNA team up to automate tumor profiling\n",
      "https://www.fiercebiotech.com/medtech/sophia-genetics-automates-tumor-profiling-adding-oncodna-s-interpretation-tools-to-its\n",
      "2021-10-01\n",
      "MedTech\n",
      "Siemens nets groundbreaking FDA clearance for photon-counting CT\n",
      "https://www.fiercebiotech.com/medtech/siemens-nets-groundbreaking-fda-clearance-for-photon-counting-ct-scanner\n",
      "2021-10-01\n",
      "MedTech\n",
      "SpinaFX taps Medtronic, Zimmer Biomet alum as CEO\n",
      "https://www.fiercebiotech.com/medtech/spinafx-taps-medtronic-zimmer-biomet-alum-as-ceo-image-guided-pain-treatment-startup\n",
      "2021-10-01\n",
      "MedTech\n",
      "FDA's vaccine office now headed by Marks—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-fda-s-vaccine-office-gets-new-leader-as-two-officials-head-toward-exit\n",
      "2021-10-01\n",
      "Biotech\n",
      "New cancer targets unveiled in map of protein interactions\n",
      "https://www.fiercebiotech.com/research/new-map-protein-interactions-offers-opportunity-to-do-such-damage-to-cancer-scientists-say\n",
      "2021-10-01\n",
      "Research\n",
      "Micreos lands $37M to show whether antibiotic alternative works\n",
      "https://www.fiercebiotech.com/biotech/micreos-lands-37m-to-show-if-antibiotic-alternative-delivers-clinic\n",
      "2021-10-01\n",
      "Biotech\n",
      "Merck's oral COVID-19 antiviral slashes hospitalizations\n",
      "https://www.fiercebiotech.com/biotech/merck-s-oral-covid-19-antiviral-slashes-hospitalizations-prevents-deaths-phase-3-sparking\n",
      "2021-10-01\n",
      "Biotech\n",
      "BioNTech's life after Pfizer COVID jab gets boost via cancer vax\n",
      "https://www.fiercebiotech.com/biotech/biontech-looks-beyond-pfizer-covid-19-shot-mrna-vaccine-for-colorectal-cancer\n",
      "2021-10-01\n",
      "Biotech\n",
      "Blood storage tech developer Hemanext adds $15M to VC stores\n",
      "https://www.fiercebiotech.com/medtech/blood-storage-tech-developer-hemanext-adds-15m-to-vc-stores-as-it-preps-for-fda-submission\n",
      "2021-09-30\n",
      "MedTech\n",
      "Ventyx files for $100M IPO to fund 6 or more trials by 2023\n",
      "https://www.fiercebiotech.com/biotech/at-least-six-trials-planned-before-2023-ventyx-biosciences-lines-up-for-100m-ipo\n",
      "2021-09-30\n",
      "Biotech\n",
      "Laurent's COVID oral therapy fails in hospitalized patient trial\n",
      "https://www.fiercebiotech.com/biotech/laurent-s-covid-19-pill-fails-phase-2-but-data-helps-narrow-down-patients-who-may-benefit\n",
      "2021-09-30\n",
      "Biotech\n",
      "AR software maker Activ Surgical augments VC funding with $45M\n",
      "https://www.fiercebiotech.com/medtech/activ-surgical-augments-vc-funding-45m-for-ar-based-software\n",
      "2021-09-30\n",
      "MedTech\n",
      "Artificial heart maker SynCardia beamed up by Picard Medical\n",
      "https://www.fiercebiotech.com/medtech/total-artificial-heart-maker-syncardia-beamed-up-by-newcomer-picard-medical\n",
      "2021-09-30\n",
      "MedTech\n",
      "Merck KGaA, GSK cut ties on $4.2B bintrafusp alfa deal\n",
      "https://www.fiercebiotech.com/biotech/merck-kgaa-gsk-cut-ties-bintrafusp-alfa-deal-had-4-2b-biobucks-line\n",
      "2021-09-30\n",
      "Biotech\n",
      "Bausch-Novaliq's eye drop beats placebo again in phase 3 trial\n",
      "https://www.fiercebiotech.com/biotech/bausch-novaliq-s-eye-drop-beats-placebo-2nd-phase-3-trial-dry-eye-disease-filing-2022\n",
      "2021-09-30\n",
      "Biotech\n",
      "AstraZeneca, others support newly private Cellular with $120M\n",
      "https://www.fiercebiotech.com/biotech/now-private-cellular-biomedicine-snags-120m-from-astrazeneca-others-for-oncology\n",
      "2021-09-30\n",
      "Biotech\n",
      "Novartis claims win with BTK inhibitor where others have failed\n",
      "https://www.fiercebiotech.com/biotech/novartis-btk-inhibitor-successful-phase-2b-clinical-trial-remibrutinib\n",
      "2021-09-30\n",
      "Biotech\n",
      "Apple Watch ECG could detect multiple arrhythmias: study\n",
      "https://www.fiercebiotech.com/medtech/apple-watch-s-built-ecg-could-detect-non-afib-arrhythmias-follow-up-analysis-finds\n",
      "2021-09-30\n",
      "MedTech\n",
      "AstraZeneca closes in on EUA filing for COVID-19 antibody\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-nearly-ready-to-seek-approval-for-its-covid-19-antibody-can-it-stick-landing\n",
      "2021-09-30\n",
      "Biotech\n",
      "Researchers unravel a potentially preventable genetic disease\n",
      "https://www.fiercebiotech.com/research/researchers-discover-genetic-condition-might-be-prevented-via-wnt-focused-drug\n",
      "2021-09-30\n",
      "Research\n",
      "Lilly adds liver fat data to mountain of tirzepatide evidence\n",
      "https://www.fiercebiotech.com/biotech/lilly-adds-liver-fat-cgm-blood-sugar-data-to-mountain-evidence-hot-diabetes-prospect\n",
      "2021-09-30\n",
      "Biotech\n",
      "Sunovion pens $890M Otsuka neuropsychiatric drug pact\n",
      "https://www.fiercebiotech.com/biotech/sunovion-pens-890m-otsuka-pact-for-a-clutch-neuropsychiatric-drugs\n",
      "2021-09-30\n",
      "Biotech\n",
      "Exploiting a protective gene mutation to fend off Alzheimer's\n",
      "https://www.fiercebiotech.com/research/how-a-genetic-factor-might-protect-brain-from-alzheimer-s-disease\n",
      "2021-09-29\n",
      "Research\n",
      "Biotech incubator Sporos' new CEO arrives from Ovid\n",
      "https://www.fiercebiotech.com/biotech/ovid-cmo-amit-rakhit-heads-to-houston-biotech-incubator-sporos-as-ceo\n",
      "2021-09-29\n",
      "Biotech\n",
      "FDA takes note of stroke-preventing heart implant risk in women\n",
      "https://www.fiercebiotech.com/medtech/study-finds-stroke-preventing-heart-implant-more-risky-for-women-as-fda-takes-notice\n",
      "2021-09-29\n",
      "MedTech\n",
      "FDA approves TransMedics’ donor liver preservation system\n",
      "https://www.fiercebiotech.com/medtech/transmedics-locks-2nd-fda-approval-a-month-nod-for-donor-liver-preservation-system\n",
      "2021-09-29\n",
      "MedTech\n",
      "Bayer, Huma begin building AI to classify lung cancer types\n",
      "https://www.fiercebiotech.com/medtech/bayer-strengthens-ties-huma-collaborating-ai-to-classify-lung-cancer-types\n",
      "2021-09-29\n",
      "MedTech\n",
      "FDA said no in July, so Iterum will test UTI antibiotic again\n",
      "https://www.fiercebiotech.com/biotech/iterum-will-give-uti-antibiotic-another-go-new-trial-after-meeting-fda\n",
      "2021-09-29\n",
      "Biotech\n",
      "FDA clears wireless, blood pressure-monitoring finger sensor\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-wireless-blood-pressure-monitoring-finger-sensor-from-caretaker-medical\n",
      "2021-09-29\n",
      "MedTech\n",
      "What's next for the NIH's RADx program for COVID tests?\n",
      "https://www.fiercebiotech.com/medtech/what-s-next-for-radx-nih-drafts-a-to-do-list-for-its-1-5b-diagnostics-competition-through\n",
      "2021-09-29\n",
      "MedTech\n",
      "Editas claims proof of concept in vision loss gene-editing\n",
      "https://www.fiercebiotech.com/biotech/editas-presents-gene-editing-first-human-results-for-edit-101-lca10\n",
      "2021-09-29\n",
      "Biotech\n",
      "Amicus spins off gene therapy unit in $600M SPAC deal\n",
      "https://www.fiercebiotech.com/biotech/amicus-spins-off-gene-therapy-unit-600m-spac-deal-as-ceo-moves-over-to-caritas-therapeutics\n",
      "2021-09-29\n",
      "Biotech\n",
      "I-Mab hits the deal table with biopharma majors: report\n",
      "https://www.fiercebiotech.com/biotech/i-mab-hits-deal-table-biopharma-majors-to-talk-partnerships-and-investments-report\n",
      "2021-09-29\n",
      "Biotech\n",
      "Leo Pharma inks digital clinical trials partnership with Veeva\n",
      "https://www.fiercebiotech.com/cro/leo-pharma-inks-partnerships-veeva-systems-industry-movement-toward-digital-trials\n",
      "2021-09-29\n",
      "CRO\n",
      "AstraZeneca bags late-phase hematology prospect in $150M buyout\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-moves-deeper-into-rare-diseases-spending-150m-late-phase-hematology-prospect\n",
      "2021-09-29\n",
      "Biotech\n",
      "Sanofi-backed Expansion nabs $80M for RNA neurodegenerative work\n",
      "https://www.fiercebiotech.com/biotech/novartis-sanofi-backed-expansion-snags-80m-for-neurodegenerative-assets-to-rival-dyne\n",
      "2021-09-29\n",
      "Biotech\n",
      "In vivo gene editing grabs the spotlight after Intellia triumph\n",
      "https://www.fiercebiotech.com/research/vivo-gene-editing-grabs-spotlight-after-intellia-triumph-but-challenges-loom\n",
      "2021-09-29\n",
      "Research\n",
      "Medtronic's newly acquired radial artery catheters go global\n",
      "https://www.fiercebiotech.com/medtech/medtronic-s-newly-acquired-radial-artery-catheters-go-global-european-approval\n",
      "2021-09-28\n",
      "MedTech\n",
      "Eli Lilly taps Reify's Care Access to diversify oncology trials\n",
      "https://www.fiercebiotech.com/cro/eli-lilly-taps-reify-health-s-care-access-to-diversify-oncology-clinical-trials\n",
      "2021-09-28\n",
      "CRO\n",
      "Pfizer tightens DMD trial criteria over safety concerns\n",
      "https://www.fiercebiotech.com/biotech/pfizer-tightening-duchenne-muscular-dystrophy-phase-3-criteria-adverse-events\n",
      "2021-09-28\n",
      "Biotech\n",
      "FDA asks for study do-overs at 2 CROs due to data concerns\n",
      "https://www.fiercebiotech.com/cro/fda-asks-pharmas-to-repeat-studies-done-at-two-indian-cros-due-to-data-integrity-issues-report\n",
      "2021-09-28\n",
      "CRO\n",
      "MIT cell-engineering spinout nets $30M for production platform\n",
      "https://www.fiercebiotech.com/medtech/mit-cell-engineering-spinout-nets-30m-for-mass-manufacturing-platform\n",
      "2021-09-28\n",
      "MedTech\n",
      "Vensana Capital ups medtech investments with $325M 2nd fund\n",
      "https://www.fiercebiotech.com/medtech/vensana-capital-redoubles-medtech-investment-efforts-325m-second-fund\n",
      "2021-09-28\n",
      "MedTech\n",
      "Ziopharm's new CEO fires half of his workforce in first month\n",
      "https://www.fiercebiotech.com/biotech/ziopharm-s-new-ceo-cuts-50-workforce-amid-trial-delays-for-t-cell-receptor-therapy\n",
      "2021-09-28\n",
      "Biotech\n",
      "Shionogi licenses out 3rd-gen HIV asset to ViiV\n",
      "https://www.fiercebiotech.com/biotech/shionogi-licences-third-gen-hiv-asset-ultra-long-dosing-prospect-from-its-partly-owned\n",
      "2021-09-28\n",
      "Biotech\n",
      "Eisai, Biogen start rolling submission for Alzheimer's drug\n",
      "https://www.fiercebiotech.com/biotech/here-we-go-again-eisai-starts-rolling-fda-approval-submission-for-biogen-partnered\n",
      "2021-09-28\n",
      "Biotech\n",
      "Sanofi dumps mRNA COVID-19 vaccine after seeing early data\n",
      "https://www.fiercebiotech.com/biotech/after-3-2b-deal-sanofi-pivots-mrna-dumping-covid-19-vaccine-and-accelerating-switch-to\n",
      "2021-09-28\n",
      "Biotech\n",
      "Valneva sees Lyme disease vaccine drop-off in phase 2\n",
      "https://www.fiercebiotech.com/biotech/valneva-hit-by-covid-contract-chaos-sees-lyme-disease-vaccine-drop-off-phase-2-but-boosters\n",
      "2021-09-28\n",
      "Biotech\n",
      "Anji Pharma snags $70M for phase 3 diabetes and mid-stage asset\n",
      "https://www.fiercebiotech.com/biotech/anji-pharma-secures-70m-series-b-for-phase-3-diabetes-asset-mid-stage-constipation\n",
      "2021-09-28\n",
      "Biotech\n",
      "Roche's Genentech to use Lifelink Systems' chatbot for patients\n",
      "https://www.fiercebiotech.com/cro/roche-s-genentech-will-communicate-patients-trial-participants-using-lifelink-system-s-chatbot\n",
      "2021-09-28\n",
      "CRO\n",
      "Union, Innovent ink $247M biobucks deal for psoriasis therapy\n",
      "https://www.fiercebiotech.com/biotech/innovent-to-pay-union-up-to-267m-for-china-rights-to-mid-stage-psoriasis-eczema-asset\n",
      "2021-09-28\n",
      "Biotech\n",
      "Eyevensys upgrades ocular device to advance gene therapy trials\n",
      "https://www.fiercebiotech.com/medtech/eyevensys-taps-phillips-medisize-minnetronix-to-up-production-gene-therapy-device-for-eye\n",
      "2021-09-27\n",
      "MedTech\n",
      "Elligo’s $135M fuels acquisition to expand digital R&D platforms\n",
      "https://www.fiercebiotech.com/medtech/135m-bank-elligo-taps-new-buyout-to-build-out-its-digital-r-d-platforms\n",
      "2021-09-27\n",
      "MedTech\n",
      "Biohaven's CNS drug from AstraZeneca fails phase 3 trial\n",
      "https://www.fiercebiotech.com/biotech/a-phase-3-fail-biohaven-learned-hard-way-why-astrazeneca-dropped-cns-drug-2018\n",
      "2021-09-27\n",
      "Biotech\n",
      "Zebra Medical earns its stripes with heart disease-spotting AI\n",
      "https://www.fiercebiotech.com/medtech/zebra-medical-earns-its-stripes-fda-nod-for-ai-to-measure-calcium-build-up-arteries-0\n",
      "2021-09-27\n",
      "MedTech\n",
      "Novo Nordisk, Biocorp sign digital insulin pen deal\n",
      "https://www.fiercebiotech.com/medtech/novo-nordisk-to-smarten-up-its-disposable-insulin-pens-digital-diabetes-devicemaker-biocorp\n",
      "2021-09-27\n",
      "MedTech\n",
      "Novel 'nanosized' drug carriers tamp down HIV in the brain\n",
      "https://www.fiercebiotech.com/research/novel-nanosized-drug-carriers-tamp-down-hiv-brain-and-other-remote-tissues-mice\n",
      "2021-09-27\n",
      "Research\n",
      "Pfizer's oral COVID-19 antiviral gets rolling in phase 2/3 trial\n",
      "https://www.fiercebiotech.com/biotech/pfizer-s-preventative-covid-19-oral-antiviral-gets-rolling-phase-2-3-trial\n",
      "2021-09-27\n",
      "Biotech\n",
      "Connecting Big Pharma's shelved drugs with new investors: report\n",
      "https://www.fiercebiotech.com/biotech/milken-institute-report-big-pharma-donating-shelved-medicines-to-nonoprofits\n",
      "2021-09-27\n",
      "Biotech\n",
      "Delix snags $70M series A for psychedelic analog trials in 2022\n",
      "https://www.fiercebiotech.com/biotech/delix-raises-70m-to-test-psychedelic-analogs-for-treating-brain-disorders-clinical-trials\n",
      "2021-09-27\n",
      "Biotech\n",
      "Syndax, Incyte pen chronic graft-versus-host disease collab\n",
      "https://www.fiercebiotech.com/biotech/syndax-and-incyte-both-reeling-from-cancer-drug-setbacks-pen-chronic-graft-versus-host\n",
      "2021-09-27\n",
      "Biotech\n",
      "Mystery suitor lines up $11B Acceleron acquisition: report\n",
      "https://www.fiercebiotech.com/biotech/mystery-suitor-lines-up-11b-acceleron-acquisition-report\n",
      "2021-09-27\n",
      "Biotech\n",
      "Pfizer stumbles close to finish line in growth hormone race\n",
      "https://www.fiercebiotech.com/biotech/pfizer-stumbles-close-to-finish-line-growth-hormone-race-extending-lead-rival-ascendis\n",
      "2021-09-27\n",
      "Biotech\n",
      "Fierce Biotech's 2021 Fierce 15\n",
      "https://www.fiercebiotech.com/special-report/fierce-biotech-s-2021-fierce-15-0\n",
      "2021-09-27\n",
      "Special Reports\n",
      "Cue Health makes Nasdaq debut with $200M IPO\n",
      "https://www.fiercebiotech.com/medtech/cue-health-kicks-off-200m-ipo-to-expand-its-portable-diagnostics-beyond-covid-19\n",
      "2021-09-24\n",
      "MedTech\n",
      "FDA stamps Class I label on Cordis angiographic catheter recall\n",
      "https://www.fiercebiotech.com/medtech/cordis-issues-class-i-recall-angiographic-catheters-could-leave-metal-pieces-arteries\n",
      "2021-09-24\n",
      "MedTech\n",
      "CytoDyn's shareholders have a plan to get leronlimab approved\n",
      "https://www.fiercebiotech.com/biotech/cytodyn-leronlimab-shareholder-proposal-for-combination-therapy-partnership-big-pharma\n",
      "2021-09-24\n",
      "Biotech\n",
      "Brooklyn ImmunoTherapeutics snags Roivant CMO for same post\n",
      "https://www.fiercebiotech.com/biotech/brooklyn-immunotherapeutics-snags-roivant-sciences-cmo-to-lead-same-post\n",
      "2021-09-24\n",
      "Biotech\n",
      "AI improves breast cancer diagnoses by 37%, NYU study finds\n",
      "https://www.fiercebiotech.com/medtech/ultrasound-analyzing-ai-improves-breast-cancer-diagnoses-by-37-nyu-study-finds\n",
      "2021-09-24\n",
      "MedTech\n",
      "Novartis loses cell, gene leader, digital exec—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-novartis-loses-two-leaders-one-to-mirobio-another-to-a-video-game-game\n",
      "2021-09-24\n",
      "Biotech\n",
      "Bavarian Nordic gets government support for COVID booster trial\n",
      "https://www.fiercebiotech.com/biotech/vaccine-boost-bavarian-nordic-gets-government-support-to-join-second-wave-covid-19-jabs\n",
      "2021-09-24\n",
      "Biotech\n",
      "Kids suffer serious adverse reactions in AGTC gene therapy trial\n",
      "https://www.fiercebiotech.com/biotech/kids-suffer-serious-adverse-reactions-agtc-gene-therapy-trial\n",
      "2021-09-24\n",
      "Biotech\n",
      "Capricor finds efficacy in older Duchenne patients in phase 2\n",
      "https://www.fiercebiotech.com/biotech/capricor-s-cap-1002-duchenne-muscular-dystrophy-phase-2-hope-2-results\n",
      "2021-09-24\n",
      "Biotech\n",
      "NIH vouches for new kidney disease diagnostic not based on race\n",
      "https://www.fiercebiotech.com/medtech/nih-vouches-for-new-kidney-disease-diagnostic-doesn-t-rely-faulty-race-based-calculations\n",
      "2021-09-23\n",
      "MedTech\n",
      "Repairing heart damage by transiently turning back the clock\n",
      "https://www.fiercebiotech.com/research/transiently-turning-back-clock-adult-heart-cells-to-repair-damage\n",
      "2021-09-23\n",
      "Research\n",
      "Esker Therapeutics snags former Principia CEO in hiring spree\n",
      "https://www.fiercebiotech.com/biotech/esker-therapeutics-goes-hiring-spree-snagging-former-principia-ceo-seven-other-leaders\n",
      "2021-09-23\n",
      "Biotech\n",
      "Lucid Diagnostics files for $58M IPO to leave the PAVmed nest\n",
      "https://www.fiercebiotech.com/medtech/lucid-diagnostics-prepares-to-leave-pavmed-nest-57m-ipo-filing\n",
      "2021-09-23\n",
      "MedTech\n",
      "Eli Lilly-backed GenEdit inks $26M to deliver gene therapies\n",
      "https://www.fiercebiotech.com/biotech/genedit-strikes-eli-lilly-gold-26m-for-gold-nanoparticles-gene-therapy-delivery-system\n",
      "2021-09-23\n",
      "Biotech\n",
      "GE drops $1.45B to acquire OR ultrasound provider BK Medical\n",
      "https://www.fiercebiotech.com/medtech/ge-healthcare-drops-1-45b-to-acquire-bk-medical-bringing-its-ultrasound-franchise-to-or\n",
      "2021-09-23\n",
      "MedTech\n",
      "Automated lab platform Opentrons closes $200M series C\n",
      "https://www.fiercebiotech.com/medtech/lab-platform-opentrons-closes-200m-series-c-to-build-out-robotics-diagnostics-cell\n",
      "2021-09-23\n",
      "MedTech\n",
      "Solid Bio hopes a shred of positive DMD data will spark a rally\n",
      "https://www.fiercebiotech.com/biotech/solid-bio-new-data-duchenne-muscular-dystrophy-gene-therapy-sgt-001-clinical-hold\n",
      "2021-09-23\n",
      "Biotech\n",
      "Garuda bags $72M to advance off-the-shelf stem cell transplants\n",
      "https://www.fiercebiotech.com/biotech/garuda-thinks-it-has-cracked-code-to-off-shelf-stem-cell-transplants-and-investors-are\n",
      "2021-09-23\n",
      "Biotech\n",
      "AstraZeneca allies with startup to test spin on red-hot modality\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-makes-rna-play-teaming-up-startup-to-advance-twist-red-hot-modality\n",
      "2021-09-23\n",
      "Biotech\n",
      "Castor, Trialbee forge clinical trial enrollment partnership\n",
      "https://www.fiercebiotech.com/cro/castor-trialbee-team-up-for-patient-enrollment-engagement-clinical-trials\n",
      "2021-09-22\n",
      "CRO\n",
      "SAB Biotherapeutics banks $60M more for COVID-19 antibody\n",
      "https://www.fiercebiotech.com/biotech/sab-biotherapeutics-banks-60m-more-funding-from-u-s-officials-for-covid-19-antibody\n",
      "2021-09-22\n",
      "Biotech\n",
      "Summit Clinical Research, PathAI partner for NASH trial services\n",
      "https://www.fiercebiotech.com/cro/summit-clinical-research-and-pathai-partner-nash-clinical-trial-services\n",
      "2021-09-22\n",
      "CRO\n",
      "Epic success: FDA OKs Abbott's newest replacement mitral valve\n",
      "https://www.fiercebiotech.com/medtech/epic-success-fda-approves-abbott-s-upgraded-longer-lasting-replacement-mitral-valve\n",
      "2021-09-22\n",
      "MedTech\n",
      "HealthVerity will supply Janssen with real-world data for R&D\n",
      "https://www.fiercebiotech.com/cro/healthverity-partners-j-j-s-janssen-to-provide-real-world-data-for-clinical-trial-r-d-work\n",
      "2021-09-22\n",
      "CRO\n",
      "Velocity Clinical Research snags 11 sites through 2 acquisitions\n",
      "https://www.fiercebiotech.com/cro/velocity-clinical-research-acquires-11-sites-through-two-companies-after-april-buyout\n",
      "2021-09-22\n",
      "CRO\n",
      "Know Labs unveils noninvasive, pocket-sized glucose monitor\n",
      "https://www.fiercebiotech.com/medtech/know-labs-unveils-pocket-sized-glucose-monitor-swaps-fingersticks-for-radiofrequency\n",
      "2021-09-22\n",
      "MedTech\n",
      "FDA clears Paige's AI as first program to spot prostate cancer\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-paige-s-ai-as-first-program-to-spot-prostate-cancer-amid-tissue-slides\n",
      "2021-09-22\n",
      "MedTech\n",
      "Cassava drops interim Alzheimer's data with plenty of caveats\n",
      "https://www.fiercebiotech.com/biotech/cassava-drops-interim-alzheimer-s-data-plenty-caveats\n",
      "2021-09-22\n",
      "Biotech\n",
      "Hexagon nabs $61M for fungi-derived treatments for cancer\n",
      "https://www.fiercebiotech.com/biotech/fungi-funding-hexagon-bio-snags-61m-to-test-drugs-from-fungi-for-cancer-infectious-diseases\n",
      "2021-09-22\n",
      "Biotech\n",
      "ESMO: Owkin's deep learning AI predicts breast cancer relapse\n",
      "https://www.fiercebiotech.com/medtech/esmo-owkin-s-deep-learning-ai-predicts-chances-metastatic-breast-cancer-relapse-within-next\n",
      "2021-09-22\n",
      "MedTech\n",
      "Striking deals with Blueprint COO Haviland\n",
      "https://www.fiercebiotech.com/biotech/striking-deals-blueprint-coo-kate-haviland\n",
      "2021-09-22\n",
      "Biotech\n",
      "Luxturna inventor launches new gene therapy biotech with $19M\n",
      "https://www.fiercebiotech.com/biotech/luxturna-inventor-behind-new-eye-gene-therapy-biotech-opus-genetics-snags-19m\n",
      "2021-09-22\n",
      "Biotech\n",
      "Blocking a 'rogue' inflammatory response during stroke\n",
      "https://www.fiercebiotech.com/research/a-protein-blocking-inflammatory-response-improved-stroke-recovery-mice-study-finds\n",
      "2021-09-22\n",
      "Research\n",
      "Clover's COVID-19 vaccine tames delta in pivotal study\n",
      "https://www.fiercebiotech.com/biotech/clover-s-covid-19-shot-tames-delta-pivotal-study-delivering-boost-to-global-vaccination\n",
      "2021-09-22\n",
      "Biotech\n",
      "FDA objects to Summit's midstudy pooling of pivotal trials\n",
      "https://www.fiercebiotech.com/biotech/fda-objects-to-summit-s-midstudy-pooling-pivotal-trials\n",
      "2021-09-22\n",
      "Biotech\n",
      "More llama-inspired anti-COVID antibodies could be on the way\n",
      "https://www.fiercebiotech.com/research/another-research-group-joins-llama-inspired-covid-19-nanobody-treatment-arena\n",
      "2021-09-22\n",
      "Research\n",
      "European watchdog delivers ultimatum to Illumina over Grail deal\n",
      "https://www.fiercebiotech.com/medtech/european-antitrust-regulators-deliver-ultimatum-to-illumina-over-8b-grail-deal\n",
      "2021-09-21\n",
      "MedTech\n",
      "Abbott's Alinity COVID tests may give false positives, FDA says\n",
      "https://www.fiercebiotech.com/medtech/fda-warns-abbott-alinity-pcr-covid-test-results-may-only-be-presumptive-due-to-risk-false\n",
      "2021-09-21\n",
      "MedTech\n",
      "Boston Scientific offers up $336M to devour Devoro Medical\n",
      "https://www.fiercebiotech.com/medtech/boston-scientific-offers-up-336m-to-devour-devoro-medical-and-its-blood-clot-removal-tech\n",
      "2021-09-21\n",
      "MedTech\n",
      "iPhones may soon automatically assess mental health: report\n",
      "https://www.fiercebiotech.com/medtech/apple-taps-biogen-ucla-to-explore-addition-mental-health-tracking-to-iphone-report\n",
      "2021-09-21\n",
      "MedTech\n",
      "Boehringer Ingelheim acquires Abexxa for immuno-oncology assets\n",
      "https://www.fiercebiotech.com/biotech/boehringer-ingelheim-acquires-abexxa-biologics-for-precision-cancer-drug-pipeline\n",
      "2021-09-21\n",
      "Biotech\n",
      "Aerie CEO exits days after downplaying midphase eye disease flop\n",
      "https://www.fiercebiotech.com/biotech/aerie-ceo-exits-days-after-downplaying-midphase-eye-disease-flop\n",
      "2021-09-21\n",
      "Biotech\n",
      "Oncology, RNA biotech 858 Therapeutics inks $60M series A\n",
      "https://www.fiercebiotech.com/biotech/vc-versant-backed-biotech-858-therapeutics-to-develop-oncology-therapeutics-60m-series-a\n",
      "2021-09-21\n",
      "Biotech\n",
      "BioMed bets $1.2B to ease U.K. life science capacity crunch\n",
      "https://www.fiercebiotech.com/biotech/biomed-bets-1-2b-to-ease-u-k-life-science-capacity-crunch\n",
      "2021-09-21\n",
      "Biotech\n",
      "Novartis veteran Barth takes the helm at MiroBio\n",
      "https://www.fiercebiotech.com/biotech/novartis-veteran-barth-takes-helm-at-autoimmune-biotech-mirobio\n",
      "2021-09-21\n",
      "Biotech\n",
      "Novartis adds 2nd biotech to optogenetics gene therapy portfolio\n",
      "https://www.fiercebiotech.com/biotech/novartis-optogenetics-arctor-vedere-gene-therapy-eye-disease-blindness\n",
      "2021-09-21\n",
      "Biotech\n",
      "Abbott joins TAVR market with FDA approval for its Portico valve\n",
      "https://www.fiercebiotech.com/medtech/abbott-joins-tavr-market-fda-approval-for-its-portico-heart-valve\n",
      "2021-09-20\n",
      "MedTech\n",
      "Medtronic recalls brain aneurysm-blocking Pipeline Flex implant\n",
      "https://www.fiercebiotech.com/medtech/medtronic-recalls-brain-aneurysm-blocking-implant-due-to-potential-breakages-during\n",
      "2021-09-20\n",
      "MedTech\n",
      "Illumina Ventures closes $325M genomic startup fund\n",
      "https://www.fiercebiotech.com/medtech/illumina-ventures-more-than-doubles-its-capital-new-325m-fund\n",
      "2021-09-20\n",
      "MedTech\n",
      "J&J, Mauna Kea launch study of lung cancer biopsy tool\n",
      "https://www.fiercebiotech.com/medtech/johnson-johnson-mauna-kea-launch-study-lung-cancer-biopsy-guidance-tool\n",
      "2021-09-20\n",
      "MedTech\n",
      "Syros targets KRAS-mutant cancer with CDK7 inhibitor\n",
      "https://www.fiercebiotech.com/research/syros-targets-kras-mutant-cancer-as-cdk7-inhibitor-shows-early-promise\n",
      "2021-09-20\n",
      "Research\n",
      "Ventyx picks up $51M, ex-Horizon EVP as chief medical officer\n",
      "https://www.fiercebiotech.com/biotech/ventyx-biosciences-snags-51m-series-b-hires-new-cmo-from-horizon-therapeutics\n",
      "2021-09-20\n",
      "Biotech\n",
      "Gubra, Bayer ink $253M biobucks deal for heart, kidney collab\n",
      "https://www.fiercebiotech.com/biotech/gubra-strikes-253m-biobucks-deal-bayer-heart-kidney-disorder-treatments\n",
      "2021-09-20\n",
      "Biotech\n",
      "AstraZeneca’s Alexion taps Genomenon for rare disease work\n",
      "https://www.fiercebiotech.com/medtech/astrazeneca-s-alexion-taps-dna-profiler-genomenon-for-rare-disease-diagnoses\n",
      "2021-09-20\n",
      "MedTech\n",
      "Boston Scientific’s microbeads attack colorectal cancer: study\n",
      "https://www.fiercebiotech.com/medtech/boston-scientific-adds-colorectal-cancer-survival-boost-to-list-wins-for-tumor-targeting\n",
      "2021-09-20\n",
      "MedTech\n",
      "Mirati switches CEOs as KRAS drug speeds toward FDA filing\n",
      "https://www.fiercebiotech.com/biotech/mirati-names-ex-ipsen-fergene-ceo-for-top-role-as-lumakras-kras-drug-heads-to-finish-line\n",
      "2021-09-20\n",
      "Biotech\n",
      "Q&A: Eli Lilly zeros in on diversity in oncology clinical trials\n",
      "https://www.fiercebiotech.com/biotech/q-a-eli-lilly-diversity-oncology-clinical-trials\n",
      "2021-09-20\n",
      "Biotech\n",
      "Pyxis files for $100M IPO to take cancer drugs into the clinic\n",
      "https://www.fiercebiotech.com/biotech/bankrolled-by-pfizer-and-bayer-pyxis-files-for-100m-ipo-to-take-cancer-drugs-into-clinic\n",
      "2021-09-20\n",
      "Biotech\n",
      "Sanofi-backed Jeito snags $630M fund for 12-15 European biotechs\n",
      "https://www.fiercebiotech.com/biotech/sanofi-backed-jeito-capital-closes-630m-first-fund-to-help-finance-12-15-european\n",
      "2021-09-20\n",
      "Biotech\n",
      "ESMO: Mirati pulls away from Amgen in colorectal cancer\n",
      "https://www.fiercebiotech.com/biotech/esmo-mirati-pulls-away-from-amgen-colorectal-cancer-updated-data-kras-drug\n",
      "2021-09-19\n",
      "Biotech\n",
      "Bats' immunity could lead to new treatment options for COVID-19\n",
      "https://www.fiercebiotech.com/research/bats-immunity-could-point-to-new-therapeutic-approaches-for-fighting-covid-19\n",
      "2021-09-17\n",
      "Research\n",
      "Gynesonics nabs FDA OK for uterine fibroid ablation system\n",
      "https://www.fiercebiotech.com/medtech/gynesonics-nabs-fda-clearance-for-updated-ultrasound-powered-ablation-system-to-shrink\n",
      "2021-09-17\n",
      "MedTech\n",
      "Hong Kong COVID tester Prenetics sets up $1.7B SPAC deal\n",
      "https://www.fiercebiotech.com/medtech/hong-kong-covid-tester-prenetics-sets-up-1-7b-spac-deal\n",
      "2021-09-17\n",
      "MedTech\n",
      "Pyxis names ADC Therapeutics vet as CMO\n",
      "https://www.fiercebiotech.com/biotech/pyxis-oncology-names-new-chief-medical-officer-to-lead-cancer-adcs-development\n",
      "Biotech\n",
      "Everest inks $561M biobucks deal for renal disease treatment\n",
      "https://www.fiercebiotech.com/biotech/everest-inks-second-deal-week-will-pay-up-to-561m-for-sinovent-sinomab-for-renal-diseases\n",
      "2021-09-17\n",
      "Biotech\n",
      "Excision's HIV CRISPR therapy cleared for human studies by FDA\n",
      "https://www.fiercebiotech.com/biotech/excision-hiv-crispr-gene-editing-therapy-cleared-for-human-studies-by-fda\n",
      "2021-09-17\n",
      "Biotech\n",
      "Medtronic expands Type 1 diabetes reach with infusion tech buy\n",
      "https://www.fiercebiotech.com/medtech/medtronic-buys-implanted-infusion-pump-tech-to-develop-new-type-1-diabetes-treatment\n",
      "2021-09-17\n",
      "MedTech\n",
      "AltruBio snags new CMO with pivot to immunology—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-altrubio-snags-new-cmo-resume-at-sublimity-ardea-amgen-and-abbott\n",
      "2021-09-17\n",
      "Biotech\n",
      "FDA hits pause on Protagonist's blood cancer med\n",
      "https://www.fiercebiotech.com/biotech/fda-hits-pause-protagonist-s-blood-cancer-med-after-mouse-study-turns-up-skin-tumors\n",
      "2021-09-17\n",
      "Biotech\n",
      "AstraZeneca taps Dana-Farber's Rahma to lead its GI work\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-taps-dana-farber-s-osama-rahma-to-lead-its-gi-oncology-work\n",
      "2021-09-17\n",
      "Biotech\n",
      "Elevian snags $40M for stroke recovery trials in early 2023\n",
      "https://www.fiercebiotech.com/biotech/elevian-secures-40-million-for-stroke-recovery-and-age-related-diseases\n",
      "2021-09-17\n",
      "Biotech\n",
      "ESMO: Daiichi unveils first early peek at next-gen ADC\n",
      "https://www.fiercebiotech.com/biotech/esmo-daiichi-unveils-first-early-peek-at-next-gen-adc-as-analysts-see-strong-dataset\n",
      "2021-09-17\n",
      "Biotech\n",
      "Novartis links cancer drug to improved pain, quality of life\n",
      "https://www.fiercebiotech.com/biotech/esmo-novartis-links-prostate-cancer-drug-to-improved-pain-quality-life-as-regulatory\n",
      "2021-09-16\n",
      "Biotech\n",
      "The immune connection between mutated genes and cancer\n",
      "https://www.fiercebiotech.com/research/how-do-faulty-genes-drive-cancer-there-s-a-surprising-immune-connection-study-finds\n",
      "2021-09-16\n",
      "Research\n",
      "First witnesses in Holmes trial outline Theranos' corner-cutting\n",
      "https://www.fiercebiotech.com/medtech/first-witnesses-elizabeth-holmes-fraud-trial-say-theranos-manipulated-lab-data-inflated\n",
      "2021-09-16\n",
      "MedTech\n",
      "FDA names CIO, shuffles IT, cybersecurity work into new office\n",
      "https://www.fiercebiotech.com/medtech/fda-appoints-cio-reorganizes-it-cybersecurity-efforts-into-single-digital-office\n",
      "2021-09-16\n",
      "MedTech\n",
      "Vifor doles out $55M upfront to license Travere's asset\n",
      "https://www.fiercebiotech.com/biotech/vifor-doles-out-55m-upfront-to-license-travere-s-late-stage-kidney-asset-slated-for\n",
      "2021-09-16\n",
      "Biotech\n",
      "FDA clears trial for Intellia's ex vivo cancer candidate\n",
      "https://www.fiercebiotech.com/biotech/intellia-ex-vivo-gene-editing-cancer-treatment-ntla-5001-trial-cleared-by-fda\n",
      "2021-09-16\n",
      "Biotech\n",
      "Oxford Nanopore, Oracle form genomic sequencing partnership\n",
      "https://www.fiercebiotech.com/medtech/oxford-nanopore-scores-ps150m-investment-genomic-sequencing-cloud-support-from-oracle\n",
      "2021-09-16\n",
      "MedTech\n",
      "China's IASO nets $108M to advance cell therapies, antibodies\n",
      "https://www.fiercebiotech.com/biotech/china-s-iaso-nets-108m-to-advance-cell-therapies-antibodies-for-cancer-autoimmune-disease\n",
      "2021-09-16\n",
      "Biotech\n",
      "Novo-backed Amolyt Pharma snags $80M for endocrine pipeline\n",
      "https://www.fiercebiotech.com/biotech/novo-backed-amolyt-pharma-snags-80m-series-b-for-endocrine-pipeline\n",
      "2021-09-16\n",
      "Biotech\n",
      "Biogen's non-opioid painkiller offers mixed results in phase 2\n",
      "https://www.fiercebiotech.com/biotech/biogen-s-vixotrigine-fails-phase-2-small-fiber-neuropathy-trial\n",
      "2021-09-16\n",
      "Biotech\n",
      "ESMO: Zymeworks lays down marker in fight to unseat Herceptin\n",
      "https://www.fiercebiotech.com/biotech/esmo-zymeworks-lays-down-marker-fight-to-unseat-herceptin\n",
      "2021-09-16\n",
      "Biotech\n",
      "Smiths Medical recalls nearly 30 years' worth of fluid warmers\n",
      "https://www.fiercebiotech.com/medtech/smiths-medical-recalls-nearly-30-years-worth-fluid-warmers-due-to-risk-aluminum-exposure\n",
      "2021-09-16\n",
      "MedTech\n",
      "Rune Labs carves out $22M for brain data platform\n",
      "https://www.fiercebiotech.com/medtech/rune-labs-carves-out-22m-for-platform-translates-brain-data-into-neurological-devices-drugs\n",
      "2021-09-16\n",
      "MedTech\n",
      "Aerie fails its primary endpoint in eye disease test\n",
      "https://www.fiercebiotech.com/biotech/aerie-fails-its-primary-endpoint-eye-disease-test-says-it-doesn-t-matter-but-investors-feel\n",
      "2021-09-16\n",
      "Biotech\n",
      "Abingworth, Pfizer back $61M gene therapy delivery round\n",
      "https://www.fiercebiotech.com/biotech/abingworth-gimv-and-pfizer-back-stealthy-swiss-startup-s-61m-round-to-crack-gene-therapy\n",
      "2021-09-16\n",
      "Biotech\n",
      "Francis Medical nets $55M for steam-powered cancer treatment\n",
      "https://www.fiercebiotech.com/medtech/full-steam-ahead-francis-medical-heats-up-55m-for-vapor-ablation-tech-to-treat-prostate\n",
      "2021-09-15\n",
      "MedTech\n",
      "Amylyx can proceed with ALS submission to FDA afterall\n",
      "https://www.fiercebiotech.com/biotech/amylyx-als-drug-submission-to-fda-after-reversed-decision\n",
      "2021-09-15\n",
      "Biotech\n",
      "Haisco to pay Biosplice $140M for osteoarthritis drug in China\n",
      "https://www.fiercebiotech.com/biotech/haisco-to-pay-140m-to-license-biosplice-s-phase-3-osteoarthritis-drug-china\n",
      "2021-09-15\n",
      "Biotech\n",
      "Allay Therapeutics rakes in $60M for 'tunable' pain treatment\n",
      "https://www.fiercebiotech.com/medtech/allay-therapeutics-rakes-60m-for-tunable-non-opioid-treatment-for-post-surgical-pain\n",
      "2021-09-15\n",
      "MedTech\n",
      "Tyra banks $173M to bring cancer resistance programs into clinic\n",
      "https://www.fiercebiotech.com/biotech/tyra-biosciences-banks-173m-to-bring-cancer-resistance-programs-into-clinic\n",
      "2021-09-15\n",
      "Biotech\n",
      "Meet ZimVie: Zimmer Biomet's new spine, dental spinout\n",
      "https://www.fiercebiotech.com/medtech/zimmer-biomet-dubs-new-spine-dental-spinout-zimvie-names-c-suite-appointments\n",
      "2021-09-15\n",
      "MedTech\n",
      "Newly discovered immune cells block melanoma metastasis in mice\n",
      "https://www.fiercebiotech.com/research/newly-discovered-immune-cells-block-melanoma-metastasis-mice-and-could-inspire-new\n",
      "2021-09-15\n",
      "Research\n",
      "Moderna, AbCellera join forces to tackle major mRNA opportunity\n",
      "https://www.fiercebiotech.com/biotech/moderna-abcellera-join-forces-to-tackle-major-mrna-opportunity\n",
      "2021-09-15\n",
      "Biotech\n",
      "Novo Nordisk Foundation teams up with Broad Institute, Harvard\n",
      "https://www.fiercebiotech.com/biotech/novo-nordisk-foundation-teams-up-broad-institute-harvard-for-diabetes-obesity-research-hub\n",
      "2021-09-15\n",
      "Biotech\n",
      "Theravance axing 75% of staff after flunking phase 3\n",
      "https://www.fiercebiotech.com/biotech/theravance-axing-75-staff-slashing-r-d-budget-after-flunking-phase-3\n",
      "2021-09-15\n",
      "Biotech\n",
      "Flywheel raises $22M, buys Radiologics for biomedical research\n",
      "https://www.fiercebiotech.com/cro/flywheel-raises-22m-buys-radiologics-to-advance-biomedical-research\n",
      "2021-09-15\n",
      "CRO\n",
      "Mesa Labs bids $300M for genetic test maker Agena Bioscience\n",
      "https://www.fiercebiotech.com/medtech/mesa-labs-puts-300m-table-for-genetic-testing-developer-agena-bioscience\n",
      "2021-09-14\n",
      "MedTech\n",
      "Sanofi dumps Principia Biopharma's San Fran labs, cuts 38 jobs\n",
      "https://www.fiercebiotech.com/biotech/sanofi-dumps-principia-biopharma-s-san-francisco-labs-plans-to-immediately-cut-38-jobs\n",
      "2021-09-14\n",
      "Biotech\n",
      "Roche, Temedica launch 'digital companion' app for MS\n",
      "https://www.fiercebiotech.com/medtech/roche-partners-temedica-to-launch-digital-companion-app-for-multiple-sclerosis\n",
      "2021-09-14\n",
      "MedTech\n",
      "Medtronic sets up AI pilot to tackle disparities in cardiac care\n",
      "https://www.fiercebiotech.com/medtech/medtronic-launches-ai-pilot-program-to-tackle-race-gender-disparities-cardiac-care\n",
      "2021-09-14\n",
      "MedTech\n",
      "Lightstone raises $375M for third fund after 3 big exits in 2020\n",
      "https://www.fiercebiotech.com/biotech/lightstone-snags-its-largest-fund-yet-375m-geared-toward-biotechs-medtechs\n",
      "2021-09-14\n",
      "Biotech\n",
      "RedHill follows familiar biotech path after COVID-19 drug fails\n",
      "https://www.fiercebiotech.com/biotech/redhill-biopharma-slides-as-covid-drug-flops-severe-disease\n",
      "2021-09-14\n",
      "Biotech\n",
      "Pfizer and Trillium: How a $25M investment led to a $2.3B buyout\n",
      "https://www.fiercebiotech.com/biotech/pfizer-and-trillium-how-a-25m-investment-led-to-a-2-3b-buyout\n",
      "2021-09-14\n",
      "Biotech\n",
      "Vanqua nabs $85M from Lilly, OrbiMed, others for Gaucher, PD, AD\n",
      "https://www.fiercebiotech.com/biotech/vanqua-bio-snags-85m-series-b-to-vanquish-parkinson-s-gaucher-als-and-alzheimer-s\n",
      "2021-09-14\n",
      "Biotech\n",
      "Rome bags $77M to strike gold in the backwaters of the genome\n",
      "https://www.fiercebiotech.com/biotech/kapeller-s-rome-bags-77m-to-strike-gold-backwaters-genome\n",
      "2021-09-14\n",
      "Biotech\n",
      "Another death blights Astellas' $3B Audentes buy\n",
      "https://www.fiercebiotech.com/biotech/another-death-blights-astellas-3b-audentes-buy-as-fda-slaps-clinical-hold-test\n",
      "2021-09-14\n",
      "Biotech\n",
      "iRhythm finds new CEO in former Dexcom exec\n",
      "https://www.fiercebiotech.com/medtech/irhythm-gets-back-beat-tapping-former-dexcom-exec-blackford-as-ceo\n",
      "2021-09-13\n",
      "MedTech\n",
      "Attacking Alzheimer's by blocking 'frustrated' amyloid proteins\n",
      "https://www.fiercebiotech.com/research/attacking-alzheimer-s-by-blocking-frustrated-amyloid-proteins-before-they-form-plaques\n",
      "2021-09-13\n",
      "Research\n",
      "Report confirms harassment claims against anti-aging researcher\n",
      "https://www.fiercebiotech.com/biotech/independent-report-confirms-sexual-harassment-claims-against-anti-aging-researcher-de-grey\n",
      "2021-09-13\n",
      "Biotech\n",
      "ViaCyte staffs up CSO role to drive diabetes treatments\n",
      "https://www.fiercebiotech.com/biotech/clinical-stage-biotech-viacyte-taps-stem-cell-therapy-expert-timothy-kieffer-as-chief\n",
      "2021-09-13\n",
      "Biotech\n",
      "Zoll snaps up Itamar Medical in $538M sleep apnea tech deal\n",
      "https://www.fiercebiotech.com/medtech/zoll-snaps-up-itamar-medical-sleep-apnea-tech-deal-topping-538m\n",
      "2021-09-13\n",
      "MedTech\n",
      "Masimo finds pot of gold with CE mark for Rainbow SuperSensor\n",
      "https://www.fiercebiotech.com/medtech/masimo-finds-its-pot-gold-ce-mark-for-rainbow-supersensor-to-monitor-12-blood-parameters-at\n",
      "2021-09-13\n",
      "MedTech\n",
      "AI drug hunter Exscientia plans to go public with Nasdaq IPO\n",
      "https://www.fiercebiotech.com/medtech/ai-drug-hunter-exscientia-plans-to-go-public-nasdaq-ipo\n",
      "2021-09-13\n",
      "MedTech\n",
      "AltruBio snags a CMO after immunology pivot\n",
      "https://www.fiercebiotech.com/biotech/altrubio-snags-a-cmo-after-pivot-from-oncology-to-immunology\n",
      "2021-09-13\n",
      "Biotech\n",
      "FDA slaps Class I label on recall of contaminated ultrasound gel\n",
      "https://www.fiercebiotech.com/medtech/fda-slaps-most-serious-classification-recall-ultrasound-gel-potentially-contaminated-by\n",
      "2021-09-13\n",
      "MedTech\n",
      "Bellus offers a scrap of analysis for chronic cough candidate\n",
      "https://www.fiercebiotech.com/biotech/bellus-offers-a-scrap-chronic-cough-data-head-to-head-battle-merck\n",
      "2021-09-13\n",
      "Biotech\n",
      "Provention will wait for FDA to 'opine' on new teplizumab data\n",
      "https://www.fiercebiotech.com/biotech/provention-says-it-waits-for-fda-to-opine-new-data-after-teplizumab-rejection-eyes-q4-for\n",
      "2021-09-13\n",
      "Biotech\n",
      "AzurRx boosts GI pipeline through $229M First Wave buyout\n",
      "https://www.fiercebiotech.com/biotech/azurrx-boosts-gi-pipeline-through-first-wave-buyout-worth-up-to-229m\n",
      "2021-09-13\n",
      "Biotech\n",
      "Rusty Williams will lead school at new biotech Walking Fish\n",
      "https://www.fiercebiotech.com/biotech/4-years-after-leaving-prime-time-rusty-williams-lands-a-new-job-helming-walking-fish\n",
      "2021-09-13\n",
      "Biotech\n",
      "AbbVie bets $370M on pivotal eye disease gene therapy\n",
      "https://www.fiercebiotech.com/biotech/abbvie-bets-370m-pivotal-eye-disease-gene-therapy-puts-up-1-4b-biobucks\n",
      "2021-09-13\n",
      "Biotech\n",
      "Why at-home rapid COVID tests cost so much\n",
      "https://www.fiercebiotech.com/medtech/why-at-home-rapid-covid-tests-cost-so-much-even-after-biden-s-push-for-lower-prices\n",
      "2021-09-13\n",
      "MedTech\n",
      "Everest bags COVID-19 assets in bid to conquer mRNA market\n",
      "https://www.fiercebiotech.com/biotech/everest-bags-covid-19-program-bid-to-conquer-chinese-mrna-market\n",
      "2021-09-13\n",
      "Biotech\n",
      "Where are they now? Tracking down 2011’s Fierce 15\n",
      "https://www.fiercebiotech.com/special-report/where-are-they-now-tracking-down-2011-s-fierce-15\n",
      "2021-09-13\n",
      "Special Reports\n",
      "ADARx bags $75M to advance its RNA tech pipeline\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-subsidiary-backed-adarx-series-b-secures-75m-to-take-rna-tech-to-clinical-trial\n",
      "Biotech\n",
      "Ixaka's cell therapy clears interim phase 3 data review\n",
      "https://www.fiercebiotech.com/biotech/ixaka-s-cell-therapy-clears-interim-phase-3-data-review\n",
      "2021-09-10\n",
      "Biotech\n",
      "Novocure nabs breakthrough label for liver tumor-treating fields\n",
      "https://www.fiercebiotech.com/medtech/novocure-scores-breakthrough-label-for-liver-tumor-treating-electric-fields-plans-avastin\n",
      "2021-09-10\n",
      "MedTech\n",
      "Former FDA leader joins YourBio as interim CMO—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-former-fda-commissioner-hahn-takes-interim-cmo-role-at-yourbio-health\n",
      "2021-09-10\n",
      "Biotech\n",
      "Pinpointing immune antibodies that predict COVID-19 severity\n",
      "https://www.fiercebiotech.com/research/researchers-point-to-autoimmune-antibodies-could-determine-covid-19-severity-for-hospital\n",
      "2021-09-10\n",
      "Research\n",
      "Health Catalyst releases tool to connect researchers, patients\n",
      "https://www.fiercebiotech.com/cro/health-catalyst-releases-new-research-tool-to-connect-researchers-match-patients-to-trials\n",
      "2021-09-10\n",
      "CRO\n",
      "Vor's cancer cell therapy gets on FDA's fast track\n",
      "https://www.fiercebiotech.com/biotech/vor-s-cancer-cell-therapy-boards-fda-fast-track-ahead-2022-data-drop\n",
      "2021-09-10\n",
      "Biotech\n",
      "Former FDA chief Hahn takes interim CMO role at YourBio Health\n",
      "https://www.fiercebiotech.com/medtech/former-fda-commissioner-hahn-takes-interim-cmo-role-at-flagship-s-yourbio-health\n",
      "2021-09-09\n",
      "MedTech\n",
      "Orchard picks Novartis cell and gene leader as next CTO\n",
      "https://www.fiercebiotech.com/biotech/orchard-snags-novartis-cell-and-gene-leader-and-smart-immune-exec-promotes-cmo\n",
      "2021-09-09\n",
      "Biotech\n",
      "Roche ties the knot with longtime testing partner TIB Molbiol\n",
      "https://www.fiercebiotech.com/medtech/roche-ties-knot-long-time-testmaking-partner-tib-molbiol-after-covid-successes\n",
      "2021-09-09\n",
      "MedTech\n",
      "Sensyne Health reveals real-world patient data platform\n",
      "https://www.fiercebiotech.com/cro/sensyne-launches-real-world-patient-data-platform-joining-growing-push-for-such-data\n",
      "2021-09-09\n",
      "CRO\n",
      "InBrace lines up $102M for AI-powered teeth straightening tech\n",
      "https://www.fiercebiotech.com/medtech/ai-powered-orthodontics-startup-inbrace-lines-up-102m-for-behind-teeth-straightening-tech\n",
      "2021-09-09\n",
      "MedTech\n",
      "IQVIA teams up with HealthCore for real-world data movement\n",
      "https://www.fiercebiotech.com/cro/iqvia-joins-real-world-data-push-through-collaboration-healthcore-for-clinical-research\n",
      "2021-09-09\n",
      "CRO\n",
      "Broad team proposes safer, more efficient AAVs for gene therapy\n",
      "https://www.fiercebiotech.com/research/as-gene-therapy-safety-comes-into-focus-broad-institute-designs-safer-and-more-efficient\n",
      "2021-09-09\n",
      "Research\n",
      "Cardiff reveals early data on challenger to Amgen's KRAS crown\n",
      "https://www.fiercebiotech.com/biotech/cardiff-reveals-early-data-challenger-to-amgen-s-kras-crown\n",
      "2021-09-09\n",
      "Biotech\n",
      "Boehringer Ingelheim taps Twist for $710M-plus collab\n",
      "https://www.fiercebiotech.com/medtech/boehringer-ingelheim-twist-bioscience-team-up-for-710m-plus-antibody-discovery-collab\n",
      "2021-09-09\n",
      "MedTech\n",
      "Centessa hemophilia drug shows reduction of bleeding in phase 2\n",
      "https://www.fiercebiotech.com/biotech/centessa-touts-positive-results-for-hemophilia-drug-phase-2a-study-plans-for-global\n",
      "2021-09-09\n",
      "Biotech\n",
      "Mammoth nets $195M to supercharge CRISPR diagnostics, medicines\n",
      "https://www.fiercebiotech.com/biotech/mammoth-bio-scores-195m-top-up-to-supercharge-crispr-diagnostics-medicines\n",
      "2021-09-09\n",
      "Biotech\n",
      "Obsidian bags $115M to untether cell therapy from toxic sidekick\n",
      "https://www.fiercebiotech.com/biotech/obsidian-bags-115m-to-untether-cell-therapy-from-toxic-sidekick\n",
      "2021-09-09\n",
      "Biotech\n",
      "Evommune snags $83M for \"Tylenol for itch,\" three other programs\n",
      "https://www.fiercebiotech.com/biotech/ex-dermira-founders-pick-up-83m-series-a-to-advance-programs-licensed-from-lilly-s-dermira\n",
      "2021-09-09\n",
      "Biotech\n",
      "Lilly-backed Lycia Therapeutics nabs $70M round\n",
      "https://www.fiercebiotech.com/biotech/lilly-backed-lycia-therapeutics-nabs-70m-round-for-its-protein-degradation-tech\n",
      "2021-09-09\n",
      "Biotech\n",
      "iECURE lands $50M for therapies from famed gene therapy lab\n",
      "https://www.fiercebiotech.com/biotech/iecure-emerges-50m-series-a-to-develop-gene-therapies-for-liver-disorders-jim-wilson-s-penn\n",
      "2021-09-09\n",
      "Biotech\n",
      "Lexeo keeps foot on the gas pedal with $100M financing\n",
      "https://www.fiercebiotech.com/biotech/gene-therapy-biotech-lexeo-keeps-foot-gas-pedal-100m-financing-to-follow-up-stelios-buy\n",
      "2021-09-09\n",
      "Biotech\n",
      "FDA slams the door in Humanigen's face, rejecting EUA\n",
      "https://www.fiercebiotech.com/biotech/fda-slams-door-humanigen-s-face-rejects-emergency-use-green-light-wants-more-data\n",
      "2021-09-09\n",
      "Biotech\n",
      "Sanofi's BTK inhibitor flunks phase 3 autoimmune trial\n",
      "https://www.fiercebiotech.com/biotech/sanofi-s-btk-inhibitor-flunks-phase-3-autoimmune-trial-delivering-blow-to-3-7b-biotech-bet\n",
      "2021-09-09\n",
      "Biotech\n",
      "Science 37 teams up with Foundation to boost cancer trials\n",
      "https://www.fiercebiotech.com/cro/science-37-teams-up-roche-s-foundation-medicine-to-boost-home-based-oncology-trials\n",
      "2021-09-09\n",
      "CRO\n",
      "Theranos' Holmes painted as 'naive' CEO in fraud trial start\n",
      "https://www.fiercebiotech.com/medtech/theranos-founder-elizabeth-holmes-defense-paints-her-as-a-naive-but-ambitious-ceo-fraud\n",
      "2021-09-08\n",
      "MedTech\n",
      "Eli Lilly follows up MiNA pact with a 2nd $1B-plus RNA collab\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-follows-up-mina-pact-a-second-1b-plus-rna-collab-time-proqr\n",
      "2021-09-08\n",
      "Biotech\n",
      "Amyloidosis biotech Attralus nabs $116M for clinical development\n",
      "https://www.fiercebiotech.com/biotech/amyloidosis-biotech-attralus-scores-116m-funding-to-move-into-clinical-trial-stage\n",
      "Biotech\n",
      "Glympse Bio names Gilead vet as first chief medical officer\n",
      "https://www.fiercebiotech.com/medtech/glympse-bio-names-first-medical-chief-offering-a-peek-at-clinical-future-its-disease\n",
      "2021-09-08\n",
      "MedTech\n",
      "BioNTech reports promising data on anti-cancer mRNA cocktail\n",
      "https://www.fiercebiotech.com/research/biontech-reports-promising-data-mrna-cocktail-mouse-models-colon-cancer-and-melanoma\n",
      "2021-09-08\n",
      "Research\n",
      "Lilly's Alzheimer's moment has arrived thanks to Biogen approval\n",
      "https://www.fiercebiotech.com/biotech/lilly-s-alzheimer-s-moment-has-arrived-after-biogen-plows-through-fda-gates\n",
      "2021-09-08\n",
      "Biotech\n",
      "Stryker buys Gauss Surgical for its AI blood-measuring tech\n",
      "https://www.fiercebiotech.com/medtech/stryker-buys-gauss-surgical-for-its-ai-tech-aimed-at-blood-loss-childbirth\n",
      "2021-09-08\n",
      "MedTech\n",
      "Smiths shuns previous medtech deal for $2.4B from ICU Medical\n",
      "https://www.fiercebiotech.com/medtech/smiths-shuns-previous-medtech-deal-for-2-4b-from-icu-medical\n",
      "2021-09-08\n",
      "MedTech\n",
      "Takeda norovirus vaccine spinout HilleVax snags $135M crossover\n",
      "https://www.fiercebiotech.com/biotech/takeda-s-norovirus-vaccine-spinout-hillevax-secures-135-million-crossover\n",
      "2021-09-08\n",
      "Biotech\n",
      "DOJ charges SpineFrontier for alleged kickback scheme\n",
      "https://www.fiercebiotech.com/medtech/massachusetts-devicemaker-spinefrontier-faces-federal-bribery-money-laundering-charges\n",
      "2021-09-08\n",
      "MedTech\n",
      "Moderna donates ultra-rare disease therapy to nonprofit\n",
      "https://www.fiercebiotech.com/biotech/moderna-donates-ultra-rare-disease-therapy-to-nonprofit\n",
      "2021-09-08\n",
      "Biotech\n",
      "Kyowa Kirin licenses AM-Pharma phase 3 asset for up to $289M\n",
      "https://www.fiercebiotech.com/biotech/kyowa-kirin-to-pay-am-pharma-up-to-289m-licensing-deal-for-late-stage-sepsis-asset\n",
      "2021-09-08\n",
      "Biotech\n",
      "Microbiome-focused EnteroBiotix raises $21.5M in funding\n",
      "https://www.fiercebiotech.com/biotech/enterobiotix-secures-21-5m-series-a-funding-round-to-advance-its-microbiome-drug-pipeline\n",
      "Biotech\n",
      "Merck taps Illumina’s genomic tests to spot cancer mutations\n",
      "https://www.fiercebiotech.com/medtech/illumina-tapped-by-merck-to-develop-companion-diagnostics-for-ovarian-cancer-treatment\n",
      "2021-09-08\n",
      "MedTech\n",
      "Catabasis Pharmaceuticals no more: Meet Astria Therapeutics\n",
      "https://www.fiercebiotech.com/biotech/catabasis-pharmaceuticals-no-more-meet-astria-therapeutics-hoping-to-be-a-phoenix-from\n",
      "2021-09-08\n",
      "Biotech\n",
      "Insilico puts undruggable cancer targets in its crosshairs\n",
      "https://www.fiercebiotech.com/biotech/insilico-puts-undruggable-cancer-targets-its-crosshairs-huadong-alliance\n",
      "2021-09-08\n",
      "Biotech\n",
      "Merck sells clinical-phase cancer prospect to French startup\n",
      "https://www.fiercebiotech.com/biotech/goodbye-pam-merck-kgaa-sells-clinical-phase-cancer-prospect-to-french-startup\n",
      "2021-09-08\n",
      "Biotech\n",
      "Medrio, PHASTAR team up clinical trial data visualization\n",
      "https://www.fiercebiotech.com/cro/medrio-and-phastar-collaborate-clinical-trial-data-visualization\n",
      "2021-09-08\n",
      "CRO\n",
      "Replicate unveils with $40M for 4 self-replicating RNA programs\n",
      "https://www.fiercebiotech.com/biotech/replicate-bioscience-looks-to-replicate-rna-s-pandemic-response-success-40m-to-go-after\n",
      "2021-09-08\n",
      "Biotech\n",
      "Exscientia, Gates Foundation commit $70M to COVID, pandemic work\n",
      "https://www.fiercebiotech.com/biotech/exscientia-snags-35m-from-gates-foundation-for-anti-viral-therapeutics-against-covid-19\n",
      "2021-09-08\n",
      "Biotech\n",
      "Medable hires ex-IQVIA, Oracle VP as chief strategy officer\n",
      "https://www.fiercebiotech.com/cro/medable-hires-chief-strategy-officer-leadership-roles-at-iqvia-oracle-medidata-merck\n",
      "2021-09-07\n",
      "CRO\n",
      "Organ-on-a-chip maker Emulate nets $82M to grow in vitro efforts\n",
      "https://www.fiercebiotech.com/medtech/organ-a-chip-maker-emulate-secures-82m-to-expand-scientific-commercial-efforts\n",
      "2021-09-07\n",
      "MedTech\n",
      "FDA approves TransMedics' 'heart in a box' transport system\n",
      "https://www.fiercebiotech.com/medtech/transmedics-warm-perfusion-transport-system-for-donor-hearts-secures-fda-approval\n",
      "2021-09-07\n",
      "MedTech\n",
      "Pliant lung med reaches target, with efficacy data to come\n",
      "https://www.fiercebiotech.com/biotech/pliant-s-liver-disease-drug-has-reached-intended-target-but-efficacy-data-will-have-to-wait\n",
      "2021-09-07\n",
      "Biotech\n",
      "Breath biopsy company Owlstone Medical hoovers up $58M\n",
      "https://www.fiercebiotech.com/medtech/breath-biopsy-company-owlstone-medical-hoovers-up-58m-funding-round\n",
      "2021-09-07\n",
      "MedTech\n",
      "Exelixis stunned by death of Chief Medical Officer Schwab\n",
      "https://www.fiercebiotech.com/biotech/exelixis-stunned-by-death-chief-medical-officer-gisela-schwab-sales-lead-jon-berndt\n",
      "2021-09-07\n",
      "Biotech\n",
      "Roche inks $3B biobucks deal for Adaptimmune's T cells\n",
      "https://www.fiercebiotech.com/biotech/roche-s-genentech-to-pay-adaptimmune-150m-upfront-3b-or-more-biobucks-for-t-cell-therapies\n",
      "2021-09-07\n",
      "Biotech\n",
      "Google, Mayo Clinic build new type of brain-mapping AI algorithm\n",
      "https://www.fiercebiotech.com/medtech/google-mayo-clinic-build-new-type-ai-algorithm-to-map-interactions-between-areas-brain\n",
      "2021-09-07\n",
      "MedTech\n",
      "Up-and-coming JAK inhibitors face 'shrinking' potential\n",
      "https://www.fiercebiotech.com/biotech/after-fda-s-new-jak-safety-restrictions-what-s-next-for-jaks-biopharma-s-pipeline-shrinking\n",
      "2021-09-07\n",
      "Biotech\n",
      "Amgen, AstraZeneca move needle in hard-to-treat asthma subgroup\n",
      "https://www.fiercebiotech.com/biotech/amgen-astrazeneca-dig-into-data-from-phase-3-asthma-trial-emerging-evidence-efficacy-hard\n",
      "2021-09-07\n",
      "Biotech\n",
      "FDA slaps clinical hold on BioMarin gene therapy trial\n",
      "https://www.fiercebiotech.com/biotech/fda-slaps-clinical-hold-biomarin-gene-therapy-trial-after-tumors-seen-mice\n",
      "2021-09-07\n",
      "Biotech\n",
      "Roche pens $190M NeuExcell Huntington's disease pact\n",
      "https://www.fiercebiotech.com/biotech/roche-hoping-to-move-from-recent-failure-pens-190m-neuexcell-huntington-s-disease-pact\n",
      "2021-09-07\n",
      "Biotech\n",
      "Journey Colab scores $12M to move psychedelic into the clinic\n",
      "https://www.fiercebiotech.com/biotech/journey-colab-scores-12m-to-move-psychedelics-based-addiction-treatment-into-clinic\n",
      "2021-09-07\n",
      "Biotech\n",
      "SPAC Attack: The 10 biggest in biotech\n",
      "https://www.fiercebiotech.com/special-report/spac-attack-10-biggest-biotech\n",
      "2021-09-07\n",
      "Special Reports\n",
      "LumiraDx begins U.S. rollout of COVID-19 surveillance test\n",
      "https://www.fiercebiotech.com/medtech/lumiradx-begins-u-s-rollout-pooled-antigen-test-for-covid-19-tracking\n",
      "2021-09-03\n",
      "MedTech\n",
      "AI predicts which COVID patients will need a ventilator: study\n",
      "https://www.fiercebiotech.com/medtech/ai-analysis-covid-patients-chest-ct-scans-predicts-ventilator-need-84-accuracy-study\n",
      "2021-09-03\n",
      "MedTech\n",
      "A mini-CRISPR system could be 'Swiss knife' in gene editing\n",
      "https://www.fiercebiotech.com/research/stanford-researchers-develop-a-mini-crispr-system-could-be-swiss-knife-gene-editing\n",
      "2021-09-03\n",
      "Research\n",
      "Lab-grown 'mini-lungs' replicate COVID-19 infections in a dish\n",
      "https://www.fiercebiotech.com/medtech/researchers-replicate-covid-19-infections-a-dish-lab-grown-mini-lungs\n",
      "2021-09-03\n",
      "MedTech\n",
      "Rhythm installs Shapiro to replace departing CMO\n",
      "https://www.fiercebiotech.com/biotech/rhythm-without-missing-a-beat-installs-shapiro-to-replace-departing-cmo\n",
      "2021-09-03\n",
      "Biotech\n",
      "FDA committee takes on complex gene therapy safety questions\n",
      "https://www.fiercebiotech.com/biotech/fda-committee-takes-complex-gene-therapy-safety-questions-novartis-zolgensma-providing\n",
      "2021-09-03\n",
      "Biotech\n",
      "FDA's top 2 vaccine leaders to depart this fall—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-fda-s-top-two-vaccine-leaders-to-depart-fall-as-questions-loom-over-booster\n",
      "2021-09-03\n",
      "Biotech\n",
      "New bionic arm operates via two-way communication with the brain\n",
      "https://www.fiercebiotech.com/medtech/cleveland-clinic-led-team-debuts-brain-powered-bionic-arm-restores-sense-touch-to-amputees\n",
      "2021-09-03\n",
      "MedTech\n",
      "Cassava CEO blames short sellers for data woes\n",
      "https://www.fiercebiotech.com/biotech/cassava-ceo-dazed-and-confused-takes-to-biotech-defense-handbook-blames-short-sellers-for\n",
      "2021-09-03\n",
      "Biotech\n",
      "Pfizer kick-starts phase 3 respiratory syncytial virus trial\n",
      "https://www.fiercebiotech.com/biotech/pfizer-jumping-feet-first-into-rsv-vaccine-race-kickstarts-phase-3-test\n",
      "2021-09-03\n",
      "Biotech\n",
      "Novartis scraps transplant trial after control beats study drug\n",
      "https://www.fiercebiotech.com/biotech/novartis-scraps-kidney-transplant-trial-after-control-beats-study-drug\n",
      "2021-09-03\n",
      "Biotech\n",
      "Forte's lead atopic dermatitis therapy fails phase 2\n",
      "https://www.fiercebiotech.com/biotech/forte-searching-for-a-new-direction-after-lead-atopic-dermatitis-therapy-fails-phase-2\n",
      "2021-09-02\n",
      "Biotech\n",
      "Abbott builds out endovascular offerings with Walk Vascular buy\n",
      "https://www.fiercebiotech.com/medtech/abbott-gets-its-blood-pumping-acquisition-clot-removing-device-maker-walk-vascular\n",
      "2021-09-02\n",
      "MedTech\n",
      "Baxter's deal for hospital bed maker Hill-Rom swells to $10.5B\n",
      "https://www.fiercebiotech.com/medtech/baxter-s-deal-for-smart-hospital-bed-maker-hill-rom-swells-to-10-5b\n",
      "2021-09-02\n",
      "MedTech\n",
      "COVID test maker Cue Health takes aim at $100M IPO\n",
      "https://www.fiercebiotech.com/medtech/covid-test-maker-cue-health-takes-aim-at-public-debut-ipo-up-to-100m\n",
      "2021-09-02\n",
      "MedTech\n",
      "Bristol Myers greenlights neurodegenerative drug from Evotec\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-green-lights-neurodegenerative-medicine-from-evotec-pact-for-20m\n",
      "2021-09-02\n",
      "Biotech\n",
      "Takeda blood cancer drug flunks phase 3 in setback to R&D plans\n",
      "https://www.fiercebiotech.com/biotech/not-waving-but-drowning-takeda-s-blood-cancer-drug-flunks-phase-3-dealing-further-blow-to\n",
      "2021-09-02\n",
      "Biotech\n",
      "Brain-computer interfaces: overhyped or underappreciated?\n",
      "https://www.fiercebiotech.com/medtech/separating-science-from-sci-fi-battelle-s-justin-sanchez-balancing-buzz-brain-computer\n",
      "2021-09-02\n",
      "MedTech\n",
      "Disc Medicine nabs $90M for blood disease pipeline\n",
      "https://www.fiercebiotech.com/biotech/disc-medicine-nabs-90m-for-blood-disease-pipeline-new-roche-asset\n",
      "2021-09-02\n",
      "Biotech\n",
      "Assembly drops hepatitis asset amid safety concerns\n",
      "https://www.fiercebiotech.com/biotech/after-one-hbv-flop-assembly-biosciences-forced-to-drop-a-hepatitis-asset-amid-safety-woes\n",
      "2021-09-02\n",
      "Biotech\n",
      "Exit of Avidity CMO on cusp of the clinic sparks stock rout\n",
      "https://www.fiercebiotech.com/biotech/exit-avidity-cmo-cusp-first-clinical-trial-sparks-stock-rout\n",
      "2021-09-02\n",
      "Biotech\n",
      "IQVIA pairs AI with human agents for patient, HCP inquiries\n",
      "https://www.fiercebiotech.com/cro/iqvia-enlists-ai-to-help-human-agents-respond-to-patient-healthcare-professional-inquiries\n",
      "2021-09-01\n",
      "CRO\n",
      "Brickell to pay Voronoi up to $320M for inhibitors, hires CMO\n",
      "https://www.fiercebiotech.com/biotech/brickell-biotech-pays-voronoi-5m-upfront-up-to-320m-biobucks-for-autoimmune-inflammatory\n",
      "2021-09-01\n",
      "Biotech\n",
      "Philips to begin repairing recalled sleep apnea machines\n",
      "https://www.fiercebiotech.com/medtech/philips-gets-green-light-to-begin-repairing-millions-recalled-sleep-apnea-machines\n",
      "2021-09-01\n",
      "MedTech\n",
      "Asensus scores FDA OK to upgrade AI tools for its surgical robot\n",
      "https://www.fiercebiotech.com/medtech/asensus-surgical-nabs-third-fda-clearance-2021-time-for-upgraded-ai-tools-for-senhance\n",
      "2021-09-01\n",
      "MedTech\n",
      "The mRNA era after COVID-19: What's next in the pipeline\n",
      "https://www.fiercebiotech.com/biotech/mrna-era-here-after-covid-19-so-where-are-we-headed-next-experts-say-sky-s-limit\n",
      "2021-09-01\n",
      "Biotech\n",
      "Mesoblast told to try again by FDA on Novartis-backed COVID drug\n",
      "https://www.fiercebiotech.com/biotech/mesoblast-craters-again-as-fda-requests-another-trial-failed-covid-19-respiratory-treatment\n",
      "2021-09-01\n",
      "Biotech\n",
      "AstraZeneca, Thermo Fisher launch multiyear diagnostic project\n",
      "https://www.fiercebiotech.com/medtech/thermo-fisher-launches-multi-year-companion-diagnostic-project-for-astrazeneca-s-precision\n",
      "2021-09-01\n",
      "MedTech\n",
      "NIH blood test spots cancer in those with genetic predisposition\n",
      "https://www.fiercebiotech.com/medtech/nih-blood-test-spots-cancerous-tumors-people-nf1-most-common-cancer-predisposition-syndrome\n",
      "2021-09-01\n",
      "MedTech\n",
      "Vanderbilt team offers new clues for targeting p53\n",
      "https://www.fiercebiotech.com/research/vanderbilt-scientists-offer-new-clues-for-developing-cancer-drugs-against-mutant-tumor\n",
      "2021-09-01\n",
      "Research\n",
      "HebeCell lands $53M to make a splash in busy CAR-NK space\n",
      "https://www.fiercebiotech.com/biotech/hebecell-lands-53m-chinese-collaborator-to-make-a-splash-busy-car-nk-space\n",
      "2021-09-01\n",
      "Biotech\n",
      "Astellas pauses gene therapy trial after low dose liver issue\n",
      "https://www.fiercebiotech.com/biotech/after-cutting-dose-because-deaths-astellas-pauses-gene-therapy-trial-as-new-liver-issue\n",
      "2021-09-01\n",
      "Biotech\n",
      "Asher Bio snags $108M series B for three immunotherapy programs\n",
      "https://www.fiercebiotech.com/biotech/asher-bio-snags-108m-series-b-for-three-immunotherapy-programs-clinic-entry-second-half\n",
      "2021-09-01\n",
      "Biotech\n",
      "Massive Bio, veterans nonprofit to boost prostate cancer studies\n",
      "https://www.fiercebiotech.com/cro/massive-bio-teams-up-veterans-nonprofit-to-increase-prostate-cancer-research-trial-enrollment\n",
      "2021-08-31\n",
      "CRO\n",
      "Ex-Theranos CEO Elizabeth Holmes' fraud trial begins\n",
      "https://www.fiercebiotech.com/medtech/elizabeth-holmes-fraud-trial-begins-a-timeline-blood-testing-startup-theranos-downfall\n",
      "2021-08-31\n",
      "MedTech\n",
      "Surgical glue maker Tissium nets €50M to move into nerve repair\n",
      "https://www.fiercebiotech.com/medtech/surgical-glue-developer-tissium-banks-eu50m-to-expand-into-nerve-hernia-repairs\n",
      "2021-08-31\n",
      "MedTech\n",
      "Versanis to test ex-Novartis drug with $70M, Jimenez's help\n",
      "https://www.fiercebiotech.com/biotech/versanis-bio-snags-70m-to-test-ex-novartis-muscle-drug-support-from-ex-novartis-ceo-joe\n",
      "2021-08-31\n",
      "Biotech\n",
      "DnaNudge picks up $60M for lab-free COVID PCR test\n",
      "https://www.fiercebiotech.com/medtech/rapid-genetic-test-maker-dnanudge-picks-up-60m-for-global-launch-lab-free-covid-pcr-test\n",
      "2021-08-31\n",
      "MedTech\n",
      "Poseida hopes for reprieve with early solid tumor CAR-T data\n",
      "https://www.fiercebiotech.com/biotech/a-year-after-a-death-and-accompanying-trial-hold-poseida-hopes-for-reprieve-early-solid\n",
      "2021-08-31\n",
      "Biotech\n",
      "GSK and SK go head-to-head against AstraZeneca in COVID\n",
      "https://www.fiercebiotech.com/biotech/gsk-korean-biotech-sk-go-head-to-head-against-astrazeneca-s-covid-shot-their-experimental\n",
      "2021-08-31\n",
      "Biotech\n",
      "Roche-backed AC Immune shows first evidence of anti-tau activity\n",
      "https://www.fiercebiotech.com/biotech/roche-backed-ac-immune-finds-even-a-mixed-bag-alzheimer-s-trial-enough-to-make-shares\n",
      "2021-08-31\n",
      "Biotech\n",
      "J&J's HIV vaccine fails phase 2b, extending long wait for a jab\n",
      "https://www.fiercebiotech.com/biotech/j-j-s-hiv-vaccine-fails-phase-2b-extending-long-wait-for-effective-jab\n",
      "2021-08-31\n",
      "Biotech\n",
      "Galapagos CEO exits after R&D setbacks destroy billions in value\n",
      "https://www.fiercebiotech.com/biotech/descent-van-de-stolpe-galapagos-ceo-exits-after-r-d-setbacks-wipe-out-billions-value\n",
      "2021-08-31\n",
      "Biotech\n",
      "Putting the immune system in a dish to improve drug discovery\n",
      "https://www.fiercebiotech.com/biotech/parallel-bio-putting-immune-system-a-dish-to-improve-drug-discovery\n",
      "2021-08-30\n",
      "Biotech\n",
      "ESC: Abbott's Amulet goes head-to-head with Boston Scientific\n",
      "https://www.fiercebiotech.com/medtech/esc-2021-abbott-s-newly-approved-amulet-takes-boston-scientific-s-watchman-competitor-head\n",
      "2021-08-30\n",
      "MedTech\n",
      "AI study finds antibody treatment may cut COVID hospitalizations\n",
      "https://www.fiercebiotech.com/medtech/mayo-clinic-nference-ai-studies-find-antibody-treatment-may-reduce-hospitalization-high\n",
      "2021-08-30\n",
      "MedTech\n",
      "Baxter ups bid to $10B to acquire devicemaker Hill-Rom: report\n",
      "https://www.fiercebiotech.com/medtech/baxter-nears-10b-deal-to-acquire-devicemaker-hill-rom-wsj\n",
      "2021-08-30\n",
      "MedTech\n",
      "Ziopharm hires new CEO\n",
      "https://www.fiercebiotech.com/biotech/brain-cancer-biotech-ziopharm-snags-new-brains-for-ceo-post-from-kuur-therapeutics\n",
      "2021-08-30\n",
      "Biotech\n",
      "FDA clears first 'smart' knee implant from Canary, Zimmer Biomet\n",
      "https://www.fiercebiotech.com/medtech/zimmer-biomet-canary-medical-land-fda-de-novo-clearance-for-sensor-equipped-smart-knee\n",
      "2021-08-30\n",
      "MedTech\n",
      "Bone Therapeutics' lead program flops in knee osteoarthritis\n",
      "https://www.fiercebiotech.com/biotech/bone-therapeutics-lead-program-falls-short-knee-osteoarthritis\n",
      "2021-08-30\n",
      "Biotech\n",
      "Pfizer beats blockbuster Dupixent in phase 3 eczema trial\n",
      "https://www.fiercebiotech.com/biotech/pfizer-s-abrocitinib-beats-blockbuster-dupixent-phase-3-eczema-trial-but-key-questions\n",
      "2021-08-30\n",
      "Biotech\n",
      "SPAC backs Revelation to tackle respiratory viral infections\n",
      "https://www.fiercebiotech.com/biotech/spac-backs-revelation-to-tackle-respiratory-viral-infections\n",
      "2021-08-30\n",
      "Biotech\n",
      "Genome Medical plots growth spurt with VC raise, acquisition\n",
      "https://www.fiercebiotech.com/medtech/genome-medical-plots-growth-spurt-back-to-back-60m-venture-raise-genematters-acquisition\n",
      "2021-08-30\n",
      "MedTech\n",
      "Laronde banks $440M to ramp up next-gen RNA-based meds\n",
      "https://www.fiercebiotech.com/biotech/laronde-banks-440m-to-ramp-up-rna-based-meds-could-turn-cells-into-protein-factories\n",
      "2021-08-30\n",
      "Biotech\n",
      "Thwarting a cancer-promoting enzyme with a 2-pronged strategy\n",
      "https://www.fiercebiotech.com/research/thwarting-a-cancer-promoting-enzyme-a-two-pronged-strategy-to-induce-cell-death\n",
      "2021-08-27\n",
      "Research\n",
      "FDA approves first vagus nerve stim implant for stroke rehab\n",
      "https://www.fiercebiotech.com/medtech/fda-approves-first-vagus-nerve-stimulation-implant-for-stroke-rehabilitation\n",
      "2021-08-27\n",
      "MedTech\n",
      "ESC: Medtronic's leadless pacemaker improves safety in CMS study\n",
      "https://www.fiercebiotech.com/medtech/esc-2021-medtronic-s-miniaturized-leadless-implant-improves-long-term-safety-over\n",
      "2021-08-27\n",
      "MedTech\n",
      "3D-printing oncolytic viruses to treat rare cancers\n",
      "https://www.fiercebiotech.com/biotech/humane-genomics-3d-printing-oncolytic-viruses-to-treat-rare-cancers\n",
      "2021-08-27\n",
      "Biotech\n",
      "Cassava shares crash as lab denies preparing Alzheimer's data\n",
      "https://www.fiercebiotech.com/biotech/lab-named-by-cassava-to-back-up-alzheimer-s-data-says-they-weren-t-involved-sending-biotech\n",
      "2021-08-27\n",
      "Biotech\n",
      "Insilico, 4B Technologies team up for ALS drug discovery\n",
      "https://www.fiercebiotech.com/medtech/insilico-medicine-taps-4b-technologies-neurological-know-how-to-build-ai-designed-als-drugs\n",
      "2021-08-27\n",
      "MedTech\n",
      "Lynk inks $50M series B for 3 early-stage trials\n",
      "https://www.fiercebiotech.com/biotech/lynk-pharmaceuticals-inks-50m-series-b-for-3-early-stage-clinical-trials\n",
      "2021-08-27\n",
      "Biotech\n",
      "Pfizer snags McKinsey partner to lead M&A hunt—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-pfizer-taps-mckinsey-u-s-managing-partner-as-new-m-a-leader\n",
      "2021-08-27\n",
      "Biotech\n",
      "BeyondSpring, flying high from phase 3 success, inks cancer deal\n",
      "https://www.fiercebiotech.com/biotech/beyondspring-flying-high-from-phase-3-success-sells-chinese-rights-to-cancer-drug\n",
      "2021-08-27\n",
      "Biotech\n",
      "Merck teams up with McKesson's Ontada on real-world cancer data\n",
      "https://www.fiercebiotech.com/cro/merck-inks-partnership-mckesson-s-ontada-for-real-world-data-for-cancer-care\n",
      "2021-08-27\n",
      "CRO\n",
      "Agenus, with FDA approval in sight, showcases anti-PD-1 data\n",
      "https://www.fiercebiotech.com/biotech/agenus-fda-approval-site-showcases-anti-pd-1-drug-data\n",
      "2021-08-27\n",
      "Biotech\n",
      "Drones airdrop defibrillators to heart attack patients\n",
      "https://www.fiercebiotech.com/medtech/drones-outpace-ambulances-by-airdropping-defibrillators-to-heart-attack-patients-real-world\n",
      "2021-08-26\n",
      "MedTech\n",
      "AZ, rHealth develop fingerstick test for low platelet count\n",
      "https://www.fiercebiotech.com/medtech/astrazeneca-rhealth-develop-fingerstick-test-for-low-platelet-count-a-rare-side-effect-az-s\n",
      "2021-08-26\n",
      "MedTech\n",
      "Overjet mints $27M to expand adoption of dental AI\n",
      "https://www.fiercebiotech.com/medtech/overjet-pockets-27m-to-bring-x-ray-reading-ai-to-more-dental-clinics\n",
      "2021-08-26\n",
      "MedTech\n",
      "FDA greenlights first smartphone-based home COVID-19 test\n",
      "https://www.fiercebiotech.com/medtech/fda-greenlights-first-smartphone-based-home-covid-19-test\n",
      "2021-08-26\n",
      "MedTech\n",
      "NovaRock goes global with Flame BioSciences development deal\n",
      "https://www.fiercebiotech.com/biotech/novarock-takes-stomach-cancer-program-global-through-flame-biosciences-deal-worth-up-to\n",
      "2021-08-26\n",
      "Biotech\n",
      "Inovio heads to Brazil for phase 3 COVID-19 vaccine trial\n",
      "https://www.fiercebiotech.com/biotech/inovio-heads-to-brazil-for-covid-19-vaccine-trial-promising-to-deliver-a-shelf-stable-shot\n",
      "2021-08-26\n",
      "Biotech\n",
      "NIH awards Synchron $10M to trial brain-computer interface\n",
      "https://www.fiercebiotech.com/medtech/synchron-bags-10m-nih-grant-to-kick-off-u-s-trial-implant-using-thoughts-to-navigate\n",
      "2021-08-26\n",
      "MedTech\n",
      "DiCE Molecules: another preclinical bio rolling dice on an IPO\n",
      "https://www.fiercebiotech.com/biotech/preclinical-dice-molecules-will-roll-its-dice-to-wall-street-amid-biotech-ipo-frenzy\n",
      "2021-08-26\n",
      "Biotech\n",
      "Curebase, AppliedVR unite for remote trials of VR pain treatment\n",
      "https://www.fiercebiotech.com/cro/it-s-a-virtual-world-curebase-appliedvr-team-up-virtual-reality-based-at-home-clinical-trials\n",
      "2021-08-26\n",
      "CRO\n",
      "AstraZeneca hails late-phase win for Alexion rare disease drug\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-s-39b-buyout-bears-fruit-yielding-late-phase-win-for-potential-blockbuster-rare\n",
      "2021-08-26\n",
      "Biotech\n",
      "Sesen, still reeling from FDA rejection, pulls EU cancer filing\n",
      "https://www.fiercebiotech.com/biotech/sesen-still-reeling-from-fda-rejection-pulls-filing-for-eu-approval-cancer-drug\n",
      "2021-08-26\n",
      "Biotech\n",
      "Replimune axes CMO role and CMO Pirzkall along with it\n",
      "https://www.fiercebiotech.com/biotech/replimune-axes-cmo-role-and-its-cmo-andrea-pirzkall-along-it\n",
      "2021-08-26\n",
      "Biotech\n",
      "Neurogastrx bags $60M to join crowded gastrointestinal field\n",
      "https://www.fiercebiotech.com/biotech/neurogastrx-served-platter-60m-for-phase-2-3-gi-drugs-adds-cmo-cfo-and-cbo\n",
      "2021-08-26\n",
      "Biotech\n",
      "How migraines might offer protection against diabetes\n",
      "https://www.fiercebiotech.com/research/mouse-study-shows-how-causes-behind-migraine-pain-can-improve-diabetes-treatment\n",
      "2021-08-26\n",
      "Research\n",
      "Faulty repair piece puts BD's Alaris pump back in FDA crosshairs\n",
      "https://www.fiercebiotech.com/medtech/fda-doles-out-class-i-rating-to-recall-replacement-part-for-bd-s-alaris-infusion-pump\n",
      "2021-08-25\n",
      "MedTech\n",
      "Ex-Novartis, Chiasma leader joins Recordati Rare Diseases as CMO\n",
      "https://www.fiercebiotech.com/biotech/ex-novartis-pituitary-senior-medical-director-chiasma-svp-jumps-to-recordati-rare-disease\n",
      "2021-08-25\n",
      "Biotech\n",
      "With FDA nod, BD brings automated diagnostics system to U.S.\n",
      "https://www.fiercebiotech.com/medtech/bd-locks-down-fda-approval-for-automated-molecular-diagnostics-platform-initial-test-for\n",
      "2021-08-25\n",
      "MedTech\n",
      "FDA clears battery-free surgical wound closure suction pump\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-battery-free-suction-pump-for-surgical-wound-closures\n",
      "2021-08-25\n",
      "MedTech\n",
      "Lilly doubles down on protein degradation with $35M Lycia deal\n",
      "https://www.fiercebiotech.com/biotech/lilly-doubles-down-protein-degradation-inking-35m-deal-lycia-and-promising-1-6b-more\n",
      "2021-08-25\n",
      "Biotech\n",
      "Intuitive replies to FDA notice about robot use in mastectomies\n",
      "https://www.fiercebiotech.com/medtech/fda-warns-against-unauthorized-use-surgical-robots-mastectomy-procedures\n",
      "2021-08-25\n",
      "MedTech\n",
      "Cassava defends Alzheimer's data after manipulation claims\n",
      "https://www.fiercebiotech.com/biotech/cassava-defends-alzheimer-s-science-after-citizen-petition-raises-grave-concerns-about\n",
      "2021-08-25\n",
      "Biotech\n",
      "Is the science solid for gut health-focused microbiome startups?\n",
      "https://www.fiercebiotech.com/medtech/microbiome-startups-promise-to-improve-your-gut-health-but-science-solid\n",
      "2021-08-25\n",
      "MedTech\n",
      "Massachusetts biopharmas raise $4.3B in 1Q\n",
      "https://www.fiercebiotech.com/biotech/massachusetts-based-biopharmas-reel-state-s-third-largest-vc-funding-year-record-one\n",
      "2021-08-25\n",
      "Biotech\n",
      "Cardior gets $75M to run midphase antisense heart failure trial\n",
      "https://www.fiercebiotech.com/biotech/bristol-backed-cardior-gets-75m-to-run-midphase-antisense-heart-failure-trial\n",
      "2021-08-25\n",
      "Biotech\n",
      "Improving CAR-T with more sensitive tumor ID\n",
      "https://www.fiercebiotech.com/research/improving-car-t-cell-therapy-more-sensitive-tumor-identification\n",
      "2021-08-25\n",
      "Research\n",
      "Brii's COVID-19 antibody slashes hospitalizations and deaths\n",
      "https://www.fiercebiotech.com/biotech/brii-s-covid-19-antibody-slashes-hospitalizations-and-deaths-late-phase-trial-teeing-it-up\n",
      "2021-08-25\n",
      "Biotech\n",
      "Atavistik Bio snags $60M to tackle metabolic diseases, cancers\n",
      "https://www.fiercebiotech.com/biotech/atavistik-bio-secures-60m-series-a-to-tackle-metabolic-diseases-cancers-former-peloton\n",
      "2021-08-24\n",
      "Biotech\n",
      "The link between COVID-19, rattlesnake venom and a killer enzyme\n",
      "https://www.fiercebiotech.com/research/link-between-covid-19-rattlesnake-venom-and-a-killer-enzyme-inspires-treatment-target\n",
      "2021-08-24\n",
      "Research\n",
      "J&J-backed FlexDex Surgical sews up $13M funding round\n",
      "https://www.fiercebiotech.com/medtech/flexdex-surgical-sews-up-j-j-led-13m-funding-round-for-surgeon-powered-robotics\n",
      "2021-08-24\n",
      "MedTech\n",
      "Datavant, Real Chemistry unite on real-world data for biopharma\n",
      "https://www.fiercebiotech.com/cro/fresh-off-7b-merger-datavant-inks-real-world-data-partnership-real-chemistry\n",
      "2021-08-24\n",
      "CRO\n",
      "Roche's gene therapy plans take Shape with $3B-plus deal\n",
      "https://www.fiercebiotech.com/biotech/roche-taps-rna-editing-shape-biobucks-deal-worth-up-to-3b\n",
      "2021-08-24\n",
      "Biotech\n",
      "Medtronic earnings sidestep delta variant, HeartWare stoppage\n",
      "https://www.fiercebiotech.com/medtech/medtronic-staves-off-financial-impact-delta-variant-and-faulty-heart-pumps-shielded-by\n",
      "2021-08-24\n",
      "MedTech\n",
      "Rare disease data-focused AllStripes raises $50M to expand reach\n",
      "https://www.fiercebiotech.com/medtech/rare-disease-data-focused-allstripes-raises-50m-to-expand-global-reach\n",
      "2021-08-24\n",
      "MedTech\n",
      "Pfizer deal a spark for M&A, or fuel for an empty pipeline?\n",
      "https://www.fiercebiotech.com/biotech/pfizer-deal-a-spark-for-m-a-or-just-fuel-for-its-pipeline-embers-analysts-hope-for-more\n",
      "2021-08-24\n",
      "Biotech\n",
      "HealthTree unveils AML trial finder to ease CT.gov 'mind cramp'\n",
      "https://www.fiercebiotech.com/cro/healthtree-foundation-wants-to-ease-demystify-clinical-trial-process-for-aml-patients\n",
      "2021-08-24\n",
      "CRO\n",
      "The FDA wants more data. Stealth is filing for approval anyway\n",
      "https://www.fiercebiotech.com/biotech/fda-wants-more-data-stealth-filing-for-approval-anyway\n",
      "2021-08-24\n",
      "Biotech\n",
      "BlueWillow shares early look at data on nasal anthrax vaccine\n",
      "https://www.fiercebiotech.com/biotech/bluewillow-shares-early-look-at-data-nasal-anthrax-vaccine\n",
      "2021-08-24\n",
      "Biotech\n",
      "Vertex adds to CRISPR fever with $1.2B Arbor gene-editing pact\n",
      "https://www.fiercebiotech.com/biotech/vertex-ups-arbor-ante-potential-1-2b-biobucks-for-crispr-cell-therapies\n",
      "2021-08-24\n",
      "Biotech\n",
      "Theravance, J&J's phase 2b ulcerative colitis trial fails\n",
      "https://www.fiercebiotech.com/biotech/theravance-s-phase-2b-ulcerative-colitis-trial-fails-will-limit-future-expenses-for-program\n",
      "2021-08-23\n",
      "Biotech\n",
      "A 3rd strike for Merck KGaA's $4.2B bintrafusp alfa\n",
      "https://www.fiercebiotech.com/biotech/merck-s-4-2b-bintrafusp-alfa-nabs-a-3rd-strike-cancer-hopeful-out\n",
      "2021-08-23\n",
      "Biotech\n",
      "Siemens' NAFLD/NASH blood test nets de novo clearance from FDA\n",
      "https://www.fiercebiotech.com/medtech/siemens-blood-test-for-fatty-liver-disease-scores-de-novo-clearance-from-fda\n",
      "2021-08-23\n",
      "MedTech\n",
      "Vivos Therapeutics nets one FDA win, one loss for apnea devices\n",
      "https://www.fiercebiotech.com/medtech/vivos-therapeutics-breaks-even-one-fda-clearance-one-rejection-for-sleep-apnea-treatment\n",
      "2021-08-23\n",
      "MedTech\n",
      "Abbott scrambles to produce COVID tests after big inventory cull\n",
      "https://www.fiercebiotech.com/medtech/as-covid-surges-yet-again-abbott-responds-to-report-it-destroyed-old-diagnostic-tests\n",
      "2021-08-23\n",
      "MedTech\n",
      "Cardinal Health recalls land back-to-back FDA Class I labels\n",
      "https://www.fiercebiotech.com/medtech/cardinal-health-lands-fda-s-class-i-rating-for-recalls-catheter-insertion-kits-prefilled\n",
      "2021-08-23\n",
      "MedTech\n",
      "Anti-aging foundation SENS parts ways with de Grey\n",
      "https://www.fiercebiotech.com/biotech/anti-aging-foundation-sens-turfs-de-grey-after-allegations-he-interfered-investigation-into\n",
      "2021-08-23\n",
      "Biotech\n",
      "Elixiron secures $27M to bankroll Alzheimer's, vitiligo trials\n",
      "https://www.fiercebiotech.com/biotech/elixiron-closes-27m-series-a-for-alzheimer-s-and-vitiligo-clinical-trials\n",
      "2021-08-23\n",
      "Biotech\n",
      "Axsome sees depression drug decision delayed\n",
      "https://www.fiercebiotech.com/biotech/axsome-sees-depression-drug-decision-delayed-as-fda-kicks-expected-crl-can-down-road\n",
      "2021-08-23\n",
      "Biotech\n",
      "CRISPR pinpoints new AML target and its 'druggable pocket'\n",
      "https://www.fiercebiotech.com/research/crispr-pinpoints-new-leukemia-target-and-a-pocket-could-make-it-druggable\n",
      "2021-08-23\n",
      "Research\n",
      "Pfizer swallows CD47 biotech Trillium in $2.3B takeover\n",
      "https://www.fiercebiotech.com/biotech/eat-me-pfizer-swallows-cd47-biotech-trillium-2-3b-takeover\n",
      "2021-08-23\n",
      "Biotech\n",
      "Genevant pens $303M biobucks pact with Takeda\n",
      "https://www.fiercebiotech.com/biotech/genevant-pens-303m-biobucks-pact-takeda-aiming-at-rare-liver-diseases-using-gene-therapy\n",
      "2021-08-23\n",
      "Biotech\n",
      "Biotech founder Sabatini ousted after sexual harassment probe\n",
      "https://www.fiercebiotech.com/biotech/sabatini-biotech-founder-and-mtor-pioneer-ousted-after-sexual-harassment-investigation\n",
      "2021-08-23\n",
      "Biotech\n",
      "Tyra Biosciences wants to bank $100M for an IPO\n",
      "https://www.fiercebiotech.com/biotech/tyra-biosciences-wants-to-bank-100m-for-ipo\n",
      "2021-08-23\n",
      "Biotech\n",
      "COVID test drought leads LumiraDx to cut $2B off SPAC deal value\n",
      "https://www.fiercebiotech.com/medtech/covid-testing-drought-leads-lumiradx-to-cut-2b-off-spac-deal-value\n",
      "2021-08-20\n",
      "MedTech\n",
      "FDA pauses review of Nanox’s multisource digital X-ray bed\n",
      "https://www.fiercebiotech.com/medtech/nanox-faces-regulatory-roadblock-fda-review-multisource-digital-x-ray-bed\n",
      "2021-08-20\n",
      "MedTech\n",
      "AbbVie's oral migraine treatment atogepant nears FDA decision\n",
      "https://www.fiercebiotech.com/biotech/migraine-market-better-make-way-for-abbvie-as-oral-preventative-treatment-atogepant-poised\n",
      "2021-08-20\n",
      "Biotech\n",
      "Delfi Diagnostics' blood test spots 90% of cancer cases: study\n",
      "https://www.fiercebiotech.com/medtech/delfi-diagnostics-ai-based-blood-test-detects-80-early-stage-lung-cancer-cases-study-finds\n",
      "2021-08-20\n",
      "MedTech\n",
      "J&J CEO Gorsky leaves role to Duato in January—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-novavax-hires-sanofi-quality-leader-to-get-covid-19-vax-to-finish-line\n",
      "2021-08-20\n",
      "Biotech\n",
      "Regenerating muscle with patients' own skin cells\n",
      "https://www.fiercebiotech.com/research/mgh-team-shows-how-injured-muscles-could-be-repaired-patients-own-skin-cells\n",
      "2021-08-20\n",
      "Research\n",
      "FDA veteran Woodcock out of running for commish job: report\n",
      "https://www.fiercebiotech.com/biotech/after-aduhelm-fallout-fda-veteran-woodcock-out-running-for-commish-job-report\n",
      "2021-08-20\n",
      "Biotech\n",
      "AstraZeneca antibody cocktail cuts risk of symptomatic COVID-19\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-antibody-cocktail-slashes-risk-symptomatic-covid-19-setting-up-regulatory\n",
      "2021-08-20\n",
      "Biotech\n",
      "China's Abogen raises $700M series C for mRNA trials\n",
      "https://www.fiercebiotech.com/biotech/china-s-abogen-raises-700m-series-c-for-mrna-trials-catapulting-itself-into-big-leagues\n",
      "2021-08-20\n",
      "Biotech\n",
      "Fate Therapeutics' stock drops on blood cancer readout\n",
      "https://www.fiercebiotech.com/biotech/despite-upbeat-tones-from-analysts-fate-therapeutics-stock-drops-blood-cancer-readout\n",
      "2021-08-20\n",
      "Biotech\n",
      "CRISPR pioneer Feng Zhang serves up novel mRNA delivery tech\n",
      "https://www.fiercebiotech.com/research/crispr-pioneer-feng-zhang-s-latest-work-delivers-mrna-gene-therapy-human-protein\n",
      "2021-08-19\n",
      "Research\n",
      "FDA greenlights CardioNXT's 3D heart-mapping tech\n",
      "https://www.fiercebiotech.com/medtech/fda-green-lights-cardionxt-s-3d-heart-mapping-platform-to-support-arrhythmia-treatment\n",
      "2021-08-19\n",
      "MedTech\n",
      "After 30 years at Stryker, President Scannell set to retire\n",
      "https://www.fiercebiotech.com/medtech/stryker-president-scannell-lays-out-2-year-retirement-plan-after-three-decades-company\n",
      "2021-08-19\n",
      "MedTech\n",
      "Illumina completes Grail acquisition, regulators be damned\n",
      "https://www.fiercebiotech.com/medtech/illumina-completes-grail-acquisition-regulators-be-damned\n",
      "2021-08-19\n",
      "MedTech\n",
      "MYR finance chief Christély takes the helm at MetrioPharm\n",
      "https://www.fiercebiotech.com/biotech/ex-myr-finance-chief-joins-covid-19-antiviral-chronic-inflammatory-pharma-metriopharm-as\n",
      "2021-08-19\n",
      "Biotech\n",
      "MyoKardia's clinical ops lead jumps ship to Esker\n",
      "https://www.fiercebiotech.com/biotech/after-bristol-buyout-myokardia-s-clinical-ops-lead-jumps-ship-to-esker-therapeutics\n",
      "2021-08-19\n",
      "Biotech\n",
      "Sesen Bio shares crater after report of trial misconduct\n",
      "https://www.fiercebiotech.com/biotech/sesen-bio-shares-crater-after-repot-trial-misconduct-for-bladder-cancer-drug\n",
      "2021-08-19\n",
      "Biotech\n",
      "Visus, with one drug chasing AbbVie, inks deals to grow pipeline\n",
      "https://www.fiercebiotech.com/biotech/visus-one-drug-chasing-abbvie-inks-deals-to-grow-pipeline\n",
      "2021-08-19\n",
      "Biotech\n",
      "Biotech co-founder settles accusations of faked research data\n",
      "https://www.fiercebiotech.com/biotech/biotech-co-founder-settles-accusations-faked-research-data\n",
      "2021-08-19\n",
      "Biotech\n",
      "Study: More patient-reported data needed in youth cancer trials\n",
      "https://www.fiercebiotech.com/cro/study-youth-cancer-trials-should-collect-more-patient-reported-data-for-interventions\n",
      "2021-08-19\n",
      "CRO\n",
      "FDA clears EchoNous’ third portable ultrasound probe\n",
      "https://www.fiercebiotech.com/medtech/echonous-scales-up-portable-ultrasound-platform-fda-ok-for-full-body-probe\n",
      "2021-08-18\n",
      "MedTech\n",
      "Attacking Alzheimer's by protecting synapses from amyloid beta\n",
      "https://www.fiercebiotech.com/research/new-mouse-study-shows-protecting-synapses-could-lead-to-new-alzheimer-s-treatment-method\n",
      "2021-08-18\n",
      "Research\n",
      "Zimmer Biomet’s robotic hip surgery system earns FDA all-clear\n",
      "https://www.fiercebiotech.com/medtech/zimmer-biomet-rounds-out-surgical-robot-lineup-fda-cleared-rosa-hip-system\n",
      "2021-08-18\n",
      "MedTech\n",
      "Marinus tees up phase 3 for rare epilepsy med\n",
      "https://www.fiercebiotech.com/biotech/marinus-tees-up-phase-3-for-rare-epilepsy-med-after-it-slashes-seizures-phase-2\n",
      "2021-08-18\n",
      "Biotech\n",
      "DePuy debuts shoulder system aimed at smaller surgery centers\n",
      "https://www.fiercebiotech.com/medtech/j-j-s-depuy-synthes-launches-shoulder-replacement-system-geared-toward-smaller-surgical\n",
      "2021-08-18\n",
      "MedTech\n",
      "BMS strikes gold with Exscientia, pays $20M for first drug\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-pays-exscientia-20m-1-2b-deal-for-first-drug-candidate\n",
      "2021-08-18\n",
      "Biotech\n",
      "FDA OKs BrainsWay’s neurostim device to ease anxious depression\n",
      "https://www.fiercebiotech.com/medtech/brainsway-clinches-fda-nod-for-magnetic-stimulation-device-to-ease-anxious-depression\n",
      "2021-08-18\n",
      "MedTech\n",
      "Regenerative medicine nears banner year: report\n",
      "https://www.fiercebiotech.com/biotech/regenerative-medicine-nearing-a-banner-year-14-1b-cash-infusion-regulatory-milestones-and-a\n",
      "2021-08-18\n",
      "Biotech\n",
      "Ranok raises $40M to become the protein degrader CHAMP\n",
      "https://www.fiercebiotech.com/biotech/champ-ranok-raises-40m-to-show-it-can-knockout-other-protein-degrader-technologies\n",
      "2021-08-18\n",
      "Biotech\n",
      "Jnana nets $50M to push newly unveiled PKU program\n",
      "https://www.fiercebiotech.com/biotech/jnana-nets-50m-to-push-newly-unveiled-pku-program-expand-into-more-hard-to-drug-targets\n",
      "2021-08-18\n",
      "Biotech\n",
      "Vigil bags $90M to take ex-Amgen CNS assets into the clinic\n",
      "https://www.fiercebiotech.com/biotech/vigil-bags-90m-to-take-ex-amgen-assets-path-from-rare-diseases-to-alzheimer-s\n",
      "2021-08-18\n",
      "Biotech\n",
      "Bayer, Novartis-backed Immunitas gets $58M to test cancer drugs\n",
      "https://www.fiercebiotech.com/biotech/bayer-novartis-backed-immunitas-secures-58m-series-b-to-gear-up-for-clinic-next-year\n",
      "2021-08-18\n",
      "Biotech\n",
      "Verily logs first major buy, adding to Baseline trial platform\n",
      "https://www.fiercebiotech.com/medtech/verily-logs-first-major-buyout-folding-signalpath-trial-management-system-into-baseline\n",
      "2021-08-17\n",
      "MedTech\n",
      "Ra Medical sheds its skincare business with sale of Pharos laser\n",
      "https://www.fiercebiotech.com/medtech/ra-medical-sheds-its-skincare-business-sale-pharos-dermatology-laser-to-strata-skin\n",
      "2021-08-17\n",
      "MedTech\n",
      "Canadian chemistry CROs merge with $37M investment\n",
      "https://www.fiercebiotech.com/cro/nuchem-sciences-acquired-rival-canadian-cro-omegachem-and-get-37m-backing\n",
      "2021-08-17\n",
      "CRO\n",
      "Aurinia pays $7M for 2 preclinical assets after January FDA nod\n",
      "https://www.fiercebiotech.com/biotech/aurinia-dishes-out-7m-for-two-autoimmune-and-kidney-disease-preclinical-assets\n",
      "2021-08-17\n",
      "Biotech\n",
      "Akili adds inattention treatment to prescription game slate\n",
      "https://www.fiercebiotech.com/medtech/akili-expands-its-prescription-video-game-portfolio-37m-offer-for-tali-s-adhd-treatment\n",
      "2021-08-17\n",
      "MedTech\n",
      "Psychedelics inch toward approval, but market may not be ready\n",
      "https://www.fiercebiotech.com/biotech/psychedelics-are-getting-closer-to-approval-but-market-may-not-be-ready\n",
      "2021-08-17\n",
      "Biotech\n",
      "Qualigen calls it quits after pouring millions into COVID drug\n",
      "https://www.fiercebiotech.com/biotech/qualigen-calls-it-quits-after-pouring-millions-into-covid-therapy\n",
      "2021-08-17\n",
      "Biotech\n",
      "ZS invests in Intelligencia's $12M push to reduce clinical risk\n",
      "https://www.fiercebiotech.com/cro/zs-partners-intelligencia-as-part-12m-push-to-reduce-clinical-development-risk\n",
      "2021-08-17\n",
      "CRO\n",
      "ResMed rolls out new app-connected sleep apnea machine\n",
      "https://www.fiercebiotech.com/medtech/resmed-unveils-new-sleep-apnea-machine-amid-scramble-to-fill-void-left-by-philips-cpap\n",
      "2021-08-17\n",
      "MedTech\n",
      "Lilly, with Alzheimer's in its sights, forms neuroscience unit\n",
      "https://www.fiercebiotech.com/biotech/lilly-alzheimer-s-its-crosshairs-forms-new-neuroscience-unit-unifies-oncology-under-loxo\n",
      "2021-08-17\n",
      "Biotech\n",
      "Going big: Bain reels in $1.9B for more mammoth biotech bets\n",
      "https://www.fiercebiotech.com/biotech/going-big-bain-reels-1-9b-for-more-mammoth-biotech-bets\n",
      "2021-08-17\n",
      "Biotech\n",
      "Sanofi almost dumped Translate in April, but they stuck it out\n",
      "https://www.fiercebiotech.com/biotech/sanofi-wanted-to-dump-translate-bio-april-but-mrna-biotech-prevailed-a-much-higher-price\n",
      "2021-08-16\n",
      "Biotech\n",
      "Boosting CAR-T responses in CLL by waking up 'war weary' T cells\n",
      "https://www.fiercebiotech.com/research/novartis-backed-penn-study-proposes-boosting-car-t-responses-cll-by-waking-up-war-weary-t\n",
      "2021-08-16\n",
      "Research\n",
      "Beckley Psytech bags $80M to fuel psychedelics for depression\n",
      "https://www.fiercebiotech.com/biotech/beckley-psytech-bags-80m-to-fuel-psychedelics-for-depression-debilitating-headaches\n",
      "2021-08-16\n",
      "Biotech\n",
      "Thermo Fisher's variant-detecting COVID tests snare FDA EUA\n",
      "https://www.fiercebiotech.com/medtech/thermo-fisher-s-covid-tests-rack-up-another-fda-emergency-ok-to-detect-delta-and-other\n",
      "2021-08-16\n",
      "MedTech\n",
      "Abbott nets US approval for its Amplatzer Amulet heart plug\n",
      "https://www.fiercebiotech.com/medtech/abbott-nets-u-s-approval-for-its-amplatzer-amulet-heart-implant-to-help-cut-down-stroke\n",
      "2021-08-16\n",
      "MedTech\n",
      "Ultromics racks up $33M to drive its cardiac ultrasound AI\n",
      "https://www.fiercebiotech.com/medtech/ultromics-nets-33m-to-drive-its-cardiac-ultrasound-ai-software\n",
      "2021-08-16\n",
      "MedTech\n",
      "Boehringer culls $600M cancer pact with CureVac\n",
      "https://www.fiercebiotech.com/biotech/seven-year-itch-boehringer-culls-600m-cancer-pact-curevac-heaping-more-woe-to-biotech\n",
      "2021-08-16\n",
      "Biotech\n",
      "Exelixis to pay Invenra $15M upfront for expanded oncology deal\n",
      "https://www.fiercebiotech.com/biotech/exelixis-to-pay-invenra-15m-upfront-for-twice-expanded-oncology-collab\n",
      "2021-08-16\n",
      "Biotech\n",
      "Sesen Bio slapped with FDA rejection for lead cancer drug\n",
      "https://www.fiercebiotech.com/biotech/sesen-bio-slapped-fda-rejection-for-lead-cancer-drug-shares-slashed-half\n",
      "2021-08-16\n",
      "Biotech\n",
      "BrainQ nabs $40M for brainwave-reading stroke recovery device\n",
      "https://www.fiercebiotech.com/medtech/brainq-reels-40m-to-trial-ai-powered-electromagnetic-field-therapy-device-for-stroke\n",
      "2021-08-16\n",
      "MedTech\n",
      "Investors are tripping on psychedelics despite murky path ahead\n",
      "https://www.fiercebiotech.com/biotech/investors-are-tripping-psychedelics-startups-despite-a-murky-path-to-commercial-success\n",
      "2021-08-16\n",
      "Biotech\n",
      "The newest disease detection tool for COVID and beyond: Poop\n",
      "https://www.fiercebiotech.com/medtech/newest-disease-detection-tool-for-covid-and-beyond-poop\n",
      "2021-08-16\n",
      "MedTech\n",
      "FDA lifts clinical hold on Rocket gene therapy trial\n",
      "https://www.fiercebiotech.com/biotech/fda-lifts-clinical-hold-rocket-gene-therapy-trial-creating-launchpad-for-start-pediatric\n",
      "2021-08-16\n",
      "Biotech\n",
      "Lilly, swinging at the king, shows Dupixent foe works in eczema\n",
      "https://www.fiercebiotech.com/biotech/lilly-swinging-at-king-shows-dupixent-rival-works-phase-3-but-wait-for-key-figures-goes\n",
      "2021-08-16\n",
      "Biotech\n",
      "Labcorp snags digital pregnancy platform provider Ovia Health\n",
      "https://www.fiercebiotech.com/medtech/labcorp-snags-digital-pregnancy-platform-provider-ovia-health\n",
      "2021-08-13\n",
      "MedTech\n",
      "Memic takes SPAC track to boost Hominis surgical robot launch\n",
      "https://www.fiercebiotech.com/medtech/surgical-robot-maven-memic-takes-spac-track-to-boost-hominis-system-launch\n",
      "2021-08-13\n",
      "MedTech\n",
      "AI drug miner XtalPi strikes gold with $400M VC infusion\n",
      "https://www.fiercebiotech.com/medtech/ai-drug-miner-xtalpi-strikes-gold-400m-infusion-its-second-vc-megaround-a-year\n",
      "2021-08-13\n",
      "MedTech\n",
      "Baxter's infusion pump software recall nets Class I tag from FDA\n",
      "https://www.fiercebiotech.com/medtech/baxter-s-recall-drug-dosing-software-for-use-automated-infusion-pump-lands-fda-class-i\n",
      "2021-08-13\n",
      "MedTech\n",
      "CytoDyn on the right track for HIV filing after FDA comments\n",
      "https://www.fiercebiotech.com/biotech/cytodyn-previously-sent-wrong-data-to-fda-for-hiv-filing-but-agency-has-them-sorted-now\n",
      "2021-08-13\n",
      "Biotech\n",
      "Outspoken FDA veteran Unger hits the exit\n",
      "https://www.fiercebiotech.com/biotech/outspoken-fda-veteran-unger-hits-exit\n",
      "2021-08-13\n",
      "Biotech\n",
      "BMS melanoma, genitourinary commercial lead heads to miR\n",
      "https://www.fiercebiotech.com/biotech/mir-scientific-snags-bms-melanoma-and-gu-commercial-leader-for-cancer-detection-test\n",
      "2021-08-13\n",
      "Biotech\n",
      "Merck's Vaxneuvance lead departs for Affinivax—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-merck-s-vaxneuvance-lead-exits-to-make-rival-vaccine-at-affinivax\n",
      "2021-08-13\n",
      "Biotech\n",
      "Longeveron drug didn't help with anti frailty—at least not yet\n",
      "https://www.fiercebiotech.com/biotech/longeveron-s-anti-frailty-drug-could-work-it-just-might-take-a-while\n",
      "2021-08-13\n",
      "Biotech\n",
      "PureTech raids Freeline for CMO to oversee clinical trials\n",
      "https://www.fiercebiotech.com/biotech/puretech-having-built-out-internal-pipeline-raids-freeline-for-cmo-to-oversee-clinical\n",
      "2021-08-13\n",
      "Biotech\n",
      "Ipsen’s $1B bet on rare disease drug suffers another setback\n",
      "https://www.fiercebiotech.com/biotech/ipsen-pulls-fda-rare-disease-filing-dealing-yet-another-blow-to-1b-bet-rare-disease-drug\n",
      "2021-08-13\n",
      "Biotech\n",
      "Keeping up with COVID-19: Atea reveals trial changes, new data\n",
      "https://www.fiercebiotech.com/biotech/keeping-up-covid-19-atea-reveals-trial-amendments-new-data\n",
      "2021-08-12\n",
      "Biotech\n",
      "Insights into esophageal cancer could boost early detection\n",
      "https://www.fiercebiotech.com/research/insights-into-origin-esophageal-cancer-could-boost-early-detection-efforts\n",
      "2021-08-12\n",
      "Research\n",
      "Diabetes startup brews up $11M for tea spill-inspired CGM tech\n",
      "https://www.fiercebiotech.com/medtech/hagar-brews-up-11m-after-a-serendipitous-spill-led-to-creation-new-cgm-tech\n",
      "2021-08-12\n",
      "MedTech\n",
      "Wise's game-based app eases anxiety in MS patients: study\n",
      "https://www.fiercebiotech.com/medtech/wise-therapeutics-game-based-app-reduces-anxiety-multiple-sclerosis-patients-nyu-study\n",
      "2021-08-12\n",
      "MedTech\n",
      "Apple to push more data to doctors, but what's its impact?\n",
      "https://www.fiercebiotech.com/medtech/apple-aims-to-push-more-patient-data-to-doctors-but-who-can-gauge-its-impact-health\n",
      "2021-08-12\n",
      "MedTech\n",
      "Butterfly, Caption team up to bring AI to portable ultrasound\n",
      "https://www.fiercebiotech.com/medtech/match-made-butterfly-caption-health-team-up-to-bring-ai-to-portable-ultrasound\n",
      "2021-08-12\n",
      "MedTech\n",
      "ATAI forms Revixia to test psychoactive plant for mental health\n",
      "https://www.fiercebiotech.com/biotech/from-party-drug-to-ayahuasca-to-sally-d-atai-sets-up-next-shop-for-treating-mental-health\n",
      "2021-08-12\n",
      "Biotech\n",
      "Negative pressure tent for COVID treatment nets FDA emergency OK\n",
      "https://www.fiercebiotech.com/medtech/portable-negative-pressure-tent-scores-fda-emergency-ok-to-stretch-limited-covid-resources\n",
      "2021-08-12\n",
      "MedTech\n",
      "Merck NK cell ally Artiva splashes out on new digs in San Diego\n",
      "https://www.fiercebiotech.com/biotech/merck-nk-cell-ally-artiva-splashes-out-new-digs-san-diego\n",
      "2021-08-12\n",
      "Biotech\n",
      "Leading longevity researcher accused of sexual harassment\n",
      "https://www.fiercebiotech.com/biotech/leading-longevity-researcher-accused-sexual-harassment\n",
      "2021-08-12\n",
      "Biotech\n",
      "Debut Biotech snags $22M for cell-free biomanufacturing facility\n",
      "https://www.fiercebiotech.com/biotech/debut-biotech-picks-up-22m-series-a-for-cell-free-biomanufacturing-facility\n",
      "2021-08-12\n",
      "Biotech\n",
      "Aprea slapped with a full FDA clinical trial hold\n",
      "https://www.fiercebiotech.com/biotech/aprea-slapped-a-full-fda-clinical-trial-hold-lymphoid-malignancy-study-amid-safety-concerns\n",
      "2021-08-12\n",
      "Biotech\n",
      "Overcoming resistance to cancer I-O by targeting macrophages\n",
      "https://www.fiercebiotech.com/research/overcoming-resistance-to-cancer-immunotherapy-by-targeting-garbage-cleaning-cells-tumor\n",
      "2021-08-11\n",
      "Research\n",
      "Healthy 'beige' fat protects brain from dementia in mouse models\n",
      "https://www.fiercebiotech.com/research/new-mice-studies-show-beige-fat-can-protect-brain-from-dementia\n",
      "2021-08-11\n",
      "Research\n",
      "I-Mab thinks cytokine storm drug can take on Humanigen\n",
      "https://www.fiercebiotech.com/biotech/i-mab-thinks-cytokine-storm-drug-can-take-humanigen-s-lenzilumab-sickest-covid-19-patients\n",
      "2021-08-11\n",
      "Biotech\n",
      "Mahana Therapeutics rakes in $61M for IBS treatment app\n",
      "https://www.fiercebiotech.com/medtech/mahana-therapeutics-gears-up-to-launch-ibs-treatment-app-61m-series-b\n",
      "2021-08-11\n",
      "MedTech\n",
      "FDA clears 2 single-use endoscopes for airway, sinus procedures\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-two-single-use-endoscopes-for-airway-sinus-procedures\n",
      "2021-08-11\n",
      "MedTech\n",
      "BD finds new global finance chief in 20-year J&J vet\n",
      "https://www.fiercebiotech.com/medtech/bd-finds-new-global-finance-chief-20-year-johnson-johnson-vet-delorefice\n",
      "2021-08-11\n",
      "MedTech\n",
      "Fulcrum sees 'proof of biology' in phase 1 sickle cell data\n",
      "https://www.fiercebiotech.com/biotech/fulcrum-s-early-proof-biology-data-for-sickle-cell-drug-breathes-life-into-stagnant-shares\n",
      "2021-08-11\n",
      "Biotech\n",
      "Purdue subsidiary buys non-opioid pain prospect\n",
      "https://www.fiercebiotech.com/biotech/purdue-subsidiary-buys-non-opioid-pain-prospect-from-purehealth\n",
      "2021-08-11\n",
      "Biotech\n",
      "COVID-19 vaccine mandates a mixed bag in biotech\n",
      "https://www.fiercebiotech.com/biotech/biotech-a-mixed-bag-covid-19-vaccine-requirements-as-many-employees-already-have-jab\n",
      "2021-08-11\n",
      "Biotech\n",
      "Lumen teams with Google to help grow drug-producing algae\n",
      "https://www.fiercebiotech.com/medtech/using-ai-for-a-green-thumb-lumen-teams-google-to-help-grow-drug-producing-algae\n",
      "2021-08-11\n",
      "MedTech\n",
      "BioCryst scraps $200M offering after seeing share price slide\n",
      "https://www.fiercebiotech.com/biotech/biocryst-scraps-200m-offering-after-seeing-share-price-slide\n",
      "2021-08-11\n",
      "Biotech\n",
      "Eli Lilly takes its trial work on the road, literally\n",
      "https://www.fiercebiotech.com/cro/eli-lilly-takes-its-trial-work-road-literally-as-it-loads-up-rvs-to-broaden-its-study-reach\n",
      "2021-08-11\n",
      "CRO\n",
      "GentiBio banks $157M to fuel Treg treatment for Type 1 diabetes\n",
      "https://www.fiercebiotech.com/biotech/gentibio-banks-157m-to-fuel-treg-treatment-for-type-1-diabetes\n",
      "2021-08-11\n",
      "Biotech\n",
      "FTC extends probe of Allergan's $550M Soliton acquisition\n",
      "https://www.fiercebiotech.com/medtech/abbvie-s-allergan-aesthetics-faces-extended-ftc-probe-550m-soliton-acquisition\n",
      "2021-08-10\n",
      "MedTech\n",
      "GreenLight goes from farm to Wall Street in SPAC deal\n",
      "https://www.fiercebiotech.com/biotech/greenlight-biosciences-inks-1-2b-valuation-spac-deal-for-rna-vaccines-ag-work\n",
      "2021-08-10\n",
      "Biotech\n",
      "Nanox offers up to $200M for Zebra Medical merger\n",
      "https://www.fiercebiotech.com/medtech/nanox-offers-up-to-200m-to-pool-digital-x-ray-technology-zebra-medical-merger\n",
      "2021-08-10\n",
      "MedTech\n",
      "LQTT secures $19M to tackle heart diseases with Sanofi compounds\n",
      "https://www.fiercebiotech.com/biotech/lqt-therapeutics-raises-19m-to-tackle-heart-diseases\n",
      "2021-08-10\n",
      "Biotech\n",
      "Reify Health snags $220M to propel trial recruitment, enrollment\n",
      "https://www.fiercebiotech.com/cro/reify-health-scores-220m-series-c-to-speed-up-trial-recruitment-enrollment\n",
      "2021-08-10\n",
      "CRO\n",
      "'Virtual world': Diversity in clinical trials after COVID-19\n",
      "https://www.fiercebiotech.com/biotech/forced-into-a-virtual-world-after-surviving-covid-disruption-pharma-has-tools-to-tackle\n",
      "2021-08-10\n",
      "Biotech\n",
      "Takeda takes the lead on Finch-partnered microbiome drug for IBD\n",
      "https://www.fiercebiotech.com/biotech/takeda-takes-lead-finch-partnered-microbiome-drug-for-ibd\n",
      "2021-08-10\n",
      "Biotech\n",
      "Visus raises $20M ahead of data drop on rival to AbbVie prospect\n",
      "https://www.fiercebiotech.com/biotech/visus-raises-20m-ahead-data-drop-rival-to-abbvie-prospect\n",
      "2021-08-10\n",
      "Biotech\n",
      "FDA finds fault with Axsome's depression filing, sinking stock\n",
      "https://www.fiercebiotech.com/biotech/fda-finds-fault-axsome-s-depression-filing-sinking-stock\n",
      "2021-08-10\n",
      "Biotech\n",
      "Dicerna wants partner to sell nedosiran\n",
      "https://www.fiercebiotech.com/biotech/pragmatism-prevails-for-dicerna-as-it-looks-to-out-license-sales-work-for-mixed-bag\n",
      "2021-08-10\n",
      "Biotech\n",
      "Boston Scientific recalls Ingenio pacemakers due to battery flaw\n",
      "https://www.fiercebiotech.com/medtech/boston-scientific-recalls-a-decade-s-worth-ingenio-pacemakers-over-risk-unexpected-system\n",
      "2021-08-10\n",
      "MedTech\n",
      "ResMed aims to fill Philips' CPAP gap, but supplies are short\n",
      "https://www.fiercebiotech.com/medtech/resmed-looks-to-fill-cpap-gap-from-philips-recall-but-supplies-are-short\n",
      "2021-08-09\n",
      "MedTech\n",
      "GE Healthcare taps AWS to host imaging, analytics platforms\n",
      "https://www.fiercebiotech.com/medtech/ge-healthcare-moves-imaging-clinical-analytics-platforms-to-amazon-web-services-cloud\n",
      "2021-08-09\n",
      "MedTech\n",
      "Epizyme CEO Bazemore passes the baton for 'next phase of growth'\n",
      "https://www.fiercebiotech.com/biotech/epizyme-ceo-bazemore-passes-baton-as-company-looks-to-next-phase-growth\n",
      "2021-08-09\n",
      "Biotech\n",
      "SpinTech nabs FDA clearances for brain imaging software\n",
      "https://www.fiercebiotech.com/medtech/spintech-s-brain-imaging-software-nabs-fda-clearance-to-speed-diagnosis-parkinson-s-ms-and\n",
      "2021-08-09\n",
      "MedTech\n",
      "'Virtual world': Pharma R&D and the pandemic\n",
      "https://www.fiercebiotech.com/biotech/forced-into-a-virtual-world-how-pharma-r-d-bounced-back-from-a-once-a-lifetime-pandemic\n",
      "2021-08-09\n",
      "Biotech\n",
      "Stopping cancer cells by blocking a growth-promoting protein\n",
      "https://www.fiercebiotech.com/research/stopping-cancer-cells-by-blocking-a-growth-promoting-protein-and-reactivating-protective\n",
      "2021-08-09\n",
      "Research\n",
      "Injuries mount as device sales reps cozy up to surgeons in ORs\n",
      "https://www.fiercebiotech.com/medtech/injuries-mount-as-sales-reps-for-device-makers-cozy-up-to-surgeons-even-operating-rooms\n",
      "2021-08-09\n",
      "MedTech\n",
      "AbbVie snaps collab, license on Molecular Partners eye drug\n",
      "https://www.fiercebiotech.com/biotech/abbvie-ditches-late-stage-eye-drug-license-collab-molecular-partners\n",
      "2021-08-09\n",
      "Biotech\n",
      "Philip Morris snaps up heart attack biotech OtiTopic\n",
      "https://www.fiercebiotech.com/biotech/philip-morris-biopharma-addiction-ramps-up-as-its-beyond-nicotine-platform-sees-its-snap-up\n",
      "2021-08-09\n",
      "Biotech\n",
      "Altoida's dementia-predicting app snags FDA breakthrough status\n",
      "https://www.fiercebiotech.com/medtech/altoida-s-alzheimer-s-predicting-smartphone-app-snags-fda-breakthrough-status\n",
      "2021-08-09\n",
      "MedTech\n",
      "Merck's Vaxneuvance lead departs to help develop rival vaccine\n",
      "https://www.fiercebiotech.com/biotech/merck-s-vaxneuvance-lead-departs-to-help-develop-rival-vaccine\n",
      "2021-08-09\n",
      "Biotech\n",
      "AbbVie picks Alzheimer's, Parkinson's targets for Mission pact\n",
      "https://www.fiercebiotech.com/biotech/abbvie-picks-alzheimer-s-parkinson-s-targets-for-mission-pact\n",
      "2021-08-09\n",
      "Biotech\n",
      "Study of dogs and cats sheds light on key immune pathways\n",
      "https://www.fiercebiotech.com/research/study-dogs-and-cats-finds-a-certain-protein-can-create-multiple-immune-pathways\n",
      "2021-08-06\n",
      "Research\n",
      "Illumina posts 78% sales growth as cancer, DNA testing ramp up\n",
      "https://www.fiercebiotech.com/medtech/illumina-posts-78-revenue-growth-as-cancer-dna-testing-ramps-back-up\n",
      "2021-08-06\n",
      "MedTech\n",
      "Zoll scores FDA approval for updated sleep apnea implant\n",
      "https://www.fiercebiotech.com/medtech/zoll-scores-fda-approval-for-updated-sleep-apnea-implant-acquired-respicardia-buyout\n",
      "2021-08-06\n",
      "MedTech\n",
      "Telehealth firm Cadence nets $41M to bring hospital care home\n",
      "https://www.fiercebiotech.com/medtech/telehealth-provider-cadence-debuts-41m-to-bring-hospital-care-home\n",
      "2021-08-06\n",
      "MedTech\n",
      "Moderna is ready to spend COVID-19 cash on gene editing\n",
      "https://www.fiercebiotech.com/biotech/moderna-ready-to-spend-covid-19-cash-and-famed-biotech-looking-for-a-gene-editor\n",
      "2021-08-06\n",
      "Biotech\n",
      "You want discount drugs? EQRx wants $1.8B first via SPAC deal\n",
      "https://www.fiercebiotech.com/biotech/eqrx-will-raise-1-8b-through-a-spac-combination-for-lofty-discount-drug-goal\n",
      "2021-08-06\n",
      "Biotech\n",
      "Aprea's myeloid program iced by FDA on adverse events\n",
      "https://www.fiercebiotech.com/biotech/aprea-s-myeloid-program-iced-by-fda-while-tricky-adverse-event-profile-sorted-out\n",
      "2021-08-06\n",
      "Biotech\n",
      "Medtronic makes $1.1B bid for sinus implant maker Intersect ENT\n",
      "https://www.fiercebiotech.com/medtech/medtronic-boosts-ear-nose-and-throat-portfolio-1-1b-bid-for-sinus-implant-maker-intersect\n",
      "2021-08-06\n",
      "MedTech\n",
      "Novavax's latest COVID-19 vaccine delay sends shares tumbling\n",
      "https://www.fiercebiotech.com/biotech/novavax-hits-yet-another-snag-en-route-to-fda-approval-now-targets-q4\n",
      "2021-08-06\n",
      "Biotech\n",
      "Scholar Rock founding CEO returns to top spot—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-scholar-rock-founding-ceo-returns-to-top-spot-as-kingsley-swiftly-exits\n",
      "2021-08-06\n",
      "Biotech\n",
      "Dicerna drops after mixed data on rival to Alnylam drug\n",
      "https://www.fiercebiotech.com/biotech/mixed-pivotal-data-dicerna-rival-to-alnylam-drug-sinks-stock\n",
      "2021-08-06\n",
      "Biotech\n",
      "Sierra buys AstraZeneca cancer drug to pair with ex-Gilead asset\n",
      "https://www.fiercebiotech.com/biotech/sierra-raids-bargain-bin-again-picking-up-astrazeneca-cancer-drug-to-pair-gilead-cast-off\n",
      "2021-08-05\n",
      "Biotech\n",
      "Verily launches healthcare AI research center in Israel\n",
      "https://www.fiercebiotech.com/medtech/verily-launches-ai-research-center-israel-picks-up-google-health-projects\n",
      "2021-08-05\n",
      "MedTech\n",
      "Paige, Perspectum join forces to improve clinical trials\n",
      "https://www.fiercebiotech.com/medtech/paige-perspectum-combine-ai-digital-pathology-tools-bid-to-improve-clinical-trials\n",
      "2021-08-05\n",
      "MedTech\n",
      "Former Merck exec joins Kallyope as president, soon-to-be CEO\n",
      "https://www.fiercebiotech.com/biotech/former-merck-inheris-biopharma-exec-joins-kallyope-as-president-soon-to-be-ceo\n",
      "2021-08-05\n",
      "Biotech\n",
      "Gilead's Kite inks up to $875M blood cancer pact with Appia Bio\n",
      "https://www.fiercebiotech.com/biotech/gilead-s-kite-to-pay-up-to-875m-for-blood-cancer-pact-appia-bio\n",
      "2021-08-05\n",
      "Biotech\n",
      "FDA clears Abbott's AI-backed OCT system for coronary arteries\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-abbott-s-ai-powered-oct-catheter-for-scanning-coronary-arteries\n",
      "2021-08-05\n",
      "MedTech\n",
      "Moderna abandons midstage mRNA cancer asset, shifts to another\n",
      "https://www.fiercebiotech.com/biotech/moderna-abandons-mid-stage-cancer-asset-favor-similar-triple-attack-candidate\n",
      "2021-08-05\n",
      "Biotech\n",
      "Intuitive Surgical maps out $500M expansion of Georgia campus\n",
      "https://www.fiercebiotech.com/medtech/intuitive-surgical-maps-out-500m-expansion-georgia-facilities-workforce\n",
      "2021-08-05\n",
      "MedTech\n",
      "Thousands received heart pumps the FDA knew could be dangerous\n",
      "https://www.fiercebiotech.com/medtech/thousands-patients-were-implanted-heart-pumps-fda-knew-could-be-dangerous\n",
      "2021-08-05\n",
      "MedTech\n",
      "WCG Clinical postpones massive IPO that sought $720M raise\n",
      "https://www.fiercebiotech.com/cro/wcg-clinical-to-begin-trading-thursday-to-raise-up-to-765m\n",
      "2021-08-05\n",
      "CRO\n",
      "Valneva exceeds protection goal in chikungunya vaccine trial\n",
      "https://www.fiercebiotech.com/biotech/valneva-racing-merck-for-a-prv-hits-goal-vaccine-phase-3\n",
      "2021-08-05\n",
      "Biotech\n",
      "PepGen raises $113M to challenge Sarepta in DMD\n",
      "https://www.fiercebiotech.com/biotech/pepgen-raises-113m-to-challenge-sarepta-dmd-build-neuromuscular-and-neurologic-pipeline\n",
      "2021-08-05\n",
      "Biotech\n",
      "To make '1+1=3,' Bayer spends $1.5B for 'undruggables'\n",
      "https://www.fiercebiotech.com/biotech/bayer-bets-1-5b-vividion-will-help-it-target-undruggable-and-make-1-1-3\n",
      "2021-08-05\n",
      "Biotech\n",
      "Busy week for CRO deals as Inotiv, CenExel tack on new buys\n",
      "https://www.fiercebiotech.com/cro/inotiv-cenexel-both-ink-cro-deals-week-following-namsa-s-buy\n",
      "2021-08-04\n",
      "CRO\n",
      "How a century-old TB vaccine may help fight severe COVID-19\n",
      "https://www.fiercebiotech.com/research/how-a-century-old-tb-vaccine-may-help-fight-severe-covid-19\n",
      "2021-08-04\n",
      "Research\n",
      "OIG plans 2023 review of FDA's accelerated pathway after Aduhelm\n",
      "https://www.fiercebiotech.com/biotech/accelerated-pathway-nope-it-will-take-oig-until-2023-to-review-fda-s-quick-approval-process\n",
      "2021-08-04\n",
      "Biotech\n",
      "Device-focused CRO NAMSA buys Clinlogix for 3rd deal of 2021\n",
      "https://www.fiercebiotech.com/cro/device-focused-cro-namsa-buys-clinlogix-for-third-acquisition-2021\n",
      "2021-08-04\n",
      "CRO\n",
      "Robotic pill developer Rani Therapeutics nets $73M IPO\n",
      "https://www.fiercebiotech.com/medtech/rani-therapeutics-falls-short-ipo-projections-73m-for-robotic-biologic-pill\n",
      "2021-08-04\n",
      "MedTech\n",
      "Insilico's AI engines churn out candidate for kidney fibrosis\n",
      "https://www.fiercebiotech.com/medtech/insilico-medicine-s-ai-engines-continue-to-churn-out-new-drug-candidates-now-kidney\n",
      "2021-08-04\n",
      "MedTech\n",
      "Lundbeck doubles down on neuro with $10M upfront to Rgenta\n",
      "https://www.fiercebiotech.com/biotech/lundbeck-after-selling-alzheimer-s-candidate-to-pay-rgenta-up-to-110m-for-neuro-pact\n",
      "2021-08-04\n",
      "Biotech\n",
      "Zymergen’s fledgling stock tumbles amid CEO exit, product delays\n",
      "https://www.fiercebiotech.com/medtech/synthetic-biology-outfit-zymergen-sees-fledgling-stock-tumble-amid-ceo-departure-product\n",
      "2021-08-04\n",
      "MedTech\n",
      "Lumosa's stroke drug lowers risk of deadly complication\n",
      "https://www.fiercebiotech.com/biotech/lumosa-posts-positive-safety-neurological-improvement-results-for-midstage-stroke-drug\n",
      "2021-08-04\n",
      "Biotech\n",
      "Zai Lab to pay Schrödinger up to $338M in cancer R&D biobucks\n",
      "https://www.fiercebiotech.com/biotech/zai-lab-to-pay-schrodinger-up-to-338m-biobucks-for-oncology-r-d-collab\n",
      "2021-08-04\n",
      "Biotech\n",
      "Philips' respiratory devices face another Class I recall\n",
      "https://www.fiercebiotech.com/medtech/philips-faces-2nd-class-i-recall-a-month-time-for-high-flow-therapy-ventilators\n",
      "2021-08-04\n",
      "MedTech\n",
      "Pfizer hits goal in alopecia, setting up showdown with Lilly\n",
      "https://www.fiercebiotech.com/biotech/pfizer-s-ritlecitinib-hits-goal-alopecia-phase-3-setting-up-showdown-lilly\n",
      "2021-08-04\n",
      "Biotech\n",
      "Another one BiTEs the dust as Amgen halts phase 1 bispecific\n",
      "https://www.fiercebiotech.com/biotech/amgen-pauses-flt3-bispecific-trial-resumes-dosing-bcma-study\n",
      "2021-08-04\n",
      "Biotech\n",
      "Sonoma Bio bags $265M for arthritis, diabetes cell therapies\n",
      "https://www.fiercebiotech.com/biotech/sonoma-bio-bags-265m-to-rev-up-cell-therapies-for-arthritis-diabetes\n",
      "2021-08-04\n",
      "Biotech\n",
      "Anti-COVID nanobody 'remarkably active' against delta: study\n",
      "https://www.fiercebiotech.com/research/pitt-s-inhalable-anti-covid-nanobodies-inspired-by-llamas-remarkably-active-against-delta\n",
      "2021-08-03\n",
      "Research\n",
      "Marinus signs $30M upfront deal with Orion for antiseizure med\n",
      "https://www.fiercebiotech.com/biotech/marinus-hands-over-eu-rights-for-anti-seizure-med-to-orion-30m-upfront-deal\n",
      "2021-08-03\n",
      "Biotech\n",
      "Baxter ups AWS collab to support ‘digital transformation’\n",
      "https://www.fiercebiotech.com/medtech/baxter-extends-amazon-web-services-collaboration-to-support-new-digital-health-data\n",
      "2021-08-03\n",
      "MedTech\n",
      "Lilly investors get a clearer picture of Alzheimer's filing\n",
      "https://www.fiercebiotech.com/biotech/lilly-investors-hungry-for-news-alzheimer-s-drug-get-a-clearer-picture-q4-fda-filing\n",
      "2021-08-03\n",
      "Biotech\n",
      "Abbott’s Alere pays $160M to settle diabetes gear kickback case\n",
      "https://www.fiercebiotech.com/medtech/abbott-subsidiary-alere-fined-160m-by-doj-to-settle-alleged-false-medicare-claims\n",
      "2021-08-03\n",
      "MedTech\n",
      "SynOx taps chief medical, tech officers week after CEO hire\n",
      "https://www.fiercebiotech.com/biotech/synox-hires-ex-cristal-ceo-as-cmo-ex-sanofi-dupixent-supply-leader-as-cto-kyle-writing\n",
      "2021-08-03\n",
      "Biotech\n",
      "J&J, Google back inflammatory disease startup Mestag with $45M\n",
      "https://www.fiercebiotech.com/biotech/j-j-and-google-back-inflammatory-disease-startup-mestag-45m-seed\n",
      "2021-08-03\n",
      "Biotech\n",
      "Moderna's RSV vaccine catches the fast track\n",
      "https://www.fiercebiotech.com/biotech/moderna-s-rsv-vaccine-catches-fast-track-heels-pfizer-s-leap-frog-into-queue\n",
      "2021-08-03\n",
      "Biotech\n",
      "Coya Therapeutics eyes IPO, 2022 trial for ALS hopeful\n",
      "https://www.fiercebiotech.com/biotech/coya-therapeutics-wants-to-compete-radicava-rilutek-treating-als-phase-2a-data-coming-soon\n",
      "2021-08-03\n",
      "Biotech\n",
      "Bausch Health sets up IPO for aesthetics medtech Solta Medical\n",
      "https://www.fiercebiotech.com/medtech/bausch-health-s-aesthetics-devicemaker-solta-to-go-public-debt-reduction-scheme\n",
      "2021-08-03\n",
      "MedTech\n",
      "Alnylam ditches COVID-19 antiviral, citing effective vaccines\n",
      "https://www.fiercebiotech.com/biotech/alnylam-scraps-covid-19-antiviral-amid-effective-vaccines-alternative-treatments\n",
      "2021-08-03\n",
      "Biotech\n",
      "Scholar Rock founding CEO returns to the post as Kingsley exits\n",
      "https://www.fiercebiotech.com/biotech/scholar-rock-s-former-ceo-becomes-ceo-again-as-tony-kingsley-exits\n",
      "2021-08-03\n",
      "Biotech\n",
      "CytoDyn catches SEC, DOJ scrutiny over COVID-19 drug\n",
      "https://www.fiercebiotech.com/biotech/cytodyn-facing-sec-doj-investigations-over-public-claims-about-covid-19-drug-s-viability\n",
      "2021-08-03\n",
      "Biotech\n",
      "Sage axes 2 zuranolone trials deemed unnecessary for approval\n",
      "https://www.fiercebiotech.com/biotech/sage-scraps-2-zuranolone-trials-deemed-unnecessary-for-approval\n",
      "2021-08-03\n",
      "Biotech\n",
      "With $3.2B, Sanofi takes in mRNA partner Translate Bio in buyout\n",
      "https://www.fiercebiotech.com/biotech/sanofi-inks-3-2b-translate-buyout-to-get-deeper-into-mrna-r-d\n",
      "2021-08-03\n",
      "Biotech\n",
      "Arch Oncology goes on hiring spree from AbbVie, BMS, Xencor\n",
      "https://www.fiercebiotech.com/biotech/arch-oncology-boosts-medical-clinical-management-three-hires-from-abbvie-bms-xencor\n",
      "2021-08-02\n",
      "Biotech\n",
      "InterVenn bags $201M for AI-powered cancer tests\n",
      "https://www.fiercebiotech.com/medtech/intervenn-biosciences-quintuples-funding-201m-for-ai-powered-cancer-tests\n",
      "2021-08-02\n",
      "MedTech\n",
      "CymaBay's liver drug gets new life with $100M for phase 3 trial\n",
      "https://www.fiercebiotech.com/biotech/cymabay-secures-100m-to-bankroll-phase-3-development-resurrected-liver-drug\n",
      "2021-08-02\n",
      "Biotech\n",
      "Unleashing immunotherapy against 'cold' prostate tumors\n",
      "https://www.fiercebiotech.com/research/unleashing-immunotherapy-against-cold-prostate-tumors-a-new-protein-target\n",
      "2021-08-02\n",
      "Research\n",
      "FDA clears 3D hologram tech for 'science-fiction' surgical plans\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-3d-hologram-tech-for-science-fiction-surgical-planning\n",
      "2021-08-02\n",
      "MedTech\n",
      "Roivant ditches plan to reacquire Immunovant, invests $200M\n",
      "https://www.fiercebiotech.com/biotech/roivant-ditches-plan-to-reacquire-immunovant-putting-up-200m-investment-instead\n",
      "2021-08-02\n",
      "Biotech\n",
      "Ipsen commits up to $1B to Exicure for two rare neuro assets\n",
      "https://www.fiercebiotech.com/biotech/ipsen-inks-another-pact-shelling-out-20m-upfront-up-to-1b-to-exicure-for-rare-neuro\n",
      "2021-08-02\n",
      "Biotech\n",
      "MindMics’ earbud surpasses ECG in assessing arrhythmia: study\n",
      "https://www.fiercebiotech.com/medtech/mindmics-finds-ear-monitor-surpasses-ecg-assessing-cardiac-arrhythmia\n",
      "2021-08-02\n",
      "MedTech\n",
      "Abbott debuts smart monitor that spots abnormal heart rhythms\n",
      "https://www.fiercebiotech.com/medtech/abbott-debuts-smart-icm-sifts-for-abnormal-heart-rhythms-data-stream\n",
      "2021-08-02\n",
      "MedTech\n",
      "Zentera raises $75M series B to build pipeline, list in 2022\n",
      "https://www.fiercebiotech.com/biotech/zentera-therapeutics-raises-75m-series-b-to-advance-three-oncology-assets-eyes-2022-listing\n",
      "2021-08-02\n",
      "Biotech\n",
      "Moderna looks to Autolus to fuel its mRNA oncology plans\n",
      "https://www.fiercebiotech.com/biotech/moderna-lands-option-autolus-binders-to-fuel-oncology-plans\n",
      "2021-08-02\n",
      "Biotech\n",
      "T-knife bags $110M for raft of cell therapy solid tumor trials\n",
      "https://www.fiercebiotech.com/biotech/t-knife-bags-110m-for-raft-cell-therapy-solid-tumor-trials\n",
      "2021-08-02\n",
      "Biotech\n",
      "AbbVie plans to move next-gen Alzheimer's drug into the clinic\n",
      "https://www.fiercebiotech.com/biotech/abbvie-plans-to-move-next-gen-aduhelm-like-amyloid-treatment-for-alzheimer-s-to-clinic\n",
      "2021-07-30\n",
      "Biotech\n",
      "Bioventus ponies up $518M for surgical device maker Misonix\n",
      "https://www.fiercebiotech.com/medtech/bioventus-ponies-up-518m-for-ultrasonic-surgical-device-maker-misonix\n",
      "2021-07-30\n",
      "MedTech\n",
      "Astellas doles out $20M upfront to Minovia for cell therapies\n",
      "https://www.fiercebiotech.com/biotech/astellas-to-pay-minovia-20m-upfront-up-to-420m-per-product-for-mitochondrial-cell-therapies\n",
      "2021-07-30\n",
      "Biotech\n",
      "NuVasive nabs FDA OK for all-in-one spine surgery platform\n",
      "https://www.fiercebiotech.com/medtech/nuvasive-nabs-fda-clearance-amid-global-rollout-all-one-spine-surgery-platform\n",
      "2021-07-30\n",
      "MedTech\n",
      "Alector bolsters 'immuno-neurology' approach with early data\n",
      "https://www.fiercebiotech.com/biotech/alector-bolsters-immuno-neurology-approach-and-gsk-a-700m-bet-early-phase-2-data\n",
      "2021-07-30\n",
      "Biotech\n",
      "PeptiDream signs licensing deal with Alnylam worth up to $2.2B\n",
      "https://www.fiercebiotech.com/biotech/another-day-another-billion-dollar-deal-for-peptidream-time-alnylam\n",
      "2021-07-30\n",
      "Biotech\n",
      "IGM poaches Gilead cancer chief Takimoto\n",
      "https://www.fiercebiotech.com/biotech/igm-poaches-gilead-cancer-chief-takimoto-at-pivotal-moment-for-both-companies\n",
      "2021-07-30\n",
      "Biotech\n",
      "Bayer poaches Roche vet for early cancer R&D—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-bayer-picks-up-roche-vet-reuttinger-to-lead-early-cancer-r-d\n",
      "2021-07-30\n",
      "Biotech\n",
      "Takeda allies with Fraizer to spin out norovirus vaccine\n",
      "https://www.fiercebiotech.com/biotech/takeda-allies-fraizer-to-spin-out-late-phase-norovirus-vaccine\n",
      "2021-07-30\n",
      "Biotech\n",
      "Ardelyx's FDA rejection points to long path back for CKD drug\n",
      "https://www.fiercebiotech.com/biotech/ardelyx-s-fda-rejection-points-to-long-path-back-for-ckd-drug\n",
      "2021-07-30\n",
      "Biotech\n",
      "Pfizer jumps the queue and leaps into RSV vax contention\n",
      "https://www.fiercebiotech.com/biotech/surprise-pfizer-jumps-queue-and-leaps-into-rsv-vax-contention-as-covid-helps-turbo-charge\n",
      "2021-07-30\n",
      "Biotech\n",
      "IBM, Fox Foundation use AI to uncover new Parkinson's types\n",
      "https://www.fiercebiotech.com/medtech/michael-j-fox-foundation-and-ibm-uncover-multiple-underlying-types-parkinson-s-disease\n",
      "2021-07-29\n",
      "MedTech\n",
      "Lilly reveals 2 new analyses for Alzheimer's drug donanemab\n",
      "https://www.fiercebiotech.com/biotech/lilly-adds-to-biomarker-bombardment-alzheimer-s-two-new-donanemab-analyses\n",
      "2021-07-29\n",
      "Biotech\n",
      "Biofourmis’ digital heart failure guide nets breakthrough label\n",
      "https://www.fiercebiotech.com/medtech/biofourmis-nets-fda-breakthrough-label-for-digital-heart-failure-treatment-assistant\n",
      "2021-07-29\n",
      "MedTech\n",
      "New tool aims to boost diversity in trials for Alzheimer's\n",
      "https://www.fiercebiotech.com/cro/nia-releases-online-tool-to-increase-awareness-diversity-push-for-alzheimer-s-clinical-trials\n",
      "2021-07-29\n",
      "CRO\n",
      "Immune system protein prompts obese mice to 'sweat' out fat\n",
      "https://www.fiercebiotech.com/research/immune-system-protein-prompts-obese-mice-to-sweat-out-fat-inspiring-new-treatment-target\n",
      "2021-07-29\n",
      "Research\n",
      "Nuvalent banks $166M IPO to push resistance-beating cancer drugs\n",
      "https://www.fiercebiotech.com/biotech/nuvalent-pulls-off-166m-ipo-to-move-resistance-beating-lung-cancer-programs-into-clinic\n",
      "2021-07-29\n",
      "Biotech\n",
      "Rakuten Medical secures $166M series D after Japanese approval\n",
      "https://www.fiercebiotech.com/biotech/rakuten-medical-rakes-166m-series-d-following-september-approval-neck-cancer-drug-japan\n",
      "2021-07-29\n",
      "Biotech\n",
      "Lilly bets $70M upfront on immuno-oncology pact with Kumquat\n",
      "https://www.fiercebiotech.com/biotech/lilly-bets-70m-upfront-small-molecule-immuno-oncology-pact\n",
      "2021-07-29\n",
      "Biotech\n",
      "Sanofi culls early infectious disease, blood disorder asset\n",
      "https://www.fiercebiotech.com/biotech/sanofi-culls-early-infectious-disease-and-blood-disorder-asset-as-it-ramps-up-phase-3-for\n",
      "2021-07-29\n",
      "Biotech\n",
      "New GlaxoSmithKline keeping old R&D model, says embattled CEO\n",
      "https://www.fiercebiotech.com/biotech/new-glaxosmithkline-keeping-old-r-d-model-says-embattled-ceo\n",
      "2021-07-29\n",
      "Biotech\n",
      "Exo nabs $220M as hand-held ultrasound race heats up\n",
      "https://www.fiercebiotech.com/medtech/exo-nabs-220m-as-handheld-ultrasound-race-heats-up\n",
      "2021-07-29\n",
      "MedTech\n",
      "AstraZeneca drops tezepelumab from atopic dermatitis pipeline\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-drops-tezepelumab-atopic-dermatitis-from-pipeline-after-midphase-failure\n",
      "2021-07-29\n",
      "Biotech\n",
      "Rallybio banks downsized $81M IPO to fuel rare disease programs\n",
      "https://www.fiercebiotech.com/biotech/rallybio-banks-downsized-81m-ipo-to-fuel-rare-disease-programs\n",
      "2021-07-28\n",
      "Biotech\n",
      "Annovis' Alzheimer's drug fails to improve dementia symptoms\n",
      "https://www.fiercebiotech.com/biotech/annovis-bio-presents-data-alzheimer-s-treatment-says-biogen-s-aduhelm-not-remotely-as-good\n",
      "2021-07-28\n",
      "Biotech\n",
      "Strata Oncology gets $90M boost for genomic cancer testing\n",
      "https://www.fiercebiotech.com/medtech/strata-oncology-gets-90m-boost-from-pfizer-merck-and-more-for-genomic-cancer-testing\n",
      "2021-07-28\n",
      "MedTech\n",
      "Fruit compound reverses brain damage in Parkinson's models\n",
      "https://www.fiercebiotech.com/research/fruit-compound-farnesol-prevents-and-reverses-brain-damage-could-lead-to-future-parkinson\n",
      "2021-07-28\n",
      "Research\n",
      "FDA finds it in its heart to OK Medtronic’s afib-detecting AI\n",
      "https://www.fiercebiotech.com/medtech/medtronic-nets-heartening-fda-nod-for-ai-algorithms-to-detect-afib-arrhythmia\n",
      "2021-07-28\n",
      "MedTech\n",
      "Arena taps Aristea in $70M deal, snags buyout option\n",
      "https://www.fiercebiotech.com/biotech/arena-taps-aristea-70m-inflammation-deal-secures-buyout-option\n",
      "2021-07-28\n",
      "Biotech\n",
      "Novartis fine-tunes gene therapy with a 'dimmer switch'\n",
      "https://www.fiercebiotech.com/research/novartis-fine-tunes-gene-therapy-a-huntington-s-disease-candidate-as-a-dimmer-switch\n",
      "2021-07-28\n",
      "Research\n",
      "Takeda's CNS deep dive with PeptiDream could net $3.5B\n",
      "https://www.fiercebiotech.com/biotech/takeda-could-dish-out-up-to-3-5b-expanded-cns-collaboration-peptidream\n",
      "2021-07-28\n",
      "Biotech\n",
      "Ipsen pens early-stage, $14.5M programmed cell death cancer deal\n",
      "https://www.fiercebiotech.com/biotech/ipsen-pens-early-stage-14-5m-programmed-cell-death-cancer-deal-bakx-therapeutics\n",
      "2021-07-28\n",
      "Biotech\n",
      "Enyo Pharma notches a mid-stage trial win in tricky NASH\n",
      "https://www.fiercebiotech.com/biotech/enyo-pharma-s-nash-results-show-boost-kidney-function-differentiating-vonafexor-from-busy\n",
      "2021-07-28\n",
      "Biotech\n",
      "Deep Genomics scores $180M to deliver programmable RNA therapies\n",
      "https://www.fiercebiotech.com/medtech/deep-genomics-scores-180m-to-deliver-ai-programmed-rna-therapies\n",
      "2021-07-28\n",
      "MedTech\n",
      "BioIntelliSense rakes in $45M for remote monitoring platform\n",
      "https://www.fiercebiotech.com/medtech/biointellisense-rakes-45m-for-remote-monitoring-data-platform-symptom-tracking-stickers\n",
      "2021-07-28\n",
      "MedTech\n",
      "GSK drops phase 2 viral vector RSV vaccine in infants\n",
      "https://www.fiercebiotech.com/biotech/gsk-drops-phase-2-viral-vector-rsv-vaccine-pediatric-ages\n",
      "2021-07-28\n",
      "Biotech\n",
      "Pfizer dumps midphase NASH prospect in quarterly pipeline cull\n",
      "https://www.fiercebiotech.com/biotech/pfizer-dumps-midphase-nash-prospect-quarterly-pipeline-cull\n",
      "2021-07-28\n",
      "Biotech\n",
      "Flagship-backed gene therapy Ring Therapeutics reels in $117M\n",
      "https://www.fiercebiotech.com/biotech/ring-therapeutics-rings-a-whopping-117m-series-b-for-gene-therapies\n",
      "2021-07-28\n",
      "Biotech\n",
      "MedRhythms grooves its way to $25M for musical stroke treatment\n",
      "https://www.fiercebiotech.com/medtech/medrhythms-hits-a-high-note-25m-for-music-based-stroke-parkinson-s-ms-treatment\n",
      "2021-07-28\n",
      "MedTech\n",
      "Teneobio snapped up by Amgen for $2.5B\n",
      "https://www.fiercebiotech.com/biotech/gilead-partnered-teneobio-and-its-next-gen-cancer-work-snapped-up-by-amgen-for-2-5b\n",
      "2021-07-28\n",
      "Biotech\n",
      "Candel nets downsized $72M IPO to advance cancer-killing viruses\n",
      "https://www.fiercebiotech.com/biotech/candel-reels-downsized-72m-ipo-to-get-cancer-killing-viruses-through-clinic\n",
      "2021-07-27\n",
      "Biotech\n",
      "Boston Scientific tops expectations with 53% sales growth\n",
      "https://www.fiercebiotech.com/medtech/boston-scientific-tops-expectations-53-sales-growth-over-2020\n",
      "2021-07-27\n",
      "MedTech\n",
      "Signifier scores $35M for sleep apnea-treating tongue stimulator\n",
      "https://www.fiercebiotech.com/medtech/signifier-hypes-up-excite-tongue-stimulation-device-for-sleep-apnea-35m-series-d\n",
      "2021-07-27\n",
      "MedTech\n",
      "Ex-Kiadis CBO takes the helm at SynOx after $358M Sanofi buyout\n",
      "https://www.fiercebiotech.com/biotech/ex-kiadis-cbo-takes-wheel-at-synox-after-358m-sanofi-buyout\n",
      "2021-07-27\n",
      "Biotech\n",
      "Biogen, Ionis say Alzheimer's phase 1b drug is safe, tolerable\n",
      "https://www.fiercebiotech.com/biotech/biogen-ionis-say-anti-tau-alzheimer-s-drug-candidate-safe-tolerable-phase-1b-study\n",
      "2021-07-27\n",
      "Biotech\n",
      "BD buys polymer maker Tepha to fortify surgical mesh portfolio\n",
      "https://www.fiercebiotech.com/medtech/bd-fortifies-surgical-mesh-portfolio-acquisition-polymer-maker-tepha\n",
      "2021-07-27\n",
      "MedTech\n",
      "AbbVie hits go on $1B re-upped Calico deal\n",
      "https://www.fiercebiotech.com/biotech/abbvie-hits-go-1b-re-upped-calico-deal-as-google-life-science-spin-out-continues-i-o-neuro\n",
      "2021-07-27\n",
      "Biotech\n",
      "AZ teams up with Regeneron for obesity-busting drug pact\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-teams-up-regeneron-for-obesity-busting-drug-pact-focused-genetics\n",
      "2021-07-27\n",
      "Biotech\n",
      "Merck spinout Organon bags preterm labor drug ahead of phase 3\n",
      "https://www.fiercebiotech.com/biotech/merck-spinout-organon-bags-preterm-labor-drug-ahead-phase-3\n",
      "2021-07-27\n",
      "Biotech\n",
      "Artios raises $153M to fund DNA damage repair clinical trials\n",
      "https://www.fiercebiotech.com/biotech/artios-raises-153m-to-fund-dna-damage-repair-clinical-trials\n",
      "2021-07-27\n",
      "Biotech\n",
      "IMIDomics emerges with $16.5M for new approach to inflammation\n",
      "https://www.fiercebiotech.com/biotech/imidomics-emerges-16-5m-former-takeda-exec-at-helm-and-a-precision-approach-to-inflammatory\n",
      "2021-07-27\n",
      "Biotech\n",
      "PathAI branches into lab services with Poplar acquisition\n",
      "https://www.fiercebiotech.com/medtech/pathai-branches-into-clinical-lab-services-acquisition-poplar-healthcare\n",
      "2021-07-26\n",
      "MedTech\n",
      "Prothena touts early data for anti-amyloid Alzheimer's drug\n",
      "https://www.fiercebiotech.com/research/prothena-says-preclinical-alzheimer-s-drug-candidate-binds-about-11-times-more-than\n",
      "2021-07-26\n",
      "Research\n",
      "Denali's Hunter syndrome data fail to impress\n",
      "https://www.fiercebiotech.com/biotech/denali-s-hunter-syndrome-data-fails-to-impress-but-aduhelm-lenient-fda-could-still-approve\n",
      "2021-07-26\n",
      "Biotech\n",
      "Philips' CPAP recall dents Q2 connected care sales\n",
      "https://www.fiercebiotech.com/medtech/philips-cpap-recall-dents-second-quarter-connected-care-sales\n",
      "2021-07-26\n",
      "MedTech\n",
      "Bayer's BlueRock promotes CSO to CEO, president roles\n",
      "https://www.fiercebiotech.com/biotech/bayer-s-bluerock-therapeutics-adjusts-leadership-team-cso-promoted-to-ceo\n",
      "2021-07-26\n",
      "Biotech\n",
      "From speedy review to standstill: FDA spurns Iterum's antibiotic\n",
      "https://www.fiercebiotech.com/biotech/from-speedy-review-to-standstill-fda-spurns-iterum-s-antibiotic-demands-another-trial\n",
      "2021-07-26\n",
      "Biotech\n",
      "Patients, providers feel telemedicine's pandemic growing pains\n",
      "https://www.fiercebiotech.com/medtech/pandemic-made-telemedicine-instant-hit-patients-and-providers-feel-growing-pains\n",
      "2021-07-26\n",
      "MedTech\n",
      "PerkinElmer inks $5.25B deal for reagent producer BioLegend\n",
      "https://www.fiercebiotech.com/medtech/perkinelmer-inks-massive-5-25b-deal-for-reagent-producer-biolegend\n",
      "2021-07-26\n",
      "MedTech\n",
      "Talus Bio wants to knock proteins off of DNA\n",
      "https://www.fiercebiotech.com/biotech/to-tackle-disease-causing-genes-talus-bio-takes-aim-at-proteins-switch-them-off\n",
      "2021-07-26\n",
      "Biotech\n",
      "Medtronic Prevail drug-coated balloon catheter begins EU launch\n",
      "https://www.fiercebiotech.com/medtech/medtronic-begins-european-rollout-drug-coated-balloon-catheter-to-treat-blocked-arteries\n",
      "2021-07-26\n",
      "MedTech\n",
      "Lumira Ventures raises $220M for life sciences bets\n",
      "https://www.fiercebiotech.com/biotech/lumira-ventures-raises-largest-investment-pot-to-date-nabbing-220m-for-life-sciences-bets\n",
      "2021-07-26\n",
      "Biotech\n",
      "Incyte slapped with FDA rejection for PD-1 retifanlimab\n",
      "https://www.fiercebiotech.com/biotech/fda-demands-for-data-from-incyte-as-it-rejects-pd-1-retifanlimab-for-approval\n",
      "2021-07-26\n",
      "Biotech\n",
      "AbbVie posts data on drug solution for far-sightedness\n",
      "https://www.fiercebiotech.com/biotech/abbvie-posts-pivotal-data-age-related-long-sightedness-drug\n",
      "2021-07-26\n",
      "Biotech\n",
      "Bayer hires Ruettinger from Roche to head early cancer R&D\n",
      "https://www.fiercebiotech.com/biotech/bayer-hires-ruettinger-from-roche-to-head-early-cancer-r-d\n",
      "2021-07-26\n",
      "Biotech\n",
      "Passage Bio replaces May CMO, CFO exits, adds commercial leader\n",
      "https://www.fiercebiotech.com/biotech/passage-bio-hires-cmo-cfo-replacements-adds-chief-commercial-officer-following-may\n",
      "2021-07-23\n",
      "Biotech\n",
      "Caribou grabs $304M IPO to herd off-the-shelf CAR-Ts into clinic\n",
      "https://www.fiercebiotech.com/biotech/caribou-grabs-304m-ipo-to-herd-off-shelf-car-ts-into-clinic\n",
      "2021-07-23\n",
      "Biotech\n",
      "Happify debuts digital app to tackle both anxiety and depression\n",
      "https://www.fiercebiotech.com/medtech/happify-health-debuts-digital-app-to-tackle-both-anxiety-and-depression\n",
      "2021-07-23\n",
      "MedTech\n",
      "Novel degrader of cancer-driving protein slows tumors in mice\n",
      "https://www.fiercebiotech.com/research/novel-degrader-cancer-driving-protein-akt-slows-prostate-breast-tumors-mice\n",
      "2021-07-23\n",
      "Research\n",
      "FDA dishes out Class I label to Philips' ventilator recall\n",
      "https://www.fiercebiotech.com/medtech/fda-dishes-out-class-i-label-to-philips-recall-faulty-cpap-machines-and-other-ventilators\n",
      "2021-07-23\n",
      "MedTech\n",
      "Gilead nabs Arcus CMO to lead Arcus pact—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-gilead-snags-arcus-cmo-bill-grossman-to-lead-pact-arcus\n",
      "2021-07-23\n",
      "Biotech\n",
      "Lumos delays readout as COVID-19 slows growth deficiency trial\n",
      "https://www.fiercebiotech.com/biotech/lumos-delays-readout-as-covid-19-slows-growth-hormone-trial\n",
      "2021-07-23\n",
      "Biotech\n",
      "Eli Lilly pens pact with Banner for late-stage AD trial\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-pens-pact-banner-alzheimer-s-institute-for-virtual-approach-for-its-late-stage\n",
      "2021-07-23\n",
      "CRO\n",
      "Early biopharma investment nears $5B, IPOs are up\n",
      "https://www.fiercebiotech.com/biotech/biopharma-series-a-and-ipos-skyrocket-but-post-ipo-and-m-a-performance-down-1h21-report\n",
      "2021-07-23\n",
      "Biotech\n",
      "Half of Adverum eye disease pipeline 'snaps out of existence'\n",
      "https://www.fiercebiotech.com/biotech/gene-therapy-toxicity-drives-adverum-to-stop-dme-development\n",
      "2021-07-23\n",
      "Biotech\n",
      "EC launches full antitrust probe into Illumina's bid for Grail\n",
      "https://www.fiercebiotech.com/medtech/european-commission-launches-months-long-antitrust-investigation-into-illumina-s-8b-bid-for\n",
      "2021-07-22\n",
      "MedTech\n",
      "PacBio plots $800M buyout of DNA sequencing startup Omniome\n",
      "https://www.fiercebiotech.com/medtech/pacbio-snaps-up-dna-sequencing-startup-omniome-deal-worth-up-to-800m\n",
      "2021-07-22\n",
      "MedTech\n",
      "Novartis rolls out ambitious diversity plan, and they need help\n",
      "https://www.fiercebiotech.com/biotech/novartis-about-to-start-ringing-up-peers-to-join-ambitious-new-diversity-program\n",
      "2021-07-22\n",
      "Biotech\n",
      "Quest Diagnostics sees fast return in base testing business\n",
      "https://www.fiercebiotech.com/medtech/quest-diagnostics-sees-faster-than-expected-return-base-testing-business-over-second\n",
      "2021-07-22\n",
      "MedTech\n",
      "New gene therapy approach shows signs of preventing vision loss\n",
      "https://www.fiercebiotech.com/research/new-gene-therapy-approach-from-mount-sinai-researchers-shows-signs-preventing-vision-loss\n",
      "2021-07-22\n",
      "Research\n",
      "Tectonic snags Regeneron's Dupixent program leader as CMO\n",
      "https://www.fiercebiotech.com/biotech/tectonic-hires-regeneron-s-dupixent-program-leader-marcella-ruddy-as-cmo\n",
      "2021-07-22\n",
      "Biotech\n",
      "Abbott bumps up non-COVID-related sales with 11% jump from 2019\n",
      "https://www.fiercebiotech.com/medtech/abbott-returns-to-pre-pandemic-growth-clocking-11-sales-bump-from-2019-sans-covid-testing\n",
      "2021-07-22\n",
      "MedTech\n",
      "Pfizer funnels $1B into Arvinas, with more in biobucks to come\n",
      "https://www.fiercebiotech.com/biotech/pfizer-funnels-1b-into-protein-degrader-arvinas-more-biobucks-table\n",
      "2021-07-22\n",
      "Biotech\n",
      "Biogen takes $542M hit over 2 failed gene therapy trials\n",
      "https://www.fiercebiotech.com/biotech/biogen-takes-542m-hit-over-2-failed-gene-therapy-trials-as-aduhelm-revenue-trickles\n",
      "2021-07-22\n",
      "Biotech\n",
      "Roche in 'continued dialogue' with FDA over Alzheimer's prospect\n",
      "https://www.fiercebiotech.com/biotech/roche-continued-dialogue-fda-over-alzheimer-s-prospect\n",
      "2021-07-22\n",
      "Biotech\n",
      "Seres Therapeutics' microbiome therapy flops against placebo\n",
      "https://www.fiercebiotech.com/biotech/seres-therapeutics-microbiome-therapy-flops-against-placebo-as-shares-go-into-freefall\n",
      "2021-07-22\n",
      "Biotech\n",
      "Hemab raises $55M to target multiple rare bleeding indications\n",
      "https://www.fiercebiotech.com/biotech/hemab-raises-55m-to-target-multiple-rare-bleeding-indications\n",
      "2021-07-22\n",
      "Biotech\n",
      "Sanofi-Regeneron drug lowers COPD exacerbations in some patients\n",
      "https://www.fiercebiotech.com/biotech/sanofi-wants-to-capture-up-to-90-copd-patients-itepekimab-and-dupixent\n",
      "2021-07-21\n",
      "Biotech\n",
      "IQVIA and BREATHE team up on respiratory conditions, long COVID\n",
      "https://www.fiercebiotech.com/cro/iqvia-breathe-team-up-for-early-diagnosis-treatment-respiratory-conditions\n",
      "2021-07-21\n",
      "CRO\n",
      "Bayer's newly licensed breast cancer drug clears tumors in mice\n",
      "https://www.fiercebiotech.com/research/bayer-s-breast-cancer-drug-turns-up-a-tumor-protective-pathway-eradicates-tumors-mice\n",
      "2021-07-21\n",
      "Research\n",
      "Dicerna's RNAi drug curbs harmful protein in rare liver disease\n",
      "https://www.fiercebiotech.com/biotech/dicerna-s-rna-silencing-drug-curbs-harmful-protein-rare-liver-disease\n",
      "2021-07-21\n",
      "Biotech\n",
      "Boston Scientific heart implant cuts afib patients’ stroke risk\n",
      "https://www.fiercebiotech.com/medtech/boston-scientific-heart-implant-linked-to-steep-drop-off-stroke-risk-for-afib-patients\n",
      "2021-07-21\n",
      "MedTech\n",
      "FDA tells Magenta to stop blood cancer trial before it starts\n",
      "https://www.fiercebiotech.com/biotech/fda-tells-magenta-therapeutics-it-can-t-start-leukemia-phase-1-2-clinical-trial\n",
      "2021-07-21\n",
      "Biotech\n",
      "J&J's medtech companies rebound to $7B in Q2 sales\n",
      "https://www.fiercebiotech.com/medtech/light-at-end-covid-19-tunnel-as-j-j-s-medtech-companies-rebound-to-7b-second-quarter-sales\n",
      "2021-07-21\n",
      "MedTech\n",
      "AbbVie, Roche top data transparency list in new Yale report\n",
      "https://www.fiercebiotech.com/biotech/abbvie-roche-top-data-transparency-list-but-more-could-be-done-to-build-trust-medical\n",
      "2021-07-21\n",
      "Biotech\n",
      "Biotech earnings season clouded by COVID, lifted by gene editing\n",
      "https://www.fiercebiotech.com/biotech/biotech-earnings-arrive-delta-variant-clouding-expectations-but-q2-gene-editing-results\n",
      "2021-07-21\n",
      "Biotech\n",
      "Woebot perks up with $90M for AI-powered mental health platform\n",
      "https://www.fiercebiotech.com/medtech/digital-therapist-woebot-perks-up-90m-for-ai-powered-mental-health-platform\n",
      "2021-07-21\n",
      "MedTech\n",
      "Microsoft offers up cloud support for NIH biomedical research\n",
      "https://www.fiercebiotech.com/medtech/microsoft-azure-joins-aws-google-cloud-as-cloud-platforms-supporting-nih-biomedical\n",
      "2021-07-21\n",
      "MedTech\n",
      "Lexeo bolsters rare heart disease pipeline with Stelios buy\n",
      "https://www.fiercebiotech.com/biotech/lexeo-snaps-up-stelios-bolstering-pipeline-trio-rare-heart-disease-gene-therapies\n",
      "2021-07-21\n",
      "Biotech\n",
      "Vedanta raises $68M, reveals setback to Bristol Myers alliance\n",
      "https://www.fiercebiotech.com/biotech/vedanta-raises-68m-reveals-setback-to-bristol-myers-alliance\n",
      "2021-07-21\n",
      "Biotech\n",
      "IM Therapeutics' lead diabetes candidate posts positive results\n",
      "https://www.fiercebiotech.com/biotech/im-therapeutics-posts-positive-results-for-phase-1b-study-type-1-diabetes\n",
      "2021-07-21\n",
      "Biotech\n",
      "Coave raises $25M ahead of pivotal retinal gene therapy trial\n",
      "https://www.fiercebiotech.com/biotech/coave-raises-25m-ahead-pivotal-retinal-gene-therapy-trial\n",
      "2021-07-21\n",
      "Biotech\n",
      "Turnstone rounds up $80M to fly immunotherapies through clinic\n",
      "https://www.fiercebiotech.com/biotech/turnstone-biologics-rounds-up-80m-to-fly-cancer-killing-virus-til-treatment-through-clinic\n",
      "2021-07-21\n",
      "Biotech\n",
      "Novartis ditches midstage dry eye drug\n",
      "https://www.fiercebiotech.com/biotech/novartis-ditches-midstage-dry-eye-drug-gets-new-year-s-pdufa-data-for-troubled-leqvio\n",
      "2021-07-21\n",
      "Biotech\n",
      "Sanofi-GSK's COVID-19 vaccine enters EMA rolling review\n",
      "https://www.fiercebiotech.com/biotech/sanofi-gsk-s-covid-19-vaccine-enters-eu-rolling-review-as-companies-work-phase-3-trial\n",
      "2021-07-20\n",
      "Biotech\n",
      "Neuspera’s nerve implant for overactive bladder gets $65M boost\n",
      "https://www.fiercebiotech.com/medtech/neuspera-medical-scores-65m-for-nerve-stimulating-implant-to-treat-overactive-bladder\n",
      "2021-07-20\n",
      "MedTech\n",
      "BD acquires Velano for 'one-stick,' needle-free hospital stays\n",
      "https://www.fiercebiotech.com/medtech/bd-acquires-needle-free-blood-draw-company-velano-vascular-for-one-stick-hospital-stays\n",
      "2021-07-20\n",
      "MedTech\n",
      "Gilead's long-acting med curbs HIV in patients with few options\n",
      "https://www.fiercebiotech.com/biotech/ias-en-route-to-fda-decision-gilead-s-long-acting-drug-keeps-hiv-down-patients-at-end\n",
      "2021-07-20\n",
      "Biotech\n",
      "Bayer's billion-dollar Parkinson's bet snags FDA fast-track tag\n",
      "https://www.fiercebiotech.com/biotech/bayer-s-billion-dollar-parkinson-s-disease-bet-snags-fda-fast-track-tag\n",
      "2021-07-20\n",
      "Biotech\n",
      "Omniscient Neurotechnology rakes in $29M for brain-mapping tech\n",
      "https://www.fiercebiotech.com/medtech/omniscient-neurotechnology-rakes-29m-to-map-out-electrical-networks-brain\n",
      "2021-07-20\n",
      "MedTech\n",
      "Rivus' fat-trimming therapy nabs $35M for a host of diseases\n",
      "https://www.fiercebiotech.com/biotech/rivus-fat-trimming-therapy-nabs-35m-as-it-looks-to-harness-our-own-biology-against-a-host\n",
      "2021-07-20\n",
      "Biotech\n",
      "Broad-minded firms open paths for amateurs to invest in biotech\n",
      "https://www.fiercebiotech.com/biotech/managed-marketplaces-and-reality-tv-how-amateur-investors-can-chip-into-biotech-startups\n",
      "2021-07-20\n",
      "Biotech\n",
      "Amylyx snags $135M for possible ALS drug launch, Alzheimer's R&D\n",
      "https://www.fiercebiotech.com/biotech/amylyx-raises-135m-as-it-gears-up-for-potential-canada-launch-als-drug\n",
      "2021-07-20\n",
      "Biotech\n",
      "Gilead hires Arcus CMO, puts him in charge of pact with biotech\n",
      "https://www.fiercebiotech.com/biotech/gilead-hires-arcus-cmo-puts-him-charge-pact-biotech\n",
      "2021-07-20\n",
      "Biotech\n",
      "Panakès moves into biotech investing with new €150M fund\n",
      "https://www.fiercebiotech.com/biotech/panakes-moves-into-biotech-investing-new-eu150m-fund\n",
      "2021-07-20\n",
      "Biotech\n",
      "Ardelyx stock craters as it's hit with FDA 'deficiencies' tag\n",
      "https://www.fiercebiotech.com/biotech/ardelyx-stock-craters-as-fda-hits-biotech-dreaded-deficiencies-tag-clinical-relevance-for\n",
      "2021-07-20\n",
      "Biotech\n",
      "Merck's long-acting HIV med hits protective levels in phase 2\n",
      "https://www.fiercebiotech.com/biotech/ias-merck-s-long-acting-hiv-med-hits-protective-levels-phase-2\n",
      "2021-07-20\n",
      "Biotech\n",
      "Genetic discovery in AMD points to new treatment strategy\n",
      "https://www.fiercebiotech.com/research/surprise-genetic-discovery-macular-degeneration-points-to-new-treatment-strategy\n",
      "2021-07-19\n",
      "Research\n",
      "FDA warns of potential risks of NuVasive’s scoliosis implants\n",
      "https://www.fiercebiotech.com/medtech/nuvasive-pares-down-magec-family-scoliosis-implants-amid-fda-safety-warning\n",
      "2021-07-19\n",
      "MedTech\n",
      "FDA approves Nevro’s high-frequency stimulator for diabetic pain\n",
      "https://www.fiercebiotech.com/medtech/nevro-scores-fda-approval-for-high-frequency-neurostimulation-painful-diabetic-neuropathy\n",
      "2021-07-19\n",
      "MedTech\n",
      "Ancora nets $80M for ventricle-binding heart failure treatment\n",
      "https://www.fiercebiotech.com/medtech/ancora-heart-stitches-up-80m-for-its-ventricle-reshaping-treatment-for-heart-failure\n",
      "2021-07-19\n",
      "MedTech\n",
      "Obesity devicemaker Gelesis maps out $1.3B SPAC deal\n",
      "https://www.fiercebiotech.com/medtech/gelesis-to-take-its-stomach-filling-weight-loss-device-public-1-3b-spac-merger\n",
      "2021-07-19\n",
      "MedTech\n",
      "Merck oncology exec Haining goes full-time at ArsenalBio\n",
      "https://www.fiercebiotech.com/biotech/merck-oncology-exec-haining-goes-full-time-at-cell-therapy-player-arsenalbio\n",
      "2021-07-19\n",
      "Biotech\n",
      "AstraZeneca hands off rights to pneumonia med for $11M upfront\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-hands-off-rights-to-pneumonia-prevention-medicine-for-11m-upfront-but-keeps-a\n",
      "2021-07-19\n",
      "Biotech\n",
      "3-peat Friday: Castle Creek, Eliem and Adagio file for IPOs\n",
      "https://www.fiercebiotech.com/biotech/castle-creek-eliem-and-adagio-three-biotechs-filed-for-ipos-friday-continued-public-frenzy\n",
      "2021-07-19\n",
      "Biotech\n",
      "Rome hires science leaders to find targets in 'junk DNA'\n",
      "https://www.fiercebiotech.com/biotech/rome-backed-by-arch-and-gv-hires-science-leaders-to-hit-targets-junk-dna\n",
      "2021-07-19\n",
      "Biotech\n",
      "Troubled Cytokinetics gets much-needed phase 2 trial win\n",
      "https://www.fiercebiotech.com/biotech/troubled-cytokinetics-gets-much-needed-phase-2-heart-drug-trial-win-plans-late-stage-effort\n",
      "2021-07-19\n",
      "Biotech\n",
      "Adagio seeks IPO to bring COVID-19 antibody to market in 2022\n",
      "https://www.fiercebiotech.com/biotech/adagio-seeks-ipo-to-bring-covid-19-antibody-to-market-2022\n",
      "2021-07-19\n",
      "Biotech\n",
      "2 pathways deal a one-two punch to melanoma cells\n",
      "https://www.fiercebiotech.com/research/two-pathways-prepare-and-kill-melanoma-cells-could-lead-to-novel-anticancer-drugs\n",
      "2021-07-16\n",
      "Research\n",
      "Dexcom gets FDA nod to pair CGMs with Garmin, Livongo and more\n",
      "https://www.fiercebiotech.com/medtech/dexcom-gets-fda-go-ahead-to-pair-diabetes-data-garmin-livongo-and-more-through-third-party\n",
      "2021-07-16\n",
      "MedTech\n",
      "Viz.ai adds Avicenna.AI's clot-spotting tech to triage platform\n",
      "https://www.fiercebiotech.com/medtech/viz-ai-upgrades-triage-platform-avicenna-ai-s-pulmonary-embolism-aortic-dissection\n",
      "2021-07-16\n",
      "MedTech\n",
      "Cheeky GSK drops data for anemia drug after competitors stumble\n",
      "https://www.fiercebiotech.com/biotech/while-fibrogen-and-astrazeneca-stumble-cheeky-gsk-drops-competing-data-for-anemia-drug\n",
      "2021-07-16\n",
      "Biotech\n",
      "Regeneron is blueprinting a major investment in New York R&D\n",
      "https://www.fiercebiotech.com/biotech/regeneron-eyes-1-8b-r-d-upgrade-at-tarrytown-campus-where-it-plans-to-enlist-1-000-new\n",
      "2021-07-16\n",
      "Biotech\n",
      "Erasca nabs $300M IPO to attack cancer's favorite pathway\n",
      "https://www.fiercebiotech.com/biotech/tight-lipped-no-more-erasca-nabs-300m-ipo-to-attack-cancer-s-favorite-pathway\n",
      "2021-07-16\n",
      "Biotech\n",
      "Canon taps Cleerly to add AI imaging analysis to cardiac CT\n",
      "https://www.fiercebiotech.com/medtech/canon-medical-thinks-cleerly-to-combine-ai-imaging-analysis-cardiac-ct-tech\n",
      "2021-07-16\n",
      "MedTech\n",
      "Anticancer Bioscience snags Eureka R&D VP—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-anticancer-bioscience-picks-up-eureka-r-d-vp-for-similar-role\n",
      "2021-07-16\n",
      "Biotech\n",
      "Polyphor to lay off staff, shutter failed breast cancer phase 3\n",
      "https://www.fiercebiotech.com/biotech/polyphor-to-lay-off-staff-shutter-failed-breast-cancer-phase-3\n",
      "2021-07-16\n",
      "Biotech\n",
      "GSK to sell part of U.K. R&D site up to form biotech cluster\n",
      "https://www.fiercebiotech.com/biotech/gsk-to-sell-part-u-k-r-d-site-up-to-form-biotech-cluster\n",
      "2021-07-16\n",
      "Biotech\n",
      "AbbVie-backed Stemson grows $15M for hairy feud in graying field\n",
      "https://www.fiercebiotech.com/biotech/abbvie-backed-stemson-snags-15m-series-a-for-hairy-brush-up-rogaine-propecia\n",
      "2021-07-15\n",
      "Biotech\n",
      "Hong Kong diagnostics maker Prenetics eyes $1.3B SPAC: report\n",
      "https://www.fiercebiotech.com/medtech/oxford-s-covid-diagnostics-partner-prenetics-eyeing-1-3b-spac-deal-report\n",
      "2021-07-15\n",
      "MedTech\n",
      "Imperative Care nets $260M, adds acquisition to stroke portfolio\n",
      "https://www.fiercebiotech.com/medtech/imperative-care-nets-260m-new-acquisition-to-build-out-stroke-care-portfolio\n",
      "2021-07-15\n",
      "MedTech\n",
      "Ipsen pays $28M upfront for IRLAB's Phase 2b Parkinson's drug\n",
      "https://www.fiercebiotech.com/biotech/ipsen-pens-28m-upfront-up-to-335m-biobuck-deal-for-irlab-s-late-stage-parkinson-s-candidate\n",
      "2021-07-15\n",
      "Biotech\n",
      "HeartFlow pumps up AI cardiac test with $2.4B SPAC deal\n",
      "https://www.fiercebiotech.com/medtech/heartflow-pumps-up-its-ai-powered-heart-disease-test-planned-2-4b-spac-deal\n",
      "2021-07-15\n",
      "MedTech\n",
      "Illumina faces months-long EU probe over Grail takeover: report\n",
      "https://www.fiercebiotech.com/medtech/illumina-faces-months-long-eu-antitrust-probe-over-grail-acquisition-report\n",
      "2021-07-15\n",
      "MedTech\n",
      "Shape Therapeutics reels in $112M to spur RNA editing tech\n",
      "https://www.fiercebiotech.com/biotech/shape-therapeutics-reels-112m-to-spur-rna-editing-tech\n",
      "2021-07-15\n",
      "Biotech\n",
      "Adlai Nortye bags another $100M for immuno-oncology pipeline\n",
      "https://www.fiercebiotech.com/biotech/adlai-nortye-matches-2020-series-c-100m-series-d-for-immuno-oncology-pipeline\n",
      "2021-07-15\n",
      "Biotech\n",
      "Palo Santo launches with $35M to support psychedelics companies\n",
      "https://www.fiercebiotech.com/biotech/psychedelics-for-mental-health-palo-santo-launches-35m-fund-for-20-plus-companies\n",
      "2021-07-15\n",
      "Biotech\n",
      "Brain implant translates paralyzed patient’s thoughts to speech\n",
      "https://www.fiercebiotech.com/medtech/brain-implant-helps-paralyzed-patient-communicate-by-translating-thoughts-into-full\n",
      "2021-07-15\n",
      "MedTech\n",
      "Brain-targeted gene therapy shows promise in rare neuro disease\n",
      "https://www.fiercebiotech.com/research/gene-therapy-delivered-to-brain-shows-promise-children-rare-neurodegenerative-disease\n",
      "2021-07-15\n",
      "Research\n",
      "Biogen's Aduhelm win opened up market frenzy in Alzheimer's\n",
      "https://www.fiercebiotech.com/biotech/biogen-s-aduhelm-win-opened-up-market-frenzy-for-alzheimer-s-focused-companies\n",
      "2021-07-15\n",
      "Biotech\n",
      "Galapagos' key anti-inflammatory drug fails in phase 2\n",
      "https://www.fiercebiotech.com/biotech/galapagos-key-sik-drug-fails-to-beat-placebo-midphase-trials\n",
      "2021-07-15\n",
      "Biotech\n",
      "Wugen banks $172M for off-the-shelf cell therapies\n",
      "https://www.fiercebiotech.com/biotech/new-ceo-check-172m-round-check-wugen-s-off-shelf-cell-therapies-are-ready-for-take-off\n",
      "2021-07-15\n",
      "Biotech\n",
      "Don't blink: PAQ gobbles up $30M series A to ink autophagy era\n",
      "https://www.fiercebiotech.com/biotech/paq-therapeutics-emerges-30m-series-a-for-autophagy-based-treatments\n",
      "2021-07-15\n",
      "Biotech\n",
      "Moderna tops $100B valuation, matching GSK\n",
      "https://www.fiercebiotech.com/biotech/a-tale-two-bio-cities-moderna-tops-100b-valuation-matching-glaxosmithkline\n",
      "2021-07-15\n",
      "Biotech\n",
      "Rockley unveils wrist sensor that may be used in the Apple Watch\n",
      "https://www.fiercebiotech.com/medtech/rockley-photonics-unveils-clinic-wrist-system-offering-a-glimpse-at-apple-watch-s-future\n",
      "2021-07-14\n",
      "MedTech\n",
      "Controlling Alzheimer's by targeting immune signaling\n",
      "https://www.fiercebiotech.com/research/controlling-alzheimer-s-disease-via-immune-signaling-between-brain-cells\n",
      "2021-07-14\n",
      "Research\n",
      "Kriya grabs $100M to bankroll gene therapies for common diseases\n",
      "https://www.fiercebiotech.com/biotech/kriya-grabs-100m-to-bankroll-gene-therapies-for-diabetes-other-prevalent-diseases\n",
      "2021-07-14\n",
      "Biotech\n",
      "Brii, now public, expects Q4 COVID-19 antibody cocktail readout\n",
      "https://www.fiercebiotech.com/biotech/brii-s-covid-19-antibody-cocktail-remains-active-against-variants-expects-q4-data-readout\n",
      "2021-07-14\n",
      "Biotech\n",
      "Entos collects $53M to bring quantum tech to AI drug design\n",
      "https://www.fiercebiotech.com/medtech/entos-collects-53m-to-bring-quantum-tech-to-ai-drug-design\n",
      "2021-07-14\n",
      "MedTech\n",
      "PathAI walks the Walk with Roche vet as new CMO\n",
      "https://www.fiercebiotech.com/medtech/roche-s-walk-strolls-over-to-pathai-as-pathology-startup-s-new-chief-medical-officer\n",
      "2021-07-14\n",
      "MedTech\n",
      "ACB hires Liu from Eureka Therapeutics to lead push into clinic\n",
      "https://www.fiercebiotech.com/biotech/acb-hires-liu-from-eureka-therapeutics-to-lead-push-into-clinic\n",
      "2021-07-14\n",
      "Biotech\n",
      "Ribon raises $65M to take PARP7 inhibitor deeper into the clinic\n",
      "https://www.fiercebiotech.com/biotech/ribon-backed-by-biopharma-majors-raises-65m-to-take-parp7-inhibitor-deeper-into-clinic\n",
      "2021-07-14\n",
      "Biotech\n",
      "Eli Lilly's $1B buyout brings smart insulin tech under its wing\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-s-1b-buyout-bet-for-protomer-sees-it-grab-next-frontier-smart-insulin-tech\n",
      "2021-07-14\n",
      "Biotech\n",
      "Castor secures $45M to mainstream burgeoning siteless trials\n",
      "https://www.fiercebiotech.com/cro/castor-raises-45m-series-b-amid-hot-decentralized-clinical-trial-environment\n",
      "2021-07-14\n",
      "CRO\n",
      "Aidoc secures $66M to help meet demand for AI imaging programs\n",
      "https://www.fiercebiotech.com/medtech/aidoc-secures-66m-to-help-meet-demand-for-ai-imaging-programs\n",
      "2021-07-14\n",
      "MedTech\n",
      "FDA stands by Aduhelm approval, use of accelerated pathway\n",
      "https://www.fiercebiotech.com/biotech/fda-stands-by-aduhelm-approval-use-accelerated-pathway-new-journal-post\n",
      "2021-07-13\n",
      "Biotech\n",
      "MOBILion Systems nets $60M for mass spectrometry tech\n",
      "https://www.fiercebiotech.com/medtech/mobilion-systems-racks-up-another-60m-to-bring-faster-smarter-mass-spectrometry-to\n",
      "2021-07-13\n",
      "MedTech\n",
      "ISA Pharma snags $30M from Regeneron, others for HPV16 hopeful\n",
      "https://www.fiercebiotech.com/biotech/isa-pharma-raises-30m-from-regeneron-others-to-bring-hpv16-treatment-to-market\n",
      "2021-07-13\n",
      "Biotech\n",
      "Hepion NASH drug clears safety bar, ready for phase 2b\n",
      "https://www.fiercebiotech.com/biotech/hepion-s-nash-drug-ready-for-phase-2b-after-clearing-safety-bar-dropping-efficacy\n",
      "2021-07-13\n",
      "Biotech\n",
      "Sofinnova Partners nets $75M for 3rd medtech accelerator fund\n",
      "https://www.fiercebiotech.com/medtech/sofinnova-partners-nets-75m-for-third-medtech-accelerator-fund\n",
      "2021-07-13\n",
      "MedTech\n",
      "Stryker scores FDA OK for rotator cuff balloon spacer\n",
      "https://www.fiercebiotech.com/medtech/a-decade-after-eu-debut-stryker-s-balloon-implant-for-shoulder-tears-lands-stateside-fda\n",
      "2021-07-13\n",
      "MedTech\n",
      "Ionis pays $45M to expand oligonucleotide delivery toolkit\n",
      "https://www.fiercebiotech.com/biotech/ionis-pays-bicycle-45m-to-expand-oligonucleotide-delivery-toolkit\n",
      "2021-07-13\n",
      "Biotech\n",
      "Nimbus raises $105M for multifront TYK2 clinical trial program\n",
      "https://www.fiercebiotech.com/biotech/nimbus-raises-105m-for-multi-front-tyk2-clinical-trial-program\n",
      "2021-07-13\n",
      "Biotech\n",
      "With steep drop in COVID test sales, Qiagen slashes 2021 outlook\n",
      "https://www.fiercebiotech.com/medtech/qiagen-slashes-full-year-forecast-as-covid-test-sales-plummet-17-q2\n",
      "2021-07-13\n",
      "MedTech\n",
      "CRISPR corrects genetic disease before and after birth in mice\n",
      "https://www.fiercebiotech.com/research/upenn-team-uses-crispr-to-edit-out-genetic-disease-before-and-after-birth-mice\n",
      "2021-07-13\n",
      "Research\n",
      "Prime launches with $315M, 'search and replace' gene editing\n",
      "https://www.fiercebiotech.com/biotech/prime-medicine-uncloaks-315m-to-push-search-and-replace-gene-editing-treatments\n",
      "2021-07-13\n",
      "Biotech\n",
      "Biogen taps Chinese biotech InnoCare in $125M MS drug pact\n",
      "https://www.fiercebiotech.com/biotech/biogen-taps-chinese-biotech-innocare-125m-midstage-ms-drug-pact\n",
      "2021-07-13\n",
      "Biotech\n",
      "AliveCor scores QT prolongation clearance for its personal ECG\n",
      "https://www.fiercebiotech.com/medtech/alivecor-scores-qt-prolongation-clearance-for-its-portable-ecg-to-track-dangerous-drug-side\n",
      "2021-07-12\n",
      "MedTech\n",
      "Imago eyes $105M IPO to fuel blood cancer programs\n",
      "https://www.fiercebiotech.com/biotech/imago-eyes-105m-ipo-to-fuel-blood-cancer-programs\n",
      "2021-07-12\n",
      "Biotech\n",
      "Quidel scores EU approval for combined COVID, flu, RSV test\n",
      "https://www.fiercebiotech.com/medtech/heels-covid-19-test-recall-quidel-notches-a-win-ce-mark-for-combined-covid-flu-rsv\n",
      "2021-07-12\n",
      "MedTech\n",
      "FibroGen taps 2nd CSO in 10 months, snagging ex-Compugen exec\n",
      "https://www.fiercebiotech.com/biotech/fibrogen-nabs-second-chief-scientific-officer-less-than-a-year-snagging-former-compugen-cso\n",
      "2021-07-12\n",
      "Biotech\n",
      "Government oversight of COVID air cleaners leaves gaping holes\n",
      "https://www.fiercebiotech.com/medtech/government-oversight-covid-air-cleaners-leaves-gaping-holes\n",
      "2021-07-12\n",
      "MedTech\n",
      "Merck KGaA taps Spanish graphene firm for bioelectric therapies\n",
      "https://www.fiercebiotech.com/medtech/merck-kgaa-taps-spanish-graphene-startup-for-ultra-fine-smart-neuromodulation-therapies\n",
      "2021-07-12\n",
      "MedTech\n",
      "Case closed: Sherlock Biosciences finds new CEO\n",
      "https://www.fiercebiotech.com/medtech/sherlock-biosciences-solves-c-suite-mystery-tapping-myriad-genetics-dechairo-as-ceo\n",
      "2021-07-12\n",
      "MedTech\n",
      "Poxel pivots to midphase rare metabolic disease programs\n",
      "https://www.fiercebiotech.com/biotech/poxel-pivots-to-mid-phase-rare-metabolic-disease-programs\n",
      "2021-07-12\n",
      "Biotech\n",
      "Novo Nordisk pays Prothena $100M for ATTR drug\n",
      "https://www.fiercebiotech.com/biotech/novo-nordisk-pays-prothena-100m-for-attr-drug-teeing-up-alnylam-challenge-and\n",
      "2021-07-12\n",
      "Biotech\n",
      "After cancer flops, Celldex shows promise in treating hives\n",
      "https://www.fiercebiotech.com/biotech/years-after-cancer-flops-revamped-celldex-shows-promise-treating-hives\n",
      "2021-07-12\n",
      "Biotech\n",
      "Tenaya Therapeutics decides now is the time to IPO\n",
      "https://www.fiercebiotech.com/biotech/targets-lined-up-and-a-106m-raise-year-tenaya-therapeutics-decides-now-time-to-ipo\n",
      "2021-07-12\n",
      "Biotech\n",
      "BGI Genomics shares DNA test data with Chinese army: Reuters\n",
      "https://www.fiercebiotech.com/medtech/bgi-genomics-accused-partnering-chinese-military-to-harvest-data-from-prenatal-tests\n",
      "2021-07-09\n",
      "MedTech\n",
      "Abbott begins laying off workers as COVID test demand evaporates\n",
      "https://www.fiercebiotech.com/medtech/abbott-begins-laying-off-hundreds-workers-as-covid-test-demand-evaporates-report\n",
      "2021-07-09\n",
      "MedTech\n",
      "FDA puts Sigilon's hemophilia cell therapy trial on hold\n",
      "https://www.fiercebiotech.com/biotech/fda-puts-sigilon-s-hemophilia-cell-therapy-trial-hold-thanks-to-safety-concerns\n",
      "2021-07-09\n",
      "Biotech\n",
      "AbbVie, Biogen, Pfizer launch public genome-disease database\n",
      "https://www.fiercebiotech.com/medtech/abbvie-biogen-pfizer-launch-public-gene-associated-disease-database\n",
      "2021-07-09\n",
      "MedTech\n",
      "St. Jude Medical, Alere settle DOJ false claims allegations\n",
      "https://www.fiercebiotech.com/medtech/st-jude-medical-alere-pay-combined-65m-to-settle-doj-claims-they-knowingly-sold-defective\n",
      "2021-07-09\n",
      "MedTech\n",
      "I-Mab boards mRNA, AI trains with 2 biotech collaboration deals\n",
      "https://www.fiercebiotech.com/biotech/i-mab-boards-popular-mrna-train-two-biotech-collaborations-following-march-deals\n",
      "2021-07-09\n",
      "Biotech\n",
      "Hyperfine to take portable MRI public in rare double-SPAC deal\n",
      "https://www.fiercebiotech.com/medtech/portable-mri-maker-hyperfine-to-go-public-add-brain-sensing-tech-rare-double-spac-deal\n",
      "2021-07-09\n",
      "MedTech\n",
      "Ovid staff shuffle reads like a who's who of Big Pharma\n",
      "https://www.fiercebiotech.com/biotech/ovid-staff-shuffle-reads-like-a-who-s-who-big-pharma-as-biotech-pivots-from-angelman\n",
      "2021-07-09\n",
      "Biotech\n",
      "GSK oncology head leaves for biotech Scorpion—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-4\n",
      "2021-07-09\n",
      "Biotech\n",
      "J&J, Vor ally to assess bispecific and stem cell therapy in AML\n",
      "https://www.fiercebiotech.com/biotech/j-j-vor-ally-to-assess-bispecific-and-stem-cell-therapy-aml\n",
      "2021-07-09\n",
      "Biotech\n",
      "U.K. regulator accepts Humanigen's COVID drug for speedy review\n",
      "https://www.fiercebiotech.com/biotech/u-k-regulator-accepts-humanigen-s-covid-drug-for-speedy-review-as-analysts-spell-out\n",
      "2021-07-09\n",
      "Biotech\n",
      "Muna raises $73M to go after Alzheimer's, Parkinson's and MS\n",
      "https://www.fiercebiotech.com/biotech/muna-raises-73m-to-go-after-alzheimer-s-parkinson-s-and-ms\n",
      "2021-07-09\n",
      "Biotech\n",
      "Sight Sciences pitches $150M IPO for its eye treatment devices\n",
      "https://www.fiercebiotech.com/medtech/sight-sciences-pitches-150m-ipo-for-its-glaucoma-dry-eye-devices\n",
      "2021-07-09\n",
      "MedTech\n",
      "Quidel recalls COVID-19 PCR tests over risk of false negatives\n",
      "https://www.fiercebiotech.com/medtech/quidel-recalls-a-year-s-worth-covid-19-pcr-tests-over-significant-risk-false-negatives\n",
      "2021-07-08\n",
      "MedTech\n",
      "Stem cell defense against RNA viruses could inspire COVID R&D\n",
      "https://www.fiercebiotech.com/research/stem-cells-show-promise-protecting-themselves-from-rna-viruses-like-sars-cov-2\n",
      "2021-07-08\n",
      "Research\n",
      "Alpha Tau to take its tumor-blasting tech public in SPAC deal\n",
      "https://www.fiercebiotech.com/medtech/alpha-tau-hops-aboard-spac-train-367m-deal-to-take-its-tumor-blasting-tech-public\n",
      "2021-07-08\n",
      "MedTech\n",
      "Merck KGaA's new Swiss biotech center inches closer to opening\n",
      "https://www.fiercebiotech.com/biotech/merck-kgaa-focused-optimizing-highly-complex-manufacturing-process-new-biotech-center\n",
      "2021-07-08\n",
      "Biotech\n",
      "Xilis’ organoid-generating platform for cancer care nets $70M\n",
      "https://www.fiercebiotech.com/medtech/xilis-nets-70m-to-build-out-organoid-generating-platform-for-cancer-treatment-drug\n",
      "2021-07-08\n",
      "MedTech\n",
      "Britain bets on biotech as billions set to boost life sciences\n",
      "https://www.fiercebiotech.com/biotech/britain-bets-biotech-as-billions-set-to-pour-for-life-sciences-boost\n",
      "2021-07-08\n",
      "Biotech\n",
      "AstraZeneca could dole out $300M for F-star's STING inhibitor\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-to-pay-f-star-12m-and-maybe-300m-more-for-preclinical-sting-inhibitors\n",
      "2021-07-08\n",
      "Biotech\n",
      "Differences in survival spark FDA hold on Oncopeptides' drug\n",
      "https://www.fiercebiotech.com/biotech/large-differences-phase-3-overall-survival-spark-fda-hold-oncopeptides-multiple-myeloma\n",
      "2021-07-08\n",
      "Biotech\n",
      "FDA grants priority review to Amgen-AstraZeneca asthma drug\n",
      "https://www.fiercebiotech.com/biotech/fda-grants-priority-review-to-amgen-astrazeneca-asthma-drug\n",
      "2021-07-08\n",
      "Biotech\n",
      "Eli Lilly taps Verge Genomics in ALS deal worth $25M upfront\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-taps-verge-genomics-als-deal-worth-25m-upfront\n",
      "2021-07-08\n",
      "Biotech\n",
      "Cel-Sci CEO tries to spin cancer trial failure into an FDA win\n",
      "https://www.fiercebiotech.com/biotech/data-mining-and-p-value-hacking-cel-sci-ceo-tries-to-spin-cancer-trial-failure-into-a-win\n",
      "2021-07-07\n",
      "Biotech\n",
      "GSK oncology exec Hoos lands at Scorpion Therapeutics as CEO\n",
      "https://www.fiercebiotech.com/biotech/gsk-oncology-exec-hoos-heads-back-to-biotech-as-ceo-scorpion-therapeutics\n",
      "2021-07-07\n",
      "Biotech\n",
      "Nuvalent newest biotech to file for $100M IPO to fund 2 trials\n",
      "https://www.fiercebiotech.com/biotech/nuvalent-files-for-customary-100m-ipo-six-months-after-launching\n",
      "2021-07-07\n",
      "Biotech\n",
      "GE, Sophia Genetics pool resources to tag-team cancer care\n",
      "https://www.fiercebiotech.com/medtech/ge-healthcare-sophia-genetics-to-tag-team-cancer-care-patient-specific-treatment-matching\n",
      "2021-07-07\n",
      "MedTech\n",
      "Thermo Fisher names first CMO to support clinical efforts\n",
      "https://www.fiercebiotech.com/medtech/for-a-post-covid-world-thermo-fisher-names-first-chief-medical-officer-to-oversee-clinical\n",
      "2021-07-07\n",
      "MedTech\n",
      "Moderna's first seasonal flu shot candidate slides into clinic\n",
      "https://www.fiercebiotech.com/biotech/moderna-s-first-flu-vaccine-candidate-slides-into-clinic-as-pharma-giants-crowd-into-mrna\n",
      "2021-07-07\n",
      "Biotech\n",
      "Ex-Immunomedics CEO takes the wheel at Danish ADC player\n",
      "https://www.fiercebiotech.com/biotech/ex-immunomedics-ceo-takes-wheel-at-danish-adc-player\n",
      "2021-07-07\n",
      "Biotech\n",
      "Surmodics gets the blood flowing with $40M thrombectomy deal\n",
      "https://www.fiercebiotech.com/medtech/surmodics-gets-blood-flowing-40m-thrombectomy-acquisition-deal\n",
      "2021-07-07\n",
      "MedTech\n",
      "Philips launches new study, AI partnership to boost stroke care\n",
      "https://www.fiercebiotech.com/medtech/philips-zeroes-stroke-care-new-triage-study-and-ai-partnership\n",
      "2021-07-07\n",
      "MedTech\n",
      "Improving I-O by reactivating the 'guardian of the genome'\n",
      "https://www.fiercebiotech.com/research/improving-response-to-cancer-immunotherapy-by-reactivating-guardian-genome\n",
      "2021-07-07\n",
      "Research\n",
      "Chasing Merck, Arrowhead posts early data on anti-cancer RNAi\n",
      "https://www.fiercebiotech.com/biotech/chasing-merck-arrowhead-posts-early-data-anticancer-rnai\n",
      "2021-07-07\n",
      "Biotech\n",
      "MIT team creates disease-sensing cell 'circuits'\n",
      "https://www.fiercebiotech.com/research/mit-team-employs-synthetic-biology-to-create-circuits-could-detect-signs-disease\n",
      "2021-07-07\n",
      "Research\n",
      "VitriVax bags funding for thermostable, single-dose vaccine R&D\n",
      "https://www.fiercebiotech.com/biotech/vitrivax-bags-funding-for-thermostable-single-dose-vaccine-r-d\n",
      "2021-07-07\n",
      "Biotech\n",
      "Locanabio nabs CRISPR Tx in vivo head as CSO and Audentes' CMO\n",
      "https://www.fiercebiotech.com/biotech/locanabio-picks-up-ex-crispr-tx-sanofi-head-as-chief-scientific-officer-also-snags-cmo\n",
      "2021-07-06\n",
      "Biotech\n",
      "Medtronic recalls unsterilized angiography guidewires\n",
      "https://www.fiercebiotech.com/medtech/medtronic-recalls-55-000-angiography-guidewires-weren-t-sterilized-before-shipping\n",
      "2021-07-06\n",
      "MedTech\n",
      "Amgen snags ex-AstraZeneca oncology R&D lead for similar post\n",
      "https://www.fiercebiotech.com/biotech/amgen-hires-former-astrazeneca-oncology-r-d-lead-to-fill-similar-role\n",
      "2021-07-06\n",
      "Biotech\n",
      "Sanofi snags multiple myeloma treatment rights for $1B or more\n",
      "https://www.fiercebiotech.com/biotech/sanofi-could-pay-over-1b-biobucks-for-rights-to-eureka-s-multiple-myeloma-treatment\n",
      "2021-07-06\n",
      "Biotech\n",
      "Rallybio tees up $100M IPO to propel rare disease programs\n",
      "https://www.fiercebiotech.com/biotech/rallybio-tees-up-100m-ipo-to-fund-treatments-for-rare-fetal-bleeding-disorder\n",
      "2021-07-06\n",
      "Biotech\n",
      "Unity posts positive phase 1 data for vascular eye disease\n",
      "https://www.fiercebiotech.com/biotech/unity-shows-promising-results-phase-1-for-advanced-vascular-eye-disease-treatment\n",
      "2021-07-06\n",
      "Biotech\n",
      "Ocugen climbs on phase 3 COVID vaccine data\n",
      "https://www.fiercebiotech.com/biotech/ocugen-climbs-phase-3-covid-vaccine-data-hitting-back-at-delta-variant\n",
      "2021-07-06\n",
      "Biotech\n",
      "Linus Health rakes in $55M for Alzheimer's screening platform\n",
      "https://www.fiercebiotech.com/medtech/linus-health-rakes-55m-for-early-alzheimer-s-screening-monitoring-platform\n",
      "2021-07-06\n",
      "MedTech\n",
      "Lilly invests in MiNA to fund trials of protein-upregulating RNA\n",
      "https://www.fiercebiotech.com/biotech/lilly-invests-mina-to-fund-trials-protein-upregulating-rna\n",
      "2021-07-06\n",
      "Biotech\n",
      "Provention Bio slapped with FDA rejection for diabetes hopeful\n",
      "https://www.fiercebiotech.com/biotech/provention-bio-slapped-fda-rejection-for-diabetes-hopeful-teplizumab\n",
      "2021-07-06\n",
      "Biotech\n",
      "Leo taps X-Chem to discover anti-inflammatory dermatology drugs\n",
      "https://www.fiercebiotech.com/biotech/leo-taps-x-chem-to-discover-anti-inflammatory-dermatology-drugs\n",
      "2021-07-06\n",
      "Biotech\n",
      "Rallybio gets proof-of-concept for fetal bleeding disorder drug\n",
      "https://www.fiercebiotech.com/biotech/fierce15-winner-rallybio-establishes-proof-concept-phase-1-2-study-for-rare-fetal-bleeding\n",
      "2021-07-02\n",
      "Biotech\n",
      "Parexel snapped up, again, as Goldman Sachs, EQT spend $8.5B\n",
      "https://www.fiercebiotech.com/cro/parexel-snapped-up-again-as-goldman-sachs-eqt-spend-8-5b-cro\n",
      "2021-07-02\n",
      "CRO\n",
      "IBM, Johns Hopkins tackle COVID vax concerns with new chatbot\n",
      "https://www.fiercebiotech.com/medtech/no-microchips-here-ibm-johns-hopkins-unveil-ai-chatbot-to-address-covid-19-vaccine\n",
      "2021-07-02\n",
      "MedTech\n",
      "Targeting tumor-driving RNA proteins in aggressive breast cancer\n",
      "https://www.fiercebiotech.com/research/new-approach-to-triple-negative-breast-cancer-targets-tumor-driving-rna-proteins\n",
      "2021-07-02\n",
      "Research\n",
      "Sirnaomics nabs a rare series E worth $105M\n",
      "https://www.fiercebiotech.com/biotech/eschewing-ipo-for-now-sirnaomics-nabs-a-rare-series-e-worth-105m-for-its-next-gen-rna-work\n",
      "2021-07-02\n",
      "Biotech\n",
      "FDA finds faults in Iterum filing as decision date looms\n",
      "https://www.fiercebiotech.com/biotech/fda-finds-faults-iterum-antibiotic-filing-decision-date-looming\n",
      "2021-07-02\n",
      "Biotech\n",
      "Arrowhead slams the brakes on phase 1/2 cystic fibrosis study\n",
      "https://www.fiercebiotech.com/biotech/arrowhead-slams-brakes-cystic-fibrosis-study-after-lung-inflammation-concerns-emerge-from\n",
      "2021-07-02\n",
      "Biotech\n",
      "Roche vet leaves Nordic Nanovector 3 months after joining as CEO\n",
      "https://www.fiercebiotech.com/biotech/roche-vet-leaves-nordic-nanovector-3-months-after-joining-as-ceo\n",
      "2021-07-02\n",
      "Biotech\n",
      "Philips' 3D ECG catheter used in first heart procedure\n",
      "https://www.fiercebiotech.com/medtech/philips-3d-echocardiogram-catheter-goes-live-mayo-clinic-heart-procedure\n",
      "2021-07-02\n",
      "MedTech\n",
      "AstraZeneca names Galbraith to lead cancer R&D—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-astrazeneca-internally-promotes-galbraith-to-helm-cancer-r-d\n",
      "2021-07-02\n",
      "Biotech\n",
      "WCG guns for a $100M IPO amid a boon in the CRO sector\n",
      "https://www.fiercebiotech.com/cro/wcg-guns-for-a-100m-ipo-amid-a-boon-cro-sector-as-it-recovers-from-covid-chaos\n",
      "2021-07-02\n",
      "CRO\n",
      "Lundbeck sells Alzheimer's drug that failed 3 late-phase trials\n",
      "https://www.fiercebiotech.com/biotech/lundbeck-sells-rights-to-alzheimer-s-drug-failed-3-late-phase-trials\n",
      "2021-07-02\n",
      "Biotech\n",
      "Astronauts perform first CRISPR gene-editing studies in space\n",
      "https://www.fiercebiotech.com/medtech/astronauts-perform-first-crispr-gene-editing-studies-space\n",
      "2021-07-02\n",
      "MedTech\n",
      "EchoNous nabs $60M to launch hand-held AI ultrasound device\n",
      "https://www.fiercebiotech.com/medtech/echonous-shoots-for-stars-60m-for-kosmos-handheld-ai-ultrasound-device\n",
      "2021-07-02\n",
      "MedTech\n",
      "GSK, under pressure to perform, pens $2.2B deal with Alector\n",
      "https://www.fiercebiotech.com/biotech/gsk-under-pressure-to-perform-pens-2-2b-deal-alector-focused-neuro-r-d-alzheimer-s\n",
      "2021-07-02\n",
      "Biotech\n",
      "Caribou eyes $100M IPO, aims off-the-shelf CAR-Ts at the clinic\n",
      "https://www.fiercebiotech.com/biotech/caribou-eyes-100m-ipo-as-it-aims-off-shelf-car-ts-at-clinic\n",
      "2021-07-01\n",
      "Biotech\n",
      "Acumen surges in IPO debut, raises $160M for Alzheimer's drug\n",
      "https://www.fiercebiotech.com/biotech/acumen-surges-first-day-trading-following-aduhelm-approval-lilly-alzheimer-s-developments\n",
      "2021-07-01\n",
      "Biotech\n",
      "Regeneron pinpoints gene variants that protect against obesity\n",
      "https://www.fiercebiotech.com/research/regeneron-pinpoints-gene-variant-protects-against-obesity-and-launches-search-for-new\n",
      "2021-07-01\n",
      "Research\n",
      "FDA pulls N95 decontamination approvals as mask supplies rebound\n",
      "https://www.fiercebiotech.com/medtech/fda-revokes-kn95-and-reuse-green-lights-as-mask-supplies-begin-to-rebound\n",
      "2021-07-01\n",
      "MedTech\n",
      "Nestlé, Seres re-up microbiome partnership in $175M deal\n",
      "https://www.fiercebiotech.com/biotech/nestle-doubles-down-seres-partnership-ponying-up-175m-for-rights-to-c-diff-treatment\n",
      "2021-07-01\n",
      "Biotech\n",
      "Aditum launches Ancora with rights to Taisho's depression drug\n",
      "https://www.fiercebiotech.com/biotech/aditum-launches-fifth-biotech-rights-to-taisho-phase-2-drug-for-depression\n",
      "2021-07-01\n",
      "Biotech\n",
      "NuVasive snags expanded CE mark for Pulse spine surgery platform\n",
      "https://www.fiercebiotech.com/medtech/updated-european-approval-nuvasive-eyes-late-summer-launch-for-spine-surgery-platform\n",
      "2021-07-01\n",
      "MedTech\n",
      "Gene therapy repairs cardiac tissue after heart attack in pigs\n",
      "https://www.fiercebiotech.com/research/gene-therapy-repairs-cardiac-tissue-after-heart-attack-animals\n",
      "2021-07-01\n",
      "Research\n",
      "Novavax pledges to help verify COVID vaccine trial participants\n",
      "https://www.fiercebiotech.com/biotech/novavax-pledges-to-help-verify-covid-vaccine-trial-participants-as-world-opens-back-up-to\n",
      "2021-07-01\n",
      "Biotech\n",
      "Roche mulls slashing 300 to 400 jobs in product development\n",
      "https://www.fiercebiotech.com/biotech/roche-eyes-300-400-job-losses-product-development\n",
      "2021-07-01\n",
      "Biotech\n",
      "Former Sanofi exec joins $750M-funded EQRx to lead drug creation\n",
      "https://www.fiercebiotech.com/biotech/former-sanofi-executive-joins-low-price-focused-biotech-eqrx-to-lead-drug-creation\n",
      "2021-07-01\n",
      "Biotech\n",
      "Abbott racks up 2 new U.S., EU approvals for Xience stents\n",
      "https://www.fiercebiotech.com/medtech/abbott-racks-up-2-more-us-eu-approvals-for-xience-family-drug-eluting-stents\n",
      "2021-07-01\n",
      "MedTech\n",
      "FDA clears miniature surgical robot for needle-based procedures\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-miniature-surgical-robot-for-needle-based-procedures\n",
      "2021-07-01\n",
      "MedTech\n",
      "ObvioHealth picks up $31M amid booming virtual clinical trials\n",
      "https://www.fiercebiotech.com/cro/obviohealth-raises-31m-series-b-amid-funding-spree-for-decentralized-clinical-trials\n",
      "2021-07-01\n",
      "CRO\n",
      "UPDATE: Roche stays focused on phase 3 data for Alzheimer's drug\n",
      "https://www.fiercebiotech.com/biotech/roche-to-seek-early-fda-approval-for-alzheimer-s-drug-following-lilly-through-door-blown\n",
      "2021-07-01\n",
      "Biotech\n",
      "CureVac looks to subgroup to save failed COVID-19 vaccine\n",
      "https://www.fiercebiotech.com/biotech/curevac-looks-to-subgroup-to-save-failed-covid-19-vaccine-as-final-analysis-confirms-sub-50\n",
      "2021-07-01\n",
      "Biotech\n",
      "ASCO calls for more cancer patients in COVID-19 vaccine trials\n",
      "https://www.fiercebiotech.com/cro/asco-and-friends-push-for-more-cancer-patients-covid-19-vaccine-trials\n",
      "2021-07-01\n",
      "CRO\n",
      "With regular use, antigen, PCR tests are equally reliable: NIH\n",
      "https://www.fiercebiotech.com/medtech/nih-study-suggests-rapid-antigen-and-pcr-tests-for-covid-19-are-equally-reliable-when-used\n",
      "2021-06-30\n",
      "MedTech\n",
      "Apellis, Beam ink $75M gene-editing deal for complement diseases\n",
      "https://www.fiercebiotech.com/biotech/apellis-beam-ink-75m-deal-to-bring-gene-editing-meds-to-complement-diseases\n",
      "2021-06-30\n",
      "Biotech\n",
      "Cambridge study spots antimalarial, arthritis drugs for COVID\n",
      "https://www.fiercebiotech.com/research/computational-studies-pinpoint-antimalarial-arthritis-drugs-for-covid-19-repurposing\n",
      "2021-06-30\n",
      "Research\n",
      "Viz.ai eyes European debut with CE mark for stroke-detecting AI\n",
      "https://www.fiercebiotech.com/medtech/viz-ai-sets-its-sights-across-pond-ce-mark-for-stroke-detecting-ai\n",
      "2021-06-30\n",
      "MedTech\n",
      "Babson Dx draws in $31M for its pharmacy blood collection device\n",
      "https://www.fiercebiotech.com/medtech/babson-diagnostics-draws-up-31m-for-its-pharmacy-blood-collection-hardware\n",
      "2021-06-30\n",
      "MedTech\n",
      "Men dominate C-suite for small cap biotechs: an expert Q&A\n",
      "https://www.fiercebiotech.com/biotech/only-13-calls-to-make-men-dominate-c-suite-for-small-cap-biotechs-executive-search-firm\n",
      "2021-06-30\n",
      "Biotech\n",
      "Gilead files long-acting HIV med for patients with few options\n",
      "https://www.fiercebiotech.com/biotech/gilead-files-long-acting-hiv-med-for-patients-running-out-options\n",
      "2021-06-30\n",
      "Biotech\n",
      "Procept Biorobotics reels in $85M for prostate surgery system\n",
      "https://www.fiercebiotech.com/medtech/procept-biorobotics-reels-85m-to-roll-out-water-based-robotic-system-for-prostate-surgery\n",
      "2021-06-30\n",
      "MedTech\n",
      "ArriVent raises $150M to bring Chinese drugs to Western markets\n",
      "https://www.fiercebiotech.com/biotech/arrivent-raises-150m-to-bring-chinese-drugs-to-western-markets\n",
      "2021-06-30\n",
      "Biotech\n",
      "Philips unveils MRI tech for total heart scans in under 1 minute\n",
      "https://www.fiercebiotech.com/medtech/philips-puts-forward-new-mri-method-enabling-total-heart-scans-less-than-one-minute\n",
      "2021-06-30\n",
      "MedTech\n",
      "Roche, Atea's COVID drug slashes viral load in small test\n",
      "https://www.fiercebiotech.com/biotech/roche-and-atea-s-small-early-data-peek-sees-experimental-covid-drug-slash-viral-load\n",
      "2021-06-30\n",
      "Biotech\n",
      "Cerevel stock doubles on success of phase 1b schizophrenia trial\n",
      "https://www.fiercebiotech.com/biotech/cerevel-stock-doubles-success-phase-1b-schizophrenia-trial\n",
      "2021-06-30\n",
      "Biotech\n",
      "A double whammy for Altimmune's COVID-19 spray, therapeutic\n",
      "https://www.fiercebiotech.com/biotech/altimmune-to-ditch-covid-19-nasal-spray-vaccine-and-stop-enrollment-therapeutic-program\n",
      "2021-06-29\n",
      "Biotech\n",
      "Medtronic launches virtual clinical research app with afib study\n",
      "https://www.fiercebiotech.com/medtech/medtronic-launches-clinical-research-app-virtual-afib-management-study\n",
      "2021-06-29\n",
      "MedTech\n",
      "Abbott's at-home COVID-19 test approved for DTC sales in Europe\n",
      "https://www.fiercebiotech.com/medtech/abbott-s-at-home-rapid-antigen-covid-19-test-cleared-europe-for-dtc-sales\n",
      "2021-06-29\n",
      "MedTech\n",
      "COVID-19 biotech Pardes goes public via $276M SPAC deal\n",
      "https://www.fiercebiotech.com/biotech/foresite-s-2nd-spac-carries-covid-19-biotech-pardes-to-wall-street-276m-deal\n",
      "2021-06-29\n",
      "Biotech\n",
      "DNA sequencing upstart Element Biosciences raises $276M\n",
      "https://www.fiercebiotech.com/medtech/dna-sequencing-upstart-element-biosciences-raises-276m-ahead-its-first-product-launch\n",
      "2021-06-29\n",
      "MedTech\n",
      "Intellia hits a 'home run' with gene-editing results\n",
      "https://www.fiercebiotech.com/biotech/intellia-hits-a-home-run-gene-editing-results-setting-up-entire-field-for-a-grand-slam\n",
      "2021-06-29\n",
      "Biotech\n",
      "FDA approves Abiomed’s sensor-equipped Impella heart pump\n",
      "https://www.fiercebiotech.com/medtech/abiomed-scores-fda-approval-for-upgraded-dual-sensor-impella-heart-pump\n",
      "2021-06-29\n",
      "MedTech\n",
      "Cel-Sci cancer phase 3 misses primary endpoint, sinking stock\n",
      "https://www.fiercebiotech.com/biotech/cel-sci-cancer-phase-3-misses-primary-endpoint-sinking-stock\n",
      "2021-06-29\n",
      "Biotech\n",
      "Sanofi commits $476M a year to mRNA vaccine center\n",
      "https://www.fiercebiotech.com/biotech/sanofi-commits-476m-a-year-to-mrna-vaccine-center-race-to-expand-tech-beyond-covid-19\n",
      "2021-06-29\n",
      "Biotech\n",
      "4G Clinical gets $230M from Goldman Sachs to expand RTSM reach\n",
      "https://www.fiercebiotech.com/cro/4g-clinical-raises-230m-to-expand-its-rtsm-global-reach-product-capabilities\n",
      "2021-06-29\n",
      "CRO\n",
      "Orphazyme sharpens its ax as pipeline in a product bursts\n",
      "https://www.fiercebiotech.com/biotech/after-orphazyme-s-pipeline-a-product-bursts-inevitable-tide-turns-its-staffers\n",
      "2021-06-29\n",
      "Biotech\n",
      "Hanmi's Type 2 diabetes drug curbs cardiovascular, kidney issues\n",
      "https://www.fiercebiotech.com/biotech/ada-hanmi-s-glp-1-drug-returned-by-sanofi-curbs-cardiovascular-kidney-events-while-tackling\n",
      "2021-06-28\n",
      "Biotech\n",
      "Outsmarting cancer with RNA and other gene-altering therapies\n",
      "https://www.fiercebiotech.com/biotech/outsmarting-cancer-rna-genome-tuning-drugs-and-other-gene-altering-therapies\n",
      "2021-06-28\n",
      "Biotech\n",
      "Anavex's neuro drug slows decline in Parkinson's disease\n",
      "https://www.fiercebiotech.com/biotech/anavex-s-neuro-drug-slows-decline-parkinson-s-disease-as-it-boosts-levels-its-biomarker\n",
      "2021-06-28\n",
      "Biotech\n",
      "ADA: Medtronic’s InPen keeps diabetes patients in target range\n",
      "https://www.fiercebiotech.com/medtech/ada-use-medtronic-smart-insulin-pen-extends-diabetes-patients-time-target-blood-sugar-range\n",
      "2021-06-28\n",
      "MedTech\n",
      "FDA’s renewed focus on oncology dosing spooks investors\n",
      "https://www.fiercebiotech.com/biotech/fda-s-renewed-focus-oncology-dosing-spooks-investors-but-companies-say-they-were-ready\n",
      "2021-06-28\n",
      "Biotech\n",
      "ADA: Senseonics shows off accuracy for 180-day glucose sensor\n",
      "https://www.fiercebiotech.com/medtech/ada-senseonics-shows-off-long-term-accuracy-its-six-month-implanted-glucose-sensor\n",
      "2021-06-28\n",
      "MedTech\n",
      "Data management platform HealthVerity locks down $100M\n",
      "https://www.fiercebiotech.com/medtech/healthverity-locks-down-100m-series-d-to-grow-real-world-data-management-platform\n",
      "2021-06-28\n",
      "MedTech\n",
      "ADA: TB vaccine restores key immune cells in Type 1 diabetes\n",
      "https://www.fiercebiotech.com/research/ada-tb-vaccine-repurposed-type-1-diabetes-restores-gene-expression-key-immune-cells\n",
      "2021-06-28\n",
      "Research\n",
      "Lingering COVID can put the brakes on elective surgeries\n",
      "https://www.fiercebiotech.com/medtech/covid-s-lingering-effects-can-put-brakes-elective-surgeries\n",
      "2021-06-28\n",
      "MedTech\n",
      "ADA: Insulet's new Omnipod shows gains in preschoolers with T1D\n",
      "https://www.fiercebiotech.com/medtech/ada-insulet-s-automated-omnipod-drops-hba1c-preschoolers-type-1-diabetes\n",
      "2021-06-28\n",
      "MedTech\n",
      "AstraZeneca names Galbraith as Baselga successor in cancer R&D\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-names-galbraith-as-baselga-successor-cancer-r-d\n",
      "2021-06-28\n",
      "Biotech\n",
      "AstraZeneca, Sanofi post RSV data ahead of 2022 approval filings\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-sanofi-post-rsv-data-ahead-2022-approval-filings\n",
      "2021-06-28\n",
      "Biotech\n",
      "AstraZeneca kick-starts new COVID variant-busting vaccine test\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-kickstarts-new-covid-variant-busting-vaccine-test\n",
      "2021-06-28\n",
      "Biotech\n",
      "Polyphor flops a phase 3, jeopardizing its future\n",
      "https://www.fiercebiotech.com/biotech/polyphor-flops-a-phase-3-jeopardizing-its-future-as-shares-more-than-halved\n",
      "2021-06-28\n",
      "Biotech\n",
      "Stroke device maker RapidPulse spins out of Syntheon incubator\n",
      "https://www.fiercebiotech.com/medtech/stroke-device-maker-rapidpulse-spins-out-syntheon-incubator-15m-its-pocket\n",
      "2021-06-28\n",
      "MedTech\n",
      "CMR Surgical amasses £425M to take robotic surgery global\n",
      "https://www.fiercebiotech.com/medtech/cmr-surgical-amasses-giant-ps425m-funding-round-to-take-its-robotic-surgery-system-global\n",
      "2021-06-28\n",
      "MedTech\n",
      "Lilly's next-gen GLP-1 cuts blood sugar in early-stage diabetes\n",
      "https://www.fiercebiotech.com/biotech/ada-lilly-s-next-gen-glp-1-moves-needle-early-stage-diabetes-ahead-2021-filing\n",
      "2021-06-26\n",
      "Biotech\n",
      "Intellia reveals first-in-human CRISPR gene editing results\n",
      "https://www.fiercebiotech.com/biotech/first-human-trial-results-intellia-shows-world-gene-editing-has-arrived\n",
      "2021-06-26\n",
      "Biotech\n",
      "Fulcrum's muscle degeneration drug fails but will push forward\n",
      "https://www.fiercebiotech.com/biotech/fulcrum-s-losmapimod-hits-another-snag-after-failing-but-company-moving-forward-basis\n",
      "2021-06-25\n",
      "Biotech\n",
      "Amgen's KRAS rival Mirati gets breakthrough tag in lung cancer\n",
      "https://www.fiercebiotech.com/biotech/amgen-s-kras-rival-mirati-gets-a-shot-arm-breakthrough-tag-for-lung-cancer\n",
      "2021-06-25\n",
      "Biotech\n",
      "Grail's blood test delivers accuracy in spotting 50 cancers\n",
      "https://www.fiercebiotech.com/medtech/grail-delivers-final-study-results-showing-its-blood-test-s-accuracy-spotting-50-different\n",
      "2021-06-25\n",
      "MedTech\n",
      "FDA committee says no to early approval for Incyte's cancer drug\n",
      "https://www.fiercebiotech.com/biotech/incyte-hits-snag-pd-1-for-anal-cancer-likely-deferral-accelerated-approval\n",
      "2021-06-25\n",
      "Biotech\n",
      "GE Healthcare taps Integra LifeSciences chief as new CEO\n",
      "https://www.fiercebiotech.com/medtech/ge-healthcare-finds-new-ceo-integra-lifesciences-longtime-head-arduini\n",
      "2021-06-25\n",
      "MedTech\n",
      "Graphite grabs $238M IPO to advance sickle cell treatment\n",
      "https://www.fiercebiotech.com/biotech/graphite-pulls-off-238m-ipo-to-push-gene-editing-sickle-cell-treatment-into-clinic\n",
      "2021-06-25\n",
      "Biotech\n",
      "TRexBio poaches Lilly VP to lead hunt as CEO—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-trexbio-snags-new-ceo-from-lilly-as-it-prowls-toward-clinic\n",
      "2021-06-25\n",
      "Biotech\n",
      "Acumen prices IPO, targets phase 2 data on amyloid-beta prospect\n",
      "https://www.fiercebiotech.com/biotech/alzheimer-s-biotech-acumen-prices-125m-ipo-targets-phase-2-data-amyloid-beta-prospect\n",
      "2021-06-25\n",
      "Biotech\n",
      "Oxurion stops investing in cancer spinout, reduces head count\n",
      "https://www.fiercebiotech.com/biotech/oxurion-stops-investing-cancer-spinout-reduces-headcount\n",
      "2021-06-25\n",
      "Biotech\n",
      "FDA calls for more terminal patients to be in cancer trials\n",
      "https://www.fiercebiotech.com/cro/fda-calls-for-more-terminal-patients-to-be-included-cancer-trials\n",
      "2021-06-25\n",
      "CRO\n",
      "Roche ditches rights to 4DMT's phase 1 blinding disease therapy\n",
      "https://www.fiercebiotech.com/biotech/4dmt-will-regain-full-rights-to-blinding-disease-therapy-from-roche-to-initiative-new\n",
      "2021-06-24\n",
      "Biotech\n",
      "Could this gene GSK failed to target be a key to liver cancer?\n",
      "https://www.fiercebiotech.com/research/could-gene-gsk-failed-be-a-key-for-treating-liver-cancer\n",
      "2021-06-24\n",
      "Research\n",
      "Corbus notches another trial setback in a long line of failures\n",
      "https://www.fiercebiotech.com/biotech/corbus-tries-to-shift-focus-to-early-stage-pipeline-as-autoimmune-treatment-notches-another\n",
      "2021-06-24\n",
      "Biotech\n",
      "Miromatrix sets $43M IPO to engineer liver, kidney transplants\n",
      "https://www.fiercebiotech.com/medtech/miromatrix-goes-hog-wild-upsized-43m-ipo-to-bioengineer-pig-organs-into-human-transplants\n",
      "2021-06-24\n",
      "MedTech\n",
      "Bristol Myers, Lilly pile into Alzheimer's rush\n",
      "https://www.fiercebiotech.com/biotech/let-games-begin-reinvigorated-alzheimer-s-pipeline-heats-up-planned-lilly-filing-bristol\n",
      "2021-06-24\n",
      "Biotech\n",
      "AbbVie vies for the multiple myeloma skies with TeneoOne buy\n",
      "https://www.fiercebiotech.com/biotech/abbvie-sees-interim-phase-1-results-as-enough-to-trigger-teneoone-acquisition\n",
      "2021-06-24\n",
      "Biotech\n",
      "FDA greenlights its first saliva-based COVID-19 antibody test\n",
      "https://www.fiercebiotech.com/medtech/fda-greenlights-its-first-saliva-based-covid-19-antibody-test\n",
      "2021-06-24\n",
      "MedTech\n",
      "Monte Rosa sticks its IPO, landing $222M for 'molecular glues'\n",
      "https://www.fiercebiotech.com/biotech/monte-rosa-sticks-its-nasdaq-landing-banking-222m-for-molecular-glues\n",
      "2021-06-24\n",
      "Biotech\n",
      "Boston Scientific pays $295M up front for Farapulse's afib tech\n",
      "https://www.fiercebiotech.com/medtech/boston-scientific-shells-out-a-hearty-295m-for-farapulse-s-electric-field-generating-afib\n",
      "2021-06-24\n",
      "MedTech\n",
      "Lilly to file for accelerated FDA approval of Alzheimer's drug\n",
      "https://www.fiercebiotech.com/biotech/lilly-to-file-for-accelerated-fda-approval-alzheimer-s-drug-after-aduhelm-ok-opens\n",
      "2021-06-24\n",
      "Biotech\n",
      "Lyndra banks $61M to bring long-acting pill into pivotal trial\n",
      "https://www.fiercebiotech.com/biotech/lyndra-banks-60-5m-to-bring-ultralong-acting-pill-into-pivotal-schizophrenia-trial\n",
      "2021-06-24\n",
      "Biotech\n",
      "Arcus, Gilead post scant analysis of clinical data on TIGIT drug\n",
      "https://www.fiercebiotech.com/biotech/arcus-shares-scant-analysis-phase-2-data-gilead-partnered-tigit-drug\n",
      "2021-06-24\n",
      "Biotech\n",
      "Belldegrun's VC firm nabs a major $825M funding well\n",
      "https://www.fiercebiotech.com/biotech/arie-belldegrun-s-vc-firm-nabs-a-major-825m-funding-well-for-next-gen-biotechs\n",
      "2021-06-24\n",
      "Biotech\n",
      "Genentech launches new coalition for diversity in cancer trials\n",
      "https://www.fiercebiotech.com/cro/roche-s-genentech-launches-new-alliance-aimed-at-achieving-greater-diversity-cancer-trials\n",
      "2021-06-24\n",
      "CRO\n",
      "EQRx, Exscientia unite to use AI to develop cheaper cancer drugs\n",
      "https://www.fiercebiotech.com/medtech/eqrx-puts-exscientia-s-ai-platform-drug-discovery-duty-its-mission-to-develop-low-cost\n",
      "2021-06-24\n",
      "MedTech\n",
      "Harnessing the immune response against moles to combat melanoma\n",
      "https://www.fiercebiotech.com/research/harnessing-immune-response-against-common-moles-to-combat-melanoma\n",
      "2021-06-23\n",
      "Research\n",
      "NIH antibody study uncovers millions of uncounted COVID-19 cases\n",
      "https://www.fiercebiotech.com/medtech/nih-antibody-studies-uncover-millions-hidden-uncounted-covid-19-cases\n",
      "2021-06-23\n",
      "MedTech\n",
      "A no-brainer: Neurostim device maker CVRx eyes $92M IPO\n",
      "https://www.fiercebiotech.com/medtech/cvrx-plots-out-92m-ipo-to-go-public-its-brain-stim-implant-for-heart-failure-treatment\n",
      "2021-06-23\n",
      "MedTech\n",
      "FDA widens clearance for BD's at-home fluid drainage system\n",
      "https://www.fiercebiotech.com/medtech/bd-s-at-home-abdomen-fluid-drainage-system-lands-1st-fda-nod-for-both-cancerous-benign\n",
      "2021-06-23\n",
      "MedTech\n",
      "Biden wants to shoot for the stars with new NIH research arm\n",
      "https://www.fiercebiotech.com/biotech/biden-officials-want-to-shoot-for-stars-new-nih-research-arm-to-push-bold-risky-biomedical\n",
      "2021-06-23\n",
      "Biotech\n",
      "Llamas inspire 'nanobody' COVID treatments to tackle variants\n",
      "https://www.fiercebiotech.com/research/covid-fighting-llamas-inspire-nanobody-treatments-to-tackle-emerging-variants\n",
      "2021-06-23\n",
      "Research\n",
      "Orum adds $54M to 2019 series B to move ADCs into the clinic\n",
      "https://www.fiercebiotech.com/biotech/orum-adds-54m-to-2019-series-b-to-take-targeted-proteins-for-cancer-into-clinic\n",
      "2021-06-23\n",
      "Biotech\n",
      "Portable dialysis machine maker Quanta lands $245M\n",
      "https://www.fiercebiotech.com/medtech/portable-dialysis-machine-maker-quanta-raises-245m-to-boost-u-s-reach\n",
      "2021-06-23\n",
      "MedTech\n",
      "Biogen to navigate an ethics minefield for post-approval trial\n",
      "https://www.fiercebiotech.com/biotech/biogen-fresh-off-coveted-fda-nod-for-aduhelm-will-now-navigate-ethics-minefield-for-post\n",
      "2021-06-23\n",
      "Biotech\n",
      "Tvardi stacks the bank with $74M series B for STAT3 inhibitor\n",
      "https://www.fiercebiotech.com/biotech/tvardi-snags-series-b-to-bring-stat3-inhibitor-candidate-into-multiple-clinical-trials-next\n",
      "2021-06-23\n",
      "Biotech\n",
      "Strand snags $52M to develop next-gen mRNA meds for cancer\n",
      "https://www.fiercebiotech.com/biotech/strand-snags-52m-to-develop-next-gen-mrna-meds-for-cancer\n",
      "2021-06-23\n",
      "Biotech\n",
      "Abata launches with $95M series A for MS cell therapy\n",
      "https://www.fiercebiotech.com/biotech/abata-hopes-to-seize-perfect-fit-ms-cell-therapy-as-it-launches-a-95m-series-a\n",
      "2021-06-23\n",
      "Biotech\n",
      "Galapagos CSO Wigerinck to leave after series of setbacks\n",
      "https://www.fiercebiotech.com/biotech/galapagos-cso-wigerinck-to-leave-after-series-setbacks\n",
      "2021-06-23\n",
      "Biotech\n",
      "FDA documents show how Biogen's Aduhelm split the agency\n",
      "https://www.fiercebiotech.com/biotech/fda-documents-show-how-biogen-s-aduhelm-split-agency\n",
      "2021-06-23\n",
      "Biotech\n",
      "uniQure rebounds from FDA setback with $55M Corlieve buy\n",
      "https://www.fiercebiotech.com/biotech/uniqure-to-pay-55m-cash-upfront-to-acquire-corlieve-will-submit-hemophilia-gene-therapy-bla\n",
      "2021-06-22\n",
      "Biotech\n",
      "Medtronic's robotic-assisted surgery system makes global debut\n",
      "https://www.fiercebiotech.com/medtech/meet-hugo-medtronic-s-robotic-assisted-surgery-system-makes-global-debut-chilean-clinic\n",
      "2021-06-22\n",
      "MedTech\n",
      "Pear Therapeutics aims to go public in $1.6B SPAC deal\n",
      "https://www.fiercebiotech.com/medtech/digital-therapy-developer-pear-therapeutics-shakes-money-tree-plans-to-go-public-1-6b-spac\n",
      "2021-06-22\n",
      "MedTech\n",
      "Moove over IPO: SAB Bio to milk the stock market via SPAC\n",
      "https://www.fiercebiotech.com/biotech/moove-over-ipo-sab-biotherapeutics-to-milk-stock-market-via-spac\n",
      "2021-06-22\n",
      "Biotech\n",
      "TRexBio roars with dino-mite snags of CEO, CMO, Big Pharma cash\n",
      "https://www.fiercebiotech.com/biotech/trexbio-has-jurassic-day-picking-up-ex-lilly-vp-as-ceo-snagging-big-pharma-funding\n",
      "2021-06-22\n",
      "Biotech\n",
      "Alchemab picks up new well-connected CEO\n",
      "https://www.fiercebiotech.com/biotech/alchemab-s-new-well-connected-ceo-will-lead-biotech-journey-to-address-hard-to-treat\n",
      "2021-06-22\n",
      "Biotech\n",
      "New research center will evaluate use of digital tools in trials\n",
      "https://www.fiercebiotech.com/medtech/humanfirst-duke-launch-center-to-ensure-digital-health-tools-are-up-to-snuff-for-use\n",
      "2021-06-22\n",
      "MedTech\n",
      "Insilico nets $255M to put AI-made drugs through clinical trials\n",
      "https://www.fiercebiotech.com/medtech/insilico-medicine-posts-255m-venture-round-to-move-ai-designed-drugs-into-human-clinical\n",
      "2021-06-22\n",
      "MedTech\n",
      "Medtronic lands upsized FDA OK for afib-freezing catheter\n",
      "https://www.fiercebiotech.com/medtech/medtronic-freezes-out-competition-expanded-fda-ok-for-afib-cryoablation-catheter\n",
      "2021-06-22\n",
      "MedTech\n",
      "BioMarin's gene therapy lead jumps ship to rival biotech Vedere\n",
      "https://www.fiercebiotech.com/biotech/biomarin-s-gene-therapy-lead-jumps-ship-to-rival-biotech-vedere-bio-ii\n",
      "2021-06-22\n",
      "Biotech\n",
      "Blackstone, Cellex and Intellia form $250M CAR-T startup\n",
      "https://www.fiercebiotech.com/biotech/blackstone-cellex-and-intellia-form-250m-car-t-startup\n",
      "2021-06-22\n",
      "Biotech\n",
      "Sanofi, Translate Bio start seasonal mRNA flu vaccine trial\n",
      "https://www.fiercebiotech.com/biotech/sanofi-translate-bio-start-seasonal-mrna-flu-vaccine-trial-gaining-early-lead-over-moderna\n",
      "2021-06-22\n",
      "Biotech\n",
      "Medable able to boost trial access, diversity with funds, execs\n",
      "https://www.fiercebiotech.com/biotech/medable-focused-diversity-trust-and-access-across-drug-development-process-new-executives\n",
      "2021-06-22\n",
      "CRO\n",
      "Cleerly launches with $43M to bring AI imaging to heart disease\n",
      "https://www.fiercebiotech.com/medtech/cleerly-launches-43m-to-tackle-heart-attacks-ai-powered-imaging\n",
      "2021-06-21\n",
      "MedTech\n",
      "AI app outperforms humans in reading rapid HIV tests: study\n",
      "https://www.fiercebiotech.com/medtech/ai-app-outperforms-humans-reading-rapid-hiv-test-results-at-point-care-study-finds\n",
      "2021-06-21\n",
      "MedTech\n",
      "Roche's Alzheimer's drug lowers biomarkers of inherited disease\n",
      "https://www.fiercebiotech.com/research/roche-s-alzheimer-s-antibody-lowers-biomarkers-early-inherited-form-disease-though-impact\n",
      "2021-06-21\n",
      "Research\n",
      "Arrowhead pointed toward Horizon with $40M upfront for gout drug\n",
      "https://www.fiercebiotech.com/biotech/arrowhead-can-see-horizon-40m-upfront-for-discovery-stage-gout-treatment\n",
      "2021-06-21\n",
      "Biotech\n",
      "Roche nets FDA OK for PCR-based, point-of-care COVID-19 test\n",
      "https://www.fiercebiotech.com/medtech/not-done-yet-roche-nets-fda-covid-authorization-for-point-care-pcr-screening-test\n",
      "2021-06-21\n",
      "MedTech\n",
      "Vir, GSK unveil final data for COVID-19 antibody\n",
      "https://www.fiercebiotech.com/biotech/vir-gsk-unveil-final-data-for-covid-19-antibody-en-route-to-2021-filing\n",
      "2021-06-21\n",
      "Biotech\n",
      "FDA clears NeuraLace’s nerve-stimulating pain relief device\n",
      "https://www.fiercebiotech.com/medtech/neuralace-ties-up-fda-clearance-for-nerve-stimulation-device-to-relieve-chronic-pain\n",
      "2021-06-21\n",
      "MedTech\n",
      "Allogene, Overland's cell therapy JV nabs WuXi unit CSO as chief\n",
      "https://www.fiercebiotech.com/biotech/allogene-overland-s-new-china-cell-therapy-jv-biotech-nabs-wuxi-cso-yao-as-new-ceo\n",
      "2021-06-21\n",
      "Biotech\n",
      "LAG-3-focused Immutep secures cash, plots new trial push\n",
      "https://www.fiercebiotech.com/biotech/after-seeing-its-gsk-backed-trial-ditched-lag-3-focused-immutep-secures-cash-plots-new\n",
      "2021-06-21\n",
      "Biotech\n",
      "Tarsus eyes FDA filing in 2022 for eyelid mange eye drop\n",
      "https://www.fiercebiotech.com/biotech/tarsus-posts-positive-results-eyedrop-treatment-for-eyelid-mange-expects-to-file-for-fda\n",
      "2021-06-21\n",
      "Biotech\n",
      "Amazon Halo measures body fat using only 4 photos and an AI app\n",
      "https://www.fiercebiotech.com/medtech/amazon-halo-app-s-ai-powered-body-fat-calculator-par-lab-quality-devices-study-finds\n",
      "2021-06-18\n",
      "MedTech\n",
      "U.K. extends use of COVID test, after FDA said to throw it away\n",
      "https://www.fiercebiotech.com/medtech/u-k-doubles-down-use-rapid-covid-test-after-fda-urged-users-to-throw-it-away\n",
      "2021-06-18\n",
      "MedTech\n",
      "Nuevocor launches with $24M to tackle diseased hearts\n",
      "https://www.fiercebiotech.com/biotech/backed-by-boehringer-ingelheim-fund-nuevocor-launches-24m-to-tackle-diseased-hearts\n",
      "2021-06-18\n",
      "Biotech\n",
      "Google Health slims down, shifts focus away from consumer health\n",
      "https://www.fiercebiotech.com/medtech/google-reorganizes-health-division-shedding-130-employees-and-dropping-consumer-health\n",
      "2021-06-18\n",
      "MedTech\n",
      "Bumpy Alzheimer's road continues with Athira CEO placed on leave\n",
      "https://www.fiercebiotech.com/biotech/athira-ceo-placed-temporary-leave-following-doctoral-research-allegations\n",
      "2021-06-18\n",
      "Biotech\n",
      "Ex-FDA chief Hahn joins Moderna backer—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-ex-fda-chief-hahn-joins-moderna-backer\n",
      "2021-06-18\n",
      "Biotech\n",
      "Gilead's Kite, Shoreline ink CAR-NK deal potentially worth $2.3B\n",
      "https://www.fiercebiotech.com/biotech/gilead-s-kite-shoreline-biosciences-ink-car-nk-deal-potentially-worth-2-3b\n",
      "2021-06-18\n",
      "Biotech\n",
      "Danish meme stock sinks as FDA rejects rare disease drug\n",
      "https://www.fiercebiotech.com/biotech/fda-rejects-orphazyme-s-rare-disease-drug-continuing-wild-ride-for-danish-meme-stock\n",
      "2021-06-18\n",
      "Biotech\n",
      "Bristol Myers pays $650M for rights to Eisai's phase 1 ADC\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-pays-650m-for-rights-to-eisai-s-phase-1-adc\n",
      "2021-06-18\n",
      "Biotech\n",
      "Researchers develop COVID test using atom-thick graphene sheets\n",
      "https://www.fiercebiotech.com/medtech/researchers-develop-fast-covid-19-test-using-atom-thick-sheets-graphene\n",
      "2021-06-17\n",
      "MedTech\n",
      "New COVID approach targets human cells' response to coronavirus\n",
      "https://www.fiercebiotech.com/research/tired-fighting-coronavirus-new-approach-treats-covid-19-by-fixing-human-cells\n",
      "2021-06-17\n",
      "Research\n",
      "From jab to pill: U.S. injects COVID-19 antiviral plans with $3B\n",
      "https://www.fiercebiotech.com/biotech/u-s-pledges-3b-plus-for-covid-19-antiviral-pill-within-a-year\n",
      "2021-06-17\n",
      "Biotech\n",
      "Sema4 recruits Mount Sinai’s Kasarskis as 1st chief data officer\n",
      "https://www.fiercebiotech.com/medtech/ahead-spac-deal-sign-off-sema4-recruits-mount-sinai-s-kasarskis-to-fill-new-data-chief-role\n",
      "2021-06-17\n",
      "MedTech\n",
      "AI study finds no strong link among COVID shots and blood clots\n",
      "https://www.fiercebiotech.com/medtech/covid-19-vaccines-aren-t-linked-to-brain-blood-clots-finds-ai-analysis-by-nference-mayo\n",
      "2021-06-17\n",
      "MedTech\n",
      "Combating BRCA-mutated tumors via a new pathway\n",
      "https://www.fiercebiotech.com/research/targeting-treatment-resistant-brca-mutated-tumors-via-newly-discovered-polq-pathway\n",
      "2021-06-17\n",
      "Research\n",
      "LENZ eyes FDA submission with $47M in fresh funds, new CEO\n",
      "https://www.fiercebiotech.com/biotech/lenz-therapeutics-gets-fresh-set-eyes-47m-series-a-to-bring-nda-into-view\n",
      "2021-06-17\n",
      "Biotech\n",
      "Diversity initiatives pick up across biotech but gaps persist\n",
      "https://www.fiercebiotech.com/biotech/diversity-initiatives-pick-up-across-biotech-industry-but-women-people-color-still-lack\n",
      "2021-06-17\n",
      "Biotech\n",
      "Targeting 'enabler cells' in triple-negative breast cancer\n",
      "https://www.fiercebiotech.com/research/how-a-small-group-enabler-cells-drives-triple-negative-cancer-metastasis\n",
      "2021-06-17\n",
      "Research\n",
      "Companies paid billions to orthopedists who use their devices\n",
      "https://www.fiercebiotech.com/medtech/device-makers-have-funneled-billions-to-orthopedic-surgeons-who-use-their-products\n",
      "2021-06-17\n",
      "MedTech\n",
      "Lilly helps Circle round up $66M for intractable target R&D\n",
      "https://www.fiercebiotech.com/biotech/lilly-helps-circle-to-66m-round-to-fund-intractable-target-r-d\n",
      "2021-06-17\n",
      "Biotech\n",
      "Biogen's $300M bet on Alzheimer's tau drug flames out in phase 2\n",
      "https://www.fiercebiotech.com/biotech/biogen-s-300m-bet-alzheimer-s-tau-drug-flames-out-phase-2\n",
      "2021-06-17\n",
      "Biotech\n",
      "After Repare IPO success, Amplitude closes CA$200M fund\n",
      "https://www.fiercebiotech.com/biotech/amplitude-vc-closes-cad-200m-plus-fund-to-boost-canadian-life-sciences-sector\n",
      "2021-06-17\n",
      "Biotech\n",
      "COVID-19 vaccine trials began at warp speed, still going strong\n",
      "https://www.fiercebiotech.com/cro/gearing-up-covid-19-vaccine-clinical-trials-took-warp-speed-effort-and-pace-not-abetting\n",
      "2021-06-17\n",
      "CRO\n",
      "Apollo Therapeutics to go 'full throttle' with $145M financing\n",
      "https://www.fiercebiotech.com/biotech/apollo-therapeutics-to-go-full-throttle-145m-raise-after-5-years-under-radar\n",
      "2021-06-17\n",
      "Biotech\n",
      "CureVac first-gen COVID-19 vaccine hits snag with 47% efficacy\n",
      "https://www.fiercebiotech.com/biotech/curevac-s-first-gen-covid-19-vaccine-shows-only-47-efficacy-market-value-halved-after-hours\n",
      "Biotech\n",
      "Amalgam nets CE mark, upsized Novo collab for insulin dosing app\n",
      "https://www.fiercebiotech.com/medtech/amalgam-rx-extends-novo-nordisk-collab-to-bring-newly-ce-marked-insulin-dosing-app-to\n",
      "2021-06-16\n",
      "MedTech\n",
      "Zai, MacroGenics team up again for $25M upfront, $1.4B potential\n",
      "https://www.fiercebiotech.com/biotech/zai-lab-to-pay-macrogenics-25m-upfront-1-4b-potential-biobucks-for-bispecific-antibodies\n",
      "Biotech\n",
      "It's a dog-eat-dog world: Elanco snaps up KindredBio for $440M\n",
      "https://www.fiercebiotech.com/biotech/elanco-continues-pet-health-acquisition-spree-deal-to-buy-kindred-biosciences\n",
      "2021-06-16\n",
      "Biotech\n",
      "Bayer to shutter San Francisco research hub after 10-year run\n",
      "https://www.fiercebiotech.com/biotech/bayer-to-shutter-san-francisco-research-hub-after-10-year-run\n",
      "2021-06-16\n",
      "Biotech\n",
      "PureTech buys out Alivio, boosting inflammatory disease pipeline\n",
      "https://www.fiercebiotech.com/biotech/puretech-buys-out-alivio-adding-inflammatory-disease-programs-to-its-pipeline\n",
      "2021-06-16\n",
      "Biotech\n",
      "Amazon begins selling its own COVID tests for $39.99\n",
      "https://www.fiercebiotech.com/medtech/amazon-kicks-off-its-new-role-as-dtc-diagnostics-provider-by-making-covid-test-available\n",
      "2021-06-16\n",
      "MedTech\n",
      "Fractyl nets $100M to finish testing its device therapy for T2D\n",
      "https://www.fiercebiotech.com/medtech/fractyl-nets-100m-to-complete-development-its-intestine-washing-device-for-type-2-diabetes\n",
      "2021-06-16\n",
      "MedTech\n",
      "Molecular Partners prices IPO, falling short of original goal\n",
      "https://www.fiercebiotech.com/biotech/molecular-partners-prices-64m-ipo-falling-short-original-goal\n",
      "2021-06-16\n",
      "Biotech\n",
      "Kahr reels in $47M to fund CD47 trial, work on TIGIT prospect\n",
      "https://www.fiercebiotech.com/biotech/kahr-reels-47m-to-fund-cd47-trial-work-tigit-prospect\n",
      "2021-06-16\n",
      "Biotech\n",
      "Medidata goes all in on decentralized clinical trials\n",
      "https://www.fiercebiotech.com/cro/medidata-goes-all-decentralized-virtual-capabilities-for-clinical-trials-end-to-end-platform\n",
      "CRO\n",
      "Mnemo banks $90M to tackle barriers in CAR-T therapy\n",
      "https://www.fiercebiotech.com/biotech/mnemo-therapeutics-banks-90m-to-tackle-barriers-car-t-therapy\n",
      "2021-06-16\n",
      "Biotech\n",
      "NIH finds COVID had spread beyond U.S. hotspots by late 2019\n",
      "https://www.fiercebiotech.com/medtech/nih-antibody-testing-study-suggests-covid-19-spread-beyond-u-s-hotspots-earlier-than\n",
      "2021-06-15\n",
      "MedTech\n",
      "FDA approves Mallinckrodt's regenerative skin burn graft\n",
      "https://www.fiercebiotech.com/medtech/fda-approves-mallinckrodt-s-regenerative-skin-burn-graft-after-four-month-delay\n",
      "2021-06-15\n",
      "MedTech\n",
      "Evotec sends out a call for pandemic prep with new program\n",
      "https://www.fiercebiotech.com/cro/evotec-propels-pandemic-preparedness-program-so-covid-19-like-suffering-never-happens-again\n",
      "2021-06-15\n",
      "CRO\n",
      "One Drop poaches another alum of Sanofi's diabetes biz\n",
      "https://www.fiercebiotech.com/medtech/one-drop-poaches-sanofi-s-head-diabetes-innovation-to-bring-cgm-biosensor-to-market\n",
      "2021-06-15\n",
      "MedTech\n",
      "Exscientia coughs up $60M for Allcyte’s cancer drug-assessing AI\n",
      "https://www.fiercebiotech.com/medtech/exscientia-steps-up-ai-powered-drug-discovery-60m-acquisition-allcyte\n",
      "2021-06-15\n",
      "MedTech\n",
      "RayzeBio raises the radiopharma field with $108M series C\n",
      "https://www.fiercebiotech.com/biotech/rayzebio-raises-potential-for-radiopharmaceuticals-round-three-financing-at-108m\n",
      "Biotech\n",
      "Biogen-Sage depression drug improves symptoms with a few caveats\n",
      "https://www.fiercebiotech.com/biotech/biogen-sage-depression-drug-hits-main-goal-improving-symptoms-then-it-gets-complicated\n",
      "2021-06-15\n",
      "Biotech\n",
      "Novo Holdings spends £400M for global diagnostics supplier BBI\n",
      "https://www.fiercebiotech.com/medtech/novo-nordisk-acquires-global-diagnostics-supplier-bbi-for-over-ps400m\n",
      "2021-06-15\n",
      "MedTech\n",
      "AstraZeneca COVID-19 antibody fails in post-exposure prevention\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-s-covid-19-antibody-combination-fails-post-exposure-prevention-trial\n",
      "2021-06-15\n",
      "Biotech\n",
      "VectorY raises $38M to develop Alzheimer's, ALS gene therapies\n",
      "https://www.fiercebiotech.com/biotech/vectory-raises-38m-to-develop-alzheimer-s-als-gene-therapies\n",
      "2021-06-15\n",
      "Biotech\n",
      "Umoja aims immunotherapies at the clinic with $210M raise\n",
      "https://www.fiercebiotech.com/biotech/umoja-banks-210m-to-bring-next-gen-immunotherapies-into-clinic\n",
      "2021-06-15\n",
      "Biotech\n",
      "CAMP4 reimagines itself with $45M for regulatory RNAs\n",
      "https://www.fiercebiotech.com/biotech/camp4-begins-fresh-start-45m-for-new-focus-gene-upregulation-and-expects-additional-capital\n",
      "2021-06-15\n",
      "Biotech\n",
      "Alentis nabs $67M to enter clinic by year-end for anti-fibrotic\n",
      "https://www.fiercebiotech.com/biotech/alentis-secures-67m-series-b-to-go-after-fibrotic-diseases-and-enter-clinic-near-december\n",
      "2021-06-15\n",
      "Biotech\n",
      "He OK'd the Moderna vaccine. Now, ex-FDA chief joins its backer\n",
      "https://www.fiercebiotech.com/biotech/six-months-after-granting-moderna-covid-19-eua-ex-fda-commish-joins-biotech-s-founding\n",
      "2021-06-14\n",
      "Biotech\n",
      "Symptom checker app Ada Health inks trio of pharma partnerships\n",
      "https://www.fiercebiotech.com/medtech/symptom-checking-platform-ada-health-inks-partnerships-takeda-sanofi-alnylam\n",
      "2021-06-14\n",
      "MedTech\n",
      "Investors shrug at yet another Biogen gene therapy failure\n",
      "https://www.fiercebiotech.com/biotech/yet-another-failure-biogen-gene-therapy-program-doesn-t-make-a-dent-wake-aduhelm-approval\n",
      "2021-06-14\n",
      "Biotech\n",
      "Twist Bioscience, Regeneron pitch global DNA sequencing test\n",
      "https://www.fiercebiotech.com/medtech/twist-bioscience-regeneron-pitch-global-sequencing-test-to-bring-new-diversity-to-large-dna\n",
      "2021-06-14\n",
      "MedTech\n",
      "Veracyte prints new prostate cancer test data after Decipher buy\n",
      "https://www.fiercebiotech.com/medtech/new-data-veracyte-aims-to-expand-prostate-cancer-test-reach-following-decipher-acquisition\n",
      "2021-06-14\n",
      "MedTech\n",
      "Terns tees up combo trial as NASH drug shows promise in phase 2\n",
      "https://www.fiercebiotech.com/biotech/lilly-backed-terns-tees-up-combo-trial-as-oral-nash-drug-shows-promise-phase-2\n",
      "2021-06-14\n",
      "Biotech\n",
      "Diabetes mainstay tamps down lung inflammation in COVID models\n",
      "https://www.fiercebiotech.com/research/diabetes-mainstay-metformin-tamps-down-lung-inflammation-covid-models\n",
      "2021-06-14\n",
      "Research\n",
      "HiFiBiO snags investor high-fives with $75M for clinic launch\n",
      "https://www.fiercebiotech.com/biotech/hifibio-gets-high-five-from-investors-75m-series-d-to-bring-two-programs-into-clinic\n",
      "Biotech\n",
      "Humanigen seeks U.K. authorization for COVID-19 therapy\n",
      "https://www.fiercebiotech.com/biotech/humanigen-angling-to-go-from-zero-to-1b-us-uk-covid-19-therapy-filings\n",
      "2021-06-14\n",
      "Biotech\n",
      "Flagship triples 7th fund for preemptive medicine focus\n",
      "https://www.fiercebiotech.com/biotech/flagship-pioneering-flags-down-another-2-2b-to-expand-preemptive-and-pioneering-medicine\n",
      "Biotech\n",
      "Celltrion's COVID-19 antibody cuts hospitalizations, deaths\n",
      "https://www.fiercebiotech.com/biotech/celltrion-s-covid-19-antibody-cuts-hospitalizations-deaths-phase-3\n",
      "2021-06-14\n",
      "Biotech\n",
      "Heartseed snags $37M to develop heart failure stem cell therapy\n",
      "https://www.fiercebiotech.com/medtech/heartseed-collects-new-venture-round-following-598m-heart-failure-stem-cell-deal-novo\n",
      "2021-06-14\n",
      "MedTech\n",
      "Moderna snares J&J veteran as next chief medical officer\n",
      "https://www.fiercebiotech.com/biotech/j-j-s-burton-grabs-hold-moderna-rocket-ship-as-vaccine-developer-s-next-chief-medical\n",
      "2021-06-14\n",
      "Biotech\n",
      "Lucid's DNA test for esophageal cancer lands EU approval\n",
      "https://www.fiercebiotech.com/medtech/lucid-s-regulatory-dreams-come-true-ce-mark-for-test-to-find-esophageal-cancer-people\n",
      "2021-06-14\n",
      "MedTech\n",
      "Epizyme's first-in-class myeloma drug candidate shows promise\n",
      "https://www.fiercebiotech.com/research/eha-epizyme-s-potential-first-class-multiple-myeloma-drug-inhibits-tumors-mice\n",
      "2021-06-14\n",
      "Research\n",
      "GSK pays iTeos $625M upfront for rights to anticancer TIGIT drug\n",
      "https://www.fiercebiotech.com/biotech/gsk-pays-iteos-625m-upfront-to-join-merck-roche-and-rest-tigit-immuno-oncology-race\n",
      "2021-06-14\n",
      "Biotech\n",
      "Novavax COVID-19 vaccine hits 90% efficacy in pivotal U.S. trial\n",
      "https://www.fiercebiotech.com/biotech/novavax-covid-19-vaccine-hits-90-efficacy-pivotal-u-s-trial\n",
      "2021-06-14\n",
      "Biotech\n",
      "The top 10 highest paid biopharma R&D executives in 2020\n",
      "https://www.fiercebiotech.com/special-report/top-10-highest-paid-biopharma-r-d-executives-2020\n",
      "2021-06-14\n",
      "Special Reports\n",
      "FDA urges public to throw out Innova's rapid COVID tests\n",
      "https://www.fiercebiotech.com/medtech/place-them-trash-fda-warns-against-using-innova-s-rapid-covid-19-antigen-tests\n",
      "2021-06-11\n",
      "MedTech\n",
      "Oxford spinout to push forward single-pair DNA resolution method\n",
      "https://www.fiercebiotech.com/medtech/oxford-spinout-spies-hidden-mechanics-dna-and-disease-single-pair-resolution-method\n",
      "2021-06-11\n",
      "MedTech\n",
      "'The Dropout' finds its Holmes family, early Theranos employees\n",
      "https://www.fiercebiotech.com/medtech/hulu-s-long-awaited-theranos-series-casts-elizabeth-holmes-parents-mentors-and-first\n",
      "2021-06-11\n",
      "MedTech\n",
      "Alira Health extends deal spree with CROS NT biometrics buy\n",
      "https://www.fiercebiotech.com/cro/alira-health-snags-third-acquisition-12-months-to-boost-biometrics-presence-europe\n",
      "CRO\n",
      "FDA loses AdComm experts after Aduhelm nod—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-fda-nod-for-biogen-s-aduhelm-sees-two-adcomm-members-hit-exit\n",
      "2021-06-11\n",
      "Biotech\n",
      "Sanofi's treatment for rare anemia hits goal in 2nd phase 3\n",
      "https://www.fiercebiotech.com/biotech/sanofi-s-treatment-for-rare-anemia-hits-goal-second-phase-3\n",
      "2021-06-11\n",
      "Biotech\n",
      "Eli Lilly, Roche's Alzheimer's prospects boosted by Aduhelm\n",
      "https://www.fiercebiotech.com/biotech/eli-lilly-roche-s-alzheimer-s-prospects-including-flops-boosted-light-fda-s-aduhelm\n",
      "2021-06-11\n",
      "Biotech\n",
      "Harvard's Kesselheim quits AdComm over FDA's Aduhelm approval\n",
      "https://www.fiercebiotech.com/biotech/harvard-s-kesselheim-quits-adcomm-over-fda-s-aduhelm-approval\n",
      "2021-06-11\n",
      "Biotech\n",
      "Facebook is planning a smartwatch to face off with Apple, Google\n",
      "https://www.fiercebiotech.com/medtech/facebook-escalates-big-tech-wars-proposed-heart-rate-tracking-smartwatch\n",
      "2021-06-11\n",
      "MedTech\n",
      "Vertex’s lung drug hits phase 2 goal—but won’t help patients\n",
      "https://www.fiercebiotech.com/biotech/vertex-s-rare-lung-disease-drug-hits-phase-2-goal-but-still-winds-up-scrapheap\n",
      "2021-06-10\n",
      "Biotech\n",
      "Making drug-resistant bacteria susceptible to antibiotics\n",
      "https://www.fiercebiotech.com/research/making-drug-resistant-bacteria-susceptible-to-antibiotics\n",
      "2021-06-10\n",
      "Research\n",
      "FDA approves Medtronic's long-lasting Vanta spinal stimulator\n",
      "https://www.fiercebiotech.com/medtech/fda-approves-medtronic-s-long-lasting-vanta-spinal-cord-stimulator\n",
      "2021-06-10\n",
      "MedTech\n",
      "DJO's orthopedics shopping spree continues with Mathys purchase\n",
      "https://www.fiercebiotech.com/medtech/shopping-spree-continues-djo-acquires-switzerland-s-mathys-to-grow-global-orthopedics\n",
      "2021-06-10\n",
      "MedTech\n",
      "'Big hole' no more as Aduhelm opens AD drug funding 'floodgates'\n",
      "https://www.fiercebiotech.com/biotech/investor-interest-alzheimer-s-changed-dime-following-fda-s-decision-biogen-s-aducanumab\n",
      "Biotech\n",
      "Home oxygen devicemaker Inogen taps BD diabetes VP for CMO\n",
      "https://www.fiercebiotech.com/medtech/inogen-snags-bd-diabetes-care-vp-glezer-to-expand-line-home-oxygen-devices-as-chief-medical\n",
      "2021-06-10\n",
      "MedTech\n",
      "Acumen rides aducanumab, amyloid waves on its IPO voyage\n",
      "https://www.fiercebiotech.com/biotech/acumen-pharmaceuticals-files-for-up-to-100m-ipo-two-days-after-biogen-s-alzheimer-s\n",
      "Biotech\n",
      "Kurome raises $15M to overcome adaptive resistance in leukemia\n",
      "https://www.fiercebiotech.com/biotech/kurome-raises-15m-to-overcome-adaptive-resistance-leukemia\n",
      "2021-06-10\n",
      "Biotech\n",
      "Synthekine snags $108M to drive two candidates into the clinic\n",
      "https://www.fiercebiotech.com/biotech/synthekine-scores-significant-series-b-to-secure-set-clinical-trials-12-months\n",
      "Biotech\n",
      "Bright Peak bags $107M to advance cytokine programs, platform\n",
      "https://www.fiercebiotech.com/biotech/bright-peak-bags-107m-to-bankroll-conveyor-belt-cytokine-programs\n",
      "2021-06-10\n",
      "Biotech\n",
      "Senda drives 3 programs to clinic with bumped-up $98M series B\n",
      "https://www.fiercebiotech.com/biotech/senda-drives-3-programs-toward-clinic-bumped-up-98m-series-b\n",
      "2021-06-10\n",
      "Biotech\n",
      "2nd AdComm expert quits over approval of Biogen's Aduhelm\n",
      "https://www.fiercebiotech.com/biotech/adcomm-exodus-second-expert-quits-over-fda-approval-biogen-s-aduhelm\n",
      "2021-06-10\n",
      "Biotech\n",
      "Old antidepressants show promise as immuno-oncology treatments\n",
      "https://www.fiercebiotech.com/research/old-antidepressants-show-promise-as-immuno-oncology-treatments-melanoma-and-colon-cancer\n",
      "2021-06-10\n",
      "Research\n",
      "Valo to go public via Khosla-backed SPAC, gaining $500M-plus\n",
      "https://www.fiercebiotech.com/biotech/valo-health-to-go-public-via-khosla-backed-spac-gaining-500m\n",
      "2021-06-10\n",
      "Biotech\n",
      "FDA doles out EUA to Amazon’s direct-to-consumer COVID-19 test\n",
      "https://www.fiercebiotech.com/medtech/prime-day-deal-amazon-lands-fda-go-ahead-to-sell-covid-19-tests-directly-to-consumers\n",
      "2021-06-09\n",
      "MedTech\n",
      "ViaCyte scores $45M for type 1 diabetes drugs in midstage trials\n",
      "https://www.fiercebiotech.com/biotech/viacyte-extends-2018-series-d-by-45m-day-after-chief-scientific-officer-announces-departure\n",
      "Biotech\n",
      "CyMedica wins FDA OK for osteoarthritis pain relief system\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-cymedica-s-app-connected-muscle-stimulation-system-to-treat-osteoarthritic-knee\n",
      "2021-06-09\n",
      "MedTech\n",
      "Datavant, Ciox Health ink $7B medical data deal\n",
      "https://www.fiercebiotech.com/medtech/datavant-to-absorb-ciox-health-7b-medical-data-deal\n",
      "2021-06-09\n",
      "MedTech\n",
      "Alcyone unveils with $23M for 12 AAV gene therapies for CNS\n",
      "https://www.fiercebiotech.com/biotech/alcyone-therapeutics-picks-up-23m-hopes-being-a-star-treating-cns-disorders\n",
      "Biotech\n",
      "GSK, Progentec partner to bring digital tools to lupus treatment\n",
      "https://www.fiercebiotech.com/medtech/glaxosmithkline-taps-progentec-to-study-effects-ai-tech-wearable-devices-lupus-treatment\n",
      "2021-06-09\n",
      "MedTech\n",
      "The FDA's decision on aducanumab will drag down science\n",
      "https://www.fiercebiotech.com/biotech/editors-corner-fda-s-decision-aducanumab-will-drag-down-innovation-for-years-to-come\n",
      "2021-06-09\n",
      "Biotech\n",
      "Kojin bags $60M to exploit weakness of drug-resistant cancers\n",
      "https://www.fiercebiotech.com/biotech/kojin-bags-60m-to-exploit-weakness-drug-resistant-cancers\n",
      "2021-06-09\n",
      "Biotech\n",
      "AdComm member quits over FDA approval of Biogen's Aduhelm\n",
      "https://www.fiercebiotech.com/biotech/adcomm-member-quits-over-fda-approval-biogen-s-aduhelm\n",
      "2021-06-09\n",
      "Biotech\n",
      "AbbVie snags preclinical Parkinson's program with $17M pact\n",
      "https://www.fiercebiotech.com/biotech/abbvie-snags-another-preclinical-parkinson-s-program-17m-caraway-pact\n",
      "2021-06-09\n",
      "Biotech\n",
      "Boehringer taps Lifebit's AI for global disease surveillance\n",
      "https://www.fiercebiotech.com/medtech/boehringer-ingelheim-taps-into-lifebit-s-ai-for-global-disease-surveillance\n",
      "2021-06-08\n",
      "MedTech\n",
      "Medtronic scores U.S. nod for brain-sensing stimulation implant\n",
      "https://www.fiercebiotech.com/medtech/medtronic-nets-u-s-approval-for-brain-activity-sensing-parkinson-s-stimulation-implant\n",
      "2021-06-08\n",
      "MedTech\n",
      "FDA nixes Verily’s request to add Parkinson's exam to smartwatch\n",
      "https://www.fiercebiotech.com/medtech/verily-loses-fda-bid-to-add-parkinson-s-motor-function-assessment-to-clinical-research\n",
      "2021-06-08\n",
      "MedTech\n",
      "Byondis ready to link up to bring Herceptin-booster to market\n",
      "https://www.fiercebiotech.com/biotech/dutch-biopharma-byondis-shows-promising-results-phase-3-trial-her2-breast-cancer-drug\n",
      "Biotech\n",
      "Remote life sci lab provider Strateos scores $56M series B\n",
      "https://www.fiercebiotech.com/medtech/strateos-scores-56m-to-smarten-up-its-smartlab-platform-for-robotic-remote-r-d-work\n",
      "2021-06-08\n",
      "MedTech\n",
      "Indivior enters cannabis use disorder field in $30M Aelis deal\n",
      "https://www.fiercebiotech.com/biotech/aelis-farma-could-snag-over-130m-cannabis-use-disorder-joint-effort-indivior\n",
      "Biotech\n",
      "Bayer's billon-dollar Parkinson's bets land in the clinic\n",
      "https://www.fiercebiotech.com/biotech/bayer-s-billon-dollar-parkinson-s-disease-bets-land-clinic\n",
      "2021-06-08\n",
      "Biotech\n",
      "At-home testing provider LetsGetChecked snags $150M\n",
      "https://www.fiercebiotech.com/medtech/letsgetchecked-hits-unicorn-status-150m-series-d-to-grow-at-home-testing-telehealth\n",
      "2021-06-08\n",
      "MedTech\n",
      "Seagen joins SpringWorks' long list of BCMA combo partners\n",
      "https://www.fiercebiotech.com/biotech/seagen-joins-springworks-long-list-bcma-combo-partners\n",
      "2021-06-08\n",
      "Biotech\n",
      "Graphite files for $100M IPO to fund push to cure sickle cell\n",
      "https://www.fiercebiotech.com/biotech/graphite-files-for-100m-ipo-to-fund-push-to-cure-sickle-cell\n",
      "2021-06-08\n",
      "Biotech\n",
      "FDA's aducanumab OK opens up a regulatory foothold for rivals\n",
      "https://www.fiercebiotech.com/biotech/fda-s-aducanumab-decision-opens-up-a-regulatory-foothold-for-leading-competitors\n",
      "2021-06-07\n",
      "Biotech\n",
      "Aducanumab approval appears to boost Biogen's AD competitors\n",
      "https://www.fiercebiotech.com/biotech/fda-approval-for-adunacumab-check-soaring-stocks-for-biogen-competitors-yes\n",
      "Biotech\n",
      "Bluebird bio to restart sickle cell trials as FDA lifts hold\n",
      "https://www.fiercebiotech.com/biotech/bluebird-bio-to-restart-sickle-cell-gene-therapy-trials-as-fda-lifts-clinical-hold\n",
      "2021-06-07\n",
      "Biotech\n",
      "Novartis rolls out positive phase 2 data in rare kidney diseases\n",
      "https://www.fiercebiotech.com/biotech/novartis-rolls-out-encouraging-phase-2-data-rare-kidney-diseases-little-competition-sight\n",
      "2021-06-07\n",
      "Biotech\n",
      "ASCO: Alpine reports 61% response in trial of CD28 I-O drug\n",
      "https://www.fiercebiotech.com/research/asco-alpine-reports-61-clinical-benefit-early-trial-cd28-targeted-immuno-oncology-drug\n",
      "2021-06-07\n",
      "Research\n",
      "Agendia test spots ultralow breast cancer recurrence risk\n",
      "https://www.fiercebiotech.com/medtech/agendia-test-spots-ultra-low-breast-cancer-recurrence-risks-out-to-20-years-study\n",
      "2021-06-07\n",
      "MedTech\n",
      "After COVID's tipping point, telehealth may be here to stay\n",
      "https://www.fiercebiotech.com/medtech/covid-was-a-tipping-point-for-telehealth-if-some-have-their-way-virtual-visits-are-here-to\n",
      "2021-06-07\n",
      "MedTech\n",
      "Polyphor's breast cancer candidate shows promise in COVID-19\n",
      "https://www.fiercebiotech.com/research/a-breast-cancer-candidate-for-covid-19-polyphor-s-drug-shows-dual-action-early-studies\n",
      "2021-06-07\n",
      "Research\n",
      "Iksuda raises $47M to take antibody-drug conjugate into clinic\n",
      "https://www.fiercebiotech.com/biotech/iksuda-raises-47m-to-take-cd19-antibody-drug-conjugate-into-clinic\n",
      "2021-06-07\n",
      "Biotech\n",
      "Elevation files for $100M IPO to fund tumor-agnostic candidate\n",
      "https://www.fiercebiotech.com/biotech/elevation-files-for-100m-ipo-to-fund-tumor-agnostic-candidate\n",
      "2021-06-07\n",
      "Biotech\n",
      "Dexcom puts up new data in T2D, teases upcoming G7 sensor\n",
      "https://www.fiercebiotech.com/medtech/dexcom-puts-up-new-data-type-2-diabetes-teases-upcoming-g7-sensor\n",
      "2021-06-07\n",
      "MedTech\n",
      "Grail launches its 50-cancer Galleri blood screening test\n",
      "https://www.fiercebiotech.com/medtech/grail-launches-its-50-cancer-galleri-blood-screening-test\n",
      "2021-06-07\n",
      "MedTech\n",
      "Study aims one blood test at many neurodegenerative diseases\n",
      "https://www.fiercebiotech.com/medtech/early-research-points-to-a-single-blood-test-for-a-range-neurodegenerative-conditions\n",
      "2021-06-07\n",
      "MedTech\n",
      "Johnson & Johnson culls $1.6B argenx blood cancer drug collab\n",
      "https://www.fiercebiotech.com/biotech/johnson-johnson-culls-1-6b-argenx-blood-cancer-drug-collab\n",
      "2021-06-07\n",
      "Biotech\n",
      "Amgen eyes decades of work post-Lumakras approval\n",
      "https://www.fiercebiotech.com/biotech/amgen-deals-knockdown-punch-lumakras-approval-but-decades-work-lay-ahead\n",
      "2021-06-04\n",
      "Biotech\n",
      "Helix doubles down on COVID-19 surveillance with $50M series C\n",
      "https://www.fiercebiotech.com/medtech/dna-sequencing-test-maker-helix-doubles-down-covid-19-testing-tracking-50m-series-c\n",
      "2021-06-04\n",
      "MedTech\n",
      "Synchron pockets $40M for thought-controlled paralysis tech\n",
      "https://www.fiercebiotech.com/medtech/synchron-raises-40m-for-u-s-trials-neurotech-helping-paralysis-patients-text-email-and\n",
      "2021-06-04\n",
      "MedTech\n",
      "Repertoire nabs ex-Celgene exec as CMO—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-repertoire-immune-medicines-buzzing-from-189m-series-b-taps-celgene-vet-as\n",
      "2021-06-04\n",
      "Biotech\n",
      "Organon launches ready to shop for women's health companies\n",
      "https://www.fiercebiotech.com/biotech/organon-launches-ready-to-shop-for-women-s-health-companies-biotech-medtech-and-more\n",
      "2021-06-04\n",
      "Biotech\n",
      "Amgen's stomach cancer drug extends patients' lives in phase 2\n",
      "https://www.fiercebiotech.com/biotech/asco-amgen-s-stomach-cancer-drug-nabbed-five-prime-buyout-extends-patients-lives-phase-2\n",
      "2021-06-04\n",
      "Biotech\n",
      "China's Stemirna raises $188M to fund mRNA COVID-19 vaccine\n",
      "https://www.fiercebiotech.com/biotech/china-s-stemirna-raises-188m-to-fund-mrna-covid-19-vaccine\n",
      "2021-06-04\n",
      "Biotech\n",
      "Skull-based immune cells could inspire new brain treatments\n",
      "https://www.fiercebiotech.com/research/how-new-insights-into-skull-based-immune-cells-could-inspire-new-treatments-for-brain\n",
      "2021-06-04\n",
      "Research\n",
      "Merck-partnered Janux hires CMO as its bispecifics near clinic\n",
      "https://www.fiercebiotech.com/biotech/merck-partnered-janux-hires-cmo-as-its-bispecifics-near-clinic\n",
      "2021-06-04\n",
      "Biotech\n",
      "Sanofi nets global phase 3 partners for breast cancer hopeful\n",
      "https://www.fiercebiotech.com/biotech/sanofi-inks-partnerships-for-phase-3-pivotal-trial-for-add-breast-cancer-therapy\n",
      "Biotech\n",
      "Medtronic stops sales of beleaguered HeartWare blood pump\n",
      "https://www.fiercebiotech.com/medtech/as-medtronic-discontinues-faulty-heartware-device-abbott-offers-up-its-own-heart-pump-to\n",
      "2021-06-03\n",
      "MedTech\n",
      "Novartis backs up Endocyte buyout with prostate cancer data\n",
      "https://www.fiercebiotech.com/biotech/asco-novartis-backs-up-endocyte-buyout-prostate-cancer-data\n",
      "2021-06-03\n",
      "Biotech\n",
      "Stellanova hopes for a bright future with $15.5M series A\n",
      "https://www.fiercebiotech.com/biotech/stellanova-hopes-namesake-new-star-not-merely-a-latin-term-but-a-bright-sign-for-its-future\n",
      "Biotech\n",
      "Vasopharm's brain injury drug fails in phase 3\n",
      "https://www.fiercebiotech.com/biotech/vasopharm-fails-phase-3-trial-for-lead-traumatic-brain-injury-treatment\n",
      "Biotech\n",
      "Bayer picks up prostate cancer-focused biotech Noria\n",
      "https://www.fiercebiotech.com/biotech/bayer-picks-up-radiotherapeutics-biotech-to-prop-up-dwindling-sales-prostate-cancer-program\n",
      "2021-06-03\n",
      "Biotech\n",
      "VenBio raises $550M to back its next batch of biotech startups\n",
      "https://www.fiercebiotech.com/biotech/venbio-raises-550m-to-back-its-next-batch-biotech-startups\n",
      "2021-06-03\n",
      "Biotech\n",
      "Ex-FDA deputy Abernethy to steer clinical research at Verily\n",
      "https://www.fiercebiotech.com/medtech/verily-taps-former-fda-deputy-commissioner-abernethy-to-lead-clinical-research-business\n",
      "2021-06-03\n",
      "MedTech\n",
      "Auris Medical pivots to RNA with Trasir Therapeutics buyout\n",
      "https://www.fiercebiotech.com/biotech/after-flops-and-setbacks-auris-medical-pivots-to-rna-trasir-therapeutics-buyout\n",
      "2021-06-03\n",
      "Biotech\n",
      "Repertoire Immune Medicines nabs ex-Celgene exec as CMO\n",
      "https://www.fiercebiotech.com/biotech/189m-freshly-bank-repertoire-immune-medicines-nabs-ex-celgene-exec-as-cmo\n",
      "2021-06-03\n",
      "Biotech\n",
      "Tmunity stops solid tumor CAR-T trial after 2 patients die\n",
      "https://www.fiercebiotech.com/biotech/tmunity-stops-solid-tumor-car-t-trial-after-2-patients-die\n",
      "2021-06-03\n",
      "Biotech\n",
      "Treating Alzheimer's by targeting a distinct tau protein\n",
      "https://www.fiercebiotech.com/research/no-tau-tangles-targeting-unique-protein-could-be-key-alzheimer-s-treatment\n",
      "2021-06-03\n",
      "Research\n",
      "Stablix emerges from stables with cash for protein stabilization\n",
      "https://www.fiercebiotech.com/biotech/stablix-lands-stable-footing-63m-series-a-for-protein-stabilization-efforts\n",
      "Biotech\n",
      "Amyl raises $22M to target common element of protein aggregates\n",
      "https://www.fiercebiotech.com/biotech/amyl-raises-22m-to-target-common-element-protein-aggregates\n",
      "2021-06-03\n",
      "Biotech\n",
      "Proteros pens AstraZeneca cancer drug pact\n",
      "https://www.fiercebiotech.com/cro/german-life-science-services-co-proteros-pens-astrazeneca-cancer-drug-development-pact\n",
      "2021-06-03\n",
      "CRO\n",
      "Cognoa's AI app for diagnosing autism gets FDA green light\n",
      "https://www.fiercebiotech.com/medtech/cognoa-s-ai-app-for-diagnosing-childhood-autism-gets-fda-green-light\n",
      "2021-06-02\n",
      "MedTech\n",
      "PAVmed’s new digital health spinout banks first acquisition\n",
      "https://www.fiercebiotech.com/medtech/pavmed-digital-health-spinout-veris-health-hits-ground-running-remote-monitoring\n",
      "2021-06-02\n",
      "MedTech\n",
      "Illumina hits legal snag as clock ticks on $8B Grail deal\n",
      "https://www.fiercebiotech.com/medtech/illumina-hits-legal-snag-as-clock-ticks-8b-deal-for-grail\n",
      "2021-06-02\n",
      "MedTech\n",
      "FDA OKs Edwards’ AI, finger cuff combo to predict hypotension\n",
      "https://www.fiercebiotech.com/medtech/edwards-gets-fda-ok-to-pair-hypotension-predicting-ai-noninvasive-finger-cuff\n",
      "2021-06-02\n",
      "MedTech\n",
      "Lyra Therapeutics taps LianBio to bring sinusitis med to Asia\n",
      "https://www.fiercebiotech.com/biotech/lyra-therapeutics-taps-lianbio-to-bring-sinusitis-med-to-asia\n",
      "2021-06-02\n",
      "Biotech\n",
      "Renovacor renovates with ex-MyoCardia CMO to push into clinic\n",
      "https://www.fiercebiotech.com/biotech/after-spac-deal-renovacor-staffs-up-ex-myocardia-cmo-to-lead-clinical-development\n",
      "Biotech\n",
      "Avicenna's pulmonary-embolism-spotting AI OKed in U.S., EU\n",
      "https://www.fiercebiotech.com/medtech/avicenna-ai-goes-two-for-two-us-eu-clearance-vascular-disease-spotting-algorithms\n",
      "2021-06-02\n",
      "MedTech\n",
      "Veracyte lays out €260M for French cancer test maker HalioDx\n",
      "https://www.fiercebiotech.com/medtech/new-ceo-veracyte-outlines-eu260m-deal-for-french-test-maker-haliodx-and-global-cancer\n",
      "2021-06-02\n",
      "MedTech\n",
      "NRx hopes 'guided missile' COVID-19 antiviral will get FDA nod\n",
      "https://www.fiercebiotech.com/biotech/nrx-files-eua-for-covid-19-intravenous-drug-as-it-predicts-covid-therapeutics-will-be\n",
      "Biotech\n",
      "MorphoSys inks $1.7B Constellation buy, $1.4B financing deal\n",
      "https://www.fiercebiotech.com/biotech/morphosys-inks-not-one-but-two-billion-dollar-deals-including-constellation-pharma-buy\n",
      "2021-06-02\n",
      "Biotech\n",
      "Abiomed acquires heart failure device maker preCARDIA\n",
      "https://www.fiercebiotech.com/medtech/abiomed-acquires-precardia-and-its-catheter-based-system-to-treat-heart-failure\n",
      "2021-06-02\n",
      "MedTech\n",
      "AB halts masitinib trials after discovering heart disease worry\n",
      "https://www.fiercebiotech.com/biotech/ab-halts-masitinib-trials-after-discovering-heart-disease-worry\n",
      "2021-06-02\n",
      "Biotech\n",
      "Genmab joins with Bolt to develop bispecific immune stimulators\n",
      "https://www.fiercebiotech.com/biotech/genmab-joins-bolt-to-develop-bispecific-immune-stimulators\n",
      "2021-06-02\n",
      "Biotech\n",
      "Immunovant shares nosedive after lead drug hits more turbulence\n",
      "https://www.fiercebiotech.com/biotech/immunovant-tanks-as-it-s-not-immune-to-leadership-shake-ups-cmo-departing-after-five-months\n",
      "2021-06-01\n",
      "Biotech\n",
      "Abbott axes sales forecast as COVID testing starts drying up\n",
      "https://www.fiercebiotech.com/medtech/covid-testing-drying-up-faster-than-expected-abbott-says-amid-vaccine-gains-and-rolled-back\n",
      "2021-06-01\n",
      "MedTech\n",
      "Lucida Medical’s prostate cancer-spotting AI nets CE mark\n",
      "https://www.fiercebiotech.com/medtech/lucida-medical-nets-ce-mark-for-prostate-cancer-detecting-ai-software\n",
      "2021-06-01\n",
      "MedTech\n",
      "'Mind-reading' platform for nonverbal ALS patients earns CE mark\n",
      "https://www.fiercebiotech.com/medtech/brain-computer-interface-allowing-locked-als-patients-to-communicate-earns-european\n",
      "2021-06-01\n",
      "MedTech\n",
      "Liminal stops plan to advance fibrosis drug after seeing PK data\n",
      "https://www.fiercebiotech.com/biotech/liminal-stops-plan-to-advance-fibrosis-drug-after-seeing-pk-data\n",
      "2021-06-01\n",
      "Biotech\n",
      "J&J's anti-BCMA CAR-T pads its case ahead of BMS showdown\n",
      "https://www.fiercebiotech.com/biotech/asco-j-j-s-anti-bcma-car-t-pads-its-case-ahead-speedy-review-and-bristol-myers-showdown\n",
      "2021-06-01\n",
      "Biotech\n",
      "Gene editing biotech Verve guns for $100M IPO\n",
      "https://www.fiercebiotech.com/biotech/gene-editing-biotech-verve-indicates-a-swift-swerve-onto-wall-street-asking-for-100m-ipo\n",
      "2021-06-01\n",
      "Biotech\n",
      "Novartis pens buyout pact with fellow Swiss native Cellerys\n",
      "https://www.fiercebiotech.com/biotech/novartis-pens-buyout-pact-fellow-swiss-native-cellerys-eyeing-midstage-ms-hopeful\n",
      "2021-06-01\n",
      "Biotech\n",
      "Please stop the unpredictable stress. Hello, psychedelic analog.\n",
      "https://www.fiercebiotech.com/biotech/a-psychedelic-analog-shows-promise-combating-unpredictable-stress\n",
      "Research\n",
      "Sanofi's venglustat fails again, ending kidney disease program\n",
      "https://www.fiercebiotech.com/biotech/sanofi-s-venglustat-fails-another-trial-ending-pursuit-kidney-disease\n",
      "2021-06-01\n",
      "Biotech\n",
      "Amgen reunites with Kyowa Kirin in $400M dermatitis deal\n",
      "https://www.fiercebiotech.com/biotech/amgen-reunites-longtime-partner-kyowa-kirin-400m-dermatitis-deal\n",
      "2021-06-01\n",
      "Biotech\n",
      "Olympus acquires BPH device developer Medi-Tate\n",
      "https://www.fiercebiotech.com/medtech/olympus-acquires-minimally-invasive-bph-device-developer-medi-tate\n",
      "2021-05-28\n",
      "MedTech\n",
      "Smartwatch data predicts flu, anemia and more in Stanford study\n",
      "https://www.fiercebiotech.com/medtech/more-than-just-a-step-tracker-smartwatches-can-predict-blood-test-results-and-infections\n",
      "2021-05-28\n",
      "MedTech\n",
      "How a 'Polaroid' led Amgen to crack the 'Achilles heel tumor'\n",
      "https://www.fiercebiotech.com/biotech/how-a-protein-polaroid-led-amgen-to-cusp-a-cancer-breakthrough-lumakras-8-years\n",
      "2021-05-28\n",
      "Biotech\n",
      "Neogene taps Bristol Myers vet as U.S. COO—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-fledgling-t-cell-player-neogene-adds-bristol-myers-vet-to-u-s-roster\n",
      "2021-05-28\n",
      "Biotech\n",
      "Microcatheter maker Scientia nabs $50M from Vivo Capital\n",
      "https://www.fiercebiotech.com/medtech/scientia-raises-50m-to-develop-guidewires-and-microcatheters-for-stroke-cancer-treatment\n",
      "2021-05-28\n",
      "MedTech\n",
      "Phase 3 data boost EQRx's plan to undercut checkpoint inhibitors\n",
      "https://www.fiercebiotech.com/biotech/phase-3-data-boost-eqrx-s-plan-to-undercut-checkpoint-inhibitors\n",
      "2021-05-28\n",
      "Biotech\n",
      "HCW files for $50M IPO to trial fusion protein in solid tumors\n",
      "https://www.fiercebiotech.com/biotech/hcw-files-for-50m-ipo-to-trial-fusion-protein-solid-tumors\n",
      "2021-05-28\n",
      "Biotech\n",
      "FDA panel narrowly backs Provention's diabetes drug in 10-7 vote\n",
      "https://www.fiercebiotech.com/biotech/fda-panel-narrowly-backs-provention-bio-s-diabetes-drug-10-7-vote\n",
      "2021-05-27\n",
      "Biotech\n",
      "Karuna investor settles insider trading charges with SEC\n",
      "https://www.fiercebiotech.com/biotech/karuna-investor-settles-insider-trading-charges-sec-netted-120k-non-public-clinical-trial\n",
      "2021-05-27\n",
      "Biotech\n",
      "A DNA COVID-19 vaccine shows early promise\n",
      "https://www.fiercebiotech.com/research/a-dna-covid-19-vaccine-delivered-help-electrical-pulse-shows-early-promise\n",
      "2021-05-27\n",
      "Research\n",
      "Medtronic scores 2 CE marks for diabetes tech\n",
      "https://www.fiercebiotech.com/medtech/medtronic-scores-european-approvals-for-2-diabetes-management-devices\n",
      "2021-05-27\n",
      "MedTech\n",
      "Verily's Onduo takes its virtual clinic into mental health\n",
      "https://www.fiercebiotech.com/medtech/verily-s-onduo-continues-virtual-clinic-expansion-moves-into-mental-and-behavioral-health\n",
      "2021-05-27\n",
      "MedTech\n",
      "EFFECTOR binds to SPAC Locust Walk to move clinical trials along\n",
      "https://www.fiercebiotech.com/biotech/effector-therapeutics-proves-effective-at-spac-game-by-signing-deal-locust-walk\n",
      "Biotech\n",
      "Magenta Therapeutics' research lead Davis hits the exit\n",
      "https://www.fiercebiotech.com/biotech/magenta-therapeutics-research-lead-john-davis-hits-exit-for-family-reasons\n",
      "2021-05-27\n",
      "Biotech\n",
      "GenapSys rakes in $70M for tabletop DNA sequencer\n",
      "https://www.fiercebiotech.com/medtech/genapsys-rakes-70m-series-d-for-tabletop-genomic-sequencing-platform\n",
      "2021-05-27\n",
      "MedTech\n",
      "FDA clears radar-powered patient monitor from Xandar Kardian\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-radar-powered-contactless-patient-monitor-from-xandar-kardian\n",
      "2021-05-27\n",
      "MedTech\n",
      "Tectonic hires McNamara from Novartis' GNF to head up research\n",
      "https://www.fiercebiotech.com/biotech/tectonic-hires-mcnamara-from-novartis-gnf-to-head-up-research\n",
      "2021-05-27\n",
      "Biotech\n",
      "Ada Health nabs $90M for AI-based symptom checker app\n",
      "https://www.fiercebiotech.com/medtech/ada-health-reels-90m-bayer-led-series-b-for-ai-powered-symptom-assessments\n",
      "2021-05-27\n",
      "MedTech\n",
      "Sanofi, GSK kick-start phase 3 COVID-19 vax test\n",
      "https://www.fiercebiotech.com/biotech/sanofi-gsk-kickstart-phase-3-covid-vax-test-as-pair-target-variants-and-a-q4-approval\n",
      "2021-05-27\n",
      "Biotech\n",
      "Novartis, Molecular Partners start global trial for COVID drug\n",
      "https://www.fiercebiotech.com/biotech/novartis-molecular-partners-kick-off-global-trial-for-covid-19-drug-phase-2-data-expected\n",
      "2021-05-27\n",
      "Biotech\n",
      "Esco raises $200M to set up Boston cell and gene therapy hub\n",
      "https://www.fiercebiotech.com/biotech/esco-raises-200m-to-set-up-boston-cell-and-gene-therapy-hub\n",
      "2021-05-26\n",
      "Biotech\n",
      "Pulmocide eyes global phase 3 registration with fresh funds\n",
      "https://www.fiercebiotech.com/biotech/pulmocide-fills-lungs-92m-series-c-to-fund-phase-iii-registration-program-ahead-potential\n",
      "Biotech\n",
      "New prostate cancer target could reactivate standard treatments\n",
      "https://www.fiercebiotech.com/biotech/new-findings-suggest-blocking-prostate-cancer-s-backup-fuel-supply-could-lead-to-new\n",
      "Research\n",
      "Inhalable 'nanobody' fights off COVID in hamsters at low doses\n",
      "https://www.fiercebiotech.com/research/pitt-s-inhalable-nanobody-fights-off-covid-19-hamsters-at-ultra-low-doses\n",
      "2021-05-26\n",
      "Research\n",
      "Abeona preps for make-or-break FDA meeting in June\n",
      "https://www.fiercebiotech.com/biotech/abeona-therapeutics-attempts-to-reassure-stockholders-updates-fda-meetings-boosted\n",
      "Biotech\n",
      "NiKang quadruples last funding round with $200M series C\n",
      "https://www.fiercebiotech.com/biotech/nikang-snags-200m-series-c-and-stacks-its-board-following-january-licensing-erasca\n",
      "Biotech\n",
      "Ibex wins CE mark for breast cancer-spotting AI pathology tool\n",
      "https://www.fiercebiotech.com/medtech/ibex-wins-european-approval-for-breast-cancer-spotting-ai-pathology-tool\n",
      "2021-05-26\n",
      "MedTech\n",
      "Women's health-focused Celmatix snags Merck KGaA vet as CSO\n",
      "https://www.fiercebiotech.com/biotech/women-s-health-focused-celmatix-snags-merck-kgaa-vet-as-cso\n",
      "2021-05-26\n",
      "Biotech\n",
      "Biotech flipper Edwards joins Verseau as CEO\n",
      "https://www.fiercebiotech.com/biotech/biotech-flipper-john-edwards-joins-verseau-as-ceo-after-overseeing-tilos-from-birth-to\n",
      "2021-05-26\n",
      "Biotech\n",
      "Akili snags $160M for prescription video game to treat ADHD\n",
      "https://www.fiercebiotech.com/medtech/akili-snags-160m-to-commercialize-prescription-video-game-treatment-for-adhd\n",
      "2021-05-26\n",
      "MedTech\n",
      "Food safety tester Clear Labs raises $60M to chase COVID-19\n",
      "https://www.fiercebiotech.com/medtech/food-safety-tester-clear-labs-raises-60m-to-chase-covid-19-variants\n",
      "2021-05-26\n",
      "MedTech\n",
      "FDA sets back Travere's plans for kidney disease drug approval\n",
      "https://www.fiercebiotech.com/biotech/fda-sets-back-travere-s-plans-for-kidney-disease-drug-approval\n",
      "2021-05-26\n",
      "Biotech\n",
      "T-cell player Neogene bolsters U.S. team, adding BMS vet as COO\n",
      "https://www.fiercebiotech.com/biotech/next-gen-t-cell-player-neogene-bolsters-u-s-team-adding-bristol-myers-vet-as-coo\n",
      "2021-05-26\n",
      "Biotech\n",
      "Worldwide Clinical Trials pens Trialbee study matchmaking pact\n",
      "https://www.fiercebiotech.com/cro/worldwide-clinical-trials-pens-trialbee-study-matchmaking-pact-aims-for-better-recruitment\n",
      "2021-05-26\n",
      "CRO\n",
      "Larimar Therapeutics slapped with FDA clinical hold\n",
      "https://www.fiercebiotech.com/biotech/larimar-therapeutics-slapped-fda-clinical-hold-forced-to-halt-95m-cash-raise\n",
      "2021-05-26\n",
      "Biotech\n",
      "Spanish VC Ysios bags €216M to build EU-skewed biotech portfolio\n",
      "https://www.fiercebiotech.com/biotech/spanish-vc-ysios-bags-eu216m-to-build-eu-skewed-biotech-portfolio\n",
      "2021-05-25\n",
      "Biotech\n",
      "Quest links up with Paige for AI-powered cancer pathology tests\n",
      "https://www.fiercebiotech.com/medtech/quest-links-up-paige-for-ai-powered-cancer-pathology-tests\n",
      "2021-05-25\n",
      "MedTech\n",
      "Provention's diabetes drug appears to have AdComm's support\n",
      "https://www.fiercebiotech.com/biotech/provention-seems-to-have-advisory-committee-s-favor-efficacy-for-diabetes-drug-flagged-by\n",
      "2021-05-25\n",
      "Biotech\n",
      "Digital health coach Noom nets $540M to tackle diabetes and more\n",
      "https://www.fiercebiotech.com/medtech/digital-health-coach-noom-nets-540m-to-tackle-diabetes-high-blood-pressure\n",
      "2021-05-25\n",
      "MedTech\n",
      "Pieris Pharma nabs $20M upfront in Genentech collaboration\n",
      "https://www.fiercebiotech.com/biotech/pieris-pharma-inks-20m-upfront-payment-from-roche-s-genentech-respiratory-and-ophthalmology\n",
      "Biotech\n",
      "Bristol Myers taps Xencor's half-life tech for COVID-19 antibody\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-taps-xencor-s-half-life-tech-for-covid-19-antibody\n",
      "2021-05-25\n",
      "Biotech\n",
      "New JV from Pyxis, Alloy aims for rapid drug development\n",
      "https://www.fiercebiotech.com/biotech/new-jv-from-upstart-biotechs-pyxis-alloy-aims-for-rapid-drug-development\n",
      "2021-05-25\n",
      "Biotech\n",
      "Mexico ramping up late-stage COVID-19 trial work\n",
      "https://www.fiercebiotech.com/biotech/mexico-ramping-up-covid-trial-work-tapping-sanofi-china-s-shots-late-stage-tests\n",
      "2021-05-25\n",
      "Biotech\n",
      "Xilio inks Merck deal to run checkpoint inhibitor combo trial\n",
      "https://www.fiercebiotech.com/biotech/xilio-inks-merck-deal-to-run-checkpoint-inhibitor-combo-trial\n",
      "2021-05-25\n",
      "Biotech\n",
      "PicnicHealth, Komodo Health link real-world evidence platforms\n",
      "https://www.fiercebiotech.com/medtech/picnichealth-komodo-health-join-data-platforms-to-improve-treatment-complex-diseases\n",
      "2021-05-25\n",
      "MedTech\n",
      "Mutation-agnostic gene therapy triggers partial vision recovery\n",
      "https://www.fiercebiotech.com/biotech/mutation-agnostic-gene-therapy-triggers-partial-vision-recovery\n",
      "2021-05-25\n",
      "Biotech\n",
      "CVS Health launches new clinical trial services biz\n",
      "https://www.fiercebiotech.com/cro/pharmacy-giant-cvs-health-launches-new-clinical-trial-services-biz-eyes-siteless-trials\n",
      "2021-05-25\n",
      "CRO\n",
      "FDA clears 2 disposable endoscopes to help cut infection risks\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-two-disposable-endoscopes-to-help-mitigate-infection-risks\n",
      "2021-05-24\n",
      "MedTech\n",
      "Lydus Medical lands seed funding for automated microsurgery tool\n",
      "https://www.fiercebiotech.com/medtech/lydus-medical-backed-by-philips-and-teva-s-jv-lands-seed-funding-for-automated-microsurgery\n",
      "2021-05-24\n",
      "MedTech\n",
      "GI AI developer Docbot nets new CEO, series A funding\n",
      "https://www.fiercebiotech.com/medtech/gi-ai-developer-docbot-nets-new-ceo-series-a-funding\n",
      "2021-05-24\n",
      "MedTech\n",
      "Centessa Pharma eyeing $250M IPO to fund early drug development\n",
      "https://www.fiercebiotech.com/biotech/centessa-pharmaceuticals-prices-ipo-expects-net-proceeds-to-be-over-250m-slightly-larger\n",
      "Biotech\n",
      "Singapore OKs 60-second breathalyzer test for COVID-19\n",
      "https://www.fiercebiotech.com/medtech/breathonix-s-covid-19-breathalyzer-test-receives-provisional-authorization-singapore\n",
      "2021-05-24\n",
      "MedTech\n",
      "NGM's NASH prospect fails phase 2b, spurring R&D rethink\n",
      "https://www.fiercebiotech.com/biotech/ngm-s-nash-prospect-fails-phase-2b-spurring-r-d-rethink\n",
      "2021-05-24\n",
      "Biotech\n",
      "Is your living room the future of hospital care?\n",
      "https://www.fiercebiotech.com/medtech/your-living-room-future-hospital-care\n",
      "2021-05-24\n",
      "MedTech\n",
      "Eliem raises $60M to take neuro programs to series of data drops\n",
      "https://www.fiercebiotech.com/biotech/eliem-raises-60m-to-take-neuro-programs-to-series-data-drops\n",
      "2021-05-24\n",
      "Biotech\n",
      "J&J's subcutaneous bispecifics tackle myeloma in phase 1\n",
      "https://www.fiercebiotech.com/biotech/asco-j-j-s-subcutaneous-bispecifics-tackles-multiple-myeloma-phase-1\n",
      "2021-05-24\n",
      "Biotech\n",
      "Fine-tuning the brain's immune cells to tackle Alzheimer's\n",
      "https://www.fiercebiotech.com/research/fine-tuning-brain-s-immune-cells-to-tackle-alzheimer-s\n",
      "2021-05-24\n",
      "Research\n",
      "Takeda’s dengue shot keeps 84% of kids out of hospital\n",
      "https://www.fiercebiotech.com/biotech/takeda-s-dengue-shot-keeps-84-kids-out-hospital-regardless-prior-infection-giving-it-a-leg\n",
      "2021-05-23\n",
      "Biotech\n",
      "Heru sets sights on virtual reality eye tests with $30M round\n",
      "https://www.fiercebiotech.com/medtech/heru-sets-sights-virtual-reality-eye-tests-and-therapies-30m-round\n",
      "2021-05-21\n",
      "MedTech\n",
      "BioTheryX skips the SPAC fervor in favor of eventual IPO\n",
      "https://www.fiercebiotech.com/biotech/biotheryx-could-begin-ipo-preparation-around-4th-quarter-as-it-targets-key-milestones\n",
      "Biotech\n",
      "ASCO: BI, OSE report promising early results for I-O drug\n",
      "https://www.fiercebiotech.com/research/asco-boehringer-ose-offer-promising-glimpse-immuno-oncology-drug-at-heart-their-1-4b-deal\n",
      "2021-05-21\n",
      "Research\n",
      "FDA issues updated guidance on brain-computer interface devices\n",
      "https://www.fiercebiotech.com/medtech/fda-finalizes-leapfrog-guidance-use-thought-controlled-tech-paralysis-patients-amputees\n",
      "2021-05-21\n",
      "MedTech\n",
      "Novartis loses another NIBR exec to biotech—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-another-novartis-exec-answers-biotech-call-time-for-gene-therapy-startup\n",
      "2021-05-21\n",
      "Biotech\n",
      "BeiGene's Novartis-partnered PD-1 drug hits goal in phase 3\n",
      "https://www.fiercebiotech.com/biotech/beigene-s-novartis-partnered-pd-1-drug-hits-goal-phase-3\n",
      "2021-05-21\n",
      "Biotech\n",
      "Janux seeks $100M IPO on preclinical promise of bispecifics\n",
      "https://www.fiercebiotech.com/biotech/merck-partnered-janux-seeks-100m-ipo-preclinical-promise-bispecific-pipeline\n",
      "2021-05-21\n",
      "Biotech\n",
      "FDA clears Overjet's gum-disease-spotting AI software\n",
      "https://www.fiercebiotech.com/medtech/overjet-nets-fda-clearance-for-gum-disease-spotting-deep-learning-software\n",
      "2021-05-21\n",
      "MedTech\n",
      "Medtronic's Evolut valve holds up to open surgery in 2-year data\n",
      "https://www.fiercebiotech.com/medtech/medtronic-s-evolut-tavr-system-holds-up-to-open-heart-surgery-two-year-study-low-risk\n",
      "2021-05-21\n",
      "MedTech\n",
      "RenBio joins hunt for COVID-19 antibodies after $24M financing\n",
      "https://www.fiercebiotech.com/biotech/renbio-targets-clinic-entry-by-year-s-end-for-bispecific-covid-19-antibody-series-a\n",
      "Biotech\n",
      "Wheel rolls into $50M series B for telehealth platform\n",
      "https://www.fiercebiotech.com/medtech/wheel-deal-virtual-care-startup-rolls-into-50m-series-b-to-grow-telehealth-software\n",
      "2021-05-20\n",
      "MedTech\n",
      "Gauging disease risk by studying the gut microbiome's genes\n",
      "https://www.fiercebiotech.com/research/gauging-risk-diseases-by-studying-gut-microbiome-s-genetic-features\n",
      "2021-05-20\n",
      "Research\n",
      "ASCO: Targeted metabolic inhibitor stabilizes solid tumors\n",
      "https://www.fiercebiotech.com/research/asco-targeted-metabolic-inhibitor-stabilizes-solid-tumors-60-patients-phase-1\n",
      "2021-05-20\n",
      "Research\n",
      "Roivant, in an unexSPACted twist, wants to reacquire Immunovant\n",
      "https://www.fiercebiotech.com/biotech/roivant-unexspacted-twist-wants-to-bring-immunovant-back-into-fold\n",
      "2021-05-20\n",
      "Biotech\n",
      "FDA drafts guidance on devices for controlling Type 2 diabetes\n",
      "https://www.fiercebiotech.com/medtech/fda-drafts-guidance-cutting-edge-devices-for-controlling-type-2-diabetes\n",
      "2021-05-20\n",
      "MedTech\n",
      "Artificial heart maker Bivacor lands $22M to begin human trials\n",
      "https://www.fiercebiotech.com/medtech/bivacor-lands-22m-venture-capital-and-nih-funds-to-begin-human-studies-artificial-heart\n",
      "2021-05-20\n",
      "MedTech\n",
      "Lilly's tirzepatide aces 5th phase 3, teeing up filings\n",
      "https://www.fiercebiotech.com/biotech/lilly-s-tirzepatide-aces-fifth-phase-3-teeing-up-approval-filings\n",
      "2021-05-20\n",
      "Biotech\n",
      "Bon voyage: Voyager Therapeutics' CEO, R&D chief exit\n",
      "https://www.fiercebiotech.com/biotech/bon-voyage-voyager-therapeutics-ceo-r-d-chief-exit-as-beleaguered-biotech-looks-to-future\n",
      "2021-05-20\n",
      "Biotech\n",
      "Haya plants a seed in long non-coding RNA with seed funding\n",
      "https://www.fiercebiotech.com/biotech/embargo-3am-et-5-20-21-haya-therapeutics-shouts-hiya-as-swiss-biotech-emerges-from-stealth\n",
      "Biotech\n",
      "Numab raises $111M to challenge Genmab for new PD-L1 opportunity\n",
      "https://www.fiercebiotech.com/biotech/numab-raises-111m-to-challenge-genmab-biontech-for-emerging-pd-l1-opportunity\n",
      "2021-05-20\n",
      "Biotech\n",
      "I-Mab's uliledlimab sees positive data in Tecentriq combo test\n",
      "https://www.fiercebiotech.com/biotech/asco-i-mab-s-checkpoint-inhibitor-drug-helper-uliledlimab-sees-early-promise-tecentriq\n",
      "2021-05-19\n",
      "Biotech\n",
      "ASCO: Veracyte sets nasal swab lung cancer test for 2021 launch\n",
      "https://www.fiercebiotech.com/medtech/asco-new-data-sets-up-veracyte-s-nasal-swab-lung-cancer-test-for-launch-later-year\n",
      "2021-05-19\n",
      "MedTech\n",
      "Tasso snags CE mark for at-home blood collection device\n",
      "https://www.fiercebiotech.com/medtech/tasso-s-at-home-blood-sampling-device-for-virtual-clinical-trials-snags-european-approval\n",
      "2021-05-19\n",
      "MedTech\n",
      "BMS' LAG-3 drug boosts Opdivo in staving off melanoma\n",
      "https://www.fiercebiotech.com/biotech/asco-2021-bms-leading-lag-3-pack-posts-phase-3-data-showing-relatlimab-boosts-opdivo\n",
      "2021-05-19\n",
      "Biotech\n",
      "Sanofi's early amcenestrant data boost pharma's optimism\n",
      "https://www.fiercebiotech.com/biotech/asco-sanofi-says-early-amcenestrant-data-could-see-it-be-endocrine-backbone-therapy-breast\n",
      "2021-05-19\n",
      "Biotech\n",
      "ASCO: Adaptimmune’s cell therapy shrinks 39% of rare sarcomas\n",
      "https://www.fiercebiotech.com/biotech/asco-adaptimmune-s-cell-therapy-shrinks-39-rare-sarcomas\n",
      "2021-05-19\n",
      "Biotech\n",
      "Merck's LAG-3 med boosts Keytruda in 'cold' colon cancer\n",
      "https://www.fiercebiotech.com/biotech/asco-merck-s-lag-3-antibody-boosts-keytruda-hard-to-treat-colon-cancer-phase-1\n",
      "2021-05-19\n",
      "Biotech\n",
      "J&J previews targeted data on bispecific lung cancer combo\n",
      "https://www.fiercebiotech.com/biotech/asco-janssen-s-bispecific-lung-cancer-combo-shows-promise-as-tagrisso-back-up-but-big\n",
      "2021-05-19\n",
      "Biotech\n",
      "Iovance CEO Maria Fardis departs after setback for TIL therapy\n",
      "https://www.fiercebiotech.com/biotech/iovance-biotherapeutics-ceo-to-resign-following-tuesday-fda-data-request\n",
      "Biotech\n",
      "Sanofi loses digital health VP to pain management tech startup\n",
      "https://www.fiercebiotech.com/medtech/sanofi-digital-health-exec-litman-jumps-ship-for-pain-management-tech-developer-remedee\n",
      "2021-05-19\n",
      "MedTech\n",
      "Exscientia pens $1.2B AI drug discovery deal with BMS\n",
      "https://www.fiercebiotech.com/medtech/exscientia-pens-1-2b-ai-drug-discovery-deal-bristol-myers-squibb\n",
      "2021-05-19\n",
      "MedTech\n",
      "Ascensia unveils online diabetes management platform\n",
      "https://www.fiercebiotech.com/medtech/ascensia-unveils-online-platform-connects-to-glucose-meters-for-diabetes-management\n",
      "2021-05-19\n",
      "MedTech\n",
      "3rd time's not the charm for Novartis as Shanker departs\n",
      "https://www.fiercebiotech.com/biotech/tevard-biosciences-picks-up-novartis-neuroscience-head-to-advance-gene-therapy-into-clinic\n",
      "Biotech\n",
      "Biopharma R&D 'surged' in 2020: report\n",
      "https://www.fiercebiotech.com/biotech/biopharma-r-d-surged-2020-but-trial-productivity-levels-a-mixed-bag-report\n",
      "2021-05-19\n",
      "Biotech\n",
      "PathAI closes $165M series C for AI-based pathology software\n",
      "https://www.fiercebiotech.com/medtech/pathai-finds-its-way-to-165m-series-c-for-diagnostic-and-drug-development-software\n",
      "2021-05-19\n",
      "MedTech\n",
      "BerGenBio fails COVID-19 trial, makes post hoc case for program\n",
      "https://www.fiercebiotech.com/biotech/bergenbio-fails-covid-19-trial-makes-post-hoc-case-for-program\n",
      "2021-05-19\n",
      "Biotech\n",
      "Romano leaves as CMO of Passage Bio with immediate effect\n",
      "https://www.fiercebiotech.com/biotech/romano-leaves-as-cmo-gene-therapy-startup-passage-bio-immediate-effect\n",
      "2021-05-19\n",
      "Biotech\n",
      "CytoDyn begs investors to stop trashing FDA in bizarre call\n",
      "https://www.fiercebiotech.com/biotech/cytodyn-begs-investors-to-stop-trashing-fda-bizarre-call-after-agency-s-public-smackdown\n",
      "2021-05-18\n",
      "Biotech\n",
      "Atonarp nets $50M to chase laser-powered point-of-care tests\n",
      "https://www.fiercebiotech.com/medtech/laser-sensor-startup-atonarp-nets-50m-to-chase-chemistry-free-point-care-diagnostics\n",
      "2021-05-18\n",
      "MedTech\n",
      "Sarepta shares rally on early successful DMD data\n",
      "https://www.fiercebiotech.com/biotech/sarepta-shares-rally-early-successful-dmd-data-also-reveals-2-serious-79-mild-adverse\n",
      "2021-05-18\n",
      "Biotech\n",
      "Artificial nabs $21M series A for lab automation platform\n",
      "https://www.fiercebiotech.com/medtech/microsoft-leads-21m-investment-artificial-s-automation-platform-for-life-science-labs\n",
      "2021-05-18\n",
      "MedTech\n",
      "Doctors now must provide patients their health data on demand\n",
      "https://www.fiercebiotech.com/medtech/doctors-now-must-provide-patients-their-health-data-online-and-demand\n",
      "2021-05-18\n",
      "MedTech\n",
      "Livongo incubator 7wireVentures launches $150M investment fund\n",
      "https://www.fiercebiotech.com/medtech/7wireventures-incubator-digital-health-giant-livongo-launches-150m-consumer-health-fund\n",
      "2021-05-18\n",
      "MedTech\n",
      "Hummingbird takes flight with $125M Novo-led series C\n",
      "https://www.fiercebiotech.com/biotech/hummingbird-bioscience-buzzes-150m-series-c-led-by-novo-holdings\n",
      "2021-05-18\n",
      "Biotech\n",
      "BMS pays $200M upfront, $1.36B in biobucks for Agenus' TIGIT\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-hands-over-200m-upfront-1-36b-biobucks-for-agenus-preclinical-tigit-asset\n",
      "2021-05-18\n",
      "Biotech\n",
      "After $150M Novartis deal, Vedere Bio team is back for round 2\n",
      "https://www.fiercebiotech.com/biotech/after-150m-novartis-deal-vedere-bio-team-back-for-round-2\n",
      "2021-05-18\n",
      "Biotech\n",
      "Medicago, GSK post data on plant-derived COVID-19 vaccine\n",
      "https://www.fiercebiotech.com/biotech/medicago-gsk-post-positive-midphase-data-plant-derived-covid-19-vaccine\n",
      "2021-05-18\n",
      "Biotech\n",
      "EureKARE raises $60M to create EU synbio and microbiome startups\n",
      "https://www.fiercebiotech.com/biotech/eurekare-raises-60m-to-create-eu-synbio-and-microbiome-startups\n",
      "2021-05-17\n",
      "Biotech\n",
      "CytoDyn accused by FDA of cherry-picking COVID-19 data\n",
      "https://www.fiercebiotech.com/biotech/cytodyn-shares-plummet-after-being-accused-by-fda-cherry-picking-covid-19-data\n",
      "2021-05-17\n",
      "Biotech\n",
      "New insight into aggressive breast cancer could drive treatment\n",
      "https://www.fiercebiotech.com/research/new-insight-into-aggressive-breast-cancer-could-drive-treatment-choices\n",
      "2021-05-17\n",
      "Research\n",
      "PerkinElmer opens COVID-flush wallet for $155M diagnostics buy\n",
      "https://www.fiercebiotech.com/medtech/perkinelmer-opens-covid-flush-wallet-for-155m-immunodiagnostics-buy\n",
      "2021-05-17\n",
      "MedTech\n",
      "Abbott wins CE mark for Navitor artificial heart valve\n",
      "https://www.fiercebiotech.com/medtech/abbott-nabs-european-approval-for-noninvasive-replacement-heart-valve-to-treat-severe\n",
      "2021-05-17\n",
      "MedTech\n",
      "Blood pressure device maker CardieX ventures into consumer tech\n",
      "https://www.fiercebiotech.com/medtech/blood-pressure-device-maker-cardiex-launches-conneqt-consumer-tech-venture-to-compete-apple\n",
      "2021-05-17\n",
      "MedTech\n",
      "Blueprint adds another BMS vet to its roster with new CSO\n",
      "https://www.fiercebiotech.com/biotech/blueprint-adds-another-bms-vet-to-its-roster-new-cso\n",
      "2021-05-17\n",
      "Biotech\n",
      "Prepping the next generation of COVID-19 vaccines and treatments\n",
      "https://www.fiercebiotech.com/research/prepping-next-generation-covid-vaccines-and-treatments\n",
      "2021-05-17\n",
      "Research\n",
      "Incyte's ruxolitinib cream hits goal in vitiligo phase 3 trials\n",
      "https://www.fiercebiotech.com/biotech/incyte-s-ruxolitinib-cream-hits-goal-vitiligo-phase-3-trials-teeing-up-regulatory\n",
      "2021-05-17\n",
      "Biotech\n",
      "PrecisionLife, Cyclica ally to co-market discovery platforms\n",
      "https://www.fiercebiotech.com/biotech/precisionlife-cyclica-ally-to-co-market-computational-discovery-platforms\n",
      "2021-05-17\n",
      "Biotech\n",
      "Cytokinetics preps omecamtiv for support role in heart failure\n",
      "https://www.fiercebiotech.com/biotech/acc-2021-as-amgen-partnership-ends-cytokinetics-preps-heart-drug-for-narrower-fda-filing\n",
      "2021-05-17\n",
      "Biotech\n",
      "Landos Biopharma teams up with LianBio for $218M-plus collab\n",
      "https://www.fiercebiotech.com/biotech/landos-biopharma-teams-up-lianbio-for-218m-plus-collab-and-sales-deal-for-two-immunology\n",
      "2021-05-17\n",
      "Biotech\n",
      "Ginkgo tees up next acquisition days after inking $2.5 SPAC deal\n",
      "https://www.fiercebiotech.com/biotech/ginkgo-tees-up-its-next-acquisition-just-days-after-inking-2-5b-spac-deal\n",
      "2021-05-17\n",
      "Biotech\n",
      "The top 10 medtech VC rounds of 2020\n",
      "https://www.fiercebiotech.com/special-report/top-10-medtech-vc-rounds-2020\n",
      "2021-05-17\n",
      "Special Reports\n",
      "2nd time lucky as Sanofi-GSK pass phase 2 COVID shot test\n",
      "https://www.fiercebiotech.com/biotech/second-time-lucky-for-sanofi-gsk-after-passing-small-midstage-covid-shot-eye-approval-by\n",
      "2021-05-17\n",
      "Biotech\n",
      "ACC: Study finds no increased death risk with paclitaxel devices\n",
      "https://www.fiercebiotech.com/medtech/acc-2021-large-scale-medicare-analysis-finds-no-increased-death-risk-paclitaxel-coated\n",
      "2021-05-16\n",
      "MedTech\n",
      "ACC: Heart ultrasound AI accurately predicts COVID-19 death risk\n",
      "https://www.fiercebiotech.com/medtech/acc-2021-cardiac-ultrasound-ai-outperforms-doctors-at-predicting-covid-19-death-risks\n",
      "2021-05-16\n",
      "MedTech\n",
      "ACC: ReCor's renal denervation device cuts drug-resistant BP\n",
      "https://www.fiercebiotech.com/medtech/acc-2021-recor-s-ultrasound-powered-renal-denervation-device-cuts-drug-resistant-high-blood\n",
      "2021-05-16\n",
      "MedTech\n",
      "ACC: Edwards' tricuspid valve cuts leaks in 98% of patients\n",
      "https://www.fiercebiotech.com/medtech/acc-2021-edwards-tricuspid-valve-replacement-cuts-leaks-98-patients\n",
      "2021-05-15\n",
      "MedTech\n",
      "BMS unveils more mavacamten data, nabbed in $13B MyoKardia deal\n",
      "https://www.fiercebiotech.com/biotech/acc-2021-bms-unveils-more-data-for-mavacamten-nabbed-13b-myokardia-buyout\n",
      "2021-05-15\n",
      "Biotech\n",
      "ACC: 10-minute add-on heart surgery cuts stroke risk by a third\n",
      "https://www.fiercebiotech.com/medtech/acc-2021-researchers-find-10-minute-add-heart-surgery-cuts-stroke-risk-by-one-third\n",
      "2021-05-15\n",
      "MedTech\n",
      "Keep that new phone away from your pacemaker, FDA says\n",
      "https://www.fiercebiotech.com/medtech/keep-new-phone-away-from-your-pacemaker-fda-says\n",
      "2021-05-14\n",
      "MedTech\n",
      "Biogen's eye disease gene therapy fails to improve vision\n",
      "https://www.fiercebiotech.com/biotech/biogen-reveals-gene-therapy-trial-failure-as-investors-remain-laser-focused-aducanumab\n",
      "2021-05-14\n",
      "Biotech\n",
      "One Drop nets CE mark for AI-powered glucose forecasts in T2D\n",
      "https://www.fiercebiotech.com/medtech/one-drop-brings-ai-powered-blood-sugar-predictions-to-type-2-diabetes-and-prediabetes\n",
      "2021-05-14\n",
      "MedTech\n",
      "Otonomy eyes clinical trial of hearing loss gene therapy\n",
      "https://www.fiercebiotech.com/research/otonomy-eyes-clinical-trial-hearing-loss-gene-therapy-promising-mice-data\n",
      "2021-05-14\n",
      "Research\n",
      "Salter-Cid joins former BMS peer at Flagship—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-gossamer-vet-salter-cid-dons-cso-mantle-at-flagship-s-new-pioneering\n",
      "2021-05-14\n",
      "Biotech\n",
      "Compass inks Trigr takeover to land clinical-phase bispecific\n",
      "https://www.fiercebiotech.com/biotech/compass-inks-trigr-takeover-to-land-clinical-phase-bispecific\n",
      "2021-05-14\n",
      "Biotech\n",
      "Kinnate, OrbiMed team up to target Chinese lung cancer market\n",
      "https://www.fiercebiotech.com/biotech/kinnate-orbimed-team-up-to-target-chinese-lung-cancer-market\n",
      "2021-05-14\n",
      "Biotech\n",
      "Humanigen eyes COVID drug emergency filing by June\n",
      "https://www.fiercebiotech.com/biotech/a-new-cmo-and-phase-3-data-to-hand-humanigen-eyes-covid-drug-emergency-filing-by-june\n",
      "2021-05-14\n",
      "Biotech\n",
      "Novartis adds AI-based diagnostic surveys to online disease hubs\n",
      "https://www.fiercebiotech.com/medtech/novartis-taps-ada-health-s-ai-powered-assessments-to-speed-diagnosis-rare-immunological\n",
      "2021-05-13\n",
      "MedTech\n",
      "Portable test maker Cue Health nets $235M for a post-COVID world\n",
      "https://www.fiercebiotech.com/medtech/portable-test-maker-cue-health-nets-235m-to-prep-for-a-post-covid-world\n",
      "2021-05-13\n",
      "MedTech\n",
      "Interline uncloaks with $92M to go after protein communities\n",
      "https://www.fiercebiotech.com/biotech/foresite-arch-fuel-92m-round-for-interline-therapeutics-a-biotech-taking-aim-at-protein\n",
      "2021-05-13\n",
      "Biotech\n",
      "Abbott and United team up to offer carry-on COVID tests\n",
      "https://www.fiercebiotech.com/medtech/plane-ticket-check-passport-check-covid-test-abbott-and-united-airlines-have-it-covered\n",
      "2021-05-13\n",
      "MedTech\n",
      "BD scores European approval for at-home HPV test\n",
      "https://www.fiercebiotech.com/medtech/bd-scores-european-approval-for-at-home-hpv-test\n",
      "2021-05-13\n",
      "MedTech\n",
      "MSD Partners, Panacea's biotech SPAC raises $200M IPO\n",
      "https://www.fiercebiotech.com/biotech/msd-partners-panacea-s-biotech-spac-hits-street-200m-ipo\n",
      "2021-05-13\n",
      "Biotech\n",
      "Medtronic’s HeartWare blood pump hit with 3rd recall this year\n",
      "https://www.fiercebiotech.com/medtech/medtronic-issues-3rd-class-i-recall-year-related-to-heartware-blood-pump\n",
      "2021-05-13\n",
      "MedTech\n",
      "NEA-backed Allay exits stealth with clinical pain data\n",
      "https://www.fiercebiotech.com/biotech/nea-backed-allay-exits-stealth-clinical-pain-data-plans-to-reduce-need-for-opioids\n",
      "2021-05-13\n",
      "Biotech\n",
      "'CopyCatcher' opens the door to CRISPR-based gene therapy\n",
      "https://www.fiercebiotech.com/research/how-genetic-copycatcher-could-open-door-to-crispr-based-precision-gene-therapy\n",
      "2021-05-13\n",
      "Research\n",
      "Autolus' CD19 CAR-T posts 100% complete response rate\n",
      "https://www.fiercebiotech.com/biotech/autolus-cd19-car-t-posts-100-complete-response-rate-zero-grade-3-crs-small-lymphoma-trial\n",
      "2021-05-13\n",
      "Biotech\n",
      "Amgen, AstraZeneca file for 1st of many tezepelumab indications\n",
      "https://www.fiercebiotech.com/biotech/amgen-and-astrazeneca-s-tezepelumab-coming-for-asthma-market-dominated-by-sanofi-s-dupixent\n",
      "2021-05-13\n",
      "Biotech\n",
      "J&J tackles childhood myopia with new FDA contact lens clearance\n",
      "https://www.fiercebiotech.com/medtech/j-j-vision-sets-sights-childhood-myopia-new-fda-contact-lens-clearance\n",
      "2021-05-12\n",
      "MedTech\n",
      "Salter-Cid reunites with BMS brethren Biondi at Flagship\n",
      "https://www.fiercebiotech.com/biotech/ex-gossamer-cso-salter-cid-reunites-bristol-myers-brethren-biondi-at-flagship-pioneering\n",
      "2021-05-12\n",
      "Biotech\n",
      "Real-world data software maker Aetion closes $110M series C\n",
      "https://www.fiercebiotech.com/medtech/aetion-doubles-lifetime-funding-110m-series-c-for-real-world-data-platform\n",
      "2021-05-12\n",
      "MedTech\n",
      "Caris Life Sciences scores $830M for sequencing platform\n",
      "https://www.fiercebiotech.com/medtech/caris-life-sciences-scores-830m-to-grow-ai-powered-genetic-sequencing-platform\n",
      "2021-05-12\n",
      "MedTech\n",
      "Bose finally launches its direct-to-consumer hearing aid\n",
      "https://www.fiercebiotech.com/medtech/bose-finally-launches-its-direct-to-consumer-soundcontrol-hearing-aid\n",
      "2021-05-12\n",
      "MedTech\n",
      "Biogen buys midphase drug to challenge Roche for stroke market\n",
      "https://www.fiercebiotech.com/biotech/biogen-buys-midphase-drug-to-challenge-roche-for-stroke-market\n",
      "2021-05-12\n",
      "Biotech\n",
      "Alexion founder Squinto helms OrbiMed-backed startup\n",
      "https://www.fiercebiotech.com/biotech/alexion-founder-stephen-squinto-helms-orbimed-backed-startup-some-yale-gene-therapy-tech\n",
      "2021-05-12\n",
      "Biotech\n",
      "As data near, U.K. rethinks AstraZeneca COVID-19 antibody deal\n",
      "https://www.fiercebiotech.com/biotech/as-data-nears-u-k-rethinks-astrazeneca-covid-19-antibody-deal\n",
      "2021-05-12\n",
      "Biotech\n",
      "Call for your Fierce Biotech Fierce 15 nominations for 2021\n",
      "https://www.fiercebiotech.com/biotech/call-for-your-fierce-15-nominations-for-2021\n",
      "2021-05-12\n",
      "Biotech\n",
      "Trials ramping back up, but slow takeup of places remains\n",
      "https://www.fiercebiotech.com/cro/trials-ramping-back-up-but-slow-take-up-places-remain-a-barrier-report\n",
      "2021-05-12\n",
      "CRO\n",
      "Perceptive unveils $515M fund, its 2nd for early-stage biotechs\n",
      "https://www.fiercebiotech.com/biotech/perceptive-advisors-unveils-515m-fund-its-2nd-for-early-stage-biotechs\n",
      "2021-05-12\n",
      "Biotech\n",
      "Huma raises $200M series C to grow its remote care platform\n",
      "https://www.fiercebiotech.com/medtech/huma-rakes-200m-to-grow-digital-health-ecosystem-surrounding-its-remote-care-platform\n",
      "2021-05-11\n",
      "MedTech\n",
      "FDA clears Bigfoot’s dose-recommending smart insulin pens\n",
      "https://www.fiercebiotech.com/medtech/bigfoot-biomedical-emerges-fda-clearance-for-its-dose-recommending-insulin-pens-and-ai\n",
      "2021-05-11\n",
      "MedTech\n",
      "Ex-Purdue CEO Timney lands at amyloidosis biotech Attralus\n",
      "https://www.fiercebiotech.com/biotech/ex-purdue-ceo-timney-lands-at-amyloidosis-biotech-attralus\n",
      "2021-05-11\n",
      "Biotech\n",
      "Follow the Whiterabbit: AI maker uncloaks with FDA OK in hand\n",
      "https://www.fiercebiotech.com/medtech/follow-whiterabbit-ai-developer-exits-stealth-mode-fda-ok-for-breast-cancer-screening-tool\n",
      "2021-05-11\n",
      "MedTech\n",
      "Novavax delays COVID-19 vaccine regulatory submissions—again\n",
      "https://www.fiercebiotech.com/biotech/novavax-delays-covid-19-vaccine-regulatory-submissions-again\n",
      "2021-05-11\n",
      "Biotech\n",
      "AbbVie cancer exec Graef jumps to cell therapy biotech Acepodia\n",
      "https://www.fiercebiotech.com/biotech/natural-killer-cell-biotech-acepodia-snaps-up-abbvie-oncology-development-chief-graef\n",
      "2021-05-11\n",
      "Biotech\n",
      "Ginkgo lands on NYSE via $2.5B SPAC merger\n",
      "https://www.fiercebiotech.com/biotech/ginkgo-lands-nyse-via-spac-merger-gaining-2-5b-to-fuel-growth\n",
      "2021-05-11\n",
      "Biotech\n",
      "Orchard gene therapy helps kids with no immune system in study\n",
      "https://www.fiercebiotech.com/biotech/orchard-gene-therapy-helps-kids-no-immune-system-new-study\n",
      "2021-05-11\n",
      "Biotech\n",
      "Nuvalent bags $135M to trial next-gen kinase inhibitors\n",
      "https://www.fiercebiotech.com/biotech/nuvalent-bags-135m-to-trial-resistance-beating-kinase-inhibitors-lung-cancer\n",
      "2021-05-11\n",
      "Biotech\n",
      "Lilly, MiNA ink broad deal to upregulate proteins using RNA\n",
      "https://www.fiercebiotech.com/biotech/lilly-mina-ink-broad-deal-to-upregulate-proteins-using-rna\n",
      "2021-05-11\n",
      "Biotech\n",
      "Appia Bio aims for new off-the-shelf CAR-T with $52M raise\n",
      "https://www.fiercebiotech.com/biotech/appia-bio-aims-for-a-new-kind-off-shelf-car-t-52m-raise\n",
      "2021-05-11\n",
      "Biotech\n",
      "Biofourmis nabs new chief medical officer from Amazon\n",
      "https://www.fiercebiotech.com/medtech/biofourmis-nabs-amazon-alum-to-lead-telehealth-expansion-as-chief-medical-officer\n",
      "2021-05-10\n",
      "MedTech\n",
      "COVID-flu combo shot from Novavax shows promise in animals\n",
      "https://www.fiercebiotech.com/research/covid-flu-combo-vaccine-from-novavax-sparks-immune-response-to-both-viruses-animals\n",
      "2021-05-10\n",
      "Research\n",
      "Allergan Aesthetics picks up cellulite, tattoo remover for $550M\n",
      "https://www.fiercebiotech.com/medtech/abbvie-s-allergan-aesthetics-dishes-out-550m-for-soliton-and-its-cellulite-tattoo-remover\n",
      "2021-05-10\n",
      "MedTech\n",
      "DaVita taps Baxter's connected dialysis system for home care\n",
      "https://www.fiercebiotech.com/medtech/davita-taps-into-baxter-s-connected-peritoneal-dialysis-system-for-home-kidney-care\n",
      "2021-05-10\n",
      "MedTech\n",
      "Mayo Clinic AI can spot early-stage heart disease in EKGs\n",
      "https://www.fiercebiotech.com/medtech/mayo-clinic-ai-algorithm-proves-effective-at-spotting-early-stage-heart-disease-routine-ekg\n",
      "2021-05-10\n",
      "MedTech\n",
      "Attacking age-related diseases by slashing 'senescent' cells\n",
      "https://www.fiercebiotech.com/research/attacking-aging-and-chronic-disease-by-eliminating-senescent-cells-immunotherapy\n",
      "2021-05-10\n",
      "Research\n",
      "LianBio poaches Lilly COVID-19 antibody leader to fill CEO role\n",
      "https://www.fiercebiotech.com/biotech/lianbio-poaches-lilly-covid-19-antibody-leader-for-its-new-ceo\n",
      "2021-05-10\n",
      "Biotech\n",
      "Centessa welcomes AstraZeneca vet Yver as chief medical officer\n",
      "https://www.fiercebiotech.com/biotech/centessa-s-new-chief-medical-officer-has-astrazeneca-s-tagrisso-lynparza-his-resume\n",
      "2021-05-10\n",
      "Biotech\n",
      "BARDA inks two software partnerships for COVID-19 triage\n",
      "https://www.fiercebiotech.com/medtech/barda-partners-perahealth-agilemd-to-build-software-for-covid-19-emergency-triage\n",
      "2021-05-10\n",
      "MedTech\n",
      "Bayer's near-approval Farxiga rival meets goal in 2nd phase 3\n",
      "https://www.fiercebiotech.com/biotech/bayer-s-near-approval-farxiga-rival-meets-goal-second-phase-3\n",
      "2021-05-10\n",
      "Biotech\n",
      "Flagship debuts Laronde to turn cells into drug factories\n",
      "https://www.fiercebiotech.com/biotech/flagship-debuts-laronde-to-develop-rna-based-meds-could-turn-cells-into-protein-factories\n",
      "2021-05-10\n",
      "Biotech\n",
      "Abingworth raises $582M clinical co-development fund\n",
      "https://www.fiercebiotech.com/biotech/abingworth-raises-582m-clinical-co-development-fund-amid-rising-biotech-interest\n",
      "2021-05-08\n",
      "Biotech\n",
      "Daiichi, AstraZeneca's $5B Enhertu follow-up shows early promise\n",
      "https://www.fiercebiotech.com/biotech/daiichi-sankyo-astrazeneca-s-5b-enhertu-follow-up-shows-early-signs-success-breast-cancer\n",
      "2021-05-08\n",
      "Biotech\n",
      "COVID testing turns into a windfall for hospitals and providers\n",
      "https://www.fiercebiotech.com/medtech/covid-testing-has-turned-into-a-financial-windfall-for-hospitals-and-other-providers\n",
      "2021-05-07\n",
      "MedTech\n",
      "Mirati's KRAS program hits some delays in battle with Amgen\n",
      "https://www.fiercebiotech.com/biotech/mirati-offers-so-so-news-for-investors-closely-watching-kras-battle-amgen\n",
      "2021-05-07\n",
      "Biotech\n",
      "Walmart Health acquires telehealth provider MeMD\n",
      "https://www.fiercebiotech.com/medtech/walmart-health-expands-into-telemedicine-acquisition-virtual-care-provider-memd\n",
      "2021-05-07\n",
      "MedTech\n",
      "J&J nets U.S., Canada OKs for vision-correcting cataract lenses\n",
      "https://www.fiercebiotech.com/medtech/j-j-vision-nets-u-s-canada-approvals-for-vision-correcting-cataract-intraocular-lenses\n",
      "2021-05-07\n",
      "MedTech\n",
      "Gyroscope finds IPO market unnavigable\n",
      "https://www.fiercebiotech.com/biotech/gene-therapy-biotech-gyroscope-finds-unnavigable-seas-ipo-market\n",
      "2021-05-07\n",
      "Biotech\n",
      "Talaris pulls off $150M IPO to tackle organ rejection\n",
      "https://www.fiercebiotech.com/biotech/talaris-pulls-off-150m-ipo-to-tackle-organ-rejection-autoimmune-disorders\n",
      "2021-05-07\n",
      "Biotech\n",
      "Viome scores FDA breakthrough nod for cancer-screening platform\n",
      "https://www.fiercebiotech.com/medtech/viome-scores-fda-breakthrough-label-for-microbiome-sequencing-ai-platform-for-cancer\n",
      "2021-05-07\n",
      "MedTech\n",
      "Inovio wants to treat an impossible brain tumor\n",
      "https://www.fiercebiotech.com/biotech/inovio-going-after-impossible-tumor-left-dust-new-cancer-meds\n",
      "2021-05-07\n",
      "Biotech\n",
      "CRISPR Tx, Nkarta pen new cutting-edge cancer tech R&D pact\n",
      "https://www.fiercebiotech.com/biotech/crispr-therapeutics-nkarta-pen-new-cutting-edge-cancer-tech-research-pact\n",
      "2021-05-07\n",
      "Biotech\n",
      "Science 37 taps a SPAC to go public, valued at $1B\n",
      "https://www.fiercebiotech.com/cro/science-37-taps-a-spac-to-go-public-siteless-trial-specialist-valued-at-a-cool-1b\n",
      "2021-05-07\n",
      "CRO\n",
      "AdComm experts split on whether to OK ChemoCentryx's avacopan\n",
      "https://www.fiercebiotech.com/biotech/adcomm-experts-split-whether-to-approve-chemocentryx-s-avacopan\n",
      "2021-05-07\n",
      "Biotech\n",
      "Galapagos cuts pipeline, targets €150M in savings after setbacks\n",
      "https://www.fiercebiotech.com/biotech/galapagos-cuts-pipeline-targets-eu150m-savings-after-setbacks\n",
      "2021-05-07\n",
      "Biotech\n",
      "Merck's Perlmutter lands CEO post at Eikon—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-former-merck-r-d-chief-perlmutter-takes-reins-at-eikon-applying-nobel\n",
      "2021-05-06\n",
      "Biotech\n",
      "GE Healthcare picks up ER-positive breast cancer imaging agent\n",
      "https://www.fiercebiotech.com/medtech/ge-healthcare-picks-up-er-positive-breast-cancer-imaging-agent-zionexa-deal\n",
      "2021-05-06\n",
      "MedTech\n",
      "NeoGenomics moves forward with $390M option to buy out Inivata\n",
      "https://www.fiercebiotech.com/medtech/neogenomics-to-acquire-inivata-for-390m-after-success-lung-cancer-liquid-biopsy-collab\n",
      "2021-05-06\n",
      "MedTech\n",
      "A stem cell vaccine shows promise in pancreatic cancer models\n",
      "https://www.fiercebiotech.com/research/a-cancer-vaccine-based-stem-cells-stanford-candidate-shows-promise-pancreatic-tumor\n",
      "2021-05-06\n",
      "Research\n",
      "BD spins off its diabetes business into a standalone company\n",
      "https://www.fiercebiotech.com/medtech/bd-to-spin-off-diabetes-care-business-into-newco-a-standalone-public-company\n",
      "2021-05-06\n",
      "MedTech\n",
      "Lilly inks smart insulin pen deals with Roche, Dexcom and more\n",
      "https://www.fiercebiotech.com/medtech/lilly-inks-smart-insulin-pen-deals-roche-dexcom-and-more\n",
      "2021-05-06\n",
      "MedTech\n",
      "Merck takes $170M charge on abandoned COVID-19 drug\n",
      "https://www.fiercebiotech.com/biotech/merck-takes-170m-charge-abandoned-covid-19-drug\n",
      "2021-05-06\n",
      "Biotech\n",
      "Bluebird names oncology spinoff, establishes leadership team\n",
      "https://www.fiercebiotech.com/biotech/bluebird-names-oncology-spinoff-establishes-leadership-team\n",
      "2021-05-06\n",
      "Biotech\n",
      "TwinStrand raises $50M for cancer-spotting sequencing tech\n",
      "https://www.fiercebiotech.com/medtech/twinstrand-biosciences-raises-50m-to-increase-adoption-dna-sequencing-tech-for-cancer\n",
      "2021-05-06\n",
      "MedTech\n",
      "Novavax shares in the red after new SA variant data drop\n",
      "https://www.fiercebiotech.com/biotech/novavax-shares-red-after-vaccine-sees-51-efficacy-against-south-african-covid-variant\n",
      "2021-05-06\n",
      "Biotech\n",
      "Novo Holdings' CRO Altasciences continues deal spree\n",
      "https://www.fiercebiotech.com/cro/novo-holdings-cro-altasciences-continues-deal-spree-snapping-up-calvert-labs-for-its\n",
      "2021-05-06\n",
      "CRO\n",
      "Dyno grabs $100M to expand tech, ink more gene therapy deals\n",
      "https://www.fiercebiotech.com/biotech/dyno-grabs-100m-to-expand-tech-build-team-ink-more-gene-therapy-partnerships\n",
      "2021-05-06\n",
      "Biotech\n",
      "Sanofi partners with Stanford on immunology research\n",
      "https://www.fiercebiotech.com/biotech/sanofi-kicks-off-new-immunology-drug-discovery-journey-stanford-pact\n",
      "2021-05-06\n",
      "Biotech\n",
      "Medtronic debuts virtual spinal cord stimulation treatment guide\n",
      "https://www.fiercebiotech.com/medtech/medtronic-debuts-virtual-spinal-cord-stimulation-treatment-guide\n",
      "2021-05-05\n",
      "MedTech\n",
      "Expelling cancer by squeezing out rogue cells\n",
      "https://www.fiercebiotech.com/research/expelling-cancer-by-squeezing-rogue-cells-out-tissue\n",
      "2021-05-05\n",
      "Research\n",
      "Phenomix, Mayo Clinic sign deal to launch obesity diagnostic\n",
      "https://www.fiercebiotech.com/medtech/phenomix-sciences-licenses-mayo-clinic-tech-for-ai-powered-obesity-phenotype-diagnostic\n",
      "2021-05-05\n",
      "MedTech\n",
      "Childhood cancer-focused Day One tees up $100M IPO\n",
      "https://www.fiercebiotech.com/biotech/childhood-cancer-focused-day-one-tees-up-100m-ipo\n",
      "2021-05-05\n",
      "Biotech\n",
      "AstraZeneca taps antibody miner Alchemab for prostate R&D deal\n",
      "https://www.fiercebiotech.com/medtech/astrazeneca-taps-antibody-mining-startup-alchemab-to-dig-into-prostate-cancer\n",
      "2021-05-05\n",
      "MedTech\n",
      "Adagio's COVID-19 antibody marches on to phase 2/3\n",
      "https://www.fiercebiotech.com/biotech/adagio-s-covid-19-antibody-marches-to-phase-2-3-after-early-data-shows-12-months-protection\n",
      "2021-05-05\n",
      "Biotech\n",
      "Oxford Nanopore raises $271M ahead of IPO\n",
      "https://www.fiercebiotech.com/medtech/oxford-nanopore-technologies-raises-271m-for-sequencing-tools-amid-ipo-plans\n",
      "2021-05-05\n",
      "MedTech\n",
      "ChemoCentryx's stock sinks as FDA flags issues with pivotal data\n",
      "https://www.fiercebiotech.com/biotech/chemocentryx-s-stock-sinks-as-fda-flags-issues-pivotal-data\n",
      "2021-05-05\n",
      "Biotech\n",
      "Esker Therapeutics launches with $70M for autoimmune diseases\n",
      "https://www.fiercebiotech.com/biotech/esker-therapeutics-launches-70m-and-a-focused-approach-for-autoimmune-diseases-beyond-jaks\n",
      "2021-05-05\n",
      "Biotech\n",
      "Perlmutter named CEO of biotech pursuing undruggable targets\n",
      "https://www.fiercebiotech.com/biotech/perlmutter-named-ceo-eikon-a-biotech-148m-to-apply-nobel-winning-tech-to-undruggable\n",
      "2021-05-05\n",
      "Biotech\n",
      "Jaguar Gene Therapy snags a CMO after banking $139M\n",
      "https://www.fiercebiotech.com/biotech/jaguar-snags-a-cmo-after-banking-139m-to-propel-its-preclinical-gene-therapies\n",
      "2021-05-04\n",
      "Biotech\n",
      "NIH unveils wireless device for long-term brain pattern tracking\n",
      "https://www.fiercebiotech.com/medtech/nih-backed-device-first-to-offer-long-term-wireless-monitoring-parkinson-s-patients-brain\n",
      "2021-05-04\n",
      "MedTech\n",
      "Beckman Coulter targets midsized labs with automated hardware\n",
      "https://www.fiercebiotech.com/medtech/beckman-coulter-targets-mid-sized-diagnostic-labs-automated-sample-prep-hardware-launch\n",
      "2021-05-04\n",
      "MedTech\n",
      "MoonLake debuts with Cosentyx challenger from Merck KGaA\n",
      "https://www.fiercebiotech.com/biotech/moonlake-debuts-cosentyx-challenger-from-merck-kgaa\n",
      "2021-05-04\n",
      "Biotech\n",
      "MindMaze’s 4 new deals spread neurotherapeutics around the globe\n",
      "https://www.fiercebiotech.com/medtech/mindmaze-inks-deals-to-bring-game-based-brain-repair-software-to-europe-south-america\n",
      "2021-05-04\n",
      "MedTech\n",
      "Pfizer stops BCMA trial due to adverse events, reports DMD delay\n",
      "https://www.fiercebiotech.com/biotech/pfizer-stops-bcma-trial-due-to-adverse-events-reports-dmd-delay\n",
      "2021-05-04\n",
      "Biotech\n",
      "Lilly takes variant-busting COVID-19 antibody into the clinic\n",
      "https://www.fiercebiotech.com/biotech/lilly-takes-variant-busting-covid-19-antibody-into-clinic\n",
      "2021-05-04\n",
      "Biotech\n",
      "Novartis loses 2nd oncology R&D exec as Hammerman exits\n",
      "https://www.fiercebiotech.com/biotech/novartis-loses-second-oncology-r-d-exec-as-peter-hammerman-leaves-through-door-left-open-by\n",
      "2021-05-04\n",
      "Biotech\n",
      "Icon: What a difference a year makes as sales jump\n",
      "https://www.fiercebiotech.com/cro/icon-what-a-difference-a-year-makes-as-sales-jump-pra-health-integration-begins\n",
      "2021-05-04\n",
      "CRO\n",
      "New 'lung-on-a-chip' models advance COVID-19 drug discovery\n",
      "https://www.fiercebiotech.com/research/how-new-lung-a-chip-models-from-harvard-teams-are-advancing-covid-19-drug-discovery\n",
      "2021-05-03\n",
      "Research\n",
      "Sarepta trial unearths new side effects for DMD candidate\n",
      "https://www.fiercebiotech.com/biotech/sarepta-s-new-dmd-therapy-could-be-more-effective-but-new-adverse-events-may-raise-eyebrows\n",
      "2021-05-03\n",
      "Biotech\n",
      "Apple Watch could gain glucose tracking with newly divulged deal\n",
      "https://www.fiercebiotech.com/medtech/apple-watch-could-gain-glucose-tracking-rockley-photonics-deal-report\n",
      "2021-05-03\n",
      "MedTech\n",
      "GN introduces 10 new smartphone-connected hearing aids\n",
      "https://www.fiercebiotech.com/medtech/gn-hearing-revamps-interton-portfolio-10-new-smartphone-connected-hearing-aids\n",
      "2021-05-03\n",
      "MedTech\n",
      "Labcorp to pick up Myriad's rheumatoid arthritis diagnostic\n",
      "https://www.fiercebiotech.com/medtech/labcorp-to-pick-up-myriad-s-vectra-rheumatoid-arthritis-diagnostic-blood-test\n",
      "2021-05-03\n",
      "MedTech\n",
      "Affinia prepares for clinic with $110M financing\n",
      "https://www.fiercebiotech.com/biotech/gene-therapy-biotech-affinia-prepares-for-clinic-110m-financing\n",
      "2021-05-03\n",
      "Biotech\n",
      "FDA clears Motus GI’s cleansing system for gastroscopies\n",
      "https://www.fiercebiotech.com/medtech/motus-gi-gets-fda-nod-to-expand-colonoscopy-cleansing-system-into-upper-gi-endoscopies\n",
      "2021-05-03\n",
      "MedTech\n",
      "Roivant catches the SPAC wave to Wall Street in $611M deal\n",
      "https://www.fiercebiotech.com/biotech/roivant-catches-spac-wave-to-wall-street-611m-deal\n",
      "2021-05-03\n",
      "Biotech\n",
      "Avrobio plans Fabrazyme trial after FDA changes path to market\n",
      "https://www.fiercebiotech.com/biotech/avrobio-plans-head-to-head-fabrazyme-trial-after-fda-changes-path-to-market\n",
      "2021-05-03\n",
      "Biotech\n",
      "Relay poaches AstraZeneca, bluebird bio R&D execs\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-s-cancer-r-d-exec-charles-ferte-joins-relay-to-run-its-lead-asset-as-another\n",
      "2021-05-03\n",
      "Biotech\n",
      "Experts urge caution, as schools rush to buy COVID air purifiers\n",
      "https://www.fiercebiotech.com/medtech/as-schools-spend-millions-air-purifiers-experts-warn-overblown-claims-and-harm-to-children\n",
      "2021-05-03\n",
      "MedTech\n",
      "Aceragen bags Enzyvant drug and $35M, plots fast path to market\n",
      "https://www.fiercebiotech.com/biotech/aceragen-bags-enzyvant-drug-and-35m-plots-fast-path-to-market\n",
      "2021-05-03\n",
      "Biotech\n",
      "KalVista bulks up executive team with CMO addition\n",
      "https://www.fiercebiotech.com/biotech/kalvista-bulks-up-executive-team-cmo-addition-as-angiodema-franchise-grinds-to\n",
      "2021-05-03\n",
      "Biotech\n",
      "Astellas quietly cuts $450M-plus Cytokinetics R&D pact\n",
      "https://www.fiercebiotech.com/biotech/astellas-quietly-cuts-cytokinetics-r-d-pact-as-450m-plus-biobucks-goes-up-smoke\n",
      "2021-05-03\n",
      "Biotech\n",
      "Palantir snags IBM Watson Health vet to be first CMO\n",
      "https://www.fiercebiotech.com/medtech/palantir-appoints-ibm-watson-health-vet-william-kassler-to-be-analytics-firm-s-first-cmo\n",
      "2021-05-03\n",
      "MedTech\n",
      "Q Bio debuts whole-body imaging platform, with Kaiser backing\n",
      "https://www.fiercebiotech.com/medtech/q-bio-unveils-digital-twin-whole-body-imaging-platform-kaiser-permanente-backing\n",
      "2021-04-30\n",
      "MedTech\n",
      "FDA OKs tablet-linked magnetic marker for breast cancer surgery\n",
      "https://www.fiercebiotech.com/medtech/molli-surgical-wins-fda-clearance-for-tablet-connected-magnetic-marker-for-breast-cancer\n",
      "2021-04-30\n",
      "MedTech\n",
      "Olympus debuts first single-use bronchoscopes after Veran buy\n",
      "https://www.fiercebiotech.com/medtech/olympus-rolls-out-first-single-use-bronchoscopes-following-veran-acquisition\n",
      "2021-04-30\n",
      "MedTech\n",
      "Vaccitech prices $110M IPO with support from original investor\n",
      "https://www.fiercebiotech.com/biotech/original-vaccitech-investor-sees-beyond-covid-shot-as-110m-ipo-priced\n",
      "2021-04-30\n",
      "Biotech\n",
      "Werewolf Therapeutics howls onto the Nasdaq with $120M IPO\n",
      "https://www.fiercebiotech.com/biotech/werewolf-therapeutics-howls-onto-nasdaq-120m-ipo\n",
      "2021-04-30\n",
      "Biotech\n",
      "Ceribell lands $53M series C for portable, rapid-response EEG\n",
      "https://www.fiercebiotech.com/medtech/ceribell-lands-53m-series-c-round-for-portable-eeg-diagnoses-nonconvulsive-seizures-minutes\n",
      "2021-04-30\n",
      "MedTech\n",
      "Lilly, Novartis R&D vets forge cancer biotech—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-lilly-vet-belinker-and-novartis-engelman-unite-to-forge-new-cancer-biotech\n",
      "2021-04-30\n",
      "Biotech\n",
      "Cara's stock tanks as atopic dermatitis phase 2 misses endpoint\n",
      "https://www.fiercebiotech.com/biotech/cara-s-stock-tanks-as-atopic-dermatitis-phase-2-misses-endpoint\n",
      "2021-04-30\n",
      "Biotech\n",
      "CRISPR screen points to spinal repair pathway in zebrafish\n",
      "https://www.fiercebiotech.com/research/crispr-screen-points-to-spinal-repair-pathway-zebrafish\n",
      "2021-04-30\n",
      "Research\n",
      "Novavax handed an extra $147M from legacy Warp Speed program\n",
      "https://www.fiercebiotech.com/biotech/novavax-handed-extra-147m-from-legacy-warp-speed-program-as-spotlight-shines-brighter\n",
      "2021-04-30\n",
      "Biotech\n",
      "AstraZeneca drops BCMA drug after seeing early clinical data\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-drops-bcma-drug-after-seeing-early-clinical-data\n",
      "2021-04-30\n",
      "Biotech\n",
      "FDA clears augmented smartglasses for guiding knee replacements\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-augmented-reality-smartglasses-for-guiding-knee-replacement-surgeries\n",
      "2021-04-29\n",
      "MedTech\n",
      "CVS Health launches $100M digital health-focused venture fund\n",
      "https://www.fiercebiotech.com/medtech/cvs-health-launches-100m-venture-fund-to-provide-investment-expertise-to-digital-health\n",
      "2021-04-29\n",
      "MedTech\n",
      "Illumina sues European Commission to stop review of Grail deal\n",
      "https://www.fiercebiotech.com/medtech/illumina-sues-european-commission-to-stop-investigation-8b-grail-acquisition\n",
      "2021-04-29\n",
      "MedTech\n",
      "Attacking solid tumors with CAR-Ts that target multiple antigens\n",
      "https://www.fiercebiotech.com/research/combined-recognition-solution-for-car-t-therapy-against-glioblastoma-other-solid-tumors\n",
      "2021-04-29\n",
      "Research\n",
      "Brii Biosciences' COVID-19 antibody combo cleared for phase 3\n",
      "https://www.fiercebiotech.com/biotech/brii-s-covid-19-antibody-combo-cleared-for-phase-3-ambulatory-care-patients\n",
      "2021-04-29\n",
      "Biotech\n",
      "After posting $4.2B in Q1 revenue, LabCorp ups its 2021 outlook\n",
      "https://www.fiercebiotech.com/medtech/labcorp-still-riding-covid-19-testing-wave-exceeds-its-own-expectations-4-2b-q1-revenue\n",
      "2021-04-29\n",
      "MedTech\n",
      "Flagship's Repertoire allies with Yale on multiple sclerosis\n",
      "https://www.fiercebiotech.com/biotech/flagship-s-repertoire-allies-yale-to-identify-drivers-multiple-sclerosis\n",
      "2021-04-29\n",
      "Biotech\n",
      "Adcendo raises €51M series A round to pursue 'ideal' ADC target\n",
      "https://www.fiercebiotech.com/biotech/adcendo-raises-eu51m-series-a-round-to-pursue-ideal-adc-target\n",
      "2021-04-29\n",
      "Biotech\n",
      "Adverum shares halved after trial patient goes blind in one eye\n",
      "https://www.fiercebiotech.com/biotech/adverum-shares-halved-after-trial-patient-goes-blind-one-eye-after-experimental-gene\n",
      "2021-04-29\n",
      "Biotech\n",
      "In a first, FDA issues a serious rebuke for trial data delay\n",
      "https://www.fiercebiotech.com/cro/a-first-fda-issues-a-serious-rebuke-for-trial-data-delay-as-it-looks-to-get-tough\n",
      "2021-04-29\n",
      "CRO\n",
      "Arrowhead, Takeda's RNAi med cuts scarring in rare liver disease\n",
      "https://www.fiercebiotech.com/biotech/arrowhead-takeda-s-rna-silencing-med-cuts-scarring-rare-liver-disease\n",
      "2021-04-28\n",
      "Biotech\n",
      "Boundless Bio corrals $105M financing to move targets to clinic\n",
      "https://www.fiercebiotech.com/biotech/boundless-bio-corrals-105m-financing-to-prep-aggressive-cancer-targets-for-clinic\n",
      "2021-04-28\n",
      "Biotech\n",
      "Roche broadens blood test reach with sweeping new use claims\n",
      "https://www.fiercebiotech.com/medtech/roche-broadens-blood-test-reach-sweeping-claims-type-2-diabetes-long-term-heart-attack-risk\n",
      "2021-04-28\n",
      "MedTech\n",
      "Boosting Biogen's Alzheimer's contender by unclogging the brain\n",
      "https://www.fiercebiotech.com/research/could-unclogging-brain-s-drainage-system-improve-efficacy-biogen-s-aducanumab-alzheimer-s\n",
      "2021-04-28\n",
      "Research\n",
      "Illumina pledges $60M to new global outbreak-tracking network\n",
      "https://www.fiercebiotech.com/medtech/illumina-pledges-60m-genomic-sequencing-expertise-to-launch-global-network-to-track\n",
      "2021-04-28\n",
      "MedTech\n",
      "Exscientia scores $225M with access to another $300M\n",
      "https://www.fiercebiotech.com/biotech/softbank-leads-225m-round-for-exscientia-offer-300m-more\n",
      "2021-04-28\n",
      "Biotech\n",
      "Amgen's up-and-coming KRAS inhibitor gets a name: Lumakras\n",
      "https://www.fiercebiotech.com/biotech/amgen-s-up-and-coming-kras-inhibitor-gets-a-name-lumakras\n",
      "2021-04-28\n",
      "Biotech\n",
      "Virtual PT provider Kaia Health nets $75M for at-home workouts\n",
      "https://www.fiercebiotech.com/medtech/virtual-physical-therapy-provider-kaia-health-nets-75m-for-at-home-workouts\n",
      "2021-04-28\n",
      "MedTech\n",
      "Caresyntax follows year of 250% growth with $100M series C\n",
      "https://www.fiercebiotech.com/medtech/caresyntax-reaps-rewards-its-250-annual-growth-100m-series-c-for-digital-surgery-platform\n",
      "2021-04-28\n",
      "MedTech\n",
      "Versiti rolls out blood tests for COVID-19 vaccine-related clots\n",
      "https://www.fiercebiotech.com/medtech/versiti-rolls-out-antibody-tests-to-screen-for-covid-vaccine-related-blood-clots\n",
      "2021-04-28\n",
      "MedTech\n",
      "Pfizer buys Amplyx to grow infectious disease pipeline\n",
      "https://www.fiercebiotech.com/biotech/pfizer-buys-amplyx-to-grow-infectious-disease-pipeline\n",
      "2021-04-28\n",
      "Biotech\n",
      "GlaxoSmithKline culls early-stage Immunocore med, DMD asset\n",
      "https://www.fiercebiotech.com/biotech/glaxosmithkline-culls-early-stage-immunocore-med-as-well-as-dmd-asset-q1-clearout\n",
      "2021-04-28\n",
      "Biotech\n",
      "Sanofi plans 2021 restart for pediatric hemophilia trial\n",
      "https://www.fiercebiotech.com/biotech/sanofi-plans-2021-restart-for-pediatric-hemophilia-trial-hit-by-fallout-from-thrombotic\n",
      "2021-04-28\n",
      "Biotech\n",
      "PPD sees major sales jump for its last financial update\n",
      "https://www.fiercebiotech.com/cro/ppd-sees-major-sales-jump-for-its-last-financial-update-as-thermo-fisher-begins-buyout\n",
      "2021-04-28\n",
      "CRO\n",
      "Trillium unveils CD47 clinical research priorities\n",
      "https://www.fiercebiotech.com/biotech/trillium-unveils-expanded-cd47-clinical-program-as-investors-await-solid-tumor-data\n",
      "2021-04-28\n",
      "Biotech\n",
      "Arch Oncology scores $105M for anti-CD47 cancer med\n",
      "https://www.fiercebiotech.com/biotech/arch-oncology-scores-105m-for-anti-cd47-med-solid-tumors-multiple-myeloma\n",
      "2021-04-27\n",
      "Biotech\n",
      "NIH develops app to screen for autism using eye-tracking tech\n",
      "https://www.fiercebiotech.com/medtech/eyes-have-it-nih-prototype-app-screens-for-autism-by-tracking-toddlers-visual-movements\n",
      "2021-04-27\n",
      "MedTech\n",
      "Abbott launches AI-powered coronary OCT imaging system in Europe\n",
      "https://www.fiercebiotech.com/medtech/abbott-launches-ai-powered-coronary-oct-imaging-system-europe\n",
      "2021-04-27\n",
      "MedTech\n",
      "Sanofi to divest Pennsylvania R&D site, cut 75 employees\n",
      "https://www.fiercebiotech.com/biotech/sanofi-to-divest-pennsylvania-r-d-site-cutting-75-employees\n",
      "2021-04-27\n",
      "Biotech\n",
      "Biogen to offer early access to ALS drug starting in July\n",
      "https://www.fiercebiotech.com/biotech/biogen-to-offer-early-access-to-experimental-als-drug-starting-july\n",
      "2021-04-27\n",
      "Biotech\n",
      "Kry raises $316M to scale telehealth platform across Europe\n",
      "https://www.fiercebiotech.com/medtech/kry-raises-316m-series-d-upping-valuation-to-2b-to-scale-telehealth-platform-across-europe\n",
      "2021-04-27\n",
      "MedTech\n",
      "Lilly scraps IL-23 psoriasis program despite phase 3 success\n",
      "https://www.fiercebiotech.com/biotech/lilly-scraps-il-23-psoriasis-program-despite-phase-3-success-focuses-ibd-race-against\n",
      "2021-04-27\n",
      "Biotech\n",
      "Pyxis debuts next-gen cancer ADCs from under Pfizer's wing\n",
      "https://www.fiercebiotech.com/biotech/pyxis-debuts-next-gen-adcs-from-under-pfizer-s-wing\n",
      "2021-04-27\n",
      "Biotech\n",
      "GV hires industry veteran Lynch to coach biotech CEOs\n",
      "https://www.fiercebiotech.com/biotech/gv-hires-industry-veteran-lynch-to-coach-biotech-ceos-identify-new-investments\n",
      "2021-04-27\n",
      "Biotech\n",
      "Astellas takes $540M impairment charge over Audentes' trial hold\n",
      "https://www.fiercebiotech.com/biotech/astellas-takes-540m-impairment-charge-over-audentes-gene-therapy-trial-hold\n",
      "2021-04-27\n",
      "Biotech\n",
      "Ex-Lilly R&D lead launches cancer biotech with Novartis alum\n",
      "https://www.fiercebiotech.com/biotech/ex-lilly-r-d-lead-bilenker-launches-new-cancer-biotech-novartis-oncology-r-d-lead-engelman\n",
      "2021-04-27\n",
      "Biotech\n",
      "How COVID outsmarts the gut's immune response\n",
      "https://www.fiercebiotech.com/research/insights-into-how-covid-outsmarts-gut-s-immune-response-could-point-to-new-treatments\n",
      "2021-04-27\n",
      "Research\n",
      "The top 15 biopharma licensing deals of 2020\n",
      "https://www.fiercebiotech.com/special-report/top-15-biopharma-licensing-deals-2020\n",
      "2021-04-27\n",
      "Special Reports\n",
      "Verily, LivaNova begin study of nerve stimulation for depression\n",
      "https://www.fiercebiotech.com/medtech/verily-livanova-kick-off-study-to-monitor-effects-nerve-stimulation-for-treatment-resistant\n",
      "2021-04-26\n",
      "MedTech\n",
      "COVID test maker Innova picks up Los Angeles-based N95 outfit\n",
      "https://www.fiercebiotech.com/medtech/covid-test-maker-innova-picks-up-los-angeles-based-n95-outfit\n",
      "2021-04-26\n",
      "MedTech\n",
      "Philips ups yearly sales projections after 9% growth in Q1\n",
      "https://www.fiercebiotech.com/medtech/philips-ups-financial-projections-for-year-despite-double-digit-drop-demand-for-connected\n",
      "2021-04-26\n",
      "MedTech\n",
      "Medtronic taps VR 'flight simulators' for brain surgery\n",
      "https://www.fiercebiotech.com/medtech/medtronic-taps-virtual-reality-flight-simulators-for-brain-surgery-built-from-3d-patient\n",
      "2021-04-26\n",
      "MedTech\n",
      "FDA says Voyager can trek on Huntington's gene therapy trial\n",
      "https://www.fiercebiotech.com/biotech/fda-says-voyager-can-trek-as-it-removes-trial-hold-for-huntington-s-gene-therapy-test\n",
      "2021-04-26\n",
      "Biotech\n",
      "Vertex advances non-opioid painkiller to phase 2\n",
      "https://www.fiercebiotech.com/biotech/vertex-picks-a-horse-race-for-opioid-painkiller-replacement\n",
      "2021-04-26\n",
      "Biotech\n",
      "Missouri system's virtual care supports 'hospital without beds'\n",
      "https://www.fiercebiotech.com/medtech/virtual-care-spreads-missouri-health-system-home-to-hospital-without-beds\n",
      "2021-04-26\n",
      "MedTech\n",
      "DJO adds orthopedic device maker MedShape to M&A collection\n",
      "https://www.fiercebiotech.com/medtech/djo-global-extends-string-orthopedic-acquisitions-purchase-device-maker-medshape\n",
      "2021-04-26\n",
      "MedTech\n",
      "I-Mab's IL-6 drug hits goal in ulcerative colitis phase 2\n",
      "https://www.fiercebiotech.com/biotech/i-mab-s-il-6-drug-hits-goal-ulcerative-colitis-phase-2\n",
      "2021-04-26\n",
      "Biotech\n",
      "FDA lifts clinical hold on uniQure's gene therapy\n",
      "https://www.fiercebiotech.com/biotech/fda-lifts-clinical-hold-uniqure-s-gene-therapy-amid-cancer-concerns-shares-jump\n",
      "2021-04-26\n",
      "Biotech\n",
      "AstraZeneca and Sanofi’s antibody prevents RSV in phase 3\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-and-sanofi-s-antibody-prevents-rsv-phase-3-accelerating-path-to-market\n",
      "2021-04-26\n",
      "Biotech\n",
      "Johnson & Johnson's D.C. incubator is open for business\n",
      "https://www.fiercebiotech.com/biotech/johnson-johnson-s-d-c-incubator-open-for-business\n",
      "2021-04-26\n",
      "Biotech\n",
      "FDA approves brain-controlled device for stroke rehabilitation\n",
      "https://www.fiercebiotech.com/medtech/fda-approves-wireless-brace-uses-brainwaves-to-improve-hand-function-stroke-patients\n",
      "2021-04-23\n",
      "MedTech\n",
      "NIH awards $21M to 15-minute PCR testing kit for COVID-19\n",
      "https://www.fiercebiotech.com/medtech/nih-s-covid-19-diagnostics-contest-doles-out-21m-for-minute-molecular-s-15-minute-pcr-test\n",
      "2021-04-23\n",
      "MedTech\n",
      "Illumina’s oncology assay to move into blood-based cancers\n",
      "https://www.fiercebiotech.com/medtech/illumina-to-move-its-oncology-assay-into-blood-based-cancers-companion-diagnostic\n",
      "2021-04-23\n",
      "MedTech\n",
      "Roche nets companion test OK in MMR-deficient endometrial cancer\n",
      "https://www.fiercebiotech.com/medtech/roche-nets-companion-diagnostic-approval-for-gsk-s-jemperli-mmr-deficient-endometrial\n",
      "2021-04-23\n",
      "MedTech\n",
      "Sanofi eyes broad portfolio for rilzabrutinib in immunology\n",
      "https://www.fiercebiotech.com/biotech/sanofi-starts-off-pipeline-a-product-rilzabrutinib-rare-skin-disease-but-eyes-bigger\n",
      "2021-04-23\n",
      "Biotech\n",
      "Bristol Myers' deucravacitinib beats out exiled Otezla\n",
      "https://www.fiercebiotech.com/biotech/bristol-myers-deucravacitinib-beats-out-exiled-otezla-eyes-2022-launch\n",
      "2021-04-23\n",
      "Biotech\n",
      "Genentech cancer exec lands at Replimune as CCO—Chutes & Ladders\n",
      "https://www.fiercebiotech.com/biotech/chutes-ladders-replimune-prepping-for-market-taps-genentech-oncology-vet-as-cmo\n",
      "2021-04-23\n",
      "Biotech\n",
      "Current Health nabs $43M series B for telehealth platform\n",
      "https://www.fiercebiotech.com/medtech/current-health-draws-43-million-series-b-funding-to-grow-telehealth-platform\n",
      "2021-04-23\n",
      "MedTech\n",
      "Inovio's COVID vaccine funding cut as U.S. vaccinations pick up\n",
      "https://www.fiercebiotech.com/biotech/inovio-s-covid-19-vaccine-funding-axed-as-us-says-thanks-but-no-thanks\n",
      "2021-04-23\n",
      "Biotech\n",
      "Oxford malaria vaccine hits WHO threshold for efficacy\n",
      "https://www.fiercebiotech.com/biotech/oxford-malaria-vaccine-hits-who-threshold-for-efficacy-plots-larger-trials\n",
      "2021-04-23\n",
      "Biotech\n",
      "Valneva kick-starts phase 3 in AZ COVID vax head-to-head\n",
      "https://www.fiercebiotech.com/biotech/valneva-kickstarts-dynavax-partnered-phase-3-pitting-its-covid-vaccine-against-astrazeneca\n",
      "2021-04-23\n",
      "Biotech\n",
      "Orthofix rolls out porous, 3D-printed titanium spine implants\n",
      "https://www.fiercebiotech.com/medtech/orthofix-rolls-out-porous-3d-printed-titanium-implants-for-neck-and-spine\n",
      "2021-04-23\n",
      "MedTech\n",
      "A COVID BOGO: Some NBA tickets now include an at-home rapid test\n",
      "https://www.fiercebiotech.com/medtech/lucira-health-sets-a-pick-covid-19-free-at-home-rapid-tests-for-some-nba-ticketholders\n",
      "2021-04-22\n",
      "MedTech\n",
      "Blocking an 'undruggable' cancer target with the help of a shrub\n",
      "https://www.fiercebiotech.com/research/how-a-novel-drug-from-a-medicinal-shrub-blocks-a-previously-undruggable-breast-cancer\n",
      "2021-04-22\n",
      "Research\n",
      "Prevencio rolls out AI-powered blood tests for heart disease\n",
      "https://www.fiercebiotech.com/medtech/prevencio-links-atlas-genomics-for-commercial-launch-ai-powered-blood-tests-for-heart\n",
      "2021-04-22\n",
      "MedTech\n",
      "Endeavour Vision launches second medtech-focused fund with $375M\n",
      "https://www.fiercebiotech.com/medtech/endeavour-vision-launches-second-medtech-focused-fund-375m\n",
      "2021-04-22\n",
      "MedTech\n",
      "Startup tackles Alzheimer's via neurons' cleaning system\n",
      "https://www.fiercebiotech.com/research/treating-alzheimer-s-disease-by-invigorating-cell-s-specialized-garbage-cleaning-system\n",
      "2021-04-22\n",
      "Research\n",
      "Vertex taps Obsidian in controllable genetic medicines deal\n",
      "https://www.fiercebiotech.com/biotech/vertex-taps-obsidian-controllable-genetic-medicines-deal\n",
      "2021-04-22\n",
      "Biotech\n",
      "Takeda, Anne Wojcicki back Seqster’s healthcare data platform\n",
      "https://www.fiercebiotech.com/medtech/seqster-attracts-funding-from-takeda-anne-wojcicki-for-silo-smashing-healthcare-data\n",
      "2021-04-22\n",
      "MedTech\n",
      "Ovid plans to shop with Takeda bucks after shedding lead asset\n",
      "https://www.fiercebiotech.com/biotech/ovid-plans-to-shop-around-takeda-bucks-after-shedding-angelman-asset\n",
      "2021-04-22\n",
      "Biotech\n",
      "Monopteros emerges with $20M, mission to reprogram T cells\n",
      "https://www.fiercebiotech.com/biotech/medicxi-unveils-monopteros-20m-mission-to-reprogram-t-cells\n",
      "2021-04-22\n",
      "Biotech\n",
      "Anavo Therapeutics launches with £20M seed and phosphatase quest\n",
      "https://www.fiercebiotech.com/biotech/anavo-therapeutics-wants-big-pharma-to-dust-off-their-shelves-search-phosphatase-drugs\n",
      "2021-04-22\n",
      "Biotech\n",
      "Centessa Pharma, wasting no time, tees up $100M IPO\n",
      "https://www.fiercebiotech.com/biotech/centessa-pharma-wasting-no-time-tees-up-100-m-ipo\n",
      "2021-04-21\n",
      "Biotech\n",
      "AZ's cholesterol combo shows promise in heart disease\n",
      "https://www.fiercebiotech.com/research/combination-astrazeneca-s-booster-good-cholesterol-and-pcsk9-inhibition-shows-promise-for\n",
      "2021-04-21\n",
      "Research\n",
      "Oxford aims to translate COVID rapid tests for other viruses\n",
      "https://www.fiercebiotech.com/medtech/oxford-prenetics-partner-to-scale-covid-19-rapid-testing-tech-for-other-infectious-diseases\n",
      "2021-04-21\n",
      "MedTech\n",
      "Genentech oncology exec jumps to oncolytics biotech Replimune\n",
      "https://www.fiercebiotech.com/biotech/genentech-oncology-exec-jumps-to-replimune-to-get-cancer-killing-meds-to-market\n",
      "2021-04-21\n",
      "Biotech\n",
      "FDA unlocks pooled screening for authorized COVID-19 tests\n",
      "https://www.fiercebiotech.com/medtech/fda-unlocks-pooled-covid-19-screening-for-previously-authorized-tests\n",
      "2021-04-21\n",
      "MedTech\n",
      "FDA OKs Medtronic's clot-resistant implant for brain aneurysms\n",
      "https://www.fiercebiotech.com/medtech/fda-approves-medtronic-s-blood-clot-resistant-implant-for-stopping-brain-aneurysms\n",
      "2021-04-21\n",
      "MedTech\n",
      "Tesseract raises $80M to pursue its eye-based diagnostic system\n",
      "https://www.fiercebiotech.com/medtech/tesseract-raises-80m-to-pursue-a-new-dimension-eye-based-diagnostics\n",
      "2021-04-21\n",
      "MedTech\n",
      "FDA clears J&J Vision system to improve cataract surgery\n",
      "https://www.fiercebiotech.com/medtech/j-j-vision-sees-fda-clearance-for-veritas-system-providing-increased-control-cataract\n",
      "2021-04-21\n",
      "MedTech\n",
      "Humanigen opens up CMO role and drops in AstraZeneca vet\n",
      "https://www.fiercebiotech.com/biotech/covid-19-treatment-developer-humanigen-opens-up-cmo-role-and-drops-astrazeneca-vet\n",
      "2021-04-21\n",
      "Biotech\n",
      "Versant nets $950M to build its next class of biotech startups\n",
      "https://www.fiercebiotech.com/biotech/versant-nets-950m-to-build-its-next-class-biotech-startups\n",
      "2021-04-21\n",
      "Biotech\n",
      "Neurotech startup Imeka builds AI to diagnose, treat Alzheimer's\n",
      "https://www.fiercebiotech.com/medtech/ai-key-to-unlocking-mysteries-alzheimer-s-neuroimaging-startup-imeka-betting-it\n",
      "2021-04-21\n",
      "MedTech\n",
      "AstraZeneca cancer R&D exec Ferté hits the exit\n",
      "https://www.fiercebiotech.com/biotech/astrazeneca-cancer-r-d-exec-charles-ferte-hits-exit\n",
      "2021-04-21\n",
      "Biotech\n",
      "Roche culls 2 COVID drug hopefuls amid Q1 clear-out\n",
      "https://www.fiercebiotech.com/biotech/roche-culls-two-covid-drug-hopefuls-amid-q1-clear-out\n",
      "2021-04-21\n",
      "Biotech\n",
      "Zai Lab aims for $750M to bankroll licensing deals\n",
      "https://www.fiercebiotech.com/biotech/gateway-to-china-zai-lab-aims-for-750m-to-bankroll-licensing-deals-clinical-trials\n",
      "2021-04-20\n",
      "Biotech\n",
      "Janssen, PhysIQ team up to make clinical data more useful\n",
      "https://www.fiercebiotech.com/medtech/janssen-licenses-physiq-s-ai-analytics-platform-to-make-data-collected-by-wearable-sensors\n",
      "2021-04-20\n",
      "MedTech\n",
      "Abbott, J&J post rebounds in surgical sales\n",
      "https://www.fiercebiotech.com/medtech/abbott-j-j-post-rebounds-surgical-sales-while-covid-testing-remains-a-cash-cow\n",
      "2021-04-20\n",
      "MedTech\n",
      "The dogtor is in: Dogs can sniff out COVID with 96% accuracy\n",
      "https://www.fiercebiotech.com/medtech/dogtor-upenn-study-finds-dogs-can-sniff-out-covid-19-96-accuracy\n",
      "2021-04-15\n",
      "MedTech\n",
      "Omada Health expands reach with computer vision, telehealth tech\n",
      "https://www.fiercebiotech.com/medtech/omada-health-adds-ai-powered-physical-therapy-and-a-virtual-clinic-for-diabetes\n",
      "2021-04-15\n",
      "MedTech\n",
      "Scientists make durable but controversial human-monkey embryos\n",
      "https://www.fiercebiotech.com/research/a-controversial-breakthrough-scientists-generate-long-lasting-human-monkey-chimeric\n",
      "2021-04-15\n",
      "Research\n",
      "GSK vaccine R&D chief heads for microbiome startup Viome\n",
      "https://www.fiercebiotech.com/biotech/gsk-vaccine-chief-heads-for-door-to-scan-microbiome-for-chronic-disease-clues-at-viome\n",
      "2021-04-15\n",
      "Biotech\n",
      "Robotics developer Vicarious Surgical inks $1.1B SPAC deal\n",
      "https://www.fiercebiotech.com/medtech/robotics-developer-vicarious-surgical-nets-bd-backing-1-1b-spac-deal\n",
      "2021-04-15\n",
      "MedTech\n",
      "GSK stops Keytruda combo trials after ICOS drug falls short\n",
      "https://www.fiercebiotech.com/biotech/gsk-stops-keytruda-combo-trials-after-icos-drug-falls-short\n",
      "2021-04-15\n",
      "Biotech\n",
      "Merck cans one COVID-19 drug, scraps a clinical trial of another\n",
      "https://www.fiercebiotech.com/biotech/merck-cans-one-covid-19-drug-scraps-a-clinical-trial-another\n",
      "2021-04-15\n",
      "Biotech\n",
      "All-new AltruBio relaunches with $63M Series A\n",
      "https://www.fiercebiotech.com/biotech/altrubio-relaunches-new-board-ceo\n",
      "2021-04-15\n",
      "Biotech\n",
      "Qlaris, with $25M round, pushes new glaucoma drug into clinic\n",
      "https://www.fiercebiotech.com/biotech/qlaris-armed-25m-round-pushes-new-glaucoma-drug-into-clinic\n",
      "2021-04-15\n",
      "Biotech\n",
      "Tectonic banks $80M to shift GPCR discovery toward biologics\n",
      "https://www.fiercebiotech.com/biotech/tectonic-therapeutic-banks-80m-to-shift-gpcr-drug-discovery-toward-biologics\n",
      "2021-04-15\n",
      "Biotech\n",
      "UPDATED: Thermo Fisher reels in PPD for $17.4B\n",
      "https://www.fiercebiotech.com/cro/thermofisher-to-buy-ppd-for-15b-wsj-report\n",
      "2021-04-15\n",
      "CRO\n",
      "How GeNeuro's experimental MS drug might help treat COVID-19\n",
      "https://www.fiercebiotech.com/research/how-experimental-ms-drug-might-help-treat-covid-19\n",
      "2021-04-15\n",
      "Research\n",
      "Benchling makes the A-team with $200M Series E\n",
      "https://www.fiercebiotech.com/medtech/benchling-logs-largest-funding-round-yet-200m-to-expand-cloud-based-r-d-platform\n",
      "2021-04-14\n",
      "MedTech\n",
      "Medtronic launches 7-day diabetes infusion tubing set in Europe\n",
      "https://www.fiercebiotech.com/medtech/medtronic-launches-seven-day-diabetes-infusion-tubing-set-europe\n",
      "2021-04-14\n",
      "MedTech\n",
      "Caption Health taps new CEO to expand its AI ultrasound tech\n",
      "https://www.fiercebiotech.com/medtech/caption-health-taps-new-ceo-as-it-eyes-expansion-its-ai-ultrasound-tech\n",
      "2021-04-14\n",
      "MedTech\n",
      "Tango finds a quick step to Wall Street via $353M SPAC deal\n",
      "https://www.fiercebiotech.com/biotech/tango-finds-a-quick-step-to-wall-street-via-353m-spac-deal\n",
      "2021-04-14\n",
      "Biotech\n",
      "AstraZeneca, Sanguina to develop app for bloodless blood testing\n",
      "https://www.fiercebiotech.com/medtech/astrazeneca-sanguina-developing-app-to-screen-for-anemia-without-drawing-blood\n",
      "2021-04-14\n",
      "MedTech\n",
      "AI could uncover a new COVID-19 drug target: Humans themselves\n",
      "https://www.fiercebiotech.com/medtech/new-approaches-ai-and-cell-biology-may-have-uncovered-a-novel-drug-target-for-covid-19\n",
      "2021-04-14\n",
      "MedTech\n",
      "Bluebird shows oncolytic virus boosts CAR-T in solid tumors\n",
      "https://www.fiercebiotech.com/biotech/bluebird-psioxus-show-oncolytic-virus-boosts-car-t-solid-tumors\n",
      "2021-04-14\n",
      "Biotech\n",
      "Bhargava leaves Gilead to take up post at biotech investor MPM\n",
      "https://www.fiercebiotech.com/biotech/bhargava-leaves-gilead-to-take-up-post-at-biotech-investor-mpm\n",
      "2021-04-14\n",
      "Biotech\n",
      "Senti Biosciences in $645M Spark pact to drive gene circuits\n",
      "https://www.fiercebiotech.com/biotech/senti-biosciences-645m-spark-pact-to-drive-gene-circuits-into-fast-lane\n",
      "2021-04-14\n",
      "Biotech\n",
      "BioAge picks up muscle-aging program from Amgen\n",
      "https://www.fiercebiotech.com/biotech/bioage-picks-up-muscle-aging-program-from-amgen-bringing-pipeline-count-to-3\n",
      "2021-04-14\n",
      "Biotech\n",
      "Moderna readies deeper line up of mRNA vaccine candidates\n",
      "https://www.fiercebiotech.com/biotech/moderna\n",
      "2021-04-14\n",
      "Biotech\n",
      "CeQur revs up to launch its insulin patch with $115M in funding\n",
      "https://www.fiercebiotech.com/medtech/cequr-nets-115m-for-2021-launch-its-wearable-insulin-delivery-patch\n",
      "2021-04-13\n",
      "MedTech\n",
      "Roche, Biocorp launch digital insulin pen add-on in France\n",
      "https://www.fiercebiotech.com/medtech/roche-biocorp-begin-french-rollout-device-sends-insulin-pen-data-to-a-smartphone-app\n",
      "2021-04-13\n",
      "MedTech\n",
      "Autoimmune biotech Kyverna snags longtime Amgen exec as CMO\n",
      "https://www.fiercebiotech.com/biotech/autoimmune-biotech-kyverna-snags-longtime-amgen-exec-as-cmo\n",
      "2021-04-13\n",
      "Biotech\n",
      "Nvidia forges trio of partnerships for AI-led drug discovery\n",
      "https://www.fiercebiotech.com/medtech/nvidia-forms-ai-based-drug-discovery-partnerships-astrazeneca-schrodinger-university\n",
      "2021-04-13\n",
      "MedTech\n",
      "Twice as nice: FDA clears pair of patient monitoring devices\n",
      "https://www.fiercebiotech.com/medtech/fda-clears-wireless-patient-monitoring-devices-from-masimo-myhomedoc\n",
      "2021-04-13\n",
      "MedTech\n",
      "Gerngross' Adagio starts testing antibody in COVID-19 patients\n",
      "https://www.fiercebiotech.com/biotech/gerngross-adagio-starts-testing-antibody-covid-19-patients\n",
      "2021-04-13\n",
      "Biotech\n",
      "Flagship's Repertoire bags $189M to go after immune targets\n",
      "https://www.fiercebiotech.com/biotech/flagship-s-repertoire-bags-189m-to-go-after-immune-targets\n",
      "2021-04-13\n",
      "Biotech\n"
     ]
    }
   ],
   "source": [
    "service = Service('geckodriver.exe')\n",
    "options = webdriver.FirefoxOptions()\n",
    "# options.add_argument('-headless')\n",
    "url = 'https://www.fiercebiotech.com/'\n",
    "driver = webdriver.Firefox(service=service, options=options)\n",
    "wait = WebDriverWait(driver, 10)\n",
    "\n",
    "driver.get(url)\n",
    "sleep(5)\n",
    "\n",
    "# body = driver.page_source\n",
    "# html = HTML(html=body)\n",
    "\n",
    "see_more_link = driver.find_element(By.LINK_TEXT, 'See more articles')\n",
    "driver.execute_script('arguments[0].scrollIntoView(true);', see_more_link)\n",
    "sleep(5)\n",
    "\n",
    "for n in range(100):\n",
    "    try:\n",
    "        close_button = driver.find_element(\n",
    "            By.CSS_SELECTOR, '.close-persistent-bar').click()\n",
    "        sleep(5)\n",
    "        driver.find_element(By.LINK_TEXT, 'See more articles').click()\n",
    "    except:\n",
    "        driver.find_element(By.LINK_TEXT, 'See more articles').click()\n",
    "\n",
    "    sleep(5)\n",
    "    see_more_link = driver.find_element(By.LINK_TEXT, 'See more articles')\n",
    "    driver.execute_script('arguments[0].scrollIntoView(true);', see_more_link)\n",
    "    see_more_link.click()\n",
    "    sleep(5)\n",
    "    n = random.randint(1, 5)\n",
    "    sleep(n)\n",
    "\n",
    "\n",
    "body = driver.page_source\n",
    "html = HTML(html=body)\n",
    "articles = html.find('article.node-listing.prosumer.row')\n",
    "article_list = []\n",
    "for article in articles:\n",
    "    try:\n",
    "        title = article.find('.element-title.small', first=True).text\n",
    "        print(title)\n",
    "    except:\n",
    "        None\n",
    "    try:\n",
    "        # link = base_url + article.find('.article-title', first=True).links.pop()\n",
    "        link = url[:-1] + article.find('.element-title.small > a', first=True).links.pop()\n",
    "        print(link)\n",
    "    except:\n",
    "        None\n",
    "    try:\n",
    "        date = article.find('span.date.d-inline-block', first=True).text\n",
    "        date = datetime.strptime(date[:-2], '%b %d, %Y %H:%M').strftime('%Y-%m-%d')\n",
    "        print(date)\n",
    "    except:\n",
    "        None\n",
    "    try:\n",
    "        channel = article.find(\n",
    "            '.label.label-small > span > a', first=True).text\n",
    "        print(channel)\n",
    "    except:\n",
    "        None\n",
    "\n",
    "    data = {\n",
    "            'date': date,\n",
    "            'source': 'fiercebiotech',\n",
    "            'channel': channel,\n",
    "            'title': title,\n",
    "            'link': link\n",
    "        }\n",
    "    \n",
    "    article_list.append(data)\n",
    "\n",
    "driver.close()\n",
    "\n",
    "df = pd.DataFrame(article_list)\n",
    "# df['date'] = pd.to_datetime(df['date']).dt.strftime('%Y-%m-%d')\n",
    "df = df[['date', 'source', 'channel', 'title', 'link']]\n",
    "df.drop_duplicates(inplace=True)\n",
    "datestamp = datetime.today().strftime('%Y%m%dT%H%M')\n",
    "df.to_csv(f'Fierce_Biotech_{datestamp}.csv', index=None)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "125\n"
     ]
    }
   ],
   "source": [
    "print(len(articles))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "close_button = driver.find_element(By.CSS_SELECTOR, '.close-persistent-bar').click()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "see_more_link = driver.find_element(By.LINK_TEXT, 'See more articles').click()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "driver.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "# target = driver.find_element(By.LINK_TEXT, 'See more articles')\n",
    "# driver.execute_script('arguments[0].scrollIntoView(true);', target)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "90\n"
     ]
    }
   ],
   "source": [
    "# body = driver.page_source\n",
    "# html = HTML(html=body)\n",
    "# articles = html.find('article.node-listing.prosumer.row')\n",
    "# print(len(articles))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# target = driver.find_element(By.LINK_TEXT, 'See more articles').click()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "driver.close()"
   ]
  }
 ],
 "metadata": {
  "interpreter": {
   "hash": "131fd78981c6f566b62824dcb6d6b09348b51205bfbb44e0a6477e16ef602b65"
  },
  "kernelspec": {
   "display_name": "Python 3.9.2 ('venv': venv)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.2"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
